Document v63rRpyLY29OKQKZ1oEZdjz1R

Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 1 of 232 PAGEID #: 40765 EXHIBIT L Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 2 of 232 PAGEID #: 40766 [REDACTED - NON-CONFIDENTIAL VERSION] EXPERT REPORT IN Carla Bartlett v. E. I. du Pont de Nemours and Company, Case No. 2:13-cv-170 (S.D. Ohio) John Wolf v. E. I. du Pont de Nemours and Company, Case No. 2:14-cv-545 (S.D. W.Va.) Michael B. Siegel, MD, MPH Prepared for: Plaintiffs' Steering Committee In re: E. I. du Pont de Nemours & Co. C-8 Personal Injury Litigation, MDL 2433 Case No. 2:13-md-2433 (S.D. Ohio) Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 3 of 232 PAGEID #: 40767 1 I, Michael B. Siegel, MD, MPH, declare as follows: 2 I. Personal Background 3 1. I am a physician trained in public health, preventive medicine, and epidemiology. I earned my 4 medical degree from Yale University School of Medicine in 1990 and my Master's in public 5 health degree from the University of California at Berkeley in 1992 with a concentration in 6 epidemiology. I completed an internship in medicine in Pittsfield, Massachusetts in 1991, and a 7 two-year residency in preventive medicine at the University of California at Berkeley in 1993. I 8 served as a medical officer at the Office on Smoking and Health at the Centers for Disease 9 Control and Prevention from 1993-1995, where I completed an epidemiology post-doctoral 10 fellowship (the Epidemic Intelligence Service program). Since 1995, I have been an Assistant, 11 Associate, and now Full Professor in the Department of Community Health Sciences at the 12 Boston University School of Public Health. 13 2. I am an expert in the area of epidemiology and public health. I have conducted epidemiologic 14 research in the fields of smoking, secondhand smoke, tobacco control, alcohol, and firearms. I 15 have nearly 30 years of experience in public health and epidemiologic research. I have 107 16 publications in peer-reviewed journals relating to these topics. 17 3. I have special expertise in the area of disease causation, having studied, conducted research on, 18 and reviewed the diseases caused by smoking and secondhand smoke. I have testified as an 19 expert in six tobacco-related lawsuits. In these cases, I was recognized as an expert in the area 20 of both general and individual disease causation and I gave testimony related to both of these 21 areas. My testimony involved an evaluation of the scientific literature and research related to 22 general causation of smoking-related diseases. 23 4. I have special expertise in the evaluation of industry documents to determine what information 24 they had about the health effects of a chemical exposure at what time. I was recognized as an 25 expert in this area in several tobacco lawsuits, in which I gave testimony related to what the 26 tobacco industry knew about the health effects of smoking and when they knew it, based on a 27 review of internal documents as well as government reports and the published literature. 28 5. The opinions in this report are based on my overall evaluation of the totality of the evidence 29 regarding the issues upon which I opine. This evidence includes, but is not limited to industry 30 documents, published studies, governmental and non-governmental reports, company press 31 releases and web site pages, and my knowledge of basic principles of epidemiology, biology, 32 chemistry, toxicology, environmental science, exposure assessment, and risk analysis. I was 33 provided by plaintiff's counsel with an extensive number of documents related to the case, 34 including depositions from prior litigation. A list of these materials I reviewed and/or considered 35 is attached as Appendix A. 36 6. To ease the process of discovery, I have included citations to the key documents upon which I 37 rely, in part, for my opinions. These represent only the most important documents upon which 38 my opinions are based, but it is not an exhaustive list. My opinions are based on the totality of 39 evidence I have reviewed, which includes many more documents than those cited in this report. 1 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 4 of 232 PAGEID #: 40768 40 I have cited those documents which I believe are particularly important, with an eye towards 41 easing the process of discovery and cross-examination. 42 II. Methodology 43 1. After reviewing the provided materials for this case, I have formed the following expert 44 opinions, which I hold to a reasonable degree of medical and scientific certainty, and which are 45 based on my training and experience as a physician, epidemiologist, and public health expert 46 using the same type of analyses used in my practice of epidemiology and public health and in 47 composing my published work. These same methodologies have been accepted by numerous 48 other courts in my past expert testimony. I reserve the right to supplement my opinions as new 49 information becomes available. My curriculum vitae detailing my qualifications, and including a 50 list of publications, is attached as Appendix B. I have not testified at trial or deposition in any 51 cases during the past four years. The last time I testified was in 2005. Cases in which I have 52 testified are listed on my curriculum vitae. My compensation for this case is $400 per hour of 53 preparation time and deposition time. I am not charging for the actual testimony at trial. 54 2. The methodologies used in the formation of my opinions include, but are not limited to: (1) 55 epidemiologic analysis (using basic principles of epidemiologic methods); (2) environmental risk 56 analysis (using basic principles of environmental risk analysis and health hazard assessment); (3) 57 causal inference; and (4) carcinogen analysis. 58 III. Chronology of Key DuPont Documents Demonstrating Knowledge of Health Effects of C-8 59 1. As early as 1965, DuPont had conducted animal studies showing that C-8 has adverse effects on 60 the liver.1 Further studies conducted in 1968 and 1969 confirmed the liver toxicity of C-8, which 61 caused liver enlargement in rats and dogs. 62 2. By 1966, DuPont was aware that C-8 waste could leach into groundwater,2and because of this 63 concern, was shipping such wastes for deep sea disposal.3 64 3. A 3M research study, dated November 6, 1978, concluded that C-8 ingestion was associated 65 with adverse liver effects in rats.4 Specifically, liver enlargement and discoloration was observed 66 in male rats exposed to a 1000 ppm dose of C-8. In addition, compound-related lesions were 67 observed (microscopically) in the liver. These lesions demonstrated liver cell enlargement. 68 4. A January 8, 1979 Haskell Laboratory document noted a consistent finding of liver toxicity of C-8 69 in animal studies.5 Haskell Laboratory was the corporate lab for DuPont. 1C-8 Toxicity Studies. Undated (1982). [EID924561] [AJP002995]. 2Alsup RG. Disposal of Solid "Teflon" Wastes Containing C-8 APFO. August 31,1966. [EID193614] [CF020541]. 3 Higginbotham JE. "Teflon" Scrap. October 28,1966. [EID193613] [CF020524]. 4Goldenthal EI. Ninety Day Subacute Rat Toxicity Study. International Research and Development Corporation (Sponsor: 3M Company; Compound: Fluorad Fluorochemical FC-143). November 6,1978. [EID071748] [DUP000874]. 5Gort PJ. Ammonium Perfluorooctanoate (APFO). DuPont, Haskell Laboratory. January 8,1979. [EID924170] [AJP001488]. 2 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 5 of 232 PAGEID #: 40769 70 5. A July 30, 1979 document indicated that DuPont was in possession of data from 3M showing 71 that fluorine was detected in the blood of 3M employees exposed to C-8 and in the blood of 72 "the general population."6 73 6. A September 7, 1979 document noted that a provisional AEL was set for C-8 at 0.01 mg/m3 as an 74 8-hour TWA based on evidence of the chemical's liver toxicity in rat studies.7This AEL 75 (acceptable exposure limit) was an internal standard set by DuPont to protect its workers from 76 potential toxicity. 77 7. In a January 1980 document, it is noted that organic fluorides were measured in the blood of 78 Teflon division employees.8The document emphasized the need to protect employees from 79 exposure to C-8 and states that workers handling this chemical should wear rubber gloves and 80 use a respirator or fresh air mask. 81 8. According to an April 28, 1981 document, C-8 blood testing continued and a standard of 0.4 82 ppm total organic fluorides was set "as a blood level that will not mandate removal of females 83 from the workplace."9 84 9. In May 1982, DuPont set a permanent AEL for C-8 at 0.01 mg/m3.10 85 10. In a November 23, 1982 document, DuPont noted the "great potential for current or future 86 exposure of members of the local community from emissions leaving the Plant perimeter."11 87 DuPont was aware that C-8 was being emitted by the facility into the air and made an attempt 88 to quantify the emissions. This prompted the medical director, Dr. Bruce Karrh, to express 89 concern about the potential for exposure of members of the local community from these air 90 emissions. 91 11. In 1983, DuPont estimated that it was discharging 21.8 million pounds of C-8 annually into the 92 Ohio River and that this might lead to the ingestion of C-8 from drinking water.12The company 93 was concerned enough that it discussed using an alternative for C-8 (TBSA). 94 12. A May 21, 1984 document noted that C-8 has a half-life in human blood of 2 years.13 95 13. A May 23, 1984 document noted that C-8 was detected in the drinking water in both the Lubeck 96 and Little Hocking districts.14The document expressed concern over liability during the past 32 97 years of plant operation and into the future and reviewed options to prevent liability going 98 forward, including equipment changes, reduction of C-8 use, and total elimination of C-8 use. 99 14. A June 1984 document noted that sampling of water in Little Hocking revealed a C-8 level of 0.8 100 ppb; sampling of water in the Lubeck district revealed levels of 1.0, 1.2, and 1.5 ppb.15 6 Berman E. Flourine Blood Levels. DuPont, Legal Department. July 30,1979. [EID107196] [RL001777]. 7Ammonium Perfluorooctanoate (C-8) (PP&R). September 7,1979. [EID924654] [AJP003092]. 8Teflon Division Chemical. January 1980. [EID924642] [AJP003080]. 9Culpepper BW. Weekly notes. April 28,1981. [EID096481] [BWK000121]. 10C-8 Toxicity Studies. Undated (1982). [EID924561] [AJP002995]. 11 Karrh BW. Scrubbing of Fine Powder Dryer Exhausts. November 23,1982. [EID096449] [BWK000014]. 12Raines JW. C-8 Environmental Status. DuPont, Polymer Products Department. October 21,1983. [EID079740] [AJP002371]. 13C-8 History. May 21, 1984. [EID951571] [RJZ009988]. 14Schmid JA. C-8 Meeting Summary. 5/22/84 - Wilmington. May 23,1984. [EID602999]. 15Schmid JA. C-8 in Water. June 13,1984. [EID079102] [RJZ009220]. 3 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 6 of 232 PAGEID #: 40770 101 15. In an August 6, 1984 document, DuPont noted the consideration of a public communication to 102 notify the community of C-8 emissions and its presence in the drinking water supply.16The 103 document reiterated the consideration of methods to reduce or eliminate C-8 emissions. 104 16. In August 1984, DuPont prepared a statement for public disclosure of the C-8 in the community 105 drinking water supplies, but decided to keep it as a standby statement to be released only if this 106 information was leaked or otherwise disclosed.17The document stated that DuPont was 107 switching to a different chemical instead of continuing to use C-8. 108 17. In 1987, DuPont air monitoring revealed air levels of C-8 at the property boundary of 4.8 pg/m3, 109 which exceeded the subsequent CEG which was set at 0.3 pg/m3.18 110 18. In May 1987, two additional drinking water samples from the Lubeck district revealed C-8 levels 111 of 1.9 ppb.19 112 19. A February 15, 1988 Haskell Laboratory document noted that C-8 has an acceptable exposure 113 level (AEL) of 0.01 mg/m3 based on sub-chronic inhalation studies in rats.20The document also 114 noted that a recently completed study of rats found liver effects in rats which ingested C-8 at 115 levels of 30 or 300 ppm. In addition, compound-related Leydig cell adenomas were observed. 116 The document recommended a Community Exposure Guideline (CEG) of 0.3 pg/m3 (24-hour 117 TWA) for air exposure to C-8. 118 20. In a February 29, 1988 document, C-8 was noted to be "highly toxic" to rats via the acute 119 inhalation route.21 Liver degeneration, liver enlargement, and increases in liver enzymes were 120 observed. A second rat study also found liver changes, as did sub-chronic studies by the oral and 121 dermal routes. Microscopically, toxic changes were found in the liver, which included 122 hepatocellular enlargement, degeneration, and necrosis. The document also refers to a study 123 showing a statistically significant increase in testicular Leydig cell adenomas in rats exposed to C124 8 that was believed to be a "compound-related" effect. In addition, the study found a slight 125 increase in hepatocellular tumors in high-dose male rats. The document notes that "all of the 126 liver tumors were carcinomas." The incidence of these carcinomas was 6% in the low dose 127 groups, 2% in the medium dose group, and 10% in the high dose group. 128 21. In another February 29, 1988 document, certain DuPont employees were directed to inform 129 "affected" workers that 3M's two-year rat feeding study results and all past studies on C-8 were 130 shared with DuPont.22That study showed "mild tumorigenic" effects in the testes of rats and 131 "reconfirmed" C-8's liver toxicity. The document also directed the employees to implement 16Serenbetz HE. EQC Procedures and Implementation Group. Meeting - August 2,1984. August 6,1984. [EID935010] [RJZ008923]. 17 KempTM. Standby Statement - FC-143. August 22,1984. [EID079554] [RJZ009764]. 18Stewart WM. Community Protection: CMA Air Toxics Control Policy. "Fenceline Screening Survey." DuPont, Washington Works. January 30,1987. [EID229345] [CF025193]. 19Vilone MJ, Vasta RM. Analytical Report: Perfluorooctanoate (C8) in Water. May 7,1987. [EID079092] [RJZ009209]. 20Graham RC. Memorandum. Central Research and Development Department, Haskell Laboratory for Toxicology and Industrial Medicine. February 15,1988. [EID086757] [RCG000094]. 21C-8 Hazard Letter. Ammonium Perfluorooctanoate. February 29,1988. [EID917954] [GLK000699]. 22Smith HA. Ammonium Perfluorooctanoate (C-8) CAS #3825-26-1 Hazard Determination and AEL Review. DuPont, Polymer Products Department. February 29,1988. [EID107384] [RL002015]. 4 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 7 of 232 PAGEID #: 40771 132 protective practices for the handling of C-8, including "dust respirators" and "ventilation" in 133 addition to air monitoring. In this document, DuPont categorized C-8 as a "small c" (possible) 134 carcinogen. The document directed staff to inform affected employees that C-8 had been 135 designated as a "small c" carcinogen. 136 22. A March 8, 1988 document recommended a Community Exposure Guideline (CEG) of 1 pg/L (1 137 ppb) for C-8 exposure in drinking water.23 138 23. In a March 24, 1988 communication to employees, Washington Works notified workers that C-8 139 could be harmful to their health if exposure levels are exceeded.24The communication also 140 noted that C-8 "is a liver toxin and has been recognized as such for a number of years." The 141 communication suggested that holding C-8 to the exposure limit is important to prevent any 142 human adverse health effects. 143 24. In August 1988, a water sample from a home served by the Lubeck district revealed a C-8 level 144 of 2.2 ppb.25 145 25. In 1988, DuPont tested water from Lubeck Public Service District water taps and detected C-8 at 146 levels ranging from 1.0 ppb to 2.2 ppb.2627 147 26. In 1989, it appears that DuPont shared with Lubeck PSD the information that C-8 had previously 148 been detected in the old Lubeck system.28 However, it does not appear that the district was 149 informed that the levels exceed the CEG, and it does not appear that public disclosure was 150 made, although a standby press release was drafted just in case the information was leaked.2627 151 Instead of notifying the Lubeck PSD that these levels exceeded the CEG, DuPont told Lubeck PSD 152 that "at these very low concentrations, it has no known toxic effects in humans." 153 27. A December 14, 1989 report noted a significantly high incidence of kidney cancer among 154 Washington Works employees.29 155 28. A March 15, 1991 email reported that a decision had been made to include a warning of 156 "potential C-8 hazards" in Material Safety Data Sheets for all products in which the C-8 157 concentration was 0.1% or higher.30 158 29. An April 1, 1991 email requested that a CEG be set for C-8 in drinking water and expressed 159 concern about potential health effects to the community from exposure to C-8.31The AEL 160 Committee or a special group from Haskell Laboratory was asked to "consider the actual health 3Graham RC. Ammonium Perfluorooctanote (C-8). DuPont, Haskell Laboratory. March 8,1988. [003-0002 0002460]. 24Lanyon RD. Employee Communication: Ammonium Perfluorooctanoate (C-8) CAS #3825-26-1 Hazard Determination and AEL Review. Washington Works, Plant Occupational Health Coordinator. March 24,1988. [EID510258] [DDJ001726]. 25 Playtis AJ. Test Results - C8 in Groundwater. August 29,1988. [EID079090] [RJZ009207]. 26 Malinowski AV. Letter to Douglas Johns. January 12, 2000. [EID718838] [AVM011183]. 27 Bradley HV. Letter to William R. Packard. DuPont, Polymer Products Department. June 13,1989. [LUB000934] [Exhibit 20]. 28Bradley HV. Standby Press Release. DuPont, Washington Works. June 12,1989. [EID079154] [RJZ009758]. 29Smith HA. Washington Works Cancer Incidence and Overall Mortality Rates. DuPont, Polymer Products Department. December 14,1989. [EID521382] [AJP009986] [Holliday Exhibit No. 30]. 30 Martin WH. C-8 Warning in MSDS for Teflon Dispersions (e-mail). March 15,1991. [EID112155] [LWB000735]. 31Anderson WP. Request for CEG for Ammonium Perfluorooctanoate in Drinking Water (email). April 1,1991. [EID107358] [RL001986]. 5 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 8 of 232 PAGEID #: 40772 161 effects to residents adjacent to our Washington Works Plant from exposure to C-8." The 162 document also states: "We believe that the level in drinking water is ca. 2.7 ppb." 163 30. According to a June 6, 1991 document, on June 4, 1991, the AEL Committee established a CEG of 164 1 ppb for C-8 in drinking water as a provisional value.32 165 31. A June 26, 1991 document reported the detection of C-8 in a number of water samples at the 166 following levels: groundwater at west end of Washington Works site (2-4 ppb), discharge to 167 Ohio River (40 ppb), groundwater at Dry Run Landfill (2-5 ppb), and drinking water at Lubeck 168 Public Service District (3.8 ppb).33 169 32. A July 18, 1991 standby press release for public notification stated that water samples from 170 Lubeck Public Service District had levels of C-8 of approximately 2-5 ppb.34 It is unclear that this 171 notification was ever made. 172 33. DuPont detected C-8 levels in the water of test wells and private wells in 1991 as high as 5.9 173 ppb.35 McClusky's home tap was reported as 3.9 ppb. 174 34. In a September 19, 1991 document, it was reported that a water sample from the new Lubeck 175 well field showed a C-8 level of 2.4 ppb on June 23, 1991.36Water samples from home taps 176 showed C-8 levels as high as 3.9 ppb. The memo noted that the Ohio River was a likely source of 177 this contamination, as travel from the supernate ponds to the new Lubeck well field would take 178 at least 50 years. The new Lubeck well field was a different field located 2 miles away (further 179 away from Washington Works) from the old well field. 180 35. An October 1, 1991 document contains another standby press release to disclose the finding of 181 C-8 in public drinking water supplies.37 182 36. According to an October 31, 1991 memo, DuPont was to switch to a new analytic method with 183 much lower recovery rates than the old method, and therefore lower C-8 results.38 A direct 184 comparison of the two methods showed that the new method derived C-8 levels that were 185 approximately 30% to 50% lower. These results are lower because they do not correct for 186 surrogate recovery rates, which are themselves lower than in the previous method. 187 37. Another round of water sampling on November 19, 1991 detected C-8 levels in the vicinity of 188 the new Lubeck PSD wellfield exceeding the 1 ppb CEG. In fact, samples apparently taken from 189 the Ohio River in the vicinity of the well field contained C-8 levels of 1.4, 1.6, and 1.7 ppb.39 190 Subsequently, DuPont switched to a new analytic method for C-8 and immediately, testing 191 revealed lower C-8 levels. It was after the analytic method switch that DuPont finalized its CEG 192 at 1 ppb. 32Graham RC. AEL Committee Notes. June 6,1991. [EID086812] [RCG000149]. 33 Background: What is C-8? June 26,1991. [EID951584] [RJZ010002]. 34 Dupont, Washington Works. Standby Press Release - Public Notification: C8. July 18,1991. [DDJ008103]. 35Stewart WM. More on C-8 Results. August 21,1991. [EID713595] [DPL000040]. 36VandellT. Attorney-Client Privileged Information. September 19,1991. [EID909790]. 37 Eaton MS. Standby Press Release - Public Notification: C-8. October 1,1991. [EID079134] [RJZ009711]. 38Weber DA. TSCA 8(e) Compliance Audit Program. October 30,1991. [011-0001-0003496]. 39Untitled. Results of River and Well Samples Taken on November 19,1991. [EID949449] [AC003618]; Weber DA. 11/19/91 C-8 Sample Collection Summary. November 20,1991. [EID949490] [AC003590]. 6 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 9 of 232 PAGEID #: 40773 193 38. On February 7, 1992, a CEG of 1 ppb for water was accepted as a final value.40 194 39. A June 30, 1992 document listed C-8 as a possible carcinogen, noting that this designation was 195 made in 1988.41 196 40. In his doctoral dissertation completed in October 1992, Frank Gilliland reported finding effects 197 of C-8 on reproductive hormones in exposed workers.42These effects included higher estradiol 198 levels, lower free testosterone levels, and higher TSH levels, as well as higher prolactin levels in 199 moderate drinkers. In an occupational mortality study, Gilliland observed a significant excess of 200 prostate cancer mortality. Gilliland concluded that: "The findings from this study are consistent 201 with the hypothesis that perfluorooctanoic acid (PFOA) affects the human hypothalamic202 pituitary-gonadal axis." He suggested that these reproductive hormone effects could be a 203 mechanism for the observed induction of Leydig cell tumors in rodents and noted that the 204 etiology of a number of cancers, including prostate cancer, has been linked to changes in levels 205 of endogenous hormones. 206 41. A 1993 document noted that C-8 is designated by the American Conference of Governmental 207 Industrial Hygienists (ACGIH) as an animal carcinogen (A3 designation) and that it is associated 208 with liver, pancreas, and testicular tumors in rats.43 The A3 designation is defined as: "Confirmed 209 animal carcinogen with unknown relevance to humans: The agent is carcinogenic in 210 experimental animals at a relatively high dose, by route(s) of administration, at site(s), of 211 histologic type(s), or by mechanism(s) that may not be relevant to worker exposure. Available 212 epidemiologic studies do not confirm an increased risk of cancer in exposed humans. Available 213 evidence does not suggest that the agent is likely to cause cancer in humans except under 214 uncommon or unlikely routes or levels of exposure."44The ACGIH designated C-8 as an A3 215 animal carcinogen in 1993.45 During this time, DuPont's Gerald Kennedy served on the TLV 216 subcommittee of the ACGIH.46 217 42. An occupational mortality study published in September 1993 reported a 3.3-fold increase in 218 prostate cancer mortality among workers employed in C-8 production at a Minnesota chemical 219 plant, notes that studies of these workers showed that C-8 was associated with gonadal 220 hormone changes (decreased free testosterone and increased estradiol), and hypothesized that 221 C-8 may cause prostate cancer by affecting reproductive hormones in men.47 The study cited a 222 number of studies published between 1983 and 1991 indicating that C-8 causes peroxisome 223 proliferation, which is known to be associated with hepatocellular carcinogenesis. 0Graham RC. AEL Action on Ammonium Perflurorooctanoate (C-8). September 28, 2000. [EID086681] [RCG000018]. 41Zipfel RJ. C-8 Information. Haskell Labs Carcinogen File. DuPont, Washington Works, DuPont Polymers. June 30, 1992. [EID943616] [RJZ020387]. 42Gilliland FD. Fluorocarbons and Human Health: Studies in an Occupational Cohort (thesis). University of Minnesota. October, 1992. [3MA00749384] [ROWE010543]. 43Ammonium Perfluorooctanoate (C-8). 1993. [EID101656] [GK001607]. 44 Playtis AJ. C-8 TLV (email). June 9, 2000. [EID076894] [RLR002852]. 45ACGIH. Ammonium perfluorooctanoate. 2001. [EID0029457]. 46 Deposition of Gerald Kennedy. Leach vs. DuPont. July 31, 2002. No. 01-C-608. 47Gilliland FD, Mandel JS. Mortality among employees of a perfluorooctanoic acid production plant. JOM 1993;35:950-954. 7 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 10 of 232 PAGEID #: 40774 224 43. A November 4, 1993 document noted that while C-8 was previously associated with a significant 225 increase only in Leydig cell tumors, results from a 2-year study showed an increased incidence of 226 liver, pancreatic, and testicular tumors.48 227 44. A November 19, 1993 document outlined multiple possible mechanisms for C-8-induced tumors 228 in rats, including but not limited to peroxisome proliferation.49 Other mechanisms discussed 229 include increasing levels of endocrine and reproductive hormones (e.g., CCK, estradiol) and 230 increasing fat content in the gut, which would increase CCK release. 231 45. A November 30, 1993 document stated that Haskell Laboratory "concluded that C-8 was a weak 232 carcinogen" in 1988, based on the observation of an increase in testicular adenomas in male 233 rats.50This document also showed that DuPont was aware of the Gilliland and Mandel study, as 234 it cited the results of that study. 235 46. Minutes from an Epidemiology Review Board meeting from October 18-20, 1994 indicate that 236 DuPont was aware that "just this year" C-8 was classified as an animal carcinogen by ACGIH and 237 given a threshold limit value of 0.01 mg/m3.51 238 47. Minutes from an October 18, 1995 Epidemiology Review Board meeting indicate that DuPont 239 was aware that: (1) a potential mechanism of C-8's tumorigenic potential was "chronic, low240 level, hormonal change related to peroxisome and estrogen"; (2) the bio-persistence of C-8 is a 241 concern; (3) C-8 workers have elevated C-8 blood levels and these levels correlate with airborne 242 concentrations.52 243 48. In a January 9, 1997 summary of the hazard characterization for C-8, the Haskell Laboratory 244 noted that there is consistent animal evidence of the liver toxicity of C-8, that there is consistent 245 evidence of hormonal effects and of tumorigenic activity in animals (liver, pancreas, and 246 testis).53 The mechanism of liver tumor formation was believed to be related to peroxisome 247 proliferation, while the mechanism of pancreatic and testis tumor formation was believed to be 248 related to hormonal changes. Effects on hormonal levels in humans were noted, including 249 higher estradiol levels, lower free testosterone levels, and higher TSH levels, as well as higher 250 prolactin levels in moderate drinkers. These effects were reported in Gilliland's doctoral 251 dissertation.54 252 49. In a 1997 manuscript co-authored by DuPont (a Haskell Laboratory scientist was a co-author), an 253 expert panel including Haskell Laboratory representation published its recommendations 8Graham RC. AEL Committee Notes. DuPont Central Research and Development: Haskell Laboratory for Toxicology and Industrial Medicine. November 4,1993. [USEPA 15640] [RCG000172]. 49Graham RC. RE: December 7,1993 AEL Meeting. DuPont Central Research and Development: Haskell Laboratory for Toxicology and Industrial Medicine. November 19,1993. [GK001407]. 50Ammonium Perfluorooctanoate (C-8) Update. C-8 Questions and Answers. November 30,1993. [EID510261] [DDJ001729]. 51 Draft Agenda: Epidemiology Review Board Meeting, October 18-20,1994. Minutes of DuPont ERB Meeting. October 24,1994. [EID713793] [DPL000250] [Holiday Exhibit No. 37]. 52 Draft - Minutes of the DuPont Epidemiology Review Board Meeting - October 17-19,1995. [EID769939] [Holliday Exhibit No. 38]. 53 Biegel LB. Hazard Characterization for Human Health C8 Exposure: CAS Registry No. 3825-26-1. DuPont Haskell Laboratory. January 9,1997. [EID171605] [RK000567]. 54Gilliland FD. Fluorocarbons and Human Health: Studies in an Occupational Cohort (thesis). University of Minnesota. October, 1992. [3MA00749384] [ROWE010543]. 8 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 11 of 232 PAGEID #: 40775 254 concerning the relevance of animal Leydig cell adenomas to humans.55The article concluded 255 that: "Occurrence of Leydig cell adenomas in test species is of potential concern as both a 256 carcinogenic and reproductive effect if the mode of induction and potential exposures cannot 257 be ruled out as relevant for humans." Estrogen agonism as a mode of action was considered to 258 be relevant to humans. The paper concluded that "the induction of adenomas in test species by 259 an agent is of concern except in situations in which there is sufficient information about the 260 mode of induction to judge that it is not relevant to humans. ... With agents causing Leydig cell 261 adenoma for which the mode of induction is unknown, it should be assumed that the increased 262 incidence of adenoma is of concern for humans unless adequate human data are available to 263 demonstrate irrelevance." 264 50. In early 1998, DuPont was faced with complaints about C8 contamination of the Dry Run landfill, 265 along with an EPA investigation and a civil lawsuit. DuPont formed a "Response Team," 266 consisting of technical, legal, and communications staff.56 267 51. In an October 30, 1998 document, the categorization of C-8 was downgraded to "not likely to be 268 a human carcinogen."57 In this review of the evidence, it is noted that one previous study found 269 a low incidence of malignant liver tumors (carcinomas) in male rats exposed at a high dose, and 270 a second study found an increase in adenomas at three sites. The document states that all three 271 tumor types have been shown to be associated with peroxisome proliferation. It then concludes 272 that because this mode of action is known, and is known not to be relevant to humans, these 273 tumor types have little or no significance to humans. The document also states that the ACGIH 274 A3 carcinogen classification designates "an animal carcinogen with little or no relevance to 275 man." 276 52. A 1998 document - a draft manuscript - stated that 277 REDACTED 278 .58The document stated: 279 280 REDACTED 281 282 283 53. A May 24, 1999 document described the human toxicity of acute exposure to C-8, including 284 health effects such as respiratory tract irritation, skin irritation, eye irritation, eye burns, gastric 285 burns, and slight oral toxicity.59 286 54. A June 30, 1999 report submitted to the EPA noted the finding of C-8 in a drinking water well at 287 a level of 1.9 ppb at the Washington Works plant site.60 Clegg ED, et al. Leydig cell hyperplasia and adenoma formation: Mechanisms and relevance to humans. Reproductive Toxicology 1997;11:107-121. 56 Dry Run Landfill Report Response Team. Agenda. January 27,1998. [EID948790] [RAK004373]. 57Trochimowicz HJ, Kennedy GL. Carcinogenic and Developmental Toxicity Hazard Determinations: Ammonium Perfluorooctanotate. DuPont, Haskell Laboratory for Toxicology and Industrial Medicine. October 30,1998. [EID086677] [RCG000014]. 58 Kennedy GL, et al. Toxicology of ammonium perfluorooctanoate. August 7,1998. [EID918337] [GLK002093]. 59C-8 Hazard Communication. May 24,1999. [EID771070]. 9 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 12 of 232 PAGEID #: 40776 288 55. A December 8, 1999 email 289 REDACTED 61 290 291 REDACTED 292 56. A July 29, 2000 document included an abstract from a scientific study designed to determine a 293 LOEL (lowest observed effect level) for C-8.62This determination was made based on a new 294 study conducted in monkeys. It found that the "liver weight increase at the low dose occurred at 295 serum concentrations which overlap those which have been observed in some workers with 296 high exposure; therefore, the liver enlargement was considered a significant effect and the low 297 dose of 3 mg/kg/day is characterized as the lowest observed effect level (LOEL)." This LOEL was 298 10 times lower than the previous level, from rat studies, that was being used to derive safe 299 exposure levels. 300 57. DuPont helped draft63 an October 31, 2000 letter from the Lubeck PSD to inform customers that 301 C-8 had been detected in the water.61 However, the letter failed to disclose that earlier samples 302 had exceeded the CEG, reassuring customers that current samples were below the CEG. 303 Moreover, the letter did not disclose that a new lab was being used with much lower surrogate 304 recovery results. The differences in the surrogate recovery results were not shared.64 305 58. An August 2001 report prepared for the DuPont Corporation Legal Department by Environ 306 International Corporation stated that the mode of action by which C-8 produces pancreatic 307 tumors in rats remains unknown and cited a 1997 article as the source for the assertion that the 308 mode of action is unknown.65The report also noted "the apparent lack of peroxisome 309 proliferation in Leydig cells from animals exposed to peroxisome proliferators" and explained 310 that because of this, "recent studies have sought to identify an endocrine-related mechanism 311 for peroxisome proliferator-induced Leydig cell hyperplasia and neoplasia." 312 59. A series of emails in October 2001 expressed concern because DuPont was switching to a new 313 company and technique for analyzing C-9 levels in water which had better recovery and that 314 levels were likely to be up to 10 times higher.66The emails expressed concern because the 315 resulting levels are almost certainly going to exceed the CEG of 1 ppb and could trigger a 316 mandate for providing alternative water to community residents. The emails expressed a desire*612345 0 Bishop E, Hartten A, Opp JS. RCRA Facility Investigation Report: DuPont Washington Works, Washington, West Virginia, USEPA Permit Number WVD04-587-5291. June 30,1999. [EID109643] [GLK002615]. 61Pinchot RF. REDACTED . December 8,1999. [EID463564] [FH000100]. 62 Butenhoff JL, et al. Abstract. July 29, 2000. [EID569962]. 63Jones HH. Lubeck PSD to Customers. Spilman Thomas & Battle, PLLC. October 16, 2000. [LPSD143]. 64Cox JM. Lubeck Public Service District. Dear Lubeck PSD Customers. October, 31, 2000. [EID147311] [DDJ001807]. 65 Environ International Corporation. A Review of the Toxicology of Ammonium Perfluorooctanoate (PFOA). August, 2001. [EID483876] [GWJ010275]. 66 Reilly BJ. Next Week at Region 3? (email). October 4, 2001. [EDD0076288]; Reilly BJ. EPA Region 3 Cannot Meet Next Week (email). October 4, 2001. [EDD0076369]; Reilly BJ. Environ Input (email). October 6, 2001. [EID303759]; Reilly BJ. FW: Oct 12 Meeting with EPA Region 3 - Privileged Communication (email). October 15, 2001. [EDD0076808]. 10 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 13 of 232 PAGEID #: 40777 317 to meet with EPA in order to try to avoid such an order. One stated that DuPont was concerned 318 that "our very conservative number may be used against us." 319 60. An October 10, 2001 report out of Haskell Laboratory reported a method to estimate blood 320 levels of C-8 from levels of C-8 in drinking water and air.67 According to this report, exposure to 321 drinking water with a concentration of C-8 at 1 ppb, in the absence of air exposure, would 322 translate into a steady state blood C-8 level of 300 ppb. 323 61. A November 12, 2001 email from Environ to DuPont indicated that the two companies were 324 collaborating on the development of a monograph that was intended to influence the EPA's 325 decision-making process.68The document expressed an unwillingness to allow that animal data 326 on carcinogenicity are relevant to humans, stating: "It is very difficult to persuade the EPA and 327 other regulators that animal data on carcinogenicity should not be considered relevant to 328 human risk, and the scientific arguments have to be set down in all detail." 329 62. In December 2001, water supply testing at Little Hocking revealed C-8 levels exceeding the 1 330 ppb CEG.69 Levels were as high as 7.7 ppb. 331 63. In 2001-2002, water testing of public drinking water supplies revealed C-8 levels in drinking 332 water as follows: Lubeck PSD - 0.3-1.04 ppb; Little Hocking Water Association - 0.74-6.22 ppb; 333 Tuppers Plains - not detected - 0.726 ppb; and Belpre - not detected - 0.107 ppb.7071 334 64. A January 2002 report for DuPont prepared by Environ omitted all mention of any uncertainty 335 regarding the mechanism of action of C-8 in producing tumors in animals and attempts to make 336 the case that all tumors are a result of PPAR-a (peroxisome proliferator-activator receptor) 337 activation. 338 65. In a January 10, 2002 document, DuPont stated that it was now trying to increase its standard 339 for C-8 in drinking water from 1 ppb to either 10 or 14 ppb.72 DuPont was trying to figure out a 340 way to manipulate the assumptions so that it could support a level of 14 ppb. 341 66. In its final report, issued on January 24, 2002, Environ was able to find a way to manipulate the 342 assumptions so that the final standard came out to be 14 ppb.73 DuPont was able to convince 343 the EPA to accept this as a standard in its consent order forcing DuPont to supply alternative 344 water if this level were to be exceeded in drinking water wells. 345 67. A March 2002 document confirmed that the ACGIH designation of C-8 as an A3 carcinogen 346 meant that its relevance to humans was unknown, rather than that it had little or no relevance 347 to humans.74 7Hinderliter PM, Jepson GW. DuPont Haskell Laboratory for Health and Environmental Sciences, Biochemical Toxicology. A Simple, Conservative Compartmental Model to Relate Ammonium Perfluorooctanoate (APFO) Exposure to Estimates of Perfluorooctanoate (PFO) Blood Levels in Humans. October 10, 2001. [EID166599] [BK004797]. 68 Harris R. Monograph (email). November 12, 2001. [EDD0079308]. 69USEPA. Consent Order. March 7, 2002. 70Jackson DD. Draft Charts for 3-05-02 Media Briefing. February 28, 2002. [EDD0064077]. 71 Environ International Corporation. A Hazard Narrative for Perfluorooctanoate (PFOA). January 2002. [EID495829] [RWR000602]. 72 Reilly BJ. 10 pg/L in Environ Hazard Narrative (email). January 20, 2002. [EDD0080154]. 73 Environ International Corporation. A Hazard Narrative for Perfluorooctanoate (PFOA). Final. January 24, 2002. 74Safety Plan for Working with Hazard Substances. March 2002. [EID570740]. 11 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 14 of 232 PAGEID #: 40778 348 68. In an April 24, 2002 document, DuPont expressed 349 REDACTED 75 350 69. A September 11, 2002 document stated that "it is the company's intent to maintain exposure 351 below the CEG" (referring to levels of C-8 in drinking water).76 352 70. A report from the Epidemiology Program at Haskell Laboratory on January 27, 2003 noted the 353 finding of a significant excess incidence of bladder and kidney cancer in Washington Works 354 employees.77 355 71. In a May 9, 2003 draft of a manuscript on the health effects of C-8, DuPont authors stated that 356 the mechanism of action of C-8 in inducing Leydig cell tumors is not known, that PPAR-a 357 activation may not be involved, that there are at least seven different mechanisms may be 358 involved, and that one or more of these mechanisms might be relevant to humans.78The 359 manuscript stated: "The extent to which the occurrence of Leydig cell tumors in rats may be 360 linked to PPARa activation is not clear. ... There are seven proposed mechanisms for Leydig cell 361 tumorigenesis in rodents, all of which disrupt the hormonal milieu within the testes ... The 362 attribution of sustained estradiol increase as part of the response to PPARa activation and as 363 the operative mechanism for PFOA-induced Leydig cell tumors as well as the relevance of these 364 tumors to humans will require additional research." The manuscript specifically noted that C-8 365 does not increase peroxisome levels in the testis. The manuscript concluded that: "Leydig cell 366 tumorigenicity could involve a distinct hormone-mediated mechanism that might be of some 367 relevance to humans." The manuscript also acknowledged that: "the mechanism by which PFOA 368 and some other PPs induce pancreatic acinar cell tumors is not well understood." and that 369 applicability of any mechanism to humans is "uncertain." 370 72. A June 2, 2003 document included a manuscript from CXR Biosciences which concluded that C-8 371 induced pancreatic tumors in rats may be mediated by a number of mechanisms that have 372 nothing to do with PPAR-a activation.79 373 73. A 2003 document noted that the action point for C-8 in drinking water is 1 ppb for employees.80 374 74. An October 16, 2003 document noted that: 375 REDACTED 81 376 75. In 2004, serum testing of 11 individuals who drank water from the Lubeck PSD and did not work 377 at Washington Works revealed C-8 levels ranging from 15.7 ng/mL to 128 ng/mL.82 ' Shomper DR. REDACTED . April 24, 2002. [076-0154-0000513]. Senkler GH. CEG Review Meeting, October 7, 2002 (email). September 11, 2002. [EID615450] [RWR003992]. 77 Leonard RC. Cancer Incidence Report 1959-2001, All-Cause Mortality Report 1957-2000, Washington Works, Parkersburg, West Virginia. Dupont, Haskell Laboratory for Health and Environmental Sciences, Epidemiology Program. January 27, 2003. [EID645647] [RL003145]. 78 Kennedy GL, et al. The toxicology of perfluorooctanoate (research manuscript). May 9, 2003. [EID729618] [JHH001323]. 79 Plummer SM, et al. The effects of ammonium perfluorooctanoate (APFO) on the transcriptional profile of pancreas and liver of male rats. 80 FC-143. Safety & Environmental Information. Undated (2003). [EID932971] [RJZ006515]. Frame SR, McConnell EE. REDACTED October 16, 2003. [EID778059] [RWR010957]. 82 Bilott RA. Re: PFOA-Exposed Community Blood Sample Results. September 15, 2004. [ROWE009242] [Exhibit 11]. 12 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 15 of 232 PAGEID #: 40779 378 76. A June 6, 2005 document still categorized C-8 as "not likely to be a human carcinogen" and told 379 employees that "it is carcinogenic in laboratory animals by a mechanism that is not considered 380 to be relevant to human exposure... ."83 381 77. In a February 24, 2006 memorandum from the Epidemiology Review Board, the Board wrote: 382 "Given the many gaps in understanding of population exposures to PFOA and of possible health 383 consequences, we strongly advise against any public statements asserting that PFOA does not 384 pose any risk to health. It appears to us that no party can claim sufficient knowledge that PFOA 385 does or does not pose any risk to health. We also question the evidential basis of DuPont's 386 public expression asserting, with what appears to be great confidence, that PFOA does not pose 387 a risk to health."84 388 78. In 2006, the EPA Scientific Advisory Board report on EPA's draft risk assessment of C-8 389 concluded that liver tumor induction in rats is mediated by a peroxisome proliferator-activated 390 receptor mechanism of action.85 Most panel members agreed that this may not be the only 391 mechanism of action. Three quarters of the panel members recommended that EPA designate 392 C-8 as "likely to be carcinogenic in humans." This recommendation was based on the possibility 393 of more than one mode of action for PFOA's liver effects, the EPA Guidelines noting that the 394 "likely to be carcinogenic in humans" descriptor be used to chemicals that are animal 395 carcinogens in more than one species, sex, strain, site or exposure route, even if there is no 396 evidence of carcinogenicity in humans, the finding of increased breast fibroadenomas and 397 adenocarcinomas in a two-year PFOA rat feeding study, and insufficient data on the mechanism 398 of action for the induction of tumors in the testis, pancreas, and mammary gland. EPA's Cancer 399 Guidelines note that in the absence of a clear mode of action, an animal carcinogen must be 400 presumed to be likely carcinogenic to humans. 401 79. In a 2007 published study of the relationship between C-8 exposure and lipid levels in 402 Washington Works employees, investigators reported a modest but statistically significant 403 relationship between C-8 levels and increased total, LDL, and VLDL cholesterol.86 404 IV. What Did DuPont Know and When Did They Know It? 405 1. As early as 1965, DuPont was aware that C-8 was toxic and had adverse liver effects in dogs. The 406 liver toxicity of C-8 to animals (rats) was confirmed in further studies in 1968 and 1969. 407 2. By 1966, DuPont was aware that C-8 could leach into groundwater. 408 3. DuPont was aware in 1978 that C-8 was associated with adverse liver effects in rats. 3Playtis AJ. Chemical Hazard Special Communication. Ammonium Perfluorooctanoate. June 6, 2005. 84 Epidemiology Review Board. Memorandum to Michael Kaplan. Re: Epidemiology Review Board and PFOA. February 24, 2006. [Seixas 00473]. 85Scientific Advisory Board. USEPA. SAB Review of EPA's Draft Risk Assessment of Potential Human Health Effects Associated with PFOA and its Salts. Washington, DC: U.S. Environmental Protection Agency. May 30, 2006. [024 0134-0063051]. 86Sakr CJ, Kreckmann KH, Green JW, Gillies PJ, Reynolds JL, Leonard RC. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. JOM 2007;49:1086-1096. 13 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 16 of 232 PAGEID #: 40780 409 4. By 1979, DuPont had consistent evidence that C-8 had liver toxicity in animal studies and was 410 concerned enough that it set a provisional AEL at 0.01 mg/m3. 411 5. By 1980, DuPont was aware that C-8 exposure was resulting in detectable levels of organic 412 fluorides in the blood of Teflon division employees and was concerned enough to require the 413 use of a respirator or fresh air mask and rubber gloves for workers handling this chemical. 414 6. By 1981, DuPont was aware that blood testing continued to show C-8 in the blood of exposed 415 workers and was concerned enough to set a standard (0.4 ppm total organic fluorides), above 416 which female employees would have to be removed from the workplace. 417 7. By 1982, DuPont was aware of the great potential for exposure of the local community to be 418 exposed to C-8 because of plant emissions. It was aware that C-8 was being emitted into the air 419 and in high amounts into the Ohio River. 420 8. By 1984, DuPont was aware that C-8 was bio-accumulative, with a half-life in blood of 421 approximately two years. 422 9. By 1984, DuPont was aware that C-8 was present in the drinking water supplies in both the 423 Lubeck and Little Hocking districts at a level in the range of and exceeding 1 ppb. 424 10. In 1984, DuPont was aware of liability concerns regarding exposure of the community to C-8 and 425 considered a range of options to reduce or eliminate this exposure. 426 11. In 1984, DuPont considered publicly disclosing its C-8 emissions and the fact that C-8 was 427 detected in community drinking water supplies, and went as far as preparing a statement to 428 make this disclosure, but failed to release the statement, keeping it only for standby in case the 429 information was leaked. The company considered switching to a different chemical so that C-8 430 would no longer be needed, but decided not to make this switch. 431 12. In 1987, DuPont was aware of additional community drinking water sampling that revealed C-8 432 levels in excess of 1 ppb in the Lubeck district and about 0.6 ppb in the Little Hocking district. 433 13. In 1988, DuPont was aware of C-8 levels as high as 2.2 ppb in household drinking water from a 434 home in the Lubeck district. 435 14. DuPont was aware in 1988 that C-8 was a potential health hazard (an acceptable exposure limit 436 had been set and was being reviewed), that further research had confirmed that C-8 produces 437 liver toxicity in rats, and that C-8 ingestion was associated with testicular Leydig cell adenomas 438 in rats. In addition, rat studies revealed that C-8 was associated with liver neoplasms, with a 439 slight increase noted in the high-dose male rats. All of these tumors were noted to be 440 carcinomas. 441 15. By 1988, DuPont internally recognized C-8 as highly toxic (liver toxicity) to rats. 442 16. By 1988, DuPont was aware that C-8 was associated with tumorigenic potential in the liver of 443 rats. 444 17. By 1988, DuPont was concerned enough about potential human health effects of C-8 to institute 445 protective procedures with its employees exposed to this chemical. It also informed employees 446 that exceeding exposure limits could be harmful to their health. 447 18. In 1988, DuPont recognized C-8 as a possible human carcinogen, designating it as such in its 448 "carcinogen file." DuPont classified C-8 as a "weak carcinogen" in that year. 14 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 17 of 232 PAGEID #: 40781 449 19. In 1988, DuPont was concerned enough about potential community exposure to C-8 that it 450 recommended Community Exposure Guidelines of 0.3 pg/m3for air exposure and 1 ppb for 451 drinking water exposure. 452 20. In 1989, DuPont was aware that C-8 was detected in water taps from the Lubeck Public Service 453 District at levels as high as 2.2 ppb, above the 1 ppb which had been set as the CEG. 454 21. In 1989, DuPont was aware of a significant excess of kidney cancer cases among Washington 455 Works employees. 456 22. By 1991, DuPont was concerned enough about the potential human toxicity of C-8 that it 457 decided to include a warning in all Material Safety Data Sheets for products containing at least 458 0.1% C-8. 459 23. By 1991, DuPont was concerned about the possible health effects from exposure to C-8 among 460 residents living adjacent to the Washington Works plant and adopted a 1 ppb CEG for drinking 461 water (provisional) so that lifetime exposure of community residents would not result in any 462 adverse health effects. 463 24. In 1991, DuPont was aware that C-8 levels in the drinking water of community residents (2.7 464 ppb) exceeded the CEG that it set for C-8 in drinking water (1 ppb), that drinking water at the 465 Lubeck Public Service District contained C-8 at a level (3.8 ppb) which exceeded the CEG, and 466 that several other groundwater samples showed C-8 levels in the 2-5 ppb range, also exceeding 467 the CEG. 468 25. In 1991, DuPont was aware that C-8 levels in the vicinity of the new Lubeck well field, based on 469 at least three samples taken in the Ohio River adjacent to the well field, exceeded the CEG of 1 470 ppb. 471 26. In 1991, DuPont was aware that leachate from the supernate pond was not sufficient to explain 472 the C-8 levels in drinking water and suspected that its contamination of the Ohio River was a 473 source of such pollution. 474 27. Through at least 1991, DuPont continued to prepare standby press releases to publicly disclose 475 the contamination of the public drinking water supply, but failed to issue these statements to 476 the public or media. 477 28. In 1991, DuPont switched to a new laboratory with lower surrogate recovery rates, but failed to 478 notify authorities or the public that C-8 levels measured with this new method were 479 systematically as much as 30%-50% lower than with the previous method. These new (and 480 lower) results were repeatedly used to argue the absence of any health hazard. 481 29. In 1992, DuPont adopted a final value of 1 ppb as the CEG for water exposure to C-8. 482 30. By 1993, DuPont was aware that the American Conference of Governmental Industrial 483 Hygienists (ACGIH) classified C-8 as an animal carcinogen (A3 designation) and that it was 484 associated with tumors of the liver, pancreas, and testis in rats. That C-8 had been classified as 485 an animal carcinogen was clearly stated in a 1994 document, and that there was a significant 486 increase in tumors at three sites in rats was clearly stated in a 1993 document. 487 31. In 1993, DuPont was aware that C-8 had been associated with an increased incidence of 488 prostate cancer in C-8 chemical plant workers, that it alters reproductive hormone levels which 489 is a potential mechanism for the induction of prostate cancer, and that it induces peroxisome 490 proliferation, which is a potential mechanism for its observed induction of liver tumors in rats. 15 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 18 of 232 PAGEID #: 40782 491 32. In 1993, DuPont was aware that there are other mechanisms by which the non-liver C-8-induced 492 tumors in rats could be explained, other than peroxisome proliferation. These include 493 alternations in reproductive and other hormones and effects on fat levels in the gut. 494 33. By 1997, DuPont had a clear recognition that C-8 is an animal carcinogen, understood that it 495 causes hepatocellular carcinoma, pancreatic acinar cell tumors, and Leydig cell adenomas in rats 496 and was aware of its effects on reproductive and other hormones. DuPont was also aware that 497 C-8 causes hormonal changes in humans, including higher estradiol levels, lower free 498 testosterone levels, and higher TSH levels, as well as higher prolactin levels in moderate 499 drinkers. DuPont was aware of Gilliland's doctoral dissertation and was therefore aware of his 500 conclusion that: "The findings from this study are consistent with the hypothesis that 501 perfluorooctanoic acid (PFOA) affects the human hypothalamic-pituitary-gonadal axis." 502 34. In 1997, DuPont was aware of the recommendations of an expert panel, upon which it served, 503 that the occurrence of Leydig cell tumors in animals must be considered potentially relevant to 504 humans unless there is enough information known about the mechanism of action to rule out 505 relevance to humans. DuPont was aware that the panel recommended that an estrogen-agonist 506 mode of action was considered to be relevant to humans. 507 35. In 1997, DuPont was aware of public concerns about possible water contamination from the Dry 508 Run landfill, and was aware that the EPA was investigating the situation and that the company 509 would face civil litigation.87 510 36. In 1998, DuPont downgraded C-8 from a possible carcinogen to "unlikely" to be a human 511 carcinogen, misrepresenting the ACGIH classification of C-8 as an animal carcinogen by claiming 512 that this designation means an animal carcinogen with little or no relevance to humans rather 513 than one with unknown relevance to humans, and violating its own published recognition that 514 Leydig cell tumors must be assumed to be relevant to humans unless the mode of action is 515 known and is known not to be relevant to humans and that an estrogen-agonist mode of action 516 was considered relevant to humans. 517 37. In 1998, DuPont was aware that 518 REDACTED 519 520 521 38. In 1999, DuPont was aware that acute C-8 exposure has adverse human health effects via 522 ingestion, inhalation, or skin or eye contact, acknowledged this, and communicated it to its 523 employees. 524 39. In June 1999, DuPont had knowledge that another test of C-8 level in drinking water at the 525 Washington Works plant found a level (1.9 ppb) that exceeded the CEG set by DuPont of 1 ppb, 526 and in the same year, REDACTED 527 528 40. In 2000, DuPont was concerned enough about potential human health effects of C-8 that it 529 conducted a study to determine a lowest observed effect level, based on toxicity observed in a 530 primate study. In that study, C-8 levels that corresponded to levels observed in some workers 87 Dry Run Landfill Report Response Team. Agenda. January 27,1998. [EID948790] [RAK004373]. 16 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 19 of 232 PAGEID #: 40783 531 with high exposure produced effects on the liver (enlargement). Moreover, the lowest observed 532 effect level based on this primate study was 10 times lower than previous estimates derived 533 from rat studies, which were being used to derive many of DuPont's C-9 safe exposure levels. 534 41. In 2001, DuPont was explicitly told by Environ that a peroxisome proliferation effect is not 535 sufficient to explain the mode of action by which C-8 in rats causes liver, pancreatic, and 536 testicular tumors, that the mode of action for the production of pancreatic tumors was 537 unknown, and that recent research was exploring other modes of action, such as effects on 538 hormones. 539 42. In 2001, DuPont was aware that its previous method used to analyze C-8 in drinking water 540 produced artificially low results and that these levels may have been underestimated by a factor 541 of up to ten-fold. DuPont was certain that the new method would show that the actual levels 542 were well above the CEG of 1 ppb and that this could trigger an order to supply replacement 543 water. 544 43. In 2001, DuPont collaborated with Environ on a risk assessment monograph that was intended 545 to influence the EPA's actions. The document expressed an unwillingness to believe that animal 546 data on carcinogenicity should be considered relevant to human risk. 547 44. In 2002, DuPont was attempting to cover up any uncertainty that PPAR-a activation is the 548 mechanism by which C-8 causes tumors in animals; Environ's report omitted previous mention 549 of this uncertainty and of studies suggesting otherwise. 550 45. In 2002, aware that drinking water levels of C-8 would exceed its old CEG, DuPont worked with 551 Environ to manipulate the assumptions and calculations so that it could increase the standard. 552 Environ found a way to increase it to 10 ppb, but DuPont convinced Environ to increase it up to 553 14 ppb, and EPA agreed to this level in its consent order requiring DuPont to provide alternative 554 water supply if this level was exceeded in drinking water wells. At the same time, DuPont stated 555 internally that its intent was to maintain exposure below the CEG. It also maintained a standard 556 of 1 ppb for its own workers. 557 46. In 2003, DuPont acknowledged that the mechanism for C-8 induction of testicular and 558 pancreatic tumors in animals was unknown and that it could involve PPAR-a-independent 559 mechanisms that are relevant to humans. 560 47. In 2003, DuPont was in possession of a manuscript from CXR Biosciences which concluded that 561 C-8 induction of testicular tumors could involve PPAR-a-independent mechanisms. 562 48. In 2003, DuPont was aware that a significant excess of kidney and bladder cancer cases had 563 been observed among Washington Works employees. 564 49. In 2004, data were submitted to EPA from an unpublished, but accepted manuscript that was in 565 press at Archives of Environmental Health. This manuscript reported that C-8 levels in drinking 566 water from Little Hocking ranged from 1.7-4.3 ppb, in water from Lubeck ranged from 0.4-3.9 567 ppb, and in 68 private wells in West Virginia and Ohio ranged from 0.05-8.6 ppb.88 568 50. In 2004, DuPont was aware of very high levels of C-8 in the blood from community members 569 who drank water from the Lubeck Public Service District. 8Dahlgren J, et al. Prevalence and incidence of cancer in populations exposed to perfluorooctanoate (PFOA) (unpublished manuscript). Santa Monica, CA: UCLA School of Medicine, 2004. [ROWE051814]. 17 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 20 of 232 PAGEID #: 40784 570 51. In 2005, DuPont still classified C-8 as "not likely to be a human carcinogen" and told workers 571 that "it is carcinogenic in laboratory animals by a mechanism that is not considered to be 572 relevant to human exposure... ." 573 52. Based on exposure modeling from 2005 blood sampling, the estimated median C-8 serum levels 574 in the population in the year 1995 were estimated as follows: Little Hocking (Washington and 575 Athens Counties, OH): 125 ng/mL; Lubeck (Wood County, WV): 65.8 ng/mL; Tupper Plains 576 (Athens and Meigs Counties, OH: 23.9 ng/mL; Belpre (Washington County, OH): 18.7 ng/mL; 577 Pomeroy (Meigs County, OH): 10.7 ng/mL; Mason (Mason County, WV): 5.3 ng/mL.89The 578 median serum C-8 levels at the time of blood sampling was 28.2 ng/mL, with a range of 0.2 579 ng/mL to 22,412 ng/mL. The median levels by current water district were: Little Hocking: 224.1 580 ng/mL; Lubeck: 66.9 ng/mL; Tupper Plains: 37.2 ng/mL; Belpre: 35.0 ng/mL; Mason County: 12.4 581 ng/mL; and Pomeroy: 12.1 ng/mL.90 582 53. At the time of sampling in 2005, the mean C-8 level in the Little Hocking water supply was 3.49 583 ppb, and levels in private wells were as high as 22.1 ppb.91 584 V. Generally Accepted Principles in Evaluating Human Carcinogenicity Based on Evidence of Animal 585 Carcinogenicity 586 1. In 1986, the Environmental Protection Agency published guidelines for carcinogen risk 587 assessment, which include key principles in evaluating the likelihood of a chemical being a 588 human carcinogen in the situation where there is evidence of animal carcinogenicity but no 589 sufficient evidence to evaluate the chemical's carcinogenicity in humans.92The guidelines 590 include the following key points. 591 2. "The weight of evidence that an agent is potentially carcinogenic for humans increases (1) with 592 the increase in number of tissue sites affected by the agent." 593 3. In assessing the weight of the evidence for carcinogenicity from studies in experimental animals, 594 sufficient evidence of carcinogenicity is defined as: "an increased incidence of malignant tumors 595 or combined malignant and benign tumors: (a) in multiple species or strains; or (b) in multiple 596 experiments (e.g., with different routes of administration or using different dose levels); or (c) to 597 an unusual degree in a single experiment with regard to high incidence, unusual site or type of 598 tumor, or early age at onset." 599 4. In assessing the weight of the evidence for carcinogenicity from studies in experimental animals, 600 limited evidence of carcinogenicity is defined as: "the data suggest a carcinogenic effect but are 601 limited because: (a) the studies involve a single species, strain or experiment and do not meet 602 criteria for sufficient evidence (see section UIV. B.I.C.); (b) the experiments are restricted by 89Vieira VM, et al. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: A geographic analysis. Environmental Health Perspectives. Published online ahead of print on January 8, 2013. 90Steenland K, et al. Predictors of PFOA levels in a community surrounding a chemical plant. Environmental Health Perspectives 2009;117:1083-1088. 91Vieira VM, et al. Perfluorooctanoic acid exposure and cancer outcomes in a contaminated community: A geographic analysis. Environmental Health Perspectives. Published online ahead of print on January 8, 2013. 92U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment. Washington, DC: USEPA, Risk Assessment Forum, September 24,1986. Federal Register 51(185):33992-34003 (EPA/630/R-00/004). 18 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 21 of 232 PAGEID #: 40785 603 inadequate dosage levels, in adequate duration of exposure to the agent, inadequate period of 604 follow-up, poor survival, too few animals, or inadequate reporting; or (c) an increase in the 605 incidence of benign tumors only." 606 5. In categorizing the overall weight of evidence for human carcinogenicity, a Probable Human 607 Carcinogen (Group B) is defined as: "agents for which the weight of evidence of human 608 carcinogenicity based on epidemiologic studies is "limited" and also includes agents for which 609 the weight of evidence of carcinogenicity based on animal studies is "sufficient." The group is 610 divided into two subgroups. Usually, Group B1 is reserved for agents for which there is limited 611 evidence of carcinogenicity from epidemiologic studies. It is reasonable, for practical purposes, 612 to regard an agent for which there is "sufficient" evidence of carcinogenicity in animals as if it 613 presented a carcinogenic risk to humans. Therefore, agents for which there is "sufficient" 614 evidence from animal studies and for which there is "inadequate evidence" or "no data" from 615 epidemiologic studies would usually be categorized under Group B2." 616 6. In categorizing the overall weight of evidence for human carcinogenicity, a Possible Human 617 Carcinogen (Group C) is defined as: "agents with limited evidence of carcinogenicity in animals 618 in the absence of human data." 619 7. In categorizing the overall weight of evidence for human carcinogenicity, a Group E classification 620 (Evidence of Non-Carcinogenicity for Humans) is defined as: "agents that show no evidence for 621 carcinogenicity in at least two adequate animal tests in different species or in both adequate 622 epidemiologic and animal studies." 623 8. In a 1994 document, DuPont sets out its own criteria for human carcinogen classification.93 624 According to this system, a chemical for which there is sufficient evidence of animal 625 carcinogenicity is to be classified as a Probable Human Carcinogen, regardless of whether there 626 are any epidemiology data available. Specifically, the criterion for classification as a Probable 627 Human Carcinogen is as follows: "There is sufficient evidence in one or more adequately 628 conducted studies that the substance is clearly carcinogenic in experimental animals." 629 Classification as a Possible Human Carcinogen (c) is based on "some or limited evidence that the 630 substance is carcinogenic in experimental animals." For a chemical where the evidence is that 631 the substance is carcinogenic by "mechanisms that are not considered relevant to potential 632 human exposure," that chemical is classified as "Not Likely to be a Human Carcinogen." 633 VI. Studies Showing Adverse Effects of PFOA on Rodents via PPAR-a-Independent Mechanisms 634 1. A 1996 study found a PPAR-independent mechanism by which fibrates (known to be peroxisome 635 proliferators) lower lipid levels in rat hepatocytes.94 636 2. A 1999 study found that PFOA can exert its effect on lipids in rats via a PPAR-a-independent 637 mechanism.95The study concludes that "the mechanisms of hypolipidemic effect caused by 3Carcinogen Classification System. DuPont. Undated (1994). [USEPA 15746] [WJB000005]. 94 Nishimaki-Mogami T, et al. The role of phosphatidylethanolamine methylation in the secretion of very low density lipoproteins by cultured rat hepatocytes: rapid inhibition of phosphatidylethanolamine methylation by bezafibrate increases the density of apolipoprotein B48-containing lipoproteins. Biochimica et Biophysica Acta 1996;1304:21-31. 19 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 22 of 232 PAGEID #: 40786 638 various classes of peroxisome proliferators are diverse" and that "peroxisome proliferators exert 639 their hypolipidemic effects by PPAR-independent as well as PPAR-dependent mechanisms." 640 3. A 2002 study found that PFOA causes liver enlargement even in PPAR-a-null mice.96The study 641 concludes that "the hepatomegaly (reflecting primarily hepatocyte proliferation) induced by 642 PFOA is not a PPARa-dependent process... ." 643 VII. Key DuPont Public Statements about Health Effects of C-8 644 1. In an August 17, 2000 draft of a corporate standby statement and outline for a communications 645 campaign, DuPont recommended the following communication statement: "Though persistent 646 in the environment and not immediately eliminated from the bloodstream of people who have 647 been exposed to it, all existing scientific knowledge indicates that there are no human health 648 concerns with the levels of C-8 detected in employees or the environment at any DuPont site or 649 in the surrounding communities. DuPont is confident that operations using C-9 are safe for 650 employees, the environment and the communities in which we operate."97 651 2. In an October 31, 2000 letter to customers of the Lubeck Public Service District, the District, with 652 collaboration with officials from DuPont, stated as follows: "Although PFOA is unregulated for 653 drinking water purposes (that is, it has no limit established by a regulatory agency), the DuPont 654 Company has established its own drinking water guideline of 1 part per billion. The DuPont 655 Company has advised the District that low concentrations have been found in drinking water at 656 Washington Works (0.2 parts per billion, or ppb, as of August 2000) and in the LPSD wells (0.2, 657 0.5, and 0.1 ppb, also as of August 2000). These levels are below the DuPont guideline and 658 DuPont has advised the District that it is confident these levels are safe."98 659 3. In a November 3, 2000 standby statement, a suggested media communication was as follows: 660 "Animal testing and epidemiology studies support confidence that there are no chronic toxicity 661 effects on humans."99 In addition, the suggested response to a question about whether DuPont 662 will monitor other drinking water wells in the Mid-Ohio Valley (other than Lubeck PSD) was: 663 "There is no need to. Hydrogeological data have determined the affected areas. That's where 664 the monitoring is being done." 665 4. In March 20, 2001 draft talking points, 666 REDACTED 667 5Okochi E, et al. Perfluorooctanoic acid, a peroxisome-proliferating hypolipidemic agent, dissociates apolipoprotein B48 from lipoprotein particles and decreases secretion of very low density lipoproteins by cultured rat hepatocytes. Biochimica et Biophysica Acta 1999;1437:393-401. 96Yang Q, et al. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochemical Pharmacology 2002;63:1893-1900. 97 DuPont Corporate Standby Statement - 8/17/00 - Use of Ammonium Perfluorooctanoate (c-8) - Discussion Draft. August 17, 2000. [EID157942]. 98Cox JM. Lubeck Public Service District. Dear Lubeck PSD Customers. October 31, 2000. [EID147311] [DDJ001807]. 99 DuPont. Standby Statement - November 3, 2000. November 3, 2000. [EID106041] [RB000012]. 20 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 23 of 232 PAGEID #: 40787 668 REDACTED 100The talking points also stated: REDACTED 669 670 5. In a November 16, 2001 email, a DuPont employee wrote to Robert Rickard: "The no observed 671 health effects and no evidence of human health impact are the basis of our whole public 672 position and as far as I know are true. What do we have without that??"101 673 6. In a March 19, 2002 letter to the editor of the Charleston Gazette, Robert Rickard, director of 674 DuPont's Haskell Laboratory, wrote that an article regarding the consent order between DuPont 675 and the EPA was misleading to the public because: "it incorrectly associated health effects 676 observed in laboratory animals with health effects in humans. The most notable example is the 677 report that C-8 'has been linked to liver damage and cancer,' leading the reader to assume the 678 statement applies to humans. ... It is important to emphasize that there is an extensive database 679 on C-8, including employee health effects studies from DuPont and others, that indicate no 680 known adverse human health impact associated with current or historic use of C-8. ... Several 681 independent assessments support the conclusions that there are no known adverse health 682 effects associated with C-8 in humans or the environment and have led to a consensus of 14 683 parts per billion as an interim screening level."102 684 7. In a March 7, 2003 statement to employees from the plant manager, the manager was quoted 685 as stating: "We have every confidence that our operation at Washington Works is safe for our 686 employees and our neighbors in the community."103 687 8. In a March 18, 2003 media update, DuPont claimed on one of its presentation slides: "C-8 is not 688 a human health issue."104The company also wrote: "We are confident that there are no health 689 effects associated with C-8 exposure." Under analysis of C-8 health effects, the box "No" was 690 checked under "Human Carcinogen" while "Yes" was checked under "Animal Carcinogen." The 691 slides also stated: "Do we understand why C-8 causes liver enlargement in rats? Yes - induces 692 peroxisome proliferation." 693 9. In a March 18, 2003 press release, DuPont stated that: "its use of C8 does not have an adverse 694 effect on human health or the environment."105The press release also stated: "Bossert also 695 disputed the statement that C8 causes cancer in animals, explaining that such statements taken 696 out of context cause undue concern in the community." William Rickard was quoted as stating: 697 "The data support that at the extremely low concentrations to which humans are exposed, the 698 effects are not relevant to humans." 699 10. March 28, 2003 talking points include the statement: "There is no evidence or data that 700 demonstrates PFOA causes adverse health effects, including developmental or reproductive 701 effects, in any segment of the population."106*1023456 DuPont Response [109-0162-0000658]. REDACTED March 20, 2001. 101Shomper DR. Re: DuPont Statement on WVDEP Consent Order (email). November 16, 2001. [EID398372]. 102 Rickard RW. Letter to the editor. March 19, 2002. [EID821189]. 103 Bossert P. DuPont Statement on Technology for Air Modeling of C-8. March 7, 2003. [EID821329]. 104 DuPont Washington Works. Media Update. Rickard RW. Assessing the Science. March 18, 2003. [EID821583]. 105 DuPont. Press release. March 18, 2003. [EID715946] [AC011023]. 106 DuPont Telomer Products. Product Stewardship Talking Points. March 28, 2003. [063-0001-0006429]. 21 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 24 of 232 PAGEID #: 40788 702 11. A press release dated March 31, 2003 claimed: "There is no evidence or data that demonstrates 703 PFOA causes adverse human health effects."107 704 12. In a press release issued on May 5, 2004, DuPont asserted that C-8 has no human health effects, 705 using the headline: "DuPont Reiterates Position on PFOA: Refutes Claim that PFOA Causes 706 Human Health Effects."108The press release stated: "DuPont's position is very clear. PFOA is not 707 a human carcinogen and there are no known health effects associated with PFOA. ... In fact, the 708 more we study PFOA, the more confident we are in our conclusions that PFOA is safe." 709 13. In a January 11, 2005 press release and an accompanying communication to Washington Works 710 employees, DuPont stated that there are no human health effects known to be caused by C-8.109 711 The press release stated: "To Date, No Human Health Effects Known to be Caused by PFOA." The 712 communication to employees stated: "there are no known human health effects associated with 713 exposure to PFOA." 714 14. In a web site news story issued on December 14, 2005, DuPont asserted that PFOA does not 715 cause any human health effects, stating: "to date no human health effects are known to be 716 caused by PFOA."110 717 15. In a DuPont statement dated January 21, 2010, the company stated that: "we do not believe 718 PFOA poses a health risk to our workers or to the general public."111This statement appeared in 719 January 2010 on the company's web site.112 720 721 VIII. Synthesis: Summary of Opinion Regarding DuPont Negligence 722 1. In articulating my opinion on whether DuPont was negligent in its actions, I am using the 723 following definition of negligence. I am considering negligence to be the failure to take actions 724 that a reasonable company, with a reasonable level of concern about the health and safety of its 725 community, would have taken in the same situation. I am not using as a standard a company 726 that I would consider to be an exemplary company, a good corporate citizen, or a company with 727 a strong sense of social responsibility. I am instead using as a standard the lowest common 728 denominator, or the minimum level at which I would expect a company to act if it has a 729 reasonable degree of concern for the health of its surrounding community. Thus, my analysis 730 considers a general duty of care that any company would be expected to fulfill. 731 2. In my opinion, DuPont acted negligently beginning in 1984 and continuing to at least 2010, 732 thereby placing those exposed to C-8 at an unnecessary increased risk of harm. I believe there 733 were five levels of increasing negligence, the severity increasing as the company's knowledge 7DuPont. DuPont Refutes Health Effects Claims About PFOA (press release). March 31, 2003. [EID821827]. 108 DuPont. DuPont Reiterates Position on PFOA: Refutes Claim that PFOA Causes Human Health Effects (press release). Dupont, Washington Works. May 5, 2004. [083-0001-0005541]. 109 DuPont. DuPont Reports First-Phase Results of Health Study Examining PFOA Exposure on Washington Works Employees (press release). January 11, 2005. [002-0001-0000743]. 110 DuPont News. DuPont Settles with U.S. EPA on PFOA Reporting Matter. December 14, 2005. http://www2.dupont.com/Media_Center/en_US/daily_news/article20051214c.html. [ROWE004000]. 111 DuPont Statement-January 21, 2010. [054-0388-0000001]. 112 DuPont. PFOA and Thyroid Changes. February 11, 2010. [ROWE050151]. 22 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 25 of 232 PAGEID #: 40789 734 about the potential or real health risks of C-8 increased and as its efforts to undermine, 735 manipulate, or dispute the scientific facts and standards began and intensified. 736 3. Level 1: Starting in 1984, DuPont acted negligently by not informing public water authorities and 737 the public that C-8 was present in drinking water supplies in the Lubeck and Little Hocking 738 districts. This act of negligence continued until January 2002, when the Little Hocking Water 739 Association was officially notified, as were its customers, that C-8 was present in its drinking 740 water. 741 4. My opinion that DuPont acted negligently in failing to inform water supply authorities and the 742 public about the presence of C-8 in public drinking water is based, in part, on the following 743 determinations: 744 a. By 1984, DuPont knew that C-8 was clearly associated with liver toxicity in animal 745 studies. 746 b. By 1984, DuPont knew that C-8 was present in the blood of Teflon division employees. 747 c. By 1984, DuPont was concerned enough about the potential health effects of C-8 748 exposure that it took steps to require protection of exposed workers, including the use 749 of a respirator or fresh air mask and rubber gloves for workers handling the chemical. 750 d. By 1984, DuPont was aware that C-8 is bioaccumulative, with a half-life in blood of 751 approximately two years. 752 e. By 1984, DuPont was aware of the great potential for exposure of the local community 753 to C-8 because of plant emissions. 754 f. By 1984, DuPont was aware that C-8 was present in the drinking water supplies in both 755 the Lubeck and Little Hocking districts. 756 g. In 1984, DuPont was aware that the C-8 present in the Little Hocking drinking water 757 supply was unlikely to have come from the Ohio River and thus should have concluded 758 that air emissions were a likely source of widespread contamination of water supplies in 759 the Ohio river valley. At this time, DuPont was aware that C-8 was being released at high 760 levels into the Ohio River. 761 h. In 1984, DuPont recognized liability concerns regarding exposure of the community to 762 C-8 and went as far as drafting a statement to make this disclosure. 763 i. DuPont failed to notify the water authorities and the public of the presence of C-8 in 764 drinking water in 1984. 765 j. Although DuPont did notify the Lubeck PSD to report the presence of C-8 in the old 766 Lubeck system in 1989, DuPont did not indicate any possible health problems, even 767 though C-8 had been detected at a level exceeding the recommended CEG. Moreover, 768 even though DuPont informed authorities about the detection of C-8 in the new Lubeck 769 wells (detected in 1991 and reported shortly thereafter), there was no disclosure that 770 earlier levels had exceeded the CEG or that a new lab was being used with much lower 771 surrogate recovery rates. At no time prior to 2001 was there any public disclosure of the 772 contamination of the Lubeck wells. 773 k. DuPont did not make official notification to the Little Hocking Water Association of C-8 774 in the drinking water until January 2002. 23 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 26 of 232 PAGEID #: 40790 775 5. Also starting in 1984, DuPont acted negligently by failing to inform authorities of the potential 776 for widespread contamination of the environment by C-8, by failing to inform authorities of the 777 potential for human exposure to C-8 due to emissions to the air and Ohio River - by which C-8 778 could enter public drinking water supplies - and by failing to conduct comprehensive testing of 779 community exposure to determine the extent of C-8 environmental contamination and potential 780 human exposure via both air and water. Despite knowledge of the large emissions DuPont was 781 making into both air and water, as well as the ability of C-8 to leach into groundwater, and 782 despite its knowledge and expressed concern about the potential for community exposure, the 783 company failed to make appropriate notifications and to do appropriate testing. 784 6. Level 2: Beginning in 1989, and continuing until January 2002, DuPont acted at a higher level of 785 negligence, as it was then aware that C-8 detected in water taps from the Lubeck Public Service 786 District were as high as 2.2 ppb, exceeding the 1 ppb level which the company itself had set as 787 the CEG. In addition, the company had itself designated C-8 as a possible human carcinogen. 788 7. My opinion that DuPont acted at a higher level of negligence starting in 1989 is based, in part, 789 on the following determinations: 790 a. In 1988, DuPont recommended a CEG of 1 ppb for drinking water exposure to C-8. 791 b. In 1988, DuPont classified C-8 as a possible human carcinogen. 792 c. In 1989, DuPont was aware that C-8 levels in water from the Lubeck district exceeded 793 the CEG. 794 8. This second level of negligence was amplified in 1991, when DuPont established a provisional C795 8 CEG of 1 ppb for drinking water and was aware that drinking water from Lubeck had C-8 levels 796 as high as 3.8 ppb, exceeding the CEG. DuPont was also aware that community drinking water 797 samples had C-8 levels as high as 2.7 ppb, exceeding the CEG. 798 9. The establishment of the 1 ppb CEG was finalized just after the switch to a new analytic 799 methods that consistently yielded lower C-8 results. 800 10. This second level of negligence was further amplified in 1992, when DuPont adopted a final CEG 801 of 1 ppb for drinking water, was aware that C-8 levels in the new Lubeck well field exceeded the 802 CEG, was aware that leachate from the supernate pond was not sufficient to explain the C-8 803 levels of drinking water, thus implicating a much more widespread source of C-8 pollution, and 804 again prepared standby press releases to publicly disclose the contamination of the public 805 drinking water supply but failed to issue these statements. 806 11. Level 3: Starting in 1993, and continuing until January 2002, DuPont acted at an even higher 807 level of negligence in failing to publicly disclose the contamination of the public water supply, as 808 it was then aware that the American Conference of Governmental and Industrial Hygienists had 809 classified C-8 as an animal carcinogen and that there were other mechanisms, beyond 810 peroxisome proliferation, that might explain the non-liver C-8-induced tumors in rats. 811 12. This third level of negligence was amplified in 1997, when DuPont became aware of the 812 recommendation of an expert panel (upon which it served) that the occurrence of Leydig cell 813 tumors in animals must be considered potentially relevant to humans unless there is enough 814 information known about the mechanism of action to rule out relevance to humans and that an 815 estrogen-agonist mode of action was considered relevant to humans. 24 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 27 of 232 PAGEID #: 40791 816 13. Level 4: Beginning in 1998, and intensifying through 2010, DuPont acted negligently by violating 817 established scientific standards in interpreting the results of C-8 health studies, manipulating its 818 health standards for liability reasons, and deviating from scientific principles in an effort to 819 protect itself. 820 14. My opinion that DuPont acted negligently by violating scientific standards and principles is 821 based in part on the following determinations: 822 I. DuPont departed from established standards for evaluating human carcinogenicity. 823 a. In 1998, DuPont was aware that C-8 824 REDACTED 825 826 b. In 1999, it was known that C-8 can exert its effect on lipids in rats via a PPAR-a827 independent mechanism. 828 c. In 2001, DuPont was told that a peroxisome proliferation effect is not sufficient to 829 explain the complete tumorigenic picture of C-8's actions. 830 d. In 2002, it was known that C-8 causes liver enlargement even in PPAR-a-null mice. 831 e. In 2003, DuPont acknowledged that the mechanism for the C-8 induction of testicular 832 and pancreatic tumors could involve PPAR-a-independent mechanisms that are relevant 833 to humans. 834 f. In 2003, DuPont was in possession of a manuscript from CSR Biosciences which 835 concluded that C-8 induction of testicular tumors could involve PPAR-a-independent 836 mechanisms. 837 838 II. DuPont downgraded the carcinogen classification of C-8 and misrepresented established 839 standards. 840 a. In 1998, DuPont downgraded C-8 from a possible carcinogen to "unlikely" to be a 841 human carcinogen, misrepresenting the ACGIH classification of C-8 as an animal 842 carcinogen by claiming that this designation means an animal carcinogen with little or 843 no relevance to humans rather than one with unknown relevance to humans. 844 b. In 1998, DuPont also violated its own published recognition that Leydig cell tumors must 845 be assumed to be relevant to humans and that an estrogen-agonist mode of action was 846 considered relevant to humans. 847 c. In 2001, DuPont collaborated with Environ on a risk assessment monograph that was 848 intended to influence the EPA's actions. This document expressed an unwillingness to 849 believe that animal data on carcinogenicity should be considered relevant to human 850 risk, violating EPA carcinogen risk assessment guidelines as well as its own guidelines. 851 III. DuPont inappropriately manipulated analytic methods and scientific assumptions 852 a. In 2001, DuPont was aware that its previous method used to analyze C-8 in drinking 853 water produced artificially low results and that these levels may have been 854 underestimated by a factor of up to ten-fold. DuPont was certain that the new method 25 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 28 of 232 PAGEID #: 40792 855 would show that the actual levels were well above the CEG of 1 ppb and that this could 856 trigger an order to supply replacement water. 857 b. In 2002, DuPont was attempting to cover up any uncertainty that PPAR-a activation is 858 the mechanism by which C-8 causes tumors in animals; Environ's report omitted 859 previous mention of this uncertainty and of studies suggesting otherwise. 860 c. In 2002, aware that drinking water levels of C-8 would exceed its old CEG, DuPont 861 worked with Environ to manipulate the assumptions and calculations so that it could 862 increase the standard. Environ found a way to increase it to 10 ppb, but DuPont 863 convinced Environ to increase it up to 14 ppb, and EPA agreed to this level in its consent 864 order requiring DuPont to provide alternative water supply if this level was exceeded in 865 drinking water wells. At the same time, DuPont stated internally that its intent was to 866 maintain exposure below the CEG. It also maintained a standard of 1 ppb for its own 867 workers. 868 d. In 2005, DuPont still classified C-8 as "not likely to be a human carcinogen" and told 869 workers that "it is carcinogenic in laboratory animals by a mechanism that is not 870 considered to be relevant to human exposure... ." 871 15. The initiation of this fourth level of negligence coincided with two events: (1) complaints about 872 contamination in the Dry Run landfill leading to an EPA investigation and civil lawsuits; and (2) 873 the process of finalizing a RCRA compliance document for submission in the late 1990s. 874 16. Level 5: Beginning in 2000, and continuing until at least 2010, DuPont acted negligently at the 875 highest level by proactively seeking to undermine the public's appreciation of potential human 876 health effects of C-8 by issuing public statements denying that C-8 has any adverse human 877 health effects or even that it is an environmental pollutant. 878 17. My opinion that DuPont acted negligently by issuing public statements denying that C-8 has any 879 adverse human health effects is based in part on the following determinations: 880 a. DuPont was aware that some of the observed tumorigenic effects of C-8 in rats were 881 likely due to PPAR-a-independent mechanisms, or that at very least, the mechanisms of 882 action were not known. 883 b. DuPont should have been aware of EPA's carcinogen risk assessment guidelines, by 884 which animal carcinogens are considered to be possible human carcinogens even with 885 limited evidence of carcinogenicity in animals. 886 c. DuPont had established its own guidelines, by which the "Not Likely to be a Human 887 Carcinogen" designation would have required that the mechanisms by which C-8 is 888 carcinogenic in animals are known, and that they are known not to be relevant to 889 humans. 890 d. DuPont was aware, from its own modeling, that C-8 water exposure levels of just 1 ppb 891 could translate into steady-state blood C-8 levels of as high as 300 ppb. 26 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 29 of 232 PAGEID #: 40793 I declare under penalty of perjury that the foregoing is true and correct and that this declaration was executed at Boston, Massachusetts on November 21, 2014. MICHAEL SIEGEL, MD, MPH Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 30 of 232 PAGEID #: 40794 APPENDIX A List of Materials Relied on, Reviewed and/or Considered Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 31 of 232 PAGEID #: 40795 Materials Relied on, Reviewed and/or Considered by Expert Michael Siegel All materials referenced and/or discussed within the report are incorporated. In addition to the materials within the report, the other materials relied on, reviewed and/or considered in the preparation of the expert report are as follows: ______ Bates Numbered Documents______ 000014 - 000027; ROWE020338 - ROWE020351 000026 - 000030; GHS006489 - GHS006493; EID722942 _______________EID722946; AR226-1693_______________ _______ 0003-0031-0002510 - 003-0031-0002518_______ 000439 - 000453; ROWE020370 - ROWE020384 001 - 0001- 0012178 - 001 - 0001- 0012179 001-00001-0012174 - 001-00001-0012175 _______ 001-0001-0002900 - 001-0001-0002901_______ _______ 001-0001-0002982 - 001-0001-0002991_______ _________________ 001-0001-0004961_________________ _______ 001-0001-0005110 - 001-0001-0005111_______ _________________ 001-0001-0005123_________________ _______ 001-0001-0008156 - 001-0001-0008161_______ _______ 001-0001-0008252 - 001-0001-0008257_______ _______ 001-0001-0008629 - 001-0001-0008630_______ _______ 001-0001-0009420 - 001-0001-0009421_______ _______ 001-0001-0009489 - 001-0001-0009490_______ _______ 001-0001-0012176 - 001-0001-0012177_______ _______ 001-0001-0012180 - 001-0001-0012181________ _______ 001-0001-0012182 - 001-0001-0012183________ _________________ 001-0001-0012184_________________ _______ 001-0001-0012413 - 001-0001-0012418_______ _______ 001-0001-0013441 - 001-0001-0013442_______ _______ 001-0001-0014385 - 001-0001-0014386_______ _______ 001-0001-0015753 - 001-0001-0015756_______ _______ 001-0001-0019548 - 001-0001-0019557_______ _______ 001-0001-0019611 - 001-0001-0019612_______ _______ 001-0001-0019652 - 001-0001-0019662_______ _______ 001-0001-0020279 - 001-0001-0020280_______ _________________ 001-0001-0024334_________________ _______ 001-0001-0027752 - 001-0001-0027753________ _______ 001-0001-0027754 - 001-0001-0027755________ _______ 001-0002-0001652 - 001-0002-0001745________ _______ 001-0002-0003108 - 001-0002-0003109_______ _______ 001-0002-0003128 - 001-0002-0003132_______ 001-0002-0003133 - 001-0002-0003136 Page 1 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 32 of 232 PAGEID #: 40796 Bates Numbered Documents 001-0002-0003554 - 001-0002-0003560 001-0004-0000098 - 001-0004-0000121 001-0004-0000140 - 001-0004-0000160 001-0004-0000237 - 001-0004-0000266 001-0004-0000237 - 001-0004-0000266 001-0004-0000395 - 001-0004-0000405 001-0004-0002572 - 001-0004-0002577 001-0018462 - 001-0018463 001-0131-0002070 - 001-0131-0002073 001-0131-0002156 -001-0131-0002162 __________ 001-0135-0001272__________ __________ 001-0135-0001373__________ 001-0135-0001400 - 001-0135-0001403 __________ 001-0135-0001998__________ 001-0135-0004999 - 001-0135-0005001 001-0135-0005080 - 001-0135-0005082 __________ 001-0135-0005171__________ 001-0135-0011616 - 001-0135-0011617 001-0135-0011618 - 001-0135-0011619 __________ 001-0135-0011620__________ 001-0135-0011621 - 001-0135-0011622 001-0229-0000578 - 001-0229-0000580 001-0229-0000585 - 001-0229-0000588 001-0235-0000125 - 001-0235-0000131 001-0235-0000848 - 001-0235-0000849 001-0235-0000973 - 001-0235-0000985 001-0235-00011475 - 001-0235-0001482 001-0235-0001484 - 001-0235-0001485 001-0235-0002814 - 001-0235-0002816 001-0235-0004379 - 001-0235-0004394 001-0235-0006772 - 001-0235-0006773 001-0235-0007004 - 001-0235-0007141 001-0235-0008338 - 001-0235-0008346 001-0235-0008391 - 001-0235-0008407 001- 0344-0000001 - 001-0344-0000113 002- 0001-0000001; 002-0001-0000003 002-0001-0000004 - 002-0001-0000049 002-0001-0000050 - 002-0001-0000053 002-0001-0000054 - 002-0001-0000056 __________ 002-0001-0000063__________ __________ 002-0001-0000064__________ __________ 002-0001-0000065__________ 002-0001-0000382 - 002-0001-0000383 002-0001-0000384 - 002-0001-0000394 002-0001-0000395 - 002-0001-0000412 Page 2 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 33 of 232 PAGEID #: 40797 Bates Numbered Documents 002-0001-0000442 - 002-0001-0000463 002-0001-0000464 - 002-0001-0000471 002-0001-0000472 - 002-0001-0000475 002-0001-0000476 - 002-0001-0000480 002-0001-0000481 - 002-0001-0000487 002-0001-0000483 - 002-0001-0000487 002-0001-0000488 - 002-0001-0000510 002-0001-0000490 - 002-0001-0000510 002-0001-0000634 - 002-0001-0000668 002-0001-0000671 - 002-0001-0000672 _________ 002-0001-0000674_________ 002-0001-0000721 - 002-0001-0000722 002-0001-0000723 - 002-0001-0000725 _________ 002-0001-0000742_________ 002-0001-0000743 - 002-0001-0000770 002-0001-0000743 - 002-0001-0000770 002-0001-0000872 - 002-0001-0000892 002-0001-0000893 - 002-0001-0000894 002-0001-0000897 - 002-0001-0000899 002-0001-0000900 - 002-0001-0000908 002-0001-0000909 - 002-0001-0000912 _________ 002-0001-0000913_________ 002-0001-0000917 - 002-0001-0000920 002-0001-0000921 - 002-0001-0000928 002-0001-0000969 - 0000976 002-0001-0000977 - 002-0001-0000979 002-0001-0000983 - 002-0001-0000991 002-0001-0000992 - 002-0001-0001058 002-0001-0001245 - 002-0001-0001248 002-0001-0001257 - 002-0001-0001453 002-0001-0001454 - 002-0001-0001480 _________ 002-0001-0001504_________ 002-0001-0001505 - 002-0001-0001569 002-0001-0001768 - 002-0001-0001771 002-0001-0001772 - 002-0001-0001774 002-0001-0001779 - 002-0001-0001801 002-0001-0001983 - 002-0001-0001986 _________ 002-0001-0001993_________ 002-0001-0001994 - 002-0001-0001995 _________ 002-0001-0001996_________ _________ 002-0001-0001996_________ 002-0001-0001997 - 002-0001-0002000 002-0001-0002001 - 002-0001-0002002 002-0001-0002003 - 002-0001-0002016 002-0001-0002017 Page 3 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 34 of 232 PAGEID #: 40798 _______ Bates Numbered Documents_______ __________________ 002-0001-0002023___________________ _________ 002-0001-0002026 - 002-0001-0002049_________ _________ 002-0001-0002073 - 002-0001-0002075_________ _________ 002-0001-0002076 - 002-0001-0002079_________ _________ 002-0001-0002080 - 002-0001-0002085_________ _________ 002-0001-0002096 - 002-0001-0002100_________ ___________________002-0001-0002101___________________ _________ 002-0001-0002103 - 002-0001-0002125_________ _________ 002-0001-0002127 - 002-0001-0002128_________ ___________________002-0001-0002168__________________ _________ 002-0001-0002257 - 002-0001-0002274_________ _________ 002-0001-0002275 - 002-0001-0002326_________ ___________________002-0001-0003896___________________ _________ 002-0001-0004854 - 002-0001-0004864_________ _________ 002-0001-0004876 - 002-0001-0004878_________ _________ 002-0001-0004893 - 002-0001-0004894_________ _________ 002-0001-0004901 - 002-0001-0004902_________ __________________ 002-0001-0004903___________________ _________ 002-0001-0004904 - 002-0001-0004919_________ _________ 002-0001-0004942 - 002-0001-0004944_________ __________________ 002-0001-0004948__________________ _________ 002-0001-0005008 - 002-0001-0005011_________ _________ 002-0001-0005012 - 002-0001-0005070_________ _________ 002-0001-0005075 - 002-0001-0005078_________ _________ 002-0001-0005102 - 002-0001-0005105_________ _________ 002-0001-0005106 - 002-0001-0005108_________ _________ 002-0001-0005109 - 002-0001-0005111_________ _________ 002-0001-0005112 - 002-0001-0005115_________ _________ 002-0001-0005179 - 002-0001-0005180_________ _________ 002-0001-0005181 - 002-0001-0005184_________ _________ 002-0001-0005185 - 002-0001-0005188_________ ___________________002-0001-0005196___________________ _________ 002-0001-0005296 - 002-0001-0005308_________ ___________________002-0001-0005309___________________ _________ 002-0001-0005310 - 002-0001-0005312_________ _________ 002-0001-0005313 - 002-0001-0005314_________ 002-0001-0005392; 002-0001-0007119 - 002-0001-0007171 002-0001-0005465 - 002-0001-0005467 002-0001-0005468 - 002-0001-0005469 002-0001-0005722 - 002-0001-0005724 002-0001-0005729 - 002-0001-0005747 002-0001-0005761 - 002-0001-0005762 002-0001-0005764 - 002-0001-0005855 002-0001-0005767 - 002-0001-0005855 Page 4 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 35 of 232 PAGEID #: 40799 Bates Numbered Documents 002-0001-0005861 - 002-0001-0005863 002-0001-0005868 - 002-0001-0005870 002-0001-0005871 - 002-0001-0005892 002-0001-0005893 - 002-0001-0005906 002-0001-0005893 - 002-0001-0005907 002-0001-0005920 - 002-0001-0005923 002-0001-0005921 - 002-0001-0005923 _________ 002-0001-0005928_________ 002-0001-0005936 - 002-0001-0005938 002-0001-0005939 - 002-0001-0005953 _________ 002-0001-0005960_________ _________ 002-0001-0005961_________ _________ 002-0001-0005962_________ 002-0001-0006007 - 002-0001-0006009 _________ 002-0001-0006466_________ 002-0001-0006644 - 002-0001-0006669 002-0001-0006838 - 002-0001-0006874 002-0001-0006913 - 002-0001-0006914 002-0001-0007119 - 002-0001-0007171 _________ 002-0001-0007895_________ 002-0001-0008039 - 002-0001-0008061 002-0001-0008039 - 002-0001-0008061 002-0001-0008085 - 002-0001-0008087 002-0001-0009136 - 002-0001-0009138 _________ 002-0001-0009178_________ 002-0001-0009179 - 002-0001-0009225 002-0001-0009226 - 002-0001-0009306 002-0001-0009307 - 002-0001-0009406 002-0001-0009407 - 002-0001-0009504 002-0001-0009602 - 002-0001-0009629 _________ 002-0001-0009630_________ 002-0001-0010541 - 002-0001-0010563 002-0001-0010564 - 002-0001-0010577 002-0001-0010960 - 002-0001-0010995 002-0001-0011035 - 002-0001-0011091 _________ 002-0001-0011116_________ 002-0001-0011117 - 002-0001-0011180 002-0001-0011181 - 002-0001-0011236 002-0001-0011237 - 002-0001-0011299 _________ 002-0001-0011387_________ _________ 002-0001-0011395_________ 002-0001-0011400 - 002-0001-0011402 002-0001-0011416 - 002-0001-0011417 _________ 002-0001-0011427_________ 002-0001-0011429 - 002-0001-0011430 Page 5 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 36 of 232 PAGEID #: 40800 Bates Numbered Documents _________ 002-0001-0011437_________ 002-0001-0011446 - 002-0001-0011448 002-0001-0011449 - 002-0001-0011451 002-0001-0011469 - 002-0001-0011470 002-0001-0011471 - 002-0001-0011472 _________ 002-0001-0011476_________ 002-0001-0011484 - 002-0001-0011486 002-0001-0011487 - 002-0001-0011490 002-0001-0011493 - 002-0001-0011496 002-0001-0011497 - 002-0001-0011498 _________ 002-0001-0011645_________ 002-0001-0011816 - 002-0001-0011818 002-0001-0011846 - 002-0001-0011849 _________ 002-0001-0011898_________ 002-0001-0011925 - 002-0001-0011930 002-0001-0012035 - 002-0001-0012036 __________ 002-0001-005965__________ __________ 002-0001-011438__________ __________ 002-0001-011440__________ 002-0001-011836 - 002-0001-0011839 _________ 002-0002-0000027_________ 002-0002-0000206 - 002-0002-0000208 002-0002-0000213 - 002-0002-0000218 002-0002-0000219 - 002-0002-0000223 002-0002-0000224 - 002-0002-0000237 002-0002-0000254 - 002-0002-0000255 002-0002-0000338 - 002-0002-0000354 002-0002-0000407 - 002-0002-0000439 _________ 002-0002-0000644_________ 002-0002-0000647 - 002-0002-0000655 _________ 002-0002-0000656_________ 002-0002-0000657 - 002-0002-0000658 _________ 002-0002-0000659_________ 002-0002-0000660 - 002-0002-0000659 002-0002-0000661 - 002-0002-0000662 002-0002-0000664 - 002-0002-0000668 002-0002-0000698 - 002-0002-0000701 002-0002-0000706 - 002-0002-0000715 002-0002-0000749 - 002-0002-0000751 002-0002-0000752 - 002-0002-0000768 _________ 002-0002-0000773_________ _________ 002-0002-0000774_________ _________ 002-0002-0000775_________ 002-0002-0000776 - 002-0002-0000782 002-0002-0000783 - 002-0002-0000786 Page 6 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 37 of 232 PAGEID #: 40801 Bates Numbered Documents 002-0002-0000809 - 002-0002-0000812 _________ 002-0002-0000817_________ _________ 002-0002-0000845_________ _________ 002-0002-0000862_________ _________ 002-0002-0000899_________ 002-0002-0000900 - 002-0002-0000901 002-0002-0000903 - 002-0002-0000904 _________ 002-0002-0000905_________ _________ 002-0002-0000906_________ 002-0002-0000908 - 002-0002-0000909 002-0002-0000910 - 002-0002-0000911 002-0002-0000912 - 002-0002-0000918 002-0002-0000924 - 002-0002-0000925 _________ 002-0002-0001000_________ 002-0007-0000033 - 002-0007-0000037 002-0007-0000038 - 002-0007-0000092 002-0007-0000111 - 002-0007-0000114 002-0007-0000120 - 002-0007-0000132 002-0007-0000188 - 002-0007-0000192 002-0007-0000198 - 002-0007-0000200 002-0007-0000224 - 002-0007-0000226 002-0007-0000230 - 002-0007-0000290 _________ 002-0007-0000298_________ 002-0007-0000299 - 002-0007-0000315 002-0007-0000305 - 002-0007-0000308 002-0007-0000309 - 002-0007-0000315 002-0007-0000316 - 002-0007-0000383 002-0007-0000384 - 002-0007-0000405 002-0007-0000406 - 002-0007-0000411 002-0007-0000493 - 002-0007-0000547 _________ 002-0007-0000561_________ 002-0007-0001060 - 002-0007-0001132 002-0007-0001341 - 002-0007-0001349 _________ 002-0007-0001350_________ 002-0007-0001351 - 002-0007-0001353 _________ 002-0007-0001376_________ _________ 002-0007-0001377_________ 002-0007-0001378 - 002-0007-0001381 _________ 002-0007-0001382_________ 002-0007-0001389 - 002-0007-0001405 002-0007-0001406 - 002-0007-0001408 002-0007-0001409 - 002-0007-0001410 002-0007-0001411 - 002-0007-0001414 002-0007-0001509 - 002-0007-0001510 002-0007-0002167 - 002-0007-0002184 Page 7 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 38 of 232 PAGEID #: 40802 Bates Numbered Documents __________ 002-004-0000794__________ __________ 002-004-0000956__________ 002-0047-0001678 - 022-0047-0001682 _________ 002-0131-0000006_________ 002-0131-0000008 - 002-0131-0000021 002-0131-0000008 - 002-0131-0000026 002-0131-0000032 - 002-0131-0000066 002-0131-0000067 - 002-0131-0000068 002-0131-0000069 - 002-0131-0000092 002-0131-0000182 - 002-0131-0000185 002-0131-0000186 - 002-0131-0000198 002-0131-0000212 - 002-0131-0000226 002-0131-0000227 - 002-0131-0000241 002-0131-0000242 - 002-0131-0000256 002-0131-0000257 - 002-0131-0000272 002-0131-0000273 - 002-0131-0000284 002-0131-0000285 - 002-0131-0000296 002-0131-0000297 - 002-0131-0000311 002-0131-0000312 - 002-0131-0000324 002-0131-0000325 - 002-0131-0000337 002-0131-0000354 - 002-0131-0000378 002-0131-0000379 - 002-0131-0000401 002-0131-0000423 - 002-0131-0000441 002-0131-0000465 - 002-0131-0000466 002-0131-0000487 - 002-0131-0000488 002-0131-0000640 - 002-0131-0000653 002-0131-0000654 - 002-0131-0000658 002-0131-0000794 - 002-0131-0000813 002-0131-0000814 - 002-0131-0000833 002-0131-0000834 - 002-0131-0000836 002-0131-0000837 - 002-0131-0000879 _________ 002-0131-0000921_________ 002-0131-0000922 - 002-0134-0000928 002-0131-0000929 - 002-0131-0000938 002-0131-0000939 - 002-0131-0000966 002-0131-0000967 - 002-0131-0000972 002-0131-0000973 - 002-0131-0000975 002-0131-0000976 - 002-0131-0000980 _________ 002-0131-0000981_________ 002-0131-0001029 - 002-0131-0001042 002-0131-0001043 - 002-0131-0001065 002-0131-0001066 - 002-0131-0001068 002-0131-0001069 - 002-0131-0001070 002-0131-0001071 - 002-0131-0001079 002-0131-0001080 - 002-0131-0001083 Page 8 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 39 of 232 PAGEID #: 40803 Bates Numbered Documents _________ 002-0131-0001084_________ 002-0131-0001085 - 002-0131-0001088 002-0131-0001089 - 002-0131-0001090 002-0131-0001262 - 002-0131-0001282 002-0131-0001283 - 002-0131-0001297 002-0131-0001298 - 002-0131-0001300 002-0131-0001305 - 002-0131-0001322 002-0131-0002682 - 002-0131-0002685 002-0131-0002749 - 002-0131-0002822 _________ 002-0131-0002824_________ _________ 002-0131-0002826_________ 002-0131-0002847; 002-0131-0000049 002-0131-0002935 - 002-0131-0002939 002-0131-0002940 - 002-0131-0002942 _________ 002-0131-0004237_________ 002-0131-0004932 - 002-0131-0004937 002-0131-0004936 - 002-0131-0004937 _________ 002-0131-0004939_________ 002-0131-0004964 - 002-0131-0004965 002-0131-0005117 - 002-0131-0005134 002-0131-0005913 - 002-0131-0005915 002-0131-0005990 - 002-0131-0005991 002-0131-0005992 - 002-0131-0005993 002-0131-0006008 - 002-0131-0006010 002-0131-0006011 - 002-0131-0006012 002-0131-0006455 - 002-0131-0006484 002-0131-0006485 - 002-0131-0006527 002-0131-0006528 - 002-0131-0006529 002-0131-0006528 - 002-0131-0006547 002-0131-0006530 - 002-0131-0006547 002-0131-0006618 - 002-0131-0006629 _________ 002-0131-0006729_________ _________ 002-0131-0006730_________ 002-0131-0006779 - 002-0131-0006781 002-0131-0006779 - 002-0131-0006781 002-0131-0006801 - 002-0131-0006821 002-0131-0006822 - 002-0131-0006838 002-0131-0006843 - 002-0131-0006867 _________ 002-0131-0006929_________ 002-0131-0006945 - 002-0131-0006991 002-0131-0006992 - 002-0131-0007031 _________ 002-0131-0007072_________ 002-0131-0007073 - 002-0131-0007094 002-0131-0007095 - 002-0131-0007115 002-0131-0007116 - 002-0131-0007155 Page 9 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 40 of 232 PAGEID #: 40804 Bates Numbered Documents 002-0131-0007178 - 002-0131-0007180 002-0131-0007182 - 002-0131-0007184 002-0131-0007185 - 002-0131-0007193 002-0131-0007297 - 002-0131-0007314 002-0131-0007355 - 002-0131-0007401 _________ 002-0131-0007849_________ _________ 002-0131-0007849_________ _________ 002-0131-0007850_________ 002-0131-0007851 - 002-0131-0007886 002-0131-0007932 - 002-0131-0007937 002-0131-0007939 - 002-0131-0007940 002-0131-0007941 - 002-0131-0007988 _________ 002-0131-0008037_________ _________ 002-0131-0008131_________ 002-0131-0008141 - 002-0131-0008146 002-0131-0008162 - 002-0131-0008163 002-0131-0008164 - 002-0131-0008172 002-0131-0008834 - 002-0131-0008835 _________ 002-0131-0008836_________ _________ 002-0131-0008837_________ 002-0131-0008861 - 002-0131-0008862 002-0131-0008863 - 002-0131-0008864 002-0131-0009087 - 002-0131-0009088 002-0131-0009283 - 002-0131-0009296 002-0131-0009297 - 002-0131-0009298 002-0131-0009756 - 002-0131-0009762 002-0131-0010136 - 002-0131-0010146 _________ 002-0131-0010355_________ 002-0131-0010355 - 002-0131-0010356 _________ 002-0131-0010356_________ _________ 002-0131-0010628_________ _________ 002-0131-0010628_________ 002-0131-0010629 - 002-0131-0010630 002-0131-0010629 - 002-0131-0010630 002-0131-0010631 - 002-0131-0010660 002-0131-0010680 - 002-0131-0010683 002-0131-0010684 - 002-0131-0010688 002-0131-0010684 - 002-0131-0010688 002-0131-0010701 - 002-0131-0010704 002-0131-0010864 - 002-0131-0010889 002-0131-0010890 - 002-0131-0010927 002-0131-0011455 - 002-0131-0011456 002-0131-0011485 - 002-0131-0011486 002-0131-0013419 - 002-0131-0013427 002-0131-0013419 - 002-0131-013427 Page 10 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 41 of 232 PAGEID #: 40805 Bates Numbered Documents __________002-0131-0013816__________ __________002-0131-0013817__________ 002-0131-0013818 - 002-0131-0013820 002-0131-0013998 - 002-0131-0014000 002-0131-0014005 - 002-0131-0014015 002-0131-0014016 - 002-0131-0014018 002-0131-0014019 - 002-0131-0014029 002-0131-0014058 - 002-0131-0014060 002-0131-0014122 - 002-0131-0014142 002-0131-0015351 - 002-0131-0015355 __________002-0131-0015455__________ __________002-0131-0015456__________ 002-0131-0015534 - 002-0131-0015536 002-0131-0015537 - 002-0131-0015539 002-0131-0015620 - 002-0131-0015620 002-0131-0015630 - 002-0131-0015635 __________002-0131-0015650__________ 002-0131-0015681 - 002-0131-0015693 002-0131-0015694 - 002-0131-0015696 002-0131-0015697 - 002-0131-0015703 002-0131-0015704 - 002-0131-0015708 002-0131-0015715 - 002-0131-0015716 002-0131-0015717 - 002-0131-0015722 __________002-0131-0015723__________ 002-0131-0015742 - 002-0131-0015743 002-0131-0015937 - 002-0131-0015938 002-0131-0016016 - 002-0131-0016018 002-0131-0016412 - 002-0131-0016424 002-0131-0016425 - 002-0131-0016427 002-0131-0016496 - 002-0131-0016538 __________002-0131-0019925__________ __________002-0131-0020080__________ __________002-0131-0020094__________ 002-0131-0020094 - 002-0131-0020100 002-0131-0020560 - 002-0131-0020562 002-0131-0020563 - 002-0131-0020567 002-0131-0023460 - 002-0131-0023461 __________002-0131-0023462__________ 002-0131-0023503 - 002-0131-0023518 __________002-0131-0023537__________ __________002-0131-0023547__________ __________002-0131-0023557__________ 002-0131-0023568 - 002-0131-0023570 __________002-0131-0023574__________ 002-0132-0003156 - 002-0132-0003183 Page 11 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 42 of 232 PAGEID #: 40806 Bates Numbered Documents __________ 002-0132-0004265__________ 002-0132-0004268 - 002-0132-0004269 __________ 002-0132-0004470__________ 002-0132-0004475 - 002-0132-0004476 __________ 002-0132-0004842__________ 002-0132-0007296 - 002-0132-0007297 002-0132-0007299 - 002-0132-0007300 002-0132-0007408 - 002-0132-0007422 __________ 002-0132-0008371__________ __________ 002-0132-0010048__________ 002-0132-0010119 - 002-0132-0010137 002-0132-0010301 - 002-0132-0010379 002-0132-0010380 - 002-0132-0010383 002-0132-0010380 - 002-0132-0010383 __________ 002-0132-0010384__________ __________ 002-0132-0010385__________ __________ 002-0132-0010386__________ 002-0134-0000027 - 002-0134-00028 __________ 002-0134-0000044__________ __________ 002-0134-0000103__________ __________ 002-0134-0000192__________ 002-0134-0000194 - 002-0134-0000195 __________ 002-0134-0000243__________ __________ 002-0134-0000244__________ 002-0134-0000301 - 002-0134-0000305 002-0135-0000192 - 002-0135-0000194 002-0135-0000201 - 002-0135-0000215 002-0135-0000788 - 002-0135-0000791 002-0135-0001696 - 002-0135-0001706 002-0135-0001707 - 002-00135-0001708 002-0135-0002507 - 002-0135-0002514 002-0166-0000001 - 00-0166-0000018 002-0166-0000019 - 002-0166-0000053 002-0166-0000019 - 002-0166-0000053 002-0166-0000054 - 002-0166-0000082 002-0166-0000054 - 002-0166-0000082 002-0166-0000054 -002-0166-0000082 002-0214- 0004534 - 002-0214- 0004537 002-0214-0001336 - 002-0214-0001337 002-0214-0001350 - 002-0214-0001357 002-0214-0001369 - 002-0214-0001371 002-0214-0002652 - 002-0214-0002654 002-0214-0004114 - 002-0214-0004124 002-0214-0004165 - 002-0214-0004167 002-0214-0004168 - 002-0214-0004169 Page 12 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 43 of 232 PAGEID #: 40807 Bates Numbered Documents 002-0214-0004228 - 002-0214-0004236 002-0214-0004328 - 002-0214-0004331 002-0214-0004427 - 002-0214-0004429 __________ 002-0214-0004430__________ 002-0214-0004775 - 002-0214-0004778 002-0214-0004789 - 02-0214-0004790 002-0214-0004791 - 002-0214-0004794 002-0214-0004806 - 002-0214-0004810 002-0214-0004811 - 002-0214-0004829 __________ 002-0218-0000001__________ 002-0218-0000022 - 002-0218-0000023 002-0218-0001394 - 002-0218-0001396 002-0218-0001880 - 002-0218-0001887 __________ 002-0218-0002110__________ __________ 002-0218-0002277__________ __________ 002-0218-0002438__________ __________ 002-0235-0000001__________ __________ 002-0235-0000003__________ 002-0235-0000042 - 002-0235-0000046 002-0235-0000158 - 002-0235-0000171 __________ 002-0235-0000288__________ __________ 002-0235-0000373__________ 002-0235-0000603 - 002-0235-0000604 002-0235-0000620 - 002-0235-0000627 002-0235-0000722 - 002-0235-0000724 __________ 002-0235-0001181__________ __________ 002-0235-0001182__________ 002-0235-0001308 - 002-0235-0001310 002-0235-0001633 - 002-0235-0001656 002-0235-0001657 - 002-0235-0001658 002-0235-0001659 - 002-0235-0001663 002-0235-0002073 - 002-0235-0002078 002-0235-0002079 - 002-0235-0002081 002-0235-0002342 - 002-0235-0002343 002-0235-0002924 - 002-0235-0002926 002-0235-0002975 - 002-0235-0003002 002-0235-0007592 - 002-0235-0007594 002-0235-0008097 - 002-0235-0008098 002- 0235-0008112 - 002-0235-0008113 ___________ 002-132-0010048___________ 003- 0001-0000167 - 003-0001-0000186 003-0001-0000537 - 003-0001-0000557 003-0001-00011908 - 003-0001-00011910 003-0001-0001903 - 003-0001-0001920 003-0001-0002377 - 003-0001-0002380 Page 13 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 44 of 232 PAGEID #: 40808 Bates Numbered Documents 003-0001-0002540 - 003-0001-0002542 _________ 003-0001-0002640_________ 003-0001-0002884 - 003-0001-0002884 _________ 003-0001-0002908_________ 003-0001-0002926 - 003-0001-0002929 _________ 003-0001-0002948_________ 003-0001-0003237 - 003-0001-0003238 003-0001-0004205 - 003-001-0004206 003-0001-0005208 - 003-0001-0005209 003-0001-0005499 - 003-0001-0005500 _________ 003-0001-0005633_________ _________ 003-0001-0005793_________ 003-0001-0005809 - 003-0001-0005810 003-0001-0005827 - 003-0001-0005828 003-0001-0005837 - 003-0001-0005838 003-0001-0005842 - 003-0001-0005843 003-0001-0005927 - 003-0001-0005949 003-0001-0006086 - 003-0001-0006087 _________ 003-0001-0006088_________ 003-0001-0006173 - 003-0001-0006175 003-0001-0008601 - 003-0001-0008602 _________ 003-0001-0010508_________ 003-0001-0010635 - 003-0001-0010636 _________ 003-0001-0010637_________ 003-0001-0010641 - 003-0001-0010643 003-0001-0010695 - 003-0001-0010697 _________ 003-0001-0011319_________ 003-0001-0012306 - 003-0001-0012307 003-0001-0014292 - 003-0001-0014345 _________ 003-0001-0014829_________ _________ 003-0001-0017691_________ _________ 003-0001-0017719_________ 003-0001-0017792 - 003-0001-0017794 _________ 003-0001-0018397_________ 003-0001-0019316 - 003-0001-0019318 _________ 003-0001-0019345_________ 003-0001-0019350 - 003-0001-0019352 003-0001-0019691 - 003-0001-0019693 003-0001-0019694 - 003-0001-0019697 _________ 003-0001-0019742_________ _________ 003-0001-0019787_________ _________ 003-0001-0019790_________ 003-0001-0024705 - 003-0001-0024707 003-0001-0024710 - 003-0001-0024722 003-0001-0024725 - 003-0001-0024751 Page 14 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 45 of 232 PAGEID #: 40809 Bates Numbered Documents 003-0001-0024823 - 003-0001-0024826 003-0001-0024871 - 003-0001-0024880 003-0001-0025116 - 003-0001-0025118 003-0001-0025116 - 003-0001-0025118 003-0001-0025121 - 003-0001-0025122 _________ 003-0001-0025132_________ _________ 003-0001-0025132_________ _________ 003-0001-0025133_________ _________ 003-0001-0025133_________ _________ 003-0001-0025154_________ _________ 003-0001-0025154_________ _________ 003-0001-0025155_________ _________ 003-0001-0025155_________ 003-0001-0025158 - 003-0001-0025159 003-0001-0025158 - 003-0001-0025159 003-0001-0025158 - 003-0001-0025159 003-0001-0025244 - 003-0001-0025247 003-0001-0025501 - 003-0001-0025505 003-0001-0025837 - 003-0001-0025840 003-0001-0026862 - 003-0001-0026863 003-0001-0028261 - 003-0001-0028262 _________ 003-0001-0028763_________ _________ 003-0001-0028764_________ 003-0001-0028885 - 003-0001-0028886 003-0001-0030158 - 003-0001-0030159 _________ 003-0001-0030170_________ _________ 003-0002-0002222_________ _________ 003-0002-0002266_________ 003-0002-0002460 - 003-0002-0002463 003-0002-0002460 - 003-0002-0002463 003-0002-0002591 - 003-0002-0002609 _________ 003-0002-0004226_________ 003-0002-0004228 - 003-0002-0004237 003-0002-0004242 - 003-0002-0004251 _________ 003-0002-0004315_________ _________ 003-0002-0004820_________ _________ 003-0002-0005875_________ 003-0029-0000034 - 003-0029-0000037 003-0029-0000671 - 003-0029-0000672 003-0029-0000676 - 003-0029-0000681 003-0029-0000808 - 003-0029-0000826 _________ 003-0029-0001239_________ 003-0029-0001263 - 003-0029-0001285 003-0029-0001325 - 003-0029-0001326 003-0029-0001327 - 003-0029-0001329 Page 15 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 46 of 232 PAGEID #: 40810 ______Bates Numbered Documents_____ _______003-0029-0001331 - 003-0029-0001350_______ _______003-0029-0001394 - 003-0029-0001395_______ _______003-0029-0001396 - 003-0029-0001398_______ _______003-0029-0001538 - 003-0029-0001539_______ _______003-0029-0001538 - 003-0029-0001539_______ _______003-0029-0001538 - 003-0029-0001539_______ _______003-0029-0001546 - 003-0029-0001548_______ _______003-0029-0001549 - 003-0029-0001553_______ 003-0029-0001554 - 003-0029-0001555; CULLEN02066 _______003-0029-0001556 - 003-0029-0001557_______ _______003-0029-0001556 - 003-0029-0001557_______ _______003-0029-0002035 - 003-0029-0002036_______ _______003-0029-0002390 - 003-0029-0002391_______ _______003-0029-0002399 - 003-0029-0002400_______ _______003-0029-0002592 - 003-0029-0002600_______ ________________ 003-0029-0002601________________ ________________ 003-0029-0002613________________ _______003-0029-0002677 - 003-0029-0002679_______ ________________ 003-0030-0000056________________ _______003-0030-0000057 - 003-0030-0000122_______ _______003-0030-0000148 - 003-0030-0000151_______ ________________ 003-0030-0000327________________ _______003-0030-0000395 - 003-0030-0000396_______ _______003-0030-0000403 - 003-0030-0000409_______ _______003-0030-0001740 - 003-0030-0001743_______ ________________ 003-0030-0001787________________ ________________ 003-0030-0002344________________ _______003-0030-0002380 - 003-0030-0002383_______ _______003-0030-0002531 - 003-0030-0002534_______ _______003-0030-0002535 - 003-0030-0002536_______ ________________ 003-0030-0002558________________ ________________ 003-0030-0002559________________ _______003-0030-0002968 - 003-0030-0002970_______ _______003-0030-0002971 - 003-0030-0002984_______ _______ 003-0030-0003232 - 003-0030-000309_______ ________________ 003-0030-0003436________________ ________________ 003-0030-0003452________________ ________________ 003-0030-0003455________________ ________________ 003-0030-0003523________________ ________________ 003-0030-0003526________________ _______003-0030-0003527 - 003-0030-0003528_______ ________________ 003-0030-0003541________________ ________________ 003-0030-0003544________________ ________________ 003-0030-0003544________________ 003-0030-0003545 Page 16 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 47 of 232 PAGEID #: 40811 Bates Numbered Documents __________ 003-0030-0003545__________ 003-0030-0003575 - 003-0030-0003582 003-0031-0000003 - 003-0031-0000005 __________ 003-0031-0000026__________ 003-0031-0000063 - 003-0031-0000064 __________ 003-0031-0000152__________ 003-0031-0000171 - 003-0031-0000188 003-0031-0000447 - 0003-0031-0000448 003-0031-0000939 - 003-0031-0000940 003-0031-0001354 - 003-0031-0001357 003-0031-0001404 - 003-0031-0001405 __________ 003-0031-0001412__________ 003-0031-0001777 - 003-0031-0001865 003-0031-0002147 - 003-0031-0002149 003-0031-0002150 - 003-0031-0002151 003-0031-0002505 - 003-0031-00002507 003-0031-0002535 - 003-0031-00025337 003-0031-0002543 - 003-0031-0002546 __________ 003-0031-0002550__________ __________ 003-0131-0000004__________ 003-0131-0000811 - 003-0131-0000827 __________ 003-0131-0000903__________ __________ 003-0131-0000903__________ __________ 003-0131-0001054__________ __________ 003-0131-0001054__________ 003-0131-0001129 - 003-0131-0001131 003-0131-0001129 - 003-0131-0001131 003-0131-0001285 - 003-0131-0001299 003-0131-0001608 - 003-0131-0001611 003-0131-0002917 - 003-0131-0002918 003-0131-0003281 - 003-0131-0003309 __________ 003-0131-0003321__________ 003-0131-0003322 - 003-0131-0003326 003-0131-0003327 - 003-0131-0003333 003-0131-0003412 - 003-0131-0003433 __________ 003-0131-0003610__________ 003-0131-0003679 - 003-0131-0003681 003-0131-0004982 - 003-0131-0005005 003-0131-0005247 - 003-0131-0005269 003-0131-0005329 - 003-0131-0005331 003-0131-0006115 - 003-0131-0006118 003-0131-0006625 - 003-0131-0006628 003-0131-0006726 - 003-0131-0006727 003-0131-0006807 - 003-0131-0006809 003-0131-0007086 - 003-0131-0007108 Page 17 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 48 of 232 PAGEID #: 40812 Bates Numbered Documents 003-0131-0007172 - 003-0131-0007173 003-0134-0000082 - 003-0134-0000082 __________ 003-0134-0000106__________ 003-0134-0000129 - 003-0134-0001134 __________ 003-0134-0000135__________ 003-0134-0000279 - 003-0134-0000280 __________ 003-0135-0002315__________ 003-0218-0002845 - 003-0218-0002848 __________ 003-0218-0003630__________ __________ 003-0218-0003631__________ __________ 003-0218-0004416__________ 003-0218-0004760 - 003-0218-0004761 003-0230-0000062 - 003-0230-0000066 __________ 003-0230-0000614__________ 003-0230-0000723 - 003-0230-0000735 003-0236-0000644 - 003-0236-0000646 __________ 003-0236-0000911__________ __________ 003-0236-0002245__________ 003-0236-0002326 - 003-0236-0002340 003-0236-0003679 - 003-0236-0003683 003-0236-0004480 - 003-0236-0004490 003-0236-0005115 - 003-0236-0005120 003-0236-0005121 - 003-0236-0005122 __________ 003-0236-0005137__________ __________ 003-0236-0005139__________ __________ 003-0236-0005201__________ __________ 003-0236-0005957__________ 003-0366-0000007 - 003-0366-0000008 003-0366-0000009 - 003-0366-0000010 003-0383-0000001 - 003-0383-0000026 003-0385-0000001 - 003-0385-0000053 __________ 003-0391-0000029__________ 003-0391-0000030 - 003-0391-0000035 003-0391-0000036 - 003-0391-0000041 003-0391-0000042 - 003-0391-0000049 __________ 003-0394-0000001__________ __________ 003-0394-0000002__________ 003-0394-0000004 - 003-0394-0000005 003-0394-0000006 - 003-0394-0000007 __________ 003-0399-0000001__________ 003-0399-00000117 - 003-0399-00000119 __________ 003-0399-0000120__________ ___________ 003114-003116___________ 003119 - 003125; EID072034 - EID072045 003126-003141 Page 18 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 49 of 232 PAGEID #: 40813 _______Bates Numbered Documents______ __________________ 003142-003165___________________ 003168 - 003172; 058-0280-0000019 - 058-0280-0000023 ___________ 003173 - 003466; T4171 - T4199___________ 003485 - 003509; WVDEP13300 - WVDEP13324 _______ 003577 - 003599; EID668369 - EID668391_______ __________________ 003581-003583___________________ __________________ 003590-003595___________________ ___________________0 0 3 5 9 6 - 0 0 3 5 9 9 __________________ ________ 004-0003-0000016 - 004-0003-0000024________ ________ 004-0003-0000030 - 004-0003-0000037________ ________ 004-0003-0000038 - 004-0003-0000040________ __________________004-0003-0000830_________________ __________________004-0003-0000837_________________ ________ 004-0003-0000841 - 004-0003-0000842________ ________ 004-0003-0000869 - 004-0003-0000872________ ________ 004-0003-0000884 - 004-0003-0000885________ ________ 004-0003-0000886 - 004-0003-0000888________ ________ 004-0003-0000960 - 004-0003-0000964________ __________________004-0003-0000975__________________ ________ 004-0003-0000976 - 004-0003-0000977________ ________ 004-0003-0000978 - 004-0003-0001000________ ________ 004-0003-0001053 - 004-0003-0001074________ ________ 004-0003-0001193 - 004-0003-0001196________ ________ 004-0003-0001201 - 004-0003-0001205________ _______ 004-0003-0001279 - 004-00003-0001349_______ ________ 004-0003-0001350 - 004-0003-0001422________ ________ 004-0003-0001423 - 004-0003-0001498________ ________ 004-0003-0001499 - 004-0003-0001544________ ________ 004-0131-0000857 - 004-0131-0000881________ ________ 004-0131-0001080 - 004-0131-0001122________ ________ 004-0131-0001138 - 004-0131-0001159________ ________ 004-0131-0001160 - 004-0131-0001163________ __________________004-0134-0000046_________________ __________________004-0134-0000049_________________ __________________004-0134-0000050_________________ ________ 004-0134-0000056 - 004-0134-0000057________ __________________004-0134-0000117_________________ ________ 004-0134-0000228 - 004-0134-0000233________ ________ 004-0134-0000247 - 004-0134-0000249________ ________ 004-0134-0000275 - 004-0134-0000278________ __________________004-0134-0000515__________________ ________ 004-0134-0000531 - 004-0134-0000535________ ________ 004-0134-0000536 - 004-0134-0000537________ _________004-0134-0000538 - 004-0134-000542_________ 004-0134-0000546 - 004-0134-0000548 Page 19 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 50 of 232 PAGEID #: 40814 Bates Numbered Documents _________ 004-0134-0000549_________ _________ 004-0134-0000557_________ 004-0134-0000608 - 004-0134-0000621 _________ 004-0134-0000626_________ _________ 004-0134-0000626_________ _________ 004-0134-0000627_________ 004-0134-0000638 - 004-0134-0000639 004-0134-0000638 - 004-0134-0000639 004-0134-0000701 - 004-0134-0000702 004-0134-0000747 - 004-0134-0000749 004-0134-0000747 - 004-0134-0000749 _________ 004-0134-0000908_________ _________ 004-0134-0000909_________ 004-0134-0000942 - 004-0134-0000943 _________ 004-0134-0001006_________ 004-0134-0001013 - 004-0134-0001015 004-0134-0001022 - 004-0134-0001023 004-0134-0001173 - 004-0134-0001174 004-0134-0001175 - 004-0134-0001176 _________ 004-0134-0001179_________ 004-0134-0001180 - 004-0134-0001182 _________ 004-0134-0001190_________ _________ 004-0134-0001199_________ 004-0134-0001200 - 004-0134-0001201 004-0134-0001200 - 004-0134-0001201 _________ 004-0134-0001211_________ _________ 004-0134-0001259_________ 004-0134-0001260 - 004-0134-0001261 004-0134-0001437 - 004-0134-0001439 004-0134-0001442 - 004-0134-0001443 _________ 004-0134-0001579_________ _________ 004-0134-0001618_________ 004-0134-0001660 - 004-0134-0001662 _________ 004-0134-0001667_________ 004-0134-0001729 - 004-0134-0001730 004-0134-0001731 - 004-0134-0001732 004-0134-0001733 - 004-0134-0001737 004-0134-0001738 - 004-0134-0001741 004-0134-0001742 - 004-0134-0001745 004-0134-0001750 - 004-0134-0001751 004-0134-0001764 - 004-0134-0001766 004-0134-0001794 - 004-0134-0001795 _________ 004-0134-0001807_________ _________ 004-0134-0001855_________ 004-0134-0001951 Page 20 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 51 of 232 PAGEID #: 40815 ________Bates Numbered Documents________ ___________________ 004-0134-0002011___________________ ___________________ 004-0134-0002012___________________ ___________________ 004-0134-0002015___________________ __________004-0134-0002016 - 004-0134-0002017__________ __________004-0134-0002018 - 004-0134-0002019__________ __________004-0134-0002070 - 004-0134-0002072__________ __________004-0134-0002070 - 004-0134-0002072__________ __________004-0134-0002077 - 004-0134-0002079__________ __________004-0134-0002086 - 004-0134-0002088__________ __________004-0134-0002130 - 004-0134-0002133__________ ___________________ 004-0134-0002151___________________ ___________________004-0134-00022025___________________ __________004-0134-0002209 - 004-0134-0002228__________ ___________________ 004-0134-0002229___________________ __________004-0134-0002230 - 004-0134-0002231__________ __________004-0134-0002259 - 004-0134-0002262__________ __________004-0134-0002289 - 004-0134-0002300__________ __________ 004-0134-0002290 004-0134-0002300__________ __________004-0134-0002326 - 004-0134-0002330__________ __________004-0134-0002377 - 004-0134-0002407__________ __________004-0134-0002605 - 004-0134-0002607__________ ___________________ 004-0134-0002684___________________ __________004-0134-0002685 - 004-0134-0002692__________ ___________________ 004-0193-0001417___________________ ___________________ 004-0193-0002119___________________ ___________________ 004-0193-0002119___________________ 004-0193-0002194; 003-0001-0022952; WEGMAN00891 __________004-0193-0002535 - 004-0193-0002538__________ 004-0193-0002782 - 004-0193-0002783; 002-0001-0000064 ___________________ 002-0001-0000082___________________ __________004-0193-0002904 - 004-0193-0002905__________ __________004-0193-0002904 - 004-0193-0002905__________ __________004-0219-0001597 - 004-0219-0001599__________ __________004-0219-0001726 - 004-0219-0001736__________ __________ 004-0219-0001748 - 004-219-0001753__________ __________ 004-0219-0001795 - 004-219-0001800__________ __________004-0219-0002217 - 004-0219-0002219__________ __________004-0219-0002229 - 004-0219-0002230__________ ___________________ 004-0219-0002242___________________ __________ 004-0219-0002505 -004-0219-0002513__________ __________004-0219-0002692 - 004-0219-0002694__________ __________004-0219-0003270 - 004-0219-0003272__________ __________004-0219-0003664 - 004-0219-0003674__________ __________004-0219-0003702 - 004-0219-0003709__________ 004-0219-0003712 - 004-0219-0003759 Page 21 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 52 of 232 PAGEID #: 40816 Bates Numbered Documents 004-0219-0003779 - 004-0219-0003808 004-0219-0004880 - 004-0219-0004886 _________ 004-0219-0004887_________ 004-0219-0004888 - 004-0219-0004894 004-0219-0004895 - 004-0219-0004897 004-0219-0004898 - 004-0219-0004909 004-0219-0004910 - 004-0219-0004915 004-0219-0004924 - 004-0219-0004931 _________ 004-0219-0004941_________ 004-0219-0005557 - 004-0219-0005579 004-0219-0005688 - 004-0219-0005689 004-0219-0005699 - 004-0219-0005701 004-0219-0005705 - 004-0219-0005708 004-0219-0005709 - 004-0219-0005712 004-0219-0005723 - 004-0219-0005725 004-0219-0005818 - 004-0219-0005820 004-0219-0005822 - 004-0219-0005862 004-0219-0005863 - 004-0219-0005868 004-0219-0005869 - 004-0219-0005874 004-0219-0005875 - 004-0219-0005880 004-0219-0005897 - 004-0219-0005901 004-0219-0005902 - 004-0219-0005916 004-0219-0005917 - 004-0219-0005936 004-0219-0005937 - 004-0219-0005939 004-0219-0005940 - 004-0219-0005946 004-0219-0005947 - 004-0219-0005948 004-0219-0005949 - 004-0219-0005974 _________ 004-0219-0005975_________ 004-0219-0006006 - 004-0219-0006028 004-0219-0006029 - 004-0219-0006031 004-0219-0006035 - 004-0219-0006037 004-0219-0006038 - 004-0219-0006040 004-0219-0006041 - 004-0219-0006043 004-0219-0006044 - 004-0219-0006047 _________ 004-0219-0006048_________ 004-0219-0006052 - 004-0219-0006054 004-0219-0006120 - 004-0219-0006123 004-0219-0006124 - 004-0219-0006127 004-0219-0006128 - 004-0219-0006130 004-0219-0006134 - 004-0219-0006148 004-0219-0006179 - 004-0219-0006181 004-0219-0006182 - 004-0219-0006201 004-0219-0006217 - 004-0219-0006219 004-0219-0006297 - 004-0219-0006300 004-0219-0006301 - 004-0219-0006303 Page 22 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 53 of 232 PAGEID #: 40817 Bates Numbered Documents 004-0219-0006304 - 004-0219-0006308 004-0219-0006463 - 004-0219-0006466 _________ 004-0219-0006495_________ 004-0219-0006500 - 004-0219-0006506 004-0219-0006533 - 004-0219-0006537 004-0219-0006592 - 004-0219-0006598 004-0219-0006599 - 004-0219-0006605 004-0219-0006606 - 004-0219-0006613 004-0219-0006736 - 004-0219-0006758 004-0219-0006768 - 004-0219-0006773 _________ 004-0219-0006774_________ 004-0219-0006781 - 004-0219-0006805 004-0219-0006908 - 004-0219-0006928 004-0219-0006929 - 004-0219-0006935 004-0219-0006936 - 004-0219-0006937 _________ 004-0219-0007093_________ 004-0219-0007094 - 004-0219-0007118 004-0219-0007119 - 004-0219-0007161 004-0219-0007186 - 004-0219-0007205 _________ 004-0219-0007220_________ _________ 004-0236-0000043_________ 004-0236-0000136 - 004-0236-0000137 004-0236-0000143 - 004-0236-0000171 004-0236-0000249 - 004-0236-0000325 _________ 004-0236-0000330_________ 004-0236-0000332 - 004-0236-0000337 _________ 004-0236-0000365_________ 004-0236-0000412 - 004-0236-0000414 004-0236-0000441 - 004-0236-0000443 004-0236-0000532 - 004-0236-0000540 004-0236-0000541 - 004-0236-0000542 004-0236-0000551 - 004-0236-0000564 004-0236-0000595 - 004-0236-0000610 004-0236-0000611 - 004-0236-0000617 004-0236-0002865 - 004-0236-0002930 _________ 004-0236-0005572_________ _________ 004-0236-0005648_________ 004-0236-0005706 - 004-0236-0005716 004-0236-0005717 - 004-0236-0005780 _________ 004-0236-0005932_________ 004-0236-0006134 - 004-0236-0006135 004-0236-0006200 - 004-0236-0006201 004-0236-0006365 - 004-0236-0006371 __________ 004150 - 004183__________ 004191 - 004193 Page 23 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 54 of 232 PAGEID #: 40818 Bates Numbered Documents 004- 219-0006614 - 004-0219-0006635 ___________ 004262 - 004276___________ 0045-0003-0001350 - 004-0003-0001422 005- 0002-0000773 - 005-0002-0000782 005-0385-0000122 - 005-0385-0000146 005-0388-0000001 - 005-0388-0000024 005- 0396-0000002 - 005-0396-0000008 ___________ 005899-005901___________ 006- 0002-0000007 - 006-0002-0000008 006-0002-0000263 - 006-0002-0000265 006-0002-0001093 - 006-0002-0001094 006-0002-0002208 - 006-0002-0002219 006-0002-0003204 - 006-0002-0003219 006-0002-0003383 - 006-0002-0003387 006-0002-0003958 - 006-0002-0003971 006-0002-0004166 - 006-0002-0004178 006-0002-0004206 - 006-0002-0004207 006-0002-0006137 - 006-0002-0006138 006-0002-0006137 - 006-0002-0006138 006-0002-0006147 - 006-0002-0006148 006-0002-0006149 - 006-0002-00051 006-0002-0006156 - 006-0002-0006158 006-0002-0006199 - 006-0002-0006201 006-0002-0006208 - 006-0002-0006209 006-0002-0006230 - 006-0002-0006231 006-0002-0006620 - 006-0002-0006623 006-0002-0006626 - 006-0002-0006627 006-0002-0006630 - 006-0002-0006633 __________ 006-0002-0006634__________ 006-0002-0006636 - 006-0002-0006637 006-0002-0006638 - 006-0002-0006639 006-0002-002220 - 006-0002-002224 006-0008-0000321 - 006-0008-0000323 006-0008-0001275 - 006-0008-0001318 006-0008-0001328 - 006-0008-0001343 006-0008-0002632 - 006-0008-0002633 006-0009-0001200 - 006-0009-0001205 __________ 006-0009-0001390__________ 006-0009-0001978 - 006-0009-0001980 006-0009-0002043 - 006-0009-0002046 006-0009-0002047 - 006-0009-0002052 006-0009-0002390 - 006-0009-0002395 006-0009-0002548 - -006-0009-0002549 006-0010-0000622 - 006-0010-0000625 006-0010-0000702 Page 24 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 55 of 232 PAGEID #: 40819 Bates Numbered Documents 006-0010-0001407 - 006-0010-0001408 006-0010-0001409 - 006-0010-0001410 006-0010-0001409 - 006-0010-0001410 006-0010-0001441 - 006-0010-0001442 006-0010-0001444 - 006-0010-0001446 006-0010-0001450 - 006-0010-0001458 006-0131-0001042 - 006-0131-00010425 006-0131-0004364 - 006-0131-0004365 006-0131-0004643 - 006-0131-0004644 006-0131-0007121 - 006-0131-0007123 006-0131-0008724 - 006-0131-0008730 006-0131-0011049 - 006-0131-0011050 006-0133-0003433 - 006-0133-0003463 006-0133-0006307 - 006-0133-0006308 006-0133-0006322 - 006-0133-0006323 006-0133-0010707 - 006-0133-0010717 006-0133-0010718 - 006-0133-0010719 _________ 006-0133-00113414_________ 006-0133-0018206 - 006-0133-0018208 006-0133-0018374 - 006-0133-0018386 006-0133-0018457 - 006-0133-0018459 006-0133-0018857 - 006-0133-0018872 __________ 006-0133-0019538__________ 006-0133-0021990 - 006-0133-0021991 __________ 006-0133-0026156__________ __________ 006-0133-0027081__________ __________ 006-0133-0027599__________ __________ 006-0133-0028346__________ 006-0133-0029157 - 006-0133-0029158 __________ 006-0133-0029171__________ 006-0133-0029292 - 006-0133-0029296 006-0133-0029730 - 006-0133-0029731 006-0133-0030806 - 006-0133-0030852 __________ 006-0133-0032093__________ __________ 006-0133-0032322__________ 006-0133-0032378 - 006-0133-0032379 006-0133-0032680 - 006-0133-0032682 __________ 006-0133-0033126__________ __________ 006-0133-0033194__________ 006-0133-0033747 - 006-0133-0033751 __________ 006-0133-0034208__________ __________ 006-0133-0035428__________ __________ 006-0133-0036331__________ 006-0133-0036347 - 006-0133-0036348 006-0133-0036576 Page 25 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 56 of 232 PAGEID #: 40820 Bates Numbered Documents __________ 006-0133-0038585__________ 006-0133-0038948 - 006-0133-0038991 006-0133-0038992 - 006-0133-0038993 __________ 006-0133-0040405__________ 006-0133-0040921 - 006-0133-0040922 __________ 006-0133-0041377__________ 006-0133-0041684 - 006-0133-0041685 __________ 006-0133-0042683__________ __________ 006-0133-0042687__________ __________ 006-0133-0042897__________ __________ 006-0133-0044387__________ 006-0133-0044441 - 006-0133-0044442 006-0133-0044772 - 006-0133-0044773 006-0133-0048711 - 006-0133-0048713 __________ 006-0133-0048805__________ 006-0133-0048905 - 006-0133-0048906 006-0133-0049232 - 006-0133-0049235 006-0133-0054251 - 006-0133-0054318 006-0133-0055648 - 006-0133-0055653 006-0133-0056442 - 006-0133-0056443 006-0133-0056447 - 006-0133-0056448 __________ 006-0133-0056514__________ __________ 006-0133-0058901__________ __________ 006-0133-0059404__________ 006-0133-0059766 - 006-0133-0059767 006-0133-0060092 - 006-0133-0060094 006-0133-0060206 - 006-0133-0060208 006-0133-0060213 - 006-0133-0060215 006-0133-0060526 - 006-0133-0060528 006-0133-0061142 - 006-0133-0061142 006-0133-0061386 - 006-0133-0061388 006-0133-0061830 - 006-0133-0061830 006-0133-0061834 - 006-0133-0061837 006-0133-0061954 - 006-0133-0061955 006-0133-0062619 - 006-0133-0062624 006-0133-0062746 - 006-0133-0062747 006-0133-0062791 - 006-0133-0062794 006-0133-0062791 - 006-0133-0062794 006-0133-0064570 - 006-0133-0064571 006-0133-0065444 - 006-01033-0065446 006-0133-0066117 - 006-0133-0086120 006-0133-0067279 - 006-0133-0067330 __________ 006-0133-0067336__________ 006-0133-0069708 - 006-0133-0069709 006-0133-00699445 - 006-0133-0069946 Page 26 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 57 of 232 PAGEID #: 40821 Bates Numbered Documents __________ 006-0133-0070179__________ 006-0133-0070184 - 006-0133-0070185 __________ 006-0133-0071712__________ __________ 006-0133-0073388__________ 006-0133-0073624 - 006-0133-0073625 006-0133-0074278 - 006-0133-0074281 __________ 006-0133-0076242__________ 006-0133-0076266 - 006-0133-0076267 __________ 006-0133-0076308__________ 006-0133-0077692 - 0077694 006-0133-00777692 - 006-0133-0077794 006-0133-0078559 - 006-0133-0078560 006-0133-0078747 - 006-0133-0078748 006-0133-0078791 - 006-0133-0078799 006-0133-0079073 - 006-0133-0079076 __________ 006-0133-0079597__________ 006-0133-0080051 - 006-0133-0080052 006-0133-0080114 -006-0133-0080118 006-0133-0081531 - 006-0133-0081532 006-0133-0082997 - 006-0133-0082998 006-0133-0082997 - 006-0133-0082998 __________ 006-0133-0083555__________ __________ 006-0133-0083555__________ 006-0133-0083664 - 006-0133-0083665 __________ 006-0133-0083772__________ 006-0133-0084066 - 006-0133-0084067 006-0133-0084189 - 006-0133-0084190 006-0133-0084189 - 006-0133-0084190 006-0133-0084196 - 006-0133-0084197 006-0133-0084219 - 006-0133-0084220 006-0133-0084219 - 006-0133-0084220 006-0133-0084223 - 006-0133-0084224 006-0133-0084223 - 006-0133-0084224 006-0133-0084421 - 006-0133-0084422 006-0133-0085077 - 006-0133-0085079 006-0133-0085420 - 006-0133-0085421 __________ 006-0133-0085479__________ 006-0133-0085733 - 006-0133-0085734 006-0133-0085869 - 006-0133-0085883 006-0133-0086130 - 006-0133-0086131 006-0133-0086134 - 006-0133-0086136 006-0133-0086309 - 006-0133-0086312 006-0133-0086757 - 006-0133-0086758 __________ 006-0133-0086939__________ 006-0133-0087024 - 006-0133-0087029 Page 27 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 58 of 232 PAGEID #: 40822 Bates Numbered Documents 006-0133-0087072 - 006-0133-0087073 _________ 006-0133-0087085_________ _________ 006-0133-0087085_________ 006-0133-0087093 - 006-0133-0087094 006-0133-0088108 - 006-0133-0088113 006-0133-0088139 - 006-0133-0088141 006-0133-0088146 -006-0133-0088151 006-0133-0088168 - 006-0133-0088175 _________ 006-0133-0088762_________ 006-0133-0088888 - 006-0133-0088889 006-0133-0089168 - 006-0133-0089182 006-0133-0089637 - 006-0133-0089639 006-0133-0090099 - 006-0133-0090100 006-0133-0090109 - 006-0133-0090110 _________ 006-0133-0090499_________ _________ 006-0133-0090878_________ 006-0133-0091622 - 006-0133-0091623 006-0133-0091679 - 006-0133-0091687 006-0133-0091738 - 006-0133-0091739 006-0133-0091815 - 006-0133-0091817 006-0133-0091815 - 006-0133-0091823 _________ 006-0133-0091832_________ _________ 006-0133-0091857_________ _________ 006-0133-0092274_________ 006-0133-0092780 - 006-0133-0092781 _________ 006-0133-0092782_________ _________ 006-0133-0093882_________ 006-0133-0094043 - 006-0133-0094061 006-0133-0094532 - 006-0133-0094535 006-0133-0094718 - 006-0133-0094720 006-0133-0095403 - 006-0133-0095409 006-0133-0095476 - 009-0133-0095478 006-0133-0095479 - 006-0133-0095483 006-0133-0095514 - 006-0133-0095519 006-0133-0095514 - 006-0133-0095519 006-0133-0096695 - 006-0133-0096704 _________ 006-0133-0096710_________ 006-0133-0097862 - 006-0133-0097875 _________ 006-0133-0098797_________ 006-0133-0100153 - 006-0133-0100154 006-0133-0100748 - 006-0133-0100756 006-0133-0100858 - 006-0133-0100859 006-0133-0101429 - 006-0133-0101431 006-0133-0101493 - 006-0133-0101506 006-0133-0101622 - 006-0133-0101635 Page 28 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 59 of 232 PAGEID #: 40823 Bates Numbered Documents 006-0133-0105256 - 006-0133-0105258 006-0133-0105256 - 006-0133-0105258 006-0133-0105477 - 006-0133-0105495 006-0133-0105477 - 006-0133-0105495 006-0133-0105849 - 006-0133-0105850 _________ 006-0133-0105882_________ 006-0133-0105889 - 006-0133-0105890 _________ 006-0133-0108123_________ 006-0133-0108233 - 006-0133-0108234 006-0133-0108584 - 006-0133-0108585 006-0133-0108754 - 006-0133-0108757 _________ 006-0133-0108770_________ 006-0133-0108841-006-0133-0108846 006-0133-0109021 - 006-0133-0109023 _________ 006-0133-0109464_________ _________ 006-0133-0110420_________ 006-0133-0111563 - 006-0133-0111564 _________ 006-0133-0112817_________ 006-0133-0113485 - 006-0133-0113486 006-0133-0113911 - 006-0133-0113915 _________ 006-0133-0113943_________ 006-0133-0114118 - 006-0133-0114119 006-0133-0114956 - 006-0133-0114957 006-0133-0115098 - 006-0133-0115124 006-0133-0115521 - 006-0133-0115523 _________ 006-0133-0115637_________ _________ 006-0133-0119725_________ 006-0133-0119730 - 006-0133-0119733 006-0133-0120154 - 006-0133-0120155 006-0133-0120325 - 006-0133-0120326 006-0133-0121130 - 006-0133-0121131 _________ 006-0133-0122229_________ 006-0133-0123812 - 006-0133-0123815 006-0133-0124091 - 006-0133-0124099 006-0133-0128079 - 006-0133-0128080 006-0133-0128457 - 006-0133-0128503 006-0133-0128666 - 006-0133-0128668 006-0133-0128831 - 006-0133-0128842 006-0133-0128843 - 006-0133-0128844 006-0133-0129174 - 006-0133-0129182 006-0133-0129526 - 006-0133-0129528 006-0133-0129529 - 006-0133-0129530 006-0133-0129657 - 006-0133-0129678 006-0133-0130567 - 006-0133-0130580 006-0133-0130689 - 006-0133-0130692 Page 29 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 60 of 232 PAGEID #: 40824 Bates Numbered Documents ____________ 006-0133-0131539____________ 006-0133-0132771 - 006-0133-0132773 ____________ 006-0133-0132878____________ ____________ 006-0133-0132878____________ 006-0133-0133-0143928 - 006-0133-0143930 006-0133-0133060 - 006-0133-0133062 006-0133-0133674 - 006-0133-0133675 ____________ 006-0133-013414____________ ____________ 006-0133-0134539____________ 006-0133-0135477 - 006-0133-0135479 006-0133-0135532 - 006-0133-0135535 ____________ 006-0133-0137412____________ 006-0133-0137468 - 006-0133-0137469 006-0133-0138440 - 006-0133-0138442 ____________ 006-0133-0140274____________ ____________ 006-0133-0140275____________ ____________ 006-0133-0140278____________ 006-0133-0140310 - 006-0133-0140314 006-0133-0140658 - 006-0133-0140664 006-0133-0140963 - 006-0133-0140966 006-0133-0141269 - 006-0133-0141270 ____________ 006-0133-0141283____________ 006-0133-0142377 - 006-0133-0142378 006-0133-0142849 - 006-0133-0142851 006-0133-0142849 - 006-0133-0142851 006-0133-0143092 - 006-0133-0143094 006-0133-0143095 - 006-0133-0143097 006-0133-0143099 - 006-0133-0143102 006-0133-0143099 - 006-0133-0143103 ____________ 006-0133-0143101____________ 006-0133-0143139 - 006-0133-0143141 006-0133-0143139 - 006-0133-0143141 006-0133-0143139 - 006-0133-0143141 ____________ 006-0133-0143415____________ 006-0133-0146157 - 006-0133-0146159 006-0133-0146855 - 006-0133-0146864 006-0133-0146959 - 006-0133-0146962 006-0133-0147203 - 006-0133-0147205 006-0133-0147437 - 006-0133-0147441 006-0133-0148088 - 006-0133-0148089 006-0133-0148090 - 006-0133-0148091 006-0133-0148092 - 006-0133-0148093 ____________ 006-0133-0148100____________ 006-0208-0000039 - 006-0208-0000042 006-0213-0000481 Page 30 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 61 of 232 PAGEID #: 40825 _______ Bates Numbered Documents_______ __________________ 006-0213-0000545___________________ ___________________006-0213-0000546___________________ _________ 006-0231-0000398 - 006-0231-0000406_________ _________ 006-0231-0000517 - 006-0231-0000518_________ _________ 006-0231-0000917 - 006-0231-0000920_________ _________ 006-0231-0001892 - 006-0231-0001926_________ _________ 006-0231-0001933 - 006-0231-0001934_________ _________ 006-0231-0001933 - 006-0231-0001934_________ _________ 006-0231-0001935 - 006-0231-0001936_________ _________ 006-0231-0001935 - 006-0231-0001936_________ _________ 006-0231-0001937 - 006-0231-0001938_________ _________ 006-0231-0001937 - 006-0231-0001938_________ _________ 006-0231-0001939 - 006-0231-0001955_________ __________________ 006-0232-0001704__________________ _________ 006-0236-0000080 - 006-0236-0000082_________ _________ 006-0236-0000701 - 006-0236-0000706_________ _________ 006-0236-0000872 - 006-0236-0000874_________ __________________ 006-0236-0004618__________________ _________ 006-0236-0006564 - 006-0236-0006566_________ _________ 006-0236-0006715 - 006-0236-0006717_________ _________ 006-0236-0006885 - 006-0236-0006888_________ _________ 006-0236-0009407 - 006-0236-0009423_________ _________ 006-0236-0009848 - 006-0236-0009849_________ ___________________006-0236-0010007___________________ __________________ 006-0236-0013254__________________ ___________________006-0236-0016030___________________ _________006-0236-0019605 - 006-0236-0020023_________ ___________________006-0339-0000016___________________ ___________________006-0339-0000019___________________ _________ 006-0342-0000001 - 006-0342-0000002_________ _________ 006-0357-0000004; 024-0357-0000004_________ _________ 006-0357-0000005 - 006-0357-0000012_________ 006-0374-0000001; 006-0376-0000339 - 006-0376-0000350 006-0374-0000005; 006-0376-0000036 - 006-0376-0000072 006-0374-0000006; 006-0376-0000073 - 006-0376-0000120 006-0374-0000007; 006-0376-0000121 - 006-0376-0000175 006-0374-0000008; 006-0376-0000176 - 006-0376-0000203 006-0374-0000010; 006-0376-0000245 - 006-0376-0000278 Page 31 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 62 of 232 PAGEID #: 40826 _______ Bates Numbered Documents_______ 006-0376-0000009; 006-0376-0000204 - 006-0376-0000244 006-0376-0000305 - 006-0376-0000338 006-0376-0000351 - 006-0376-0000496 __________006-0380-0000009__________ 006-0385-0000001 - 006-0385-0000003 __________006-0385-0000018__________ __________006-0385-0000022__________ 006-0385-0000023 - 006-0385-0000024 006-0386-0000020 - 006-0386-0000021 __________006-0391-0000013__________ 006-0391-0000024 - 006-0391-0000025 006-0391-0000026 - 006-0391-0000027 006-0391-0000029 - 006-0391-0000031 006-0394-0000001 - 006-0394-0000002 006-0394-0000003 - 006-0394-0000004 006-0394-0000038 - 006-0394-0000044 006-0394-0000046 - 006-0394-0000053 006-0394-0000054 - 006-0394-0000057 006-0394-0000058 - 006-0394-0000064 006-0396-0000028 - 00-0396-0000034 006-0396-0000035; 006-0394-0000045 006-0396-0000036 - 006-0396-0000043 006-0396-0000044 - 006-0396-0000047 __________006-0396-0000051__________ 006-0396-0000052 - 006-0396-0000053 006-0399-0000053 - 006-0399-0000057 006-0399-0000074 - 006-0399-0000107 006-0399-0000108 - 006-0399-0000112 006-0399-0000121 - 006-0399-0000124 006-0399-0000125 - 006-0399-0000127 006-0399-0000128 - 006-0399-0000158 __________006-0399-0000159__________ 006-0399-0000160 - 006-0399-0000165 006-0399-0000166 - 006-0399-0000170 006-0399-0000171 - 006-0399-0000172 006-0401-0000001 - 006-401-0000004 006-0401-0000005 - 006-0401-0000007 006-0401-0000017 - 006-0401-0000019 006-0401-0000020 - 006-0401-0000022 006-0401-0000023 - 006-0401-0000024 __________006-0401-0000025__________ 006-0401-0000026; 173-0401-0000021 __________006-0403-0000015__________ 006-0403-0000016 - 006-0403-0000017 Page 32 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 63 of 232 PAGEID #: 40827 Bates Numbered Documents 006-0440-0000001 - 006-0440-0000004 008-0020-0000421 - 008-0020-0000424 008-0020-0000421 - 008-0020-0000424 _________ 008-0020-0000426_________ 008-0020-0000426 - 008-0020-0000427 _________ 008-0020-0000427_________ 008-0020-0000428 - 008-0020-0000431 008-0020-0000428 - 008-0020-0000431 008-0131-0004274 - 008-0131-0004280 _________ 008-0135-0000186_________ _________ 008-0135-0002578_________ 008-0237-0009632 - 008-0237-0009633 _________ 008-0339-0000016_________ 008- 0357-0000004 - 008-0357-0000008 __________ 008-0357-000006__________ __________ 008-0357-000006__________ _________ 008-0366-0000004_________ _________ 008-0366-0000005_________ _________ 009-0070-0000010_________ _________ 009-0070-0000011_________ 009- 0070-0000014 - 009-0070-0000018 009-0070-0000024 - 009-0070-0000025 009-0070-0000024 - 009-0070-0000025 009-0070-0000026 - 009-0070-0000029 _________ 009-0070-0000031_________ 009-0139-0006511 - 009-0139-0006516 009-0139-0008990 - 009-0139-0008991 009-0139-0008990 - 009-0139-0008991 009-0139-0008990 - 009-0139-0008991 009-0139-0009715 - 009-0139-009718 _________ 009-0237-0001887_________ _________ 009-0237-0002475_________ _________ 009-0237-0007556_________ _________ 009-0237-0008826_________ 009- 0237-0012450 - 009-0237-0012511 010-0065500 - 010-0065503 010- 0343-0000001 - 010-0343-0000027 _________ 010-0343-0000028_________ _________ 010-0343-0000029_________ _________ 010-0343-0000030_________ _________ 010-0343-0000031_________ _________ 010-0343-0000032_________ __________ 01-0235-0000001__________ _________ 011-0001-0003496_________ 011-0001-0003811 Page 33 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 64 of 232 PAGEID #: 40828 _______ Bates Numbered Documents_______ ___________________ 011-0001-0003811___________________ _________ 011-0058-0000012 - 011-0058-0000013_________ _________ 011-0058-0000036 - 011-0058-0000037_________ _________ 011-0161-0000326 - 011-0161-0000327_________ _________ 011-0161-0001460 - 011-0161-0001461_________ _________ 013-0002-0001044 - 013-0002-0001045_________ ___________________ 014-0002-0016817___________________ ___________________ 014-0002-0019141___________________ ___________________ 014-0343-0000011___________________ _________ 015-0002-0001876 - 015-0002-0001877_________ _________ 015-0002-0001922 - 015-0002-0001930_________ _________ 015-0002-0003114 - 015-0002-0003117_________ _________ 015-0002-0004215 - 015-0002-0004218_________ ___________________ 016-000-0005698___________________ _________ 016-0002-0001314 - 016-0002-0001336_________ _________ 016-0002-0001783 - 016-0002-0001784_________ _________ 016-0002-0006573 - 016-0002-0006577_________ _________ 016-0002-0007570 - 016-0002-0007594_________ _________ 016-0002-0007970 - 016-0002-0007988_________ _________ 016-0002-0010750 - 016-0002-0010766_________ ___________________ 016-0038-0000567___________________ _________ 016-0146-0038440 - 016-0146-0038441_________ ___________________ 016-0339-0000001___________________ ___________________ 016-0339-0000001___________________ _________ 016-0376-0000001 - 016-0376-0000023_________ ___________________ 016-0376-0000024___________________ _________ 016-0385-0000005 - 016-0385-0000006_________ _________ 016-0388-0000001 - 016-0388-0000009_________ _________ 016-0388-0000010 - 016-0388-0000018_________ _________ 016-0388-0000019 - 016-0388-0000021_________ _________ 016-0388-0000022 - 016-0388-0000023_________ ___________________ 016-0388-0000024___________________ ___________________ 016-0388-0000027___________________ 019-0351-0000002 - 013-0351-0000003; 024-0353-0000003; _________________ EID256133-EID256137_________________ ___________________ 019-0351-0000007___________________ ___________________ 019-0351-0000008___________________ ___________________ 019-0353-0000002___________________ ___________________ 019-0357-0000004___________________ ___________________ 019-0388-0000001___________________ ___________________ 019-0388-0000002___________________ _________ 019-0401-0000001 - 019-0401-0000005_________ _______________020-0000052 - 020-0000053_______________ _________ 022-0044-0000109 - 022-0044-0000143_________ 022-0044-0000146 - 022-0044-0000149 Page 34 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 65 of 232 PAGEID #: 40829 Bates Numbered Documents 022-0044-0000248 - 022-0044-0000291 _________ 022-0044-0000465_________ _________ 022-0044-0000466_________ _________ 022-0044-0000467_________ _________ 022-0044-0000467_________ _________ 022-0044-0000468_________ _________ 022-0044-0000576_________ 022-0044-0000797 - 022-0044-0000798 022-0044-0001003 - 022-0044-0001005 022-0044-0001006 - 022-0044-0001008 022-0044-0001086 - 022-0044-0001088 022-0044-0001129 - 022-0044-0001135 022-0044-0001201 - 022-0044-0001230 022-0044-0001277 - 022-0044-0001288 _________ 022-0044-0001289_________ 022-0044-0001290 - 022-0044-0001293 022-0044-0001294 - 022-0044-0001297 _________ 022-0044-0001466_________ _________ 022-0044-0001467_________ 022-0044-0001503 - 022-0044-0001511 022-0044-0001512 - 022-0044-0001515 _________ 022-0044-0001516_________ 022-0044-0002358 - 022-0044-0002361 _________ 022-0044-0002409_________ 022-0044-0002457 - 022-0044-0002459 022-0045-0000026 - 022-0045-0000032 022-0045-0000186 - 022-0045-0000213 022-0045-0000411 - 022-0045-0000417 022-0045-0000418 - 022-0045-0000432 022-0045-0000440 - 022-0045-0000444 022-0045-0000445 - 022-0045-0000446 _________ 022-0045-0000894_________ _________ 022-0045-0001129_________ 022-0045-0001364 - 022-0045-0001379 _________ 022-0045-0001401_________ _________ 022-0045-0001403_________ 022-0045-0001560 - 022-0045-0001577 022-0045-0002058 - 022-0045-0002060 022-0045-0002285 - 022-0045-0002287 022-0046-0000177 - 022-0046-0000178 022-0046-0000179 - 022-0046-0000182 022-0046-0000191 - 022-0046-0000192 _________ 022-0046-0000209_________ _________ 022-0046-0000211_________ 022-0046-0000212 Page 35 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 66 of 232 PAGEID #: 40830 Bates Numbered Documents 022-0046-0000213 - 022-0046-0000214 022-0046-0000536 - 022-0046-0000538 022-0046-0000563 - 022-0046-0000564 022-0046-0000565 - 022-0046-0000567 _________ 022-0046-0000568_________ 022-0046-0000727 - 022-0046-0000728 _________ 022-0046-0000765_________ 022-0046-0001353 - 022-0046-0001354 022-0046-0001490 - 022-0046-0001495 022-0046-0001500 - 022-0046-0001501 022-0046-0001506 - 022-0046-0001507 _________ 022-0046-0001508_________ 022-0046-0002006 - 022-0046-0002013 _________ 022-0046-0002067_________ _________ 022-0046-0002068_________ 022-0046-0002069 - 022-0046-0002075 _________ 022-0046-0002076_________ _________ 022-0046-0002077_________ __________ 022-0046-000216__________ 022-0046-0002367 - 022-0046-0002369 022-0046-0002458 - 022-0046-0002459 022-0047-0001035 - 022-0047-0001037 _________ 022-0047-0001084_________ 022-0047-0001085 - 022-0047-0001088 022-0047-0001112 - 022-0047-0001119 _________ 022-0047-0001122_________ 022-0047-0001141 - 022-0047-0001151 022-0047-0001152 - 022-0047-0001156 022-0047-0001678 - 022-0047-0001679 022-0047-0001683 - 022-0047-0001685 022-0047-0001686 - 022-0047-0001688 022-0047-0001695 - 022-0047-0001696 022-0047-0001705 - 022-0047-0001724 022-0047-0001786 - 022-0047-0001789 __________ 022-0047-001785__________ 022-0048-0001522 - 022-0048-0001524 _________ 022-0048-0001525_________ 022-0048-0002196 - 022-0048-0002201 022-0049-0000098 - 022-0049-0000101 _________ 022-0049-0001310_________ _________ 022-0134-0014179_________ _________ 022-0134-0014179_________ 022-0134-0014273 - 022-0134-0014275 _________ 022-0233-0001331_________ 022-0233-0001409 - 022-0233-0001415 Page 36 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 67 of 232 PAGEID #: 40831 Bates Numbered Documents 022-0233-0003856 - 022-0233-0003857 022-0233-0004269 - 022-0233-0004274 022-0233-0004687 - 022-0233-0004688 022-0233-0006102 - 022-0233-0006103 _________ 022-0233-0007348_________ _________ 022-0233-0008336_________ _________ 022-0339-0000043_________ _________ 0 2 2 -0 3 4 5 -0 0 0 0 0 0 0 8 _________ _________ 022-0353-0000001_________ _________ 022-0353-0000001_________ 022- 0357-0000001; 022-0357-0000002 _________ 022-0357-0000002_________ _________ 022-0357-0000004_________ 023- 0135-0015957 - 023-0135-0015960 023-0242-0000045 - 023-0242-0000046 023- 0242-0015448 - 023-0242-0015452 024- 0104-0001349 - 024-0104-0001350 _________ 024-0104-0001353_________ 024-0104-0001360 - 024-0104-0001363 _________ 024-0104-0001374_________ 024-0134-0063051 - 024-0134-0063089 024-0200-0000584 - 024-0200-0000622 024-0245-0005193 - 024-0245-0005195 024-0245-0005312 - 024-0245-0005314 024-0245-0008484 - 024-0245-0008485 024-0245-0011078 - 024-0245-0011079 024-0245-0011231 - 024-0245-0011234 _________ 024-0330-0000014_________ _________ 024-0339-0000013_________ _________ 024-0339-0000017_________ _________ 024-0339-0000018_________ _________ 024-0339-0000019_________ _________ 024-0339-0000020_________ _________ 024-0339-0000022_________ _________ 024-0339-0000024_________ _________ 024-0339-0000026_________ _________ 024-0339-0000027_________ _________ 024-0339-0000028_________ _________ 024-0339-0000029_________ _________ 024-0339-0000030_________ _________ 024-0339-0000032_________ _________ 024-0339-0000035_________ _________ 024-0342-0000005_________ _________ 024-0345-0000007_________ 024-0357-0000002 Page 37 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 68 of 232 PAGEID #: 40832 _______ Bates Numbered Documents_______ _________ 024-0359-0000004; 024-0359-0000005_________ 024-0359-0000006; 024-0359-0000008; 024-0359-0000012 _________024-0359-0000015 - 024-0359-0000022_________ __________________ 024-0388-0000001__________________ _________024-0394-0000001 - 024-0394-0000003_________ _________024-0399-0000001 - 024-0399-0000001_________ __________________ 024-0399-0000003__________________ _________024-0399-0000004 - 024-0399-0000006_________ ___________________ 026-061-0000053___________________ ______________ 029-0061491 - 029-0061492______________ _____________________ 029-0104090_____________________ __________________ 030-0002-0002438__________________ _________030-0002-0002439 - 030-0002-0002440_________ __________________ 030-0162-0012279__________________ __________________ 030-0275-0000095__________________ __________________ 030-0275-0000095__________________ __________________ 031-0001-0002002__________________ _________031-0074-0000033 - 031-0074-0000041_________ _________032-0151-0002154 - 032-0151-0002155_________ ______________ 034-0006629 - 034-0006631______________ _________035-0002-0000231 - 035-0002-0000233_________ _________038-0063-0000283 - 038-0063-0000296_________ _________038-0063-0000297 - 038-0063-0000300_________ _________038-0063-0000301 - 038-0063-0000307_________ _________038-0063-0000308 - 038-0063-0000316_________ _________038-0063-0000317 - 038-0063-0000318_________ _________038-0063-0000319 - 038-0063-0000322_________ _________038-0063-0000323 - 038-0063-0000324_________ _________038-0063-0000356 - 038-0063-0000377_________ _________038-0063-0000433 - 038-0063-0000490_________ __________________ 038-0063-0000673__________________ __________________ 038-0063-0000679__________________ _________038-0236-0000029 - 038-0236-0000030_________ _________038-0236-0000037 - 038-0236-0000041_________ ______________ 040-0013871 - 040-0013875______________ ______________ 045-0122821 - 045-0122822______________ _____________________ 045-0122828_____________________ _____________________ 047-0002621_____________________ _________052-0121-0000167 - 052-0121-0000175_________ _________053-0001-0000001 - 053-0001-0000002_________ _________053-0001-0000729 - 053-0001-0000733_________ _________053-0001-0000903 - 053-0001-0000904_________ __________________ 053-0001-0001076__________________ __________________ 053-0001-0001109__________________ 053-0001-0001110 Page 38 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 69 of 232 PAGEID #: 40833 Bates Numbered Documents __________ 053-0001-0001197__________ 053-0001-0001409 - 053-0001-0001410 053-0001-0002586 - 053-0001-0002587 053-0001-0003039 - 053-0001-0003040 053-0001-0003061 - 053-0001-0003065 053-0001-0003070 - 053-0001-0003072 053-0001-0003079 - 053-0001-0003085 __________ 053-0001-0005085___________ 053-0001-0005391 - 053-0001-0005393 __________ 053-0001-0005472__________ 053-0001-0006778 - 053-001-0006779 053-0001-0012164 - 053-0001-0012166 053-0001-0012216 - 053-0001-0012218 053-0001-0018569 - 053-0001-0018585 053-0001-0018569 - 053-0001-0018585 __________ 053-0001-0018921__________ 053-0001-0019206 - 053-0001-0019207 053-0001-0019206 - 053-0001-0019207 __________ 053-0001-0019235___________ 053-0001-0019280 - 053-0001-0019281 053-0001-0019735 - 053-0001-001819758 053-0001-0019735 - 053-0001-0019758 __________ 053-0001-0026757__________ __________ 053-0001-0026758__________ __________ 053-0001-0026758__________ 053-001-0019259 - 053-0001-0019260 053-0145-0000008 - 053-0145-0000015 053-0169-0000788 - 053-0169-0000789 053- 0169-0000788 - 053-0169-0000789 __________ 053-0215-0005779__________ 054- 0001-0000203 - 054-0001-0000205 054-0001-0000203 - 054-0001-0000205 054-0001-0000228 - 054-0001-0000230 054-0001-0000332 - 054-0001-0000334 054-0001-0000341 - 054-0001-0000342 054-0001-0000346 - 054-0001-0000347 __________ 054-0001-0000517__________ __________ 054-0001-0000777__________ 054-0001-0001747 - 054-0001-0001750 054-0001-0001891 - 054-0001-0001904 054-0001-0012821 - 054-0001-0012822 __________ 054-0001-0012907__________ __________ 054-0001-0013860__________ 054-0002-0000046 - 054-0002-0000049 054-0002-0000534 - 054-0002-0000544 Page 39 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 70 of 232 PAGEID #: 40834 Bates Numbered Documents 054-0002-0000545 - 054-0002-0000604 054-0002-0000605 - 054-0002-0000616 054-0002-000073 - 054-0002-000082 054-0033-0000137 - 054-0033-0000154 054-0033-0000298 - 054-0033-0000332 054-0033-0001110 - 054-0033-0001124 054-0033-0001127 - 054-0033-0001129 054-0033-0001140 - 054-0033-0001142 054-0033-0001243 - 054-0033-0001250 054-0034-0000102 - 054-0034-0000110 054-0142-0006067 - 054-0142-0006068 054-0169-0003269 - 054-0169-0003273 054-0169-0003290 - 054-0169-0003305 054-0169-0003320 - 054-0169-0003342 054-0169-0004850 - 054-0169-0004853 054-0169-0005603 - 054-0169-0005606 054-0169-0005817 - 054-0169-0005819 054-0169-0007105 - 054-0169-0007161 054-0169-0008578 - 054-0169-0008580 054-0169-0010489 - 054-0169-0010495 054-0214-0000130 - 054-0214-0000137 054-0214-0000215 - 054-0214-0000215 054-0215-0002024 - 054-0215-0002027 __________054-0353-0000001_________ __________054-0353-0000017_________ 054-0380-0000001 - 054-0380-0000015 __________054-0388-0000001_________ __________054-0392-0000001_________ 058-0078-0000103 - 058-0078-0000107 058-0280-0000019 - 058-0280-0000023 060-0001-0004483 - 060-0001-0004485 __________060-0001-0009293__________ 060-0001-0009707 - 060-0001-0009708 060-0001-0014287 - 060-0001-0014289 060-0001-0017421 - 060-001-0017422 __________060-0001-0021541_________ 060-0001-0022196 - 060-0001-0022198 __________060-0001-0022735__________ 060-0001-0022737 - 060-0001-0022744 060-0001-0022824 - 060-0001-0022828 060-0001-0022960 - 060-0001-0022963 060-0001-0023000 - 060-0001-0023001 060-0001-0023732 - 060-0001-0023734 060-0001-0023760 - 060-0001-0023762 060-0001-0023817 Page 40 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 71 of 232 PAGEID #: 40835 Bates Numbered Documents 060-0001-0024060 - 060-0001-0024066 060-0001-0024203 - 060-0001-0024205 060-0001-0024210 - 060-0001-0024211 060-0001-0024283 - 060-0001-0024284 060-0001-0032316 - 060-0001-0032317 060-0001-0050334 - 060-0001-0050338 060-0001-0050353 - 060-0001-0050359 _________ 060-0001-0050599_________ _________ 060-0001-0050626_________ _________ 060-0001-0050626_________ _________ 060-0001-0050636_________ _________ 0 6 0 -0 0 0 2 -0 0 0 0 6 1 5 3 _________ 060-0002-0001522 - 060-0002-0001525 060-0002-0002180 - 060-0002-0002218 _________ 060-0002-0006009_________ _________ 060-0002-0006069_________ 060-0002-0006306 - 060-0002-0006308 _________ 060-0002-0011438_________ 060-0002-0012843 - 060-0002-0012848 060-0002-0012849 - 060-0002-0012862 060-0002-0012876 - 060-0002-0012878 060-0149-0003330 - 060-0149-0003349 060-0149-0003331 - 060-0149-000337 060-0149-0003338 - 060-0149-0003349 060-0208-0000004 - 060-0208-0000005 _________ 060-0208-0000006_________ _________ 060-0208-0000007_________ _________ 060-0208-0000008_________ _________ 060-0208-0000009_________ 060-0208-0000011; BJR000849 _________ 060-0208-0000012_________ 060-0208-0000013; BJR000851 060-0208-0000014; BJR000852 _________ 060-0208-0000015_________ _________ 060-0208-0000016_________ _________ 060-0208-0000017_________ 060-0208-0000018, BJR000856 060-0208-0000019; BJR000857 060-0208-0000020; BJR000858 060-0208-0000021; BJR000859 _________ 060-0219-0002884_________ 060-0219-0002884; OEPA9150 060-0219-0002885 - 060-0219-0002886 060-0219-0004494 - 060-0219-0004496 060-0219-0004495 - 060-0219-0004496 Page 41 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 72 of 232 PAGEID #: 40836 ________Bates Numbered Documents________ __________060-0219-0004769 - 060-0219-0004771__________ ___________________ 060-0219-0005670___________________ ___________________ 060-0235-0001656___________________ ___________________ 060-0345-0000001___________________ ___________________ 061-0001-0000011___________________ __________061-0001-0000012 - 061-0001-0000013__________ __________061-0001-0000026 - 061-0001-0000090__________ __________061-0001-0000187 - 061-0001-0000191__________ __________061-0001-0000294 - 061-0001-0000295__________ __________061-0001-0000445 - 061-0001-0000447__________ __________061-0001-0000706 - 061-0001-0000707__________ ___________________ 061-0001-0000712___________________ ___________________ 061-0001-0001300___________________ ___________________ 061-0001-0001393___________________ __________061-0001-0001509 - 061-0001-0001513__________ __________061-0001-0002368 - 061-0001-0002369__________ __________061-0001-0002368 - 061-0001-0002369__________ __________061-0001-0002694 - 061-0001-0002701__________ __________061-0001-0003522 - 061-0001-0003523__________ __________061-0001-0004040 - 061-0001-0004042__________ __________061-0001-0004122 - 061-0001-0004125__________ __________061-0001-0004275 - 061-0001-0004276__________ ___________________ 061-00010004672___________________ ___________________ 061-0001-0004748___________________ __________061-0001-0004765 - 061-0001-0004768__________ __________061-0001-0006508 - 061-0001-0006509__________ __________061-0001-0007040 - 061-0001-0007041__________ __________061-0001-0007543 - 061-0001-0007544__________ __________ 061-0001-0007543-061-0001-0007544__________ __________061-0001-0007550 - 061-0001-0007551__________ __________061-0001-0007550 - 061-0001-0007551__________ ___________________ 061-0001-0007611___________________ __________061-0001-0007831 - 061-0001-0007833__________ __________061-0001-0007855 - 061-0001-0007856__________ __________061-0001-0007904 - 061-0001-0007905__________ __________061-0001-0007904 - 061-0001-0007905__________ __________061-0002-0000510 - 061-0002-0000512__________ __________061-0002-0000852 - 061-0002-0000854__________ __________061-0002-0000855 - 061-0002-0000864__________ __________061-0002-0001053 - 061-0002-0001054__________ __________061-0002-0001640 - 061-0002-0001650__________ 061-0002-0001982 - 061-0002-0001984; 054-0001-0000228 ___________________ 054-0001-0000230___________________ __________061-0082-0000274 - 061-0082-0000278__________ 061-0158-0000237 Page 42 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 73 of 232 PAGEID #: 40837 Bates Numbered Documents 061- 0158-0001975 - 061-0158-0001976 _________ 061-0236-0001223_________ _________ 062-0001-0001000_________ _________ 062-0001-0001001_________ _________ 062-0001-0001004_________ 062- 0001-0001015 - 062-0001-0001016 062-0001-0001190 - 062-0001-0001192 062-0001-0001193 - 062-0001-0001194 062-0001-0001195 - 062-0001-0001196 062-0074-0000363 - 062-0074-0000367 _________ 062-0074-0000366_________ 062-0074-0000392 - 062-0074-0000402 062-0074-0001113 - 062-0074-0001128 _________ 062-0149-0000325_________ 062-0149-0000536 - 062-0149-0000537 062-0149-0000755 - 062-0149-0000757 062-0149-0000902 - 062-0149-0000904 062-0149-0001062 - 062-0149-0001063 _________ 062-0149-0002578_________ _________ 062-0149-0002578_________ _________ 062-0150-0000021_________ _________ 062-0150-0000021_________ _________ 062-0150-0000022_________ 062-0150-0000050 - 062-0150-0000056 062-0150-0000137 - 062-0150-0000139 062-0169-0002666 - 062-0169-0002665 062-0169-0002666 - 062-0169-0002667 062-0169-0002680 - 062-0169-0002684 062-0169-0002680 - 062-0169-0002684 062-0169-0003085 - 062-0169-0003088 _________ 062-0169-0003091_________ 062-0169-0003092 - 062-0169-0003095 062-0169-0005075 - 062-0169-0005083 062-0215-0000403 - 062-0215-0000404 _________ 062-0215-0000890_________ _________ 062-0215-0001001_________ _________ 062-0215-0001340_________ _________ 062-0215-0004294_________ 062- 0215-0004403 - 062-0215-0004465 063- 0001-0000482 - 063-0001-0000488 063-0001-0000489 - 063-0001-0000490 _________ 063-0001-0001128_________ _________ 063-0001-0001154_________ 063-0001-0001270 - 063-0001-0001273 Page 43 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 74 of 232 PAGEID #: 40838 ________Bates Numbered Documents________ 063-0001-0001410 - 063-0001-0001411; 063-0001-0001331 ___________________ 063-0001-0001332___________________ __________063-0001-0001942 - 063-0001-0001943__________ __________063-0001-0002710 - 063-0001-0002712__________ __________063-0001-0002829 - 063-0001-0002830__________ __________063-0001-0002831 - 063-0001-0002842__________ _________ 063-0001-0003117 - 063-0001-0003118_________ __________063-0001-0003740 - 063-0001-0003746__________ __________063-0001-0003808 - 063-0001-0003809__________ ___________________ 063-0001-0004306___________________ __________063-0001-0004465 - 063-0001-0004467__________ __________063-0001-0004500 - 063-0001-0004501__________ __________063-0001-0004906 - 063-0001-0004919__________ __________063-0001-0004939 - 063-0001-0004941__________ __________063-0001-0004942 - 063-0001-0004945__________ __________063-0001-0004985 - 063-0001-0004986__________ __________063-0001-0005112 - 063-0001-0005116__________ __________063-0001-0005831 - 063-0001-0005832__________ ___________________ 063-0001-0005834___________________ ___________________ 063-0001-0005835___________________ __________063-0001-0005880 - 063-0001-0005892__________ __________063-0001-0006163 - 063-0001-0006164__________ __________063-0001-0006429 - 063-0001-0006430__________ __________063-0001-0007062 - 063-0001-0007064__________ ___________________ 063-0001-0007073___________________ __________063-0001-0007660 - 063-0001-0007661__________ __________063-0001-0007974 - 063-0001-0007975__________ __________063-0001-0008075 - 063-0001-0008076__________ __________063-0001-0008222 - 063-0001-0008223__________ __________ 063-0001-0008403 - 0630001-0008404__________ __________063-0001-0008869 - 063-0001-0008871__________ __________063-0001-0009102 - 063-0001-0009103__________ __________063-0001-0009190 - 063-0001-0009197__________ _________ 063-0001-0009892 - 063-0001-0009895_________ __________063-0001-0010259 - 063-0001-0010260__________ ___________________ 063-0001-0010268___________________ 063-0001-0010269; 003-0001-0025133; 003-0001-0025132; ___________________ 063-0001-0010268___________________ __________063-0002-0000009 - 063-0002-0000011__________ ___________________ 063-0002-0000659___________________ __________063-0002-0000682 - 063-0002-0000730__________ __________063-0002-0000844 - 063-0002-0000850__________ __________063-0151-0002259 - 063-0151-0002260__________ ________ 063-0151-00041402 - 063-0151-00041403_________ 063-0151-0005555 - 063-0151-0005556 Page 44 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 75 of 232 PAGEID #: 40839 Bates Numbered Documents _________ 063-0151-0007708_________ _________ 063-0151-0009648_________ 063-0151-0010259 - 063-0151-0010260 063-0151-0013718 - 063-051-0013731 063-0151-0015726 - 063-0151-0015727 063-0151-0015743 - 063-0151-0015744 063-0151-0017153 - 063-0151-0017188 _________ 063-0151-0024786_________ _________ 063-0151-0025370_________ _________ 063-0151-0025371_________ 063-0151-0025372 - 063-0151-0025375 _________ 063-0151-0027486_________ 063-0151-0029672 - 063-0151-0029673 _________ 063-0151-0029677_________ _________ 063-0151-0029861_________ _________ 063-0151-0030002_________ _________ 063-0151-0030070_________ 063-0151-0030394 - 063-0151-0030395 063-0151-0032724 - 063-0151-0032725 _________ 063-0151-0032978_________ _________ 063-0151-0032979_________ 063-0151-0032980 - 063-0151-0032982 _________ 063-0151-0034126_________ _________ 063-0151-0034769_________ 063-0151-0034770 - 063-0151-0034791 063-0151-0034770 - 063-0151-0034791 063-0151-0034792 - 063-0151-0034804 063-0151-0034851 - 063-0151-0034866 063-0151-0036930 - 063-0151-0036931 063-0151-0037345 - 063-0151-0037346 063-0151-0037439 - 063-0151-0037440 _________ 063-0151-0038411_________ 063-0151-0038659 - 063-0151-0038660 _________ 063-0151-0038661_________ 063-0151-0038717 - 063-0151-0038718 063-0151-0038719 - 063-0151-0038720 _________ 063-0151-0038721_________ 063-0151-0038782 - 063-0151-0038783 063-0151-0038896 - 063-0151-0038897 _________ 063-0151-0039781_________ 063-0151-0039788 - 063-0151-0039789 _________ 063-0151-0040674_________ _________ 063-0151-0040677_________ _________ 063-0151-0040899_________ 063-0151-0041804 - 063-0151-0041807 Page 45 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 76 of 232 PAGEID #: 40840 _____ Bates Numbered Documents_____ 063-0151-0042163 - 063-0151-0042165 _______________ 063-0151-0042875________________ _______________ 063-0151-0045212_______________ _______________ 063-0151-0045638_______________ _______________ 063-0151-0045640_______________ _______________ 063-0151-0046057_______________ _______________ 063-0151-0046956_______________ _______________ 063-0151-0046957_______________ 063-0151-0046958 - 063-0151-0046964 063-0151-0046958 - 063-0151-0046964 _______________ 063-0151-0046965________________ 063-0151-0046968 - 063-0151-0046970 063-0151-0046968 - 063-0151-0046970 _______________ 063-0151-0048144_______________ 063-0151-0048450 - 063-0151-0048451 _______________ 063-0151-0048995________________ _______________ 063-0151-0049167_______________ _______________ 063-0151-0049168_______________ _______________ 063-0151-0049284_______________ _______________ 063-0151-0049388_______________ 063-0151-0049660 - 063-0151-0049661 _______________ 063-0151-0049767_______________ 063-0151-0050722 - 063-0151-0050723 _______________ 063-0151-0050871_______________ _______________ 063-0151-0051581_______________ 063-0151-0051965 - 063-0151-0051969 063-0151-0052556 - 063-0151-0052560 063-0169-0001256 - 063-0169-0001279 063-0169-0005487 - 063-0169-0005489; EID522970 _________ EID522972; SL001069 - SL001071_________ _______________ 066-0002-0000001_______________ 066-0002-0000095 - 066-0002-0000097 066-0002-0000528 - 066-0002-0000535 _______________ 066-0002-0001652_______________ 066-0002-0001851 - 066-0002-0001852 _______________ 066-0002-0001853________________ 066-0002-0001860 - 066-0002-0001863 066-0002-0002267 - 066-0002-0002269 066-0002-0002417 - 066-0002-0002420 066- 0002-0002955 - 066-0002-0002957 067- 0141-0017198 - 067-0141-0017199 067-0141-0019219 - 067-0141-0019221 067-0141-0029363 - 067-0141-0029366 067-0237-0000134 - 067-0237-0000136 067-0237-0000695 Page 46 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 77 of 232 PAGEID #: 40841 Bates Numbered Documents 070-0002-0000257 - 070-0002-0000258 070-0002-0000276 - 070-0002-0000282 070-0002-0000283 - 070-0002-0000284 070-0002-0000451 - 070-0002-0000453 _________ 070-0002-0000733_________ _________ 070-0002-0000752_________ _________ 070-0002-0001045_________ _________ 070-0002-0001046_________ 070-0002-0001180 - 070-0002-0001202 070-0002-0001284 - 070-0002-0001287 070-0002-0001288 - 070-0002-0001289 070-0002-0001297 - 070-0002-0001305 070-0002-0001629 - 070-0002-0001632 070-0002-0001725 - 070-0002-0001728 070-0002-0001803 - 070-0002-0001828 070-0002-0001803 - 070-0002-0001828 070-0002-0001897 - 070-0002-0001899 070-0106-0000001 - 070-0106-0000021 ____________ 070-0140978____________ ____________ 070-0140978____________ 075-0126-0000344 - 075-0126-0000346 075-0144-0000052 - 075-0144-0000054 075-0144-0000067 - 075-0144-0000075 _________ 075-0144-0000357_________ 075-0144-0000598 - 075-0144-0000599 075-0144-0001848 - 075-0144-0001850 075-0144-0002837 - 075-0144-0002838 075-0144-0003072 - 075-0144-0003073 _________ 075-0144-0003074_________ _________ 075-0144-0004825_________ 075-0144-0005163 - 075-0144-0005164 _________ 075-0144-0005214_________ _________ 075-0144-0006515_________ _________ 075-0144-0008330_________ _________ 075-0144-0008330_________ _________ 075-0144-0008344_________ 075-0144-0008355 - 075-0144-0008357 _________ 075-0144-0008753_________ 075-0144-0009744-075-0144-0009745 075-0144-0010634 - 075-0144-0010636 _________ 075-0144-0010992_________ 075-0144-0010993 - 075-0144-0010994 _________ 075-0144-0011119_________ _________ 075-0144-0011120_________ 075-0144-0011158 Page 47 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 78 of 232 PAGEID #: 40842 Bates Numbered Documents 075-0144-0011163 - 075-0144-0011164 _________ 075-0144-0011165_________ _________ 075-0144-0011570_________ 075-0144-0012180 - 075-0144-0012182 075-0144-0013008 - 075-0144-0013140 _________ 075-0144-0013431_________ 075-0144-0013943 - 075-0144-0013945 075-0144-0014202 - 075-0144-0014203 _________ 075-0215-0001168_________ _________ 075-0215-0001176_________ _________ 075-0215-0001177_________ 075-0215-0001178 - 075-0215-0001179 075-0215-0001180 - 075-0215-0001181 _________ 075-0237-0000665_________ _________ 076-0154-0000513_________ 080-0002-0000208 - 080-0002-0000211 _________ 082-0002-0000009_________ _________ 083-0001-0005541_________ 083-0002-0000004 - 083-0002-0000005 083-0002-0000004 - 083-0002-0000005 083-0002-0000067 - 083-0002-0000068 _________ 083-0002-0000075_________ _________ 083-0002-0000076_________ 083-0002-0000098 - 083-0002-0000114 083-0002-0000116 - 083-0002-0000117 083-0002-0000197 - 083-0002-0000199 083-0002-0000203 - 083-0002-0000204 083-0002-0000297 - 083-0002-0000299 083-0159-0010731 - 083-0159-0010735 083-0159-0011528 - 083-0159-0011530 _________ 083-0159-0012405_________ 083-0169-0002097 - 083-0169-0002099 085-0243-0000059 - 085-0243-0000060 087-0002-0000004 - 087-0002-0000006 _________ 087-0112-0000002_________ 087-0122-0000062 - 087-0122-0000075 087-0164-0000678 - 087-0164-0000679 _________ 087-0164-0001704_________ _________ 087-0164-0002029_________ 087-0171-0000511 - 087-0171-0000512 _________ 087-0216-0000284_________ _________ 087-0236-0000878_________ 092-0163-0006584 - 092-0163-0006585 092-0163-0006810 - 092-0163-0006812 092-0163-0007334 - 092-0163-0007335 Page 48 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 79 of 232 PAGEID #: 40843 Bates Numbered Documents 092-0163-0078439 - 092-0163-0078441 092-0163-0090701 - 092-0163-0090717 __________ 092-0245-029844__________ 104-0107-0000482 - 104-0107-0000484 108- 0317-0000368 - 108-0317-0000395 109- 0001-0004854 - 109-0001-0004856 109-0001-0004896 - 109-0001-0004900 109-0162-0000212 - 109-0162-0000214 _________ 109-0162-0000559_________ 109-0162-0000564 - 109-0162-0000565 109-0162-0000569 - 109-0162-0000571 _________ 109-0162-0000651_________ 109-0162-0000657 - 109-0162-0000663 109-0162-0000657 - 109-0162-0000663 109-0162-0000664 - 109-0162-0000666 109-0162-0000850 - 109-0162-0000853 _________ 109-0162-0000864_________ 109-0162-0000868 - 109-0162-0000869 _________ 109-0162-0000870_________ 109-0162-0000871 - 109-0162-0000872 109-0162-0000981 - 109-0162-0000982 109-0162-0001160 - 109-0162-0001161 109-0162-0001160 - 109-0162-0001161 118-0000328 - 118-0000336 118-0000611 - 118-0000615 ____________ 118-0000616____________ 124-0226-0001644 - 124-0226-0001673 139-0279-0000646 - 139-0279-0000653 _________ 139-0346-0000004_________ _________ 139-0346-0000006_________ _________ 139-0352-0000002_________ _________ 139-0354-0000003_________ _________ 139-0358-0000001_________ _________ 139-0358-0000001_________ _________ 139-0358-0000002_________ _________ 139-0358-0000004_________ 139-0358-0000026 - 139-0358-0000027 139-0358-0000027 - 139-0358-0000035 139-0360-0000002 - 139-0360-0000004 139-0360-0000005 - 139-0360-0000006 _________ 139-0376-0000001_________ _________ 139-0376-0000002_________ 139-0381-0000001 - 139-0381-0000037 139-0386-0000001 - 139-0386-0000003 139-0389-0000001 Page 49 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 80 of 232 PAGEID #: 40844 Bates Numbered Documents 139-0392-0000001 - 139-0392-0000002 _________ 139-0395-0000001_________ _________ 139-0397-0000001_________ 139-0402-0000001 - 139-0402-0000052 _________ 139-0404-0000001_________ _________ 161-0339-0000005_________ _________ 161-0339-0000006_________ _________ 161-0339-0000009_________ 161-0342-0000001 - 161-0342-0000023 161-0348-0000004 - 161-0348-0000006 161-0352-0000008 - 161-0352-0000025 _________ 161-0353-0000002_________ _________ 161-0353-0000005_________ _________ 161-0353-0000006_________ _________ 161-0353-0000007_________ __________ 161-0353-000001__________ _________ 161-0353-0000042_________ _________ 161-0353-0000047_________ _________ 161-0353-0000048_________ _________ 161-0353-0000050_________ _________ 161-0357-0000001_________ 161-0357-0000004 161-0357-0000005 161-0361-0000005 - 161-0361-0000006 161-0390-0000008 - 161-0390-0000010 161-0390-000001 - 161-0390-000007 _________ 161-0390-0000011_________ _________ 161-0390-0000012_________ 161-0394-0000001 - 161-0394-0000002 161-0394-0000010 - 161-0394-0000013 161-0394-0000019 - 161-0394-0000020 161-0399-0000025 - 161-0399-0000026 161-0399-0000032 - 161-0399-0000033 161-0399-0000036 - 161-0399-0000053 _________ 161-0399-0000055_________ _________ 161-0399-0000063_________ 161-0399-0000067 - 161-0399-0000068 161-0401-0000003 - 161-0401-0000073 161-0403-0000001 - 161-0403-0000004 161-0403-0000011 - 161-0403-0000014 161-0403-0000015 - 161-0403-0000016 161-0403-0000021 - 161-0403-0000025 _________ 161-0403-0000047_________ 161-0403-0000048 - 161-0403-0000049 161-0403-0000128 - 161-0403-0000133 169-0401-0000003 Page 50 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 81 of 232 PAGEID #: 40845 Bates Numbered Documents 173-0394-0000010 - 173-0394-0000023 _________ 173-0401-0000020_________ 173-0403-0000001 - 173-0403-0000002 173-0403-0000004 - 173-0403-0000007 173-0403-0000008 - 173-0403-0000013 ______________176 - 178______________ 196-2023-0000001 - 196-2023-0000006 196-2023-0000007 - 196-2023-0000010 196-2023-0000011 - 196-2023-0000017 196-2023-0000018 - 196-2023-0000024 196-2023-0000025 - 196-2023-0000031 196-2023-0000032 - 196-2023-0000037 196-2023-0000038 - 196-2023-0000042 196-2023-0000043 - 196-2023-0000047 196-2023-0000048 - 196-2023-0000049 196-2023-0000050 - 196-2023-0000055 196-2023-0000056 - 196-2023-0000062 196-2023-0000063 - 196-2023-0000068 196-2023-0000073 - 196-2023-0000079 196-2023-0000080 - 196-2023-0000085 196-2023-0000086 - 196-2023-0000094 196-2023-0000095 - 196-2023-0000101 196-2023-0000102 - 196-2023-0000103 196-2023-0000104 - 196-2023-0000112 196-2023-0000113 - 196-2023-0000122 196-2023-0000123 - 196-2023-0000130 196-2023-0000131 - 196-2023-0000137 196-2023-0000138 - 196-2023-0000152 196-2023-0000153 - 196-2023-0000163 196-2023-0000164 - 196-2023-0000176 _________ 196-2024-0000004_________ _________ 196-2024-0000016_________ 196-2024-0000017 - 196-2024-0000042 196-2024-0000043 - 196-2024-0000045 _________ 196-2024-0000051_________ _________ 196-2024-0000052_________ 196-2024-0000078 - 196-2024-0000126 196-2024-0000128 - 196-2024-0000132 _________ 196-2024-0000133_________ _________ 196-2024-0000137_________ 196-2024-0000138 - 196-2024-0000158 196-2024-0000159 - 196-2024-0000160 196-2024-0000161 - 196-2024-0000167 196-2024-0000168 - 196-2024-0000172 196-20240000173 - 196-20240000178 Page 51 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 82 of 232 PAGEID #: 40846 ________Bates Numbered Documents_______ __________196-2024-0000179 - 196-2024-0000182_________ __________196-2024-0000183 - 196-2024-0000186_________ __________196-2024-0000187 - 196-2024-0000211_________ __________196-2024-0000212 - 196-2024-0000308_________ __________196-2024-0000309 - 196-2024-0000323__________ __________196-2024-0000324 - 196-2024-0000325__________ __________196-2024-0000326 - 196-2024-0000327_________ __________ 196-2024-000048 - 196-2024-0000050__________ __________196-2025-0000001 - 196-2025-0000004_________ __________196-2025-0000005 - 196-2025-0000006_________ __________196-2025-0000007 - 196-2025-0000008_________ __________196-2025-0000009 - 196-2025-0000011_________ __________196-2025-0000012 - 196-2025-0000013__________ ___________________ 196-2025-0000014___________________ __________196-2025-0000016 - 196-2025-0000017_________ __________196-2025-0000018 - 196-2025-0000019_________ __________196-2025-0000020 - 196-2025-0000022_________ __________196-2025-0000023 - 196-2025-0000024_________ __________196-2025-0000025 - 196-2025-0000027_________ __________196-2025-0000028 - 196-2025-0000031_________ _________ 196-2026-0000001 - 196-2026-0000004_________ __________196-2026-0000005 - 196-2026-0000006_________ __________196-2026-0000007 - 196-2026-0000008_________ ___________________ 196-2026-0000009___________________ ___________________ 196-2026-0000010___________________ __________196-2026-0000011 - 196-2026-0000012_________ __________196-2026-0000013 - 196-2026-0000016_________ 207 - 211; GHS008474 - GHS008478; EID724910 - EID724914 3MA00405138 - 3MA00405151; ROWE005095 - ROWE005108 3MA00405152 - 3MA00405169; ROWE004954 - ROWE004971 3MA00405152 - 3MA00405169; ROWE004972 - ROWE004989 3MA00749384 - 3MA00749681; ROWE010543 - ROWE010840 3MA10067228 - 3MA10067230; ROWE010540 - ROWE010542 ____________ AC009647 - AC009653____________ AEL000349 - AEL00067; EID716602 - EID716620 AEL000386 - AEL000391; EID16639 - EID16644 AEL000399 - AEL000407; EID716652 - EID716660 AEL000417 - AEL000420; EID716670 - EID716673 AEL000436 - AEL000442; EID716689 - EID716695 Page 52 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 83 of 232 PAGEID #: 40847 ________ Bates Numbered Documents________ AEL000523 - AEL0000553; EID716776 - EID716806 __________________AJP001628; EID924233 AJP002394 - AJP002395; USEPA8842 - USEPA884 _________________ AJP003042- AJP003047 AJP005297 - AJP005303; EID117492 - EID117498 AJP009997 - AJP010005; EID521393 - EID521401 AJP009997 - AJP010005; EID521393 - EID521401 AJP010006 - AJP010007; EID521402 - EID521403 AJP010006 - AJP010007; EID521402 - EID521403 AJP010008 - AJP010009; EID521404 - EID521405 AJP010008 - AJP010009; EID521404 - EID521405 AJP010008 - AJP010009; EID521404 - EID521405 __________________ A JP 0 1 0 2 3 2 ;E ID 6 0 3 7 4 7 AJP010251 - AJP010255; EID603766 - EID603770 AJP010259 - AJP010260; EID603774 - EID603775 AJP010285 - AJP010286; EID603800 - EID603801 _________________ AJP010344- AJP010345 _________________ AJP010351- AJP010352 AR226-1865-1867; AR226-1869; AR226-1899; 279325; MR279024; EID713127 - EID713135; EID584159 - EID584186 EID584204; EID080233 - EID080233; AJP001418 - AJP001419; GK000378 - GK000379; EID080214 - EID080215; AJP001399 AJP001400; EID102509 - EID102534;WEF000076 WEF000101; LE5954 - LE5957; SL001108 - SL001120; EID523009 - EID523021; EID106191 - EID106205; WEF000116 WEF000130; EID090076 - EID090085; AJP002917 - AJP002923; AJP002926 -AJP002928; EID079371 - EID079375; AJP002509 AJP002511; EID871401 - EID871410; EID166599 - EID166608 ASH010156; ASH010159 - ASH010161 - ASH010164; ___________ USEPA14989 - USEPA14994___________ ASH014657 - ASH014660; EID192527 - EID192530 ___________________ASH016201___________________ _____________AVM000426; EID918750_____________ AVM010257 -AVM010259; EID717936 - EID717938 AVM010433 - AVM010440; EID718110 - EID718117 AVM011080 - AVM011081; EID718742 - EID718743 AVM011149 - AVM011171; EID7188805 - EID718827 AVM011183 - AVM011186; EID718838 - EID718841 AVM011207 - AVM011208; EID718862 - EID718863 BEAUCHAMP000020 - BEAUCHAMP000021 _______________B E A U C H A M P 0 0 0 0 3 1 ______________ BEAUCHAMP000038 - BEAUCHAMP000042 BEAUCHAMP000072 Page 53 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 84 of 232 PAGEID #: 40848 ____ Bates Numbered Documents BLD000087 - BLD000089; EID209529 - EID209531 BLD003307 - BLD003315; EID521998 - EID522006 BLD003332 - BLD003333; EID522023 - EID522024 BLH000021 - BLH000023; EID603879 - EID603881 ____________ BLH000034 - BLH000035____________ CAB000300 - CAB000308; EID719372 - EID719380 CF018853 - CF018856; EID181068 - EID181071 _____________ CF036835 - CF036878_____________ _____________ CF037249 - CF037250_____________ CHK000001 - CHK000006; EID604186 - EID604191 ____________ CMB000459; EID215645____________ CS000737 - CS000764; EID089043 - EID089070 DDJ001712 - DDJ001719; EID510244 - EID510251 __________________ DDJ006904__________________ ____________ DDJ008103 - DDJ008108____________ _____________DDJ009041; EID604811_____________ _____________DDJ009397; EID720342_____________ _____________DDJ009398; EID720343_____________ ____________ DDJ009408 - DDJ009409____________ DDJ009432 - DDJ009433; EID720377 - EID720378 _____________ DE000274;EID909818_____________ DFA006722 - DFA006723; EID720457 - EID720458 ____________ DFA006725;EID720460____________ DMR018545 - DMR018552; EID720690 - EID720697 DMR019635 - DMR019662; EID721776 - EID721803 ___________ DMR020403 - DMR020408___________ ____________ DMR034127; EID794564____________ DMR034508 - DMR034509; EID794914 - EID794915 DPL000017 - DPL000019; EID713572 - EID713574 _____________DPL000042; EID713597_____________ _____________ DPL000043; EID13598_____________ DPL000156 - DPL000165; EID713700 - EID713709 DPL000206 - DPL000210; EID713750 - EID713754 DPL000211 - DPL000213; EID713755 - EID713757 _____________DPL000219; EID713763_____________ DPL000226- DPL000231; EID713770 - EID713775 DPL000250 -DPL000258; EID713793 - EID713801 DPL000250 -DPL000258; EID713793 - EID713801 DPL000260 - DPL000272; EID713802 - EID713814 ___________ DPZ0332640 - DPZ0332650___________ DPZ033265; DPZ0332652 - DPZ0332653 ___________ DPZ0332751 - DPZ0332789___________ ___________ DPZ0332751 - DPZ0332789___________ ___________ DPZ0338890 - DPZ0338896___________ ____________ DUP000987; EID123133____________ Page 54 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 85 of 232 PAGEID #: 40849 _______Bates Numbered Documents_______ DUP000989 - DUP000991; EID071855 - EID071857 DWS1036528 - DWS1036529; HLAB003912 - HLAB003913; ________________EID123463 - EID123464________________ DWS1036530 - DWS1036532; EID071855 - EID071857; _______________DUP000989 - DUP000991_______________ ______________EDD0013043 - EDD0013044______________ ______________EDD0013496 - EDD0013497______________ ______________EDD0013498 - EDD0013499______________ ______________EDD0017605 - EDD0017647______________ ____________________ EDD0017672____________________ ______________EDD0017685 - EDD0017729______________ ____________________ EDD0018037____________________ ____________________ EDD0020382____________________ ____________________ EDD0023058____________________ ______________EDD0025578 - EDD0025603______________ ______________EDD0025633 - EDD0025635______________ ____________________ EDD0025666____________________ ______________EDD0025696 - EDD0025717______________ ____________________ EDD0025754____________________ ____________________ EDD0025792____________________ ______________EDD0025794 - EDD0025795______________ ____________________ EDD0025805____________________ ______________EDD0029187 - EDD0029188______________ ____________________ EDD0029352____________________ ______________EDD0029457 - EDD0029461______________ ______________EDD0029531 - EDD0029533______________ ____________________ EDD0029719____________________ ____________________ EDD0029720____________________ ______________EDD0030720 - EDD0030723______________ ______________EDD0030832 - EDD0030836______________ ______________EDD0031057 - EDD0031134______________ ______________EDD0032428 - EDD0032437______________ ____________________ EDD0032459____________________ ____________________ EDD0032530____________________ ______________ EDD0034838; EDD0053985______________ ____________________ EDD0036870____________________ ______________EDD0037501 - EDD0037502______________ ____________________ EDD0038069____________________ ____________________ EDD0038481____________________ ______________EDD0039236 - EDD0039259______________ ______________EDD0040293 - EDD0040294______________ ____________________ EDD0040516____________________ ______________EDD0040583 - EDD0040584______________ ______________EDD0040817 - EDD0040818______________ EDD0040935 Page 55 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 86 of 232 PAGEID #: 40850 Bates Numbered Documents EDD0041002 - EDD0041003 ___________ EDD0041115___________ ___________ EDD0041201___________ ___________ EDD0041202___________ ___________ EDD0041203___________ EDD0041296 - EDD0041297 EDD0041303 - EDD0041304 EDD0041340 - EDD0041341 ___________ EDD0047524___________ EDD0048763 - EDD48764 ___________ EDD0052262___________ EDD0052575 - EDD0052576 ___________ EDD0053400___________ ___________ EDD0053811___________ ___________ EDD0053985___________ EDD0054275 - EDD0054312 ___________ EDD0058879___________ EDD0059977 - EDD0059978 EDD0064077 - EDD0064096 EDD0064573 - EDD0064617 EDD0064618 - EDD0064665 EDD0065093 - EDD0065124 EDD0065933 - EDD0065936 EDD0066018 - EDD0066026 EDD0069422 - EDD0069424 ___________ EDD0069533___________ ___________ EDD0069702___________ EDD0069863 - EDD0069864 ___________ EDD0070085___________ ___________ EDD0070264___________ EDD0070290 - EDD0070294 ___________ EDD0070679___________ ___________ EDD0070715___________ ___________ EDD0071319___________ ___________ EDD0071329___________ EDD0071408 - EDD0071409 ___________ EDD0071711___________ EDD0071765 - EDD0071767 EDD0071768 - EDD0071769 EDD0071832 - EDD0071833 EDD0072219 - EDD0072220 ___________ EDD0072286___________ ___________ EDD0072289___________ EDD0072377 - EDD0072378 EDD0072486 - EDD0072489 Page 56 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 87 of 232 PAGEID #: 40851 ______ Bates Numbered Documents______ _____________ EDD0072506 - EDD0072508_____________ EDD0072617 - EDD0072622; EDD0072648 - EDD0072649 ____________________ EDD0072900____________________ _____________ EDD0072939 - EDD0072951_____________ ____________________ EDD0073329____________________ _____________ EDD0073366 - EDD0073368_____________ ____________________ EDD0073522____________________ ____________________ EDD0073854____________________ ____________________ EDD0073854____________________ ____________________ EDD0073970____________________ ____________________ EDD0073970____________________ ____________________ EDD0074006____________________ ____________________ EDD0075341____________________ _____________ EDD0075365 - EDD0075370_____________ _____________ EDD0075378 - EDD0075391_____________ _____________ EDD0075677 - EDD0075695_____________ _____________ EDD0076050 - EDD0076051_____________ _____________ EDD0076050 - EDD0076051_____________ _____________ EDD0076180 - EDD0076185_____________ _____________ EDD0076245 - EDD0076247_____________ _____________ EDD0076245 - EDD0076247_____________ ____________________ EDD0076288____________________ ____________________ EDD0076288____________________ ____________________ EDD0076288____________________ ____________________ EDD0076369____________________ ____________________ EDD0076369____________________ _____________ EDD0076385 - EDD0076386_____________ ____________________ EDD0076388____________________ _____________ EDD0076442 - EDD0076445_____________ ____________________ EDD0076605____________________ ____________________ EDD0076764____________________ ____________________ EDD0076791____________________ ____________________ EDD0076804____________________ ____________________ EDD0076808____________________ ____________________ EDD0076808____________________ ____________________ EDD0076831____________________ ____________________ EDD0076839____________________ ____________________ EDD0076852____________________ ____________________ EDD0076876____________________ ____________________ EDD0076877____________________ ____________________ EDD0076880____________________ ____________________ EDD0076881____________________ ____________________ EDD0076883____________________ ____________________ EDD0076995____________________ EDD0077002 Page 57 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 88 of 232 PAGEID #: 40852 Bates Numbered Documents EDD0077229 - EDD0077234 ___________ EDD0077316___________ EDD0077455 - EDD0077465 ___________ EDD0077485___________ ___________ EDD0077485___________ ___________ EDD0077532___________ EDD0078223 - EDD0078224 EDD0078223 - EDD0078224 ___________ EDD0078225___________ ___________ EDD0078228___________ ___________ EDD0078308___________ ___________ EDD0078308___________ ___________ EDD0078308___________ EDD0078312 - EDD0078313 ___________ EDD0078793___________ ___________ EDD0078793___________ __________ EDD00788225__________ ___________ EDD0078997___________ ___________ EDD0078997___________ EDD0079155 - EDD0079157 EDD0079158 - EDD0079159 ___________ EDD0079181___________ ___________ EDD0079181___________ EDD0079199 - EDD0079200 ___________ EDD0079253___________ ___________ EDD0079253___________ EDD0079559 - EDD0079585 EDD0079587 - EDD0079619 EDD0079587 - EDD0079619 EDD0079620 - EDD0079651 EDD0079620 - EDD0079651 EDD0080020 - EDD0080063 EDD0080020 - EDD0080063 ___________ EDD0080154___________ ___________ EDD0080154___________ EDD0080907 - EDD0080949 EDD0081245 - EDD0081419 ___________ EDD0081421___________ EDD0081423 - EDD0081631 EDD0081768 - EDD0081798 EDD0081768 - EID0081798 EDD0081935 - EDD0082144 EDD0091226 - EDD0091268 EDD0091548 - EDD0091557 EDD303759 - EID303760 Page 58 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 89 of 232 PAGEID #: 40853 ________ Bates Numbered Documents________ _______________________ EDD397484 _______________________EID0077532 EID009818 - EID009823; RLR001835 - RLR001840 __________________EID010448; RLR000536 EID017446 - EID017447; RLR001040 - RLR001041 EID017452 - EID017454; RLR001006 - RLR001008 EID017457 - EID017457; RLR000818 - RLR000819 EID018445 - EID018446; LKI000066 - LKI000067; ENV0006163 ______________________ ENV0006164 EID071353 - EID071357; JMM002365 - JMM002369 _________________ EID071527; DUP000598 EID071660 - EID071675; DUP000729 - DUP000743 EID071660; DUP000729; EID071662; DUP000730; EID071663; DUP000731; EID071664; DUP000732; EID071665; DUP000733; EID071666; DUP000734; EID071667; DUP000735; EID071668; DUP000736; EID071669; DUP000737; EID071670; DUP000738; EID071671; DUP000739; EID071672; DUP000740; EID071673; DUP000741; EID071674; DUP000742; EID071675; ______________________ DUP000743; _________________ EID071704; DUP000772 EID071705 - EID071706; DUP000773 - DUP000774 EID071705 - EID071706; DUP000773 - DUP000774 EID071705 - EID071706; DUP000773 - DUP000774 EID071705 - EID071706; DUP000773 - DUP000774 _________________ EID071707; DUP000775 EID071712 - EID071713; DUP000779 - DUP000780 EID071712 - EID071713; DUP000779 - DUP000780 _________________ EID071717; DUP000814 _________________ EID071734; DUP000860 _________________ EID071748 - EID071796 _______________________ EID071865 _________________ EID071866 - EID071905 __________________EID071934; EID071935 _________________ EID072032 - EID072033 _________________ EID072046 - EID072051 _______________________ EID072052 EID072164 - EID072166; DUP000574 - DUP000576 _________________ EID072167; DUP000578 EID072168 - EID072176; DUP000579 - DUP000587 _________________ EID072183; DUP000783 _________________ EID072185; DUP000785 _________________ EID072185; DUP000785 _________________ EID072186; DUP000786 _________________ EID072186; DUP000786 Page 59 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 90 of 232 PAGEID #: 40854 ________Bates Numbered Documents________ EID072196 - EID072199; DUP001001 - DUP001004 _______________________ EID072214_______________________ _______________________ EID072215_______________________ _________________ EID072216 - EID072233_________________ _______________________ EID072234_______________________ _______________________ EID072240_______________________ EID072278 - EID72281; RLR003002 - RLR003005 _______________________ EID072367_______________________ EID072378 - EID072380; GW007426 - GW0007428 _________________ EID072531; AJP000027_________________ _________________ EID072968; AJP000563_________________ _________________ EID076894; RLR002852_________________ _________________ EID076926; RLR002898_________________ EID077233 - EID077236; AJP003805 - AJP003808 EID077237 - EID077262; AJP003809- AJP003834 EID077263 - EID077268; AJP003835 - AJP003840 EID077553 - EID077576; AJP003140 - AJP003163 EID077553 - EID077576; AJP003140 - AJP003163 EID077577 - EID077578; AJP003165 - AJP003166 EID077579 - EID077580; AJP003169 - AJP003170 EID077579 - EID077580; AJP003169 - AJP003170 _________________ EID077622; AJP003241_________________ EID077623 - EID077624; AJP003242 - AJP003243 EID077625 - EID077646; AJP003244 - AJP003265 EID077676 - EID077680; AJP003406 - AJP003410 EID077720 - EID077733; AJP003452 - AJP003465 _________________ EID077758; DFA000031_________________ EID078567 - EID078571; RJZ004937 - RJZ004941 _________________ EID078581; RJZ004947_________________ _________________ EID078689; RJZ005066_________________ _________________ EID078719; RJZ005098_________________ _________________ EID078719; RJZ005098_________________ EID078738 - EID078739; RJZ005154 - RJZ005155 _________________ EID078738; RJZ005154_________________ _________________ EID078739; RJZ005155_________________ EID078752 - EID078777; RJZ005372 - RJZ005397 EID078779 - EID078780; RJZ005408 - RJZ005409 EID078781 - EID078784; RJZ005426 - RJZ005429 EID078781 - EID078784; RJZ005426 - RJZ005429; EID078784 ____________EID078801; RJZ005445 - RJZ005446____________ EID078781 - EID078799; RJZ005426 - RJZ005444 EID078812 - EID078814; RJZ006502 - RJZ006504 EID078877 - EID078878; RJZ007143 - RJZ007146 _________________ EID079036; RJZ009056_________________ EID079049 - EID079057; RJZ009070 - RJZ009078 Page 60 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 91 of 232 PAGEID #: 40855 Bates Numbered Documents ____________EID079066; RJZ009087____________ ____________EID079084; RJZ009105____________ ____________EID079089; RJZ009206____________ EID079091 - EID079094; RJZ009208 - RJZ009211 EID079096 - EID079100; RJZ009213 - RJZ009218 EID079099 - EID079100; RJZ009217 - RJZ009218 ____________EID079102; RJZ009220____________ EID079107 - EID079108; RJZ009226 - RJZ009228 EID079110 - EID079118; RJZ009253 - RJZ009261 _________________ EID079124_________________ EID079134 - EID079140; RJZ009711 - RJZ009716 EID079154 - EID079158; RJZ009758 - RJZ009762 EID079177 - EID079182; RJZ009794 - RJZ009799 EID079183 - EID079189; RJZ009800 - RJZ009806 ____________EID079198; RJZ009815____________ EID079200 - EID079202; RJZ009817 -RJZ009819 EID079212 - EID079218; RJZ009828 - RJZ009834 _________________ EID079219_________________ EID079256 - EID079257; RJZ009901 - RJZ009902 EID079258 - EID079259; EID079269 ____________EID079268; RJZ010046____________ _________________ EID079273_________________ EID079274 - EID079276; AJP002397- AJP002399 EID079277 - EID079281; AJP002400 - AJP002404 EID079287 - EID079292; AJP002414 - AJP002419 EID079294 - EID079296; AJP002432- AJP002434 ___________ EID079309; AJP002447____________ EID079310;AJP002448; EID571588 - EID571591 EID079349 - EID079352; AJP002487 - AJP002490 ___________ EID079367; AJP002505____________ EID079371 - EID079375; AJP002509- AJP002511 EID079371 - EID079375; AJP002509- AJP002511 _________________ EID079375_________________ _________________ EID079375_________________ _________________ EID079375_________________ _________________ EID079375_________________ EID079399 - EID079418; AJP002552 - AJP002571 EID079419 - EID079421; AJP002585 - AJP002587 EID079423 - EID079497; AJP002593 - AJP002667 EID079434 - EID079438; AJP002604 - AJP002608 EID079507 - EID079508; AJP002834 - AJP002835 EID079519 - EID079521; AJP002847 - AJP002849 ___________ EID079520; AJP002848___________ ___________ EID079521; AJP002849____________ EID079522 - EID079530; AJP002850- AJP002858 Page 61 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 92 of 232 PAGEID #: 40856 Bates Numbered Documents EID079531 - EID079539; AJP002859- AJP002867 EID079538 - EID079539; AJP002866- AJP002867 EID079541; AJP002869 EID079544 - EID079550; AJP002872- AJP002878 EID079547 - EID079550; AJP002875 - AJP002878 EID079554 - EID079563; RJZ009764 - RJZ009764 - RJZ009773 EID079567 - EID079576; AJP002882- AJP002891 EID079603 - EID079606; AJP002940- AJP002943 EID079607 - EID079612; AJP002944-AJP002949 EID079613 - EID079626; AJP002950- AJP002963 EID079631 EID079633 EID079641 - EID079642; AJP002267- AJP002268 EID079682 - EID079684; AJP002312 - AJP002314 EID079735 - EID079736; AJP002366- AJP0079736 EID079740 - EID079754; AJP002371- AJP002385 EID079758 - EID079759; AJP002389- AJP002390 EID079829 - EID079832; AJP002223 - AJP002248 EID079930; AJP001868 EID079945 - EID079954; AJP001886- AJP001895 EID080125 EID080127 - EID080128; AJP001522 EID080180 - EID080188; AJP001365 - AJP001373 EID080214 - EID080215; AJP001399- AJP001400 EID080214 - EID080217; AJP001399- AJP001402 EID080223 - EID080225; AJP001408- AJP001410 EID080229 - EID080231; AJP001414- AJP001416 EID080233 - EID080234; AJP001418- AJP001419 EID080233 - EID080234; AJP001418- AJP001419 EID080236 - EID080240; AJP001421- AJP001425 EID080241 - EID080246; AJP001426- AJP001431 EID080253 - EID080254; AJP001438- AJP001439 EID080266; AJP001451 EID080267 - EID080270; AJP001452- AJP001455 EID080271 - EID080285; AJP001456- AJP001470 EID080531 - EID080533; AJP001131- AJP001133 EID080543 - EID080547; AJP001143 - AJP001147 EID080591 - EID080592; AJP001191- AJP001192 EID080601 - EID080611; AJP001201- AJP001211 EID080604 - EID080611; AJP001204- AJP001211 EID080630; AJP001230 EID080632; AJP001232 EID080633; AJP001233 EID080635 - EID080636; AJP001235 - AJP001236 EID080637 - EID080644; AJP001237- AJP001244 Page 62 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 93 of 232 PAGEID #: 40857 Bates Numbered Documents _____________EID080657; AJP001257_____________ _____________EID080662; AJP001262_____________ EID080677 - EID080692; AJP001277 - AJP001292 _____________EID080693; AJP001293_____________ _____________EID080694; AJP001294_____________ EID080695 - EID080706; AJP001295 - AJP001306 EID080707 - EID080709; AJP001307 - AJP001309 EID080710 - EID080711; AJP001310 - AJP001311 EID080748 - EID080756; AJP001347 - AJP001355 EID080757 - EID080764; AJP001356 - AJP001363 ____________ EID080797 - EID080801____________ EID080797 - EID080801; GW006836 - GW006840 _____________EID080803; LK1001393_____________ EID081573 - EID081598; JLO000305 - JLO000330 EID082037 - EID082047; RJZ015393 - RJZ0153403 EID082048 - EID082051; RJZ015405 - RJZ015407 _____________ EID082077; RJZ015499_____________ EID082081 - EID082090; RJZ015511 - RJZ015521 ____________ EID0821132 - EID821136____________ EID082729 - EID082731; BSD000199 - BSD000201 EID083053 - EID083064; RP000737 - RP000748 EID083053 - EID083064; RP000737 - RPP000748 EID086275; RJZ013179 - EID086276; RJZ013180 EID086677 - EID086680; RCG000014 - RCG000017 EID086677 - EID086680; RCG000014 - RCG000017 EID086681 - EID086682; RCG000018 - RCG000019 EID086757 - EID086768; RCG000094 - RCG000105 EID086757 - EID086768; RCG000094 - RCG000105 EID086757 - EID086768; RCG000094 - RCG000105 EID086784 - EID086796; RCG000121 - RCG000133 EID086797 - EID086803; RCG000134 - RCG000140 EID086812 - EID086820; RCG000149 - RCG000157 EID086821 - EID086834; RCG000158 - RCG000171 ____________ EID087880; HDR001824____________ EID088521 - EID088528; RV000914 - RV000921 EID088672 - EID088696; GWJ000091 - GWJ000115 ____________ EID088847; GWJ000305____________ ____________________ EID089____________________ EID089300 - EID089303; DDJ001536 - DDJ001539 __________________ EID089407__________________ __________________ EID089418__________________ __________________ EID089418__________________ __________________ EID089421__________________ EID089443 - EID089448; DDJ001701 - DDJ001706 EID089449 - EID089453; DDJ001707 - DDJ001711 Page 63 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 94 of 232 PAGEID #: 40858 ______ Bates Numbered Documents______ EID089462 - EID089463; DDJ001720 - DDJ001721 _______________ EID089464 - EID089466_______________ _______________ EID089515; HDR001920_______________ EID090073 - EID090075; AJP002935 - AJP002937 EID090076 - EID090085; AJP002917 - AJP002928 EID090076 - EID090085; AJP002917 - AJP002928 EID091316 - EID091317; RJZ026696 - RJZ026697 EID091340 - EID091354; RJZ026743 - RJZ026757 EID091378 - EID091402; RJZ02655 - RJZ02668; RJZ02670 _____________________ RJZ026580_____________________ ________________EID091388; RJZ026565________________ EID092770 - EID092810; RJZ021593 - RJZ021633 EID093140 - EID093147; RJZ020573 - RJZ020588 EID096399 - EID096406; AJP003848 - AJP003855 _______________ EID096447; BWK000012_______________ EID096449 - EID096450; BWK000014 - BWK000015 EID096449 - EID096450; BWK000014 - BWK000015 _______________ EID096456; BWK000021_______________ EID096458 - EID096459; BWK000023 - BWK000024 _______________ EID096464; BWK000104_______________ EID096465 - EID096472; BWK000105 - BWK000112 EID096478 - EID096480; BWK000118 - BWK000120 _______________ EID096481; BWK000121_______________ _______________ EID096481; BWK000121_______________ EID096482 - EID096483; BWK000127 - BWK000128 _______________ EID096486; BWK000131_______________ EID096487 - EID096491; BWK000132 - BWK000136 _______________ EID096492; BWK000137_______________ EID096494 - EID096495; BWK000139 - BWK000140 EID096494 - EID096495; BWK000139 - BWK000140 EID096496 - EID096502; BWK000141 - BWK000147 _______________ EID096503; BWK000148_______________ EID096504 - EID096508; BWK000150 - BWK000154 _________ EID096510 - EID096511; BWK000157_________ _________ EID096510; EID096511: BWK000157__________ _______________ EID096514; BWK000160_______________ _______________ EID096515; BWK000161_______________ EID096516 - EID096519; BWK000162 - BWK000165 EID096523 - EID096525; BWK000172 - BWK000174 EID097177 - EID097185; RAM000001 - RAM000009 _______________ EID097177; RAM000001_______________ ________________ EID098719;JW000048________________ EID099433 - EID099434; BJR000090 - BJR000091 EID099795 - EID099796; GK000521 - GK000522 EID101656 - EID101662; GK001607 - GK001613 Page 64 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 95 of 232 PAGEID #: 40859 ________ Bates Numbered Documents________ _______EID102117 - EID102121; GK002312 - GK002316 ________EID102174 - EID102175; GK002377 - GK2378________ __________________ EID102437; BR000086__________________ EID102439 - EID102471; WEF000002 - WEF000034 _________________ EID102477; WEF000044_________________ EID102478 - EID102507; WEF000045 - WEF000074 EID102508 - EID102534; WEF000075 - WEF000101 EID102509 - EID102534; WEF000076 - WEF000101 EID102509; WEF000076; EID102510; WEF000077; EID102511; WEF000078; EID102512; WEF000079; EID102513; WEF000080;EID102514; WEF000081; EID102515; WEF000082; EID102516; WEF000083; EID102517; WEF000084; EID102518; WEF000085; EID102519; WEF000086; EID102520; WEF000087; EID102521; W EF000088;; EID102522; WEF000089; EID102523; WEF000090; EID102524; WEF000091; EID102525; WEF000092; EID102526; WEF000093; EID102527; WEF000094; EID102528; WEF000095; EID102529; WEF000096; EID102530; WEF000097; EID102531; WEF000098; EID102532; WEF000099; EID102533; ___________WEF000100; EID102534; WEF000101;___________ _________________ EID102539; RRS000004_________________ EID102616 - EID102624; RRS000087 - RRS000095 EID102770 - EID102771; AVM000200 - AVM000201 _________________ EID102770; AVM000200_________________ EID102777 - EID102781; AVM000213 - AVM000217 EID102805 - 102817; AVM000242 - AVM000254 _________________ EID102805; AVM000242_________________ EID102806 - EID102817; AVM000243 - AVM000254 _________________ EID102984; ASH010015_________________ EID103027 - EID103031; ASH010172 - ASH010177 EID103032 - EID103035; ASH010179 - ASH010182 EID104354 - EID104356; ASH008956 - ASH008958 _______EID104879 - EID104880; RL000133 - RL000134_______ ________EID104924 - EID104931; RL000191 RL000197________ _______ EID104960 - EID104968; RL000258 - RL000266_______ EID104960; RL000258; EID104961; RL000259; EID104962; RL000260; EID104963; RL000261; EID104964; RL000262; EID104965; RL000263; EID104966; RL000264; EID104967; _____________ RL000265;EID104968; RL000266_____________ _______ EID104969 - EID104977; RL000267 - RL000275_______ EID104969; RL000267; EID104970; RL000268; EID104971; RL000269; EID104972; RL000270; EID104973; RL000271; EID104974; RL000272; EID104975; RL000273; EID104976; RL000274; EID104977; RL000275 Page 65 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 96 of 232 PAGEID #: 40860 ________ Bates Numbered Documents________ _______EID106039 - EID106046; RB000010 - RB000017_______ _______EID106039 - EID106046; RB000010 - RB000017_______ EID106191 - EID106195; WEF000116 - WEF000120; EID106180; EID106215; WEF000105; WEF000167 _________________ EID106191 - EID106205_________________ EID106191; WEF000116; EID106192; WEF000117; EID106193; WEF000118; EID106194; WEF000119; EID106195; WEF000120; EID106196; WEF000121; EID106197; WEF000122; EID106198; WEF000123; EID106199; WEF000124; EID106200; WEF000125; EID106201; WEF000126; EID106202; WEF000127; EID106203; WEF000128; EID106204; WEF000129; EID106205; WEF000130; EID924540; AJP002916; EID924541; AJP002926; EID924542; AJP002927; EID924543; AJP002928; EID924544; AJP002929; EID924545; AJP002930; EID079375 EID106206 - EID106212; WEF000131 - WEF000137 EID106216 - EID106223; WEF000168 - WEF000175 EID106225 - EID106275; WEF000177 - WEF000227 EID106336 - EID106340; WEF000288 - WEF000292 _________________ EID106354; WEF000308_________________ EID106418 - EID106428; WEF000372 - WEF000382 EID106418; WEF000372; EID106419; WEF000373; EID106420; WEF000374; EID106421; WEF000375; EID106422; WEF000376; EID106423; WEF000377; EID106424; WEF000378; EID106425; WEF000379; EID106426; WEF000380; EID106427; WEF000381; EID106428; ______________________ WEF000382;______________________ EID106488 - EID106498; WEF000442 - WEF000452 _________________ EID106594; WEF000549_________________ ____________ EID106596; EID106603 - EID106684____________ EID106597 - EID106602; WEF000552 - WEF000557 _________________ EID106598; WEF000553_________________ _________________ EID106599; WEF000554_________________ _________________ EID106600; WEF000555_________________ _________________ EID106601; WEF000556_________________ EID106685 - EID106686; WEF000640 - WEF000641 EID106687 - EID106696; WEF000642 - WEF000651 _______ EID106953; RL001264; EID769927 - EID769938_______ _______ EID107066 - EID107071; RL001483 - RL001488_______ EID107066; RL001483; EID107067; RL001484; EID107068; RL001485; EID107069; RL001486; EID107070; RL001487; __________________ EID107071; RL001488__________________ _______ EID107111 - EID107129; RL001539 - RL001557_______ _______ EID107133 - EDI107154; RL001690 - RL001711_______ Page 66 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 97 of 232 PAGEID #: 40861 _______ Bates Numbered Documents_______ EID107155 - EID107156; RL001722- RL001723 _________________ EID107157; RL001724_________________ EID107158 - EID107159; RL001725 - RL001726 EID107159 - EID107160; RL001725 - RL001727 EID107161 - EID107172; RL001728- RL001739 EID107173 - EID107175; RL001743 - RL001745 EID107173 - EID107175; RL001743 - RL001745 EID107176 - EID107182; RL001746- RL001752 EID107192 - EID107193; RL001773 - RL001774 EID107194 - EID107195; RL001775 - RL001776 EID107194 - EID107195; RL001775 - RL001776 EID107194 - EID107195; RL001775 - RL001776 _________________ EID107196; RL001777_________________ _________________ EID107196; RL001777_________________ _________________ EID107196; RL001777_________________ EID107198 - EID107200; RL001779- RL001781 _________________ EID107201; RL001782_________________ EID107347 - EID107348; RL001944 - RL001945 _________________ EID107349; RL001946_________________ EID107350 - EID107355; DWS1040708 - DWS1040713; _________________ RL001978 - RL001983_________________ EID107350 - EID107355; DWS1040708 - DWS1040713; _________________ RL001978 - RL001983_________________ EID107350 - EID107355; DWS1040708 - DWS1040713; _________________ RL001978 - RL001983_________________ EID107356 - EID107363; RL001984 - RL001991 _________________ EID107357; RL001985_________________ _________________ EID107358; RL001986_________________ _________________ EID107358; RL001986_________________ EID107384 - EID107386; RL002015 - RL002017 EID107384 - EID107386; RL002015 - RL002017 EID107384 - EID107386; RL002015 - RL002017 EID107462 - EID107465; RL002093 - RL002096; EID079268; ______________________ RJZ010046______________________ EID107462 - EID107465; RL002093 - RL002096; EID117451; ______________________ RJZ016982______________________ EID107654 - EID107657; WJB000344 - WJB000347 EID107654 - EID107657; WJB000344 - WJB000347 EID108184 - EID108186; LAB000047 - LAB000049 EID108608 - EID108615; RP001967 - RP001974 EID108802 - EID108819; GLK001121 - GLK001138 EID109493 - EID109525; GLK002502 - GLK002541 Page 67 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 98 of 232 PAGEID #: 40862 ________ Bates Numbered Documents________ EID109642 - EID109643; GLK002614-GLK002615; EID109687 EID109768; GLK002659 - GLK002740; EID109781 - EID109784; GLK002753 - GLK002756; EID109786; GLK002758 EID109642 - EID109649; GLK002614 - GLK002621; EID109687 EID109698; GLK002659 - GLK002670; EID109782 - EID109786; _________________ GLK002754 - GLK002758 EID110113 - EID110115; ARF000015 - ARF000017 __________________ EID110142; JJP000006 _______EID110260 - EID110261; JJP000202 - JJP000203 EID110517 - EID110521; BLD000009 - BLD000013 EID110522 - EID100526; BLD000014 - BLD000018 _______EID110651 - EID110653; BLD00172 - BLD00174 EID110654 - EID110658; BLD000175 - BLD000179 EID111009 - EID111010; RJA000232 - RJA000233 EID111565 -EID111602; RJC000945 - RJC000982 EID112155 - EID112156; LWB000735 - LWB000736 EID112798 - EID112830; RJZ029978 - RJZ030010 _________________ EID112971; DDJ001815 _______EID114185 - EID114197; RP002056 - RP002068 EID118383 - EID118386; GIL000007 - GIL000010 EID118757 - EID118781; WAB000514 - WAB000538 EID118986 - EID118988; MEM000430 - MEM000432 EID120806 - EID120818; RP002159 - RPP002171 _______ EID121879 - EID121894; RL002146 - RL002161 __________________ EID121879; RL002146 _______ EID121880 - EID121894; RL002147 - RL002161 _______EID121895 - EID121898; GK003122 - GK003125 _______ EID122022 - EID122031; RL000382- RL000391 EID123110 - EID123112; DWS1036517 - DWS1036519; ________________ DUP000824 - DUP000826 _________________ EID123115; DUP000829 _________________ EID123132; DUP000973 EID123138 - EID123141; DUP001005 - DUP001008 EID123142 - EID123143; DUP001009 - DUP001010 _________________ EID123175; HLAB003624 _________________ EID123176; HLAB003625 EID123531 - EID123532; RLR003481 - RLR003482 EID123531 - EID123532; RLR003481 - RLR003482 EID123558 - EID123595; EWM000125 - EWM000162 EID143358 - EID143361; BSL000250 - BSL000253 _________________ EID147311; DDJ001807 EID147511 - EID147513; DDJ002286 - DDJ002288 _______ EID147883 - EID147923; FS000010 - FS000050 _______ EID147886 - EID147893; FS000013 - FS000020 Page 68 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 99 of 232 PAGEID #: 40863 _______ Bates Numbered Documents_______ EID147894 - EID147923;FS000021- FS000050 EID147927 - EID147931; FS000054 - FS000058 _________________ EID147954; FS000107_________________ EID148048 - EID148052; FS000252 - FS000256 _________________ EID148070;FS000275_________________ EID148274 - EID148275; GK003559 - GK003560 EID152790; STB000168; EID152751; STB000129; EID152756; ____________STB00134;EID152903; STB000281____________ _________________EID156076 - EID156080________________ _________________EID156108 - EID156116________________ _________________EID156165 - EID156166________________ ______________________ EID156362______________________ ______________________ EID156362______________________ ______________________ EID156477______________________ _________________EID156563 - EID156567________________ _________________EID156808 - EID156809________________ _________________EID156808 - EID156809________________ ______________________ EID156870______________________ ______________________ EID156889______________________ _________________EID156891 - EID156892________________ ______________________ EID156918______________________ ______________________ EID157029______________________ ______________________ EID157030______________________ _________________EID157284 - EID157287________________ _________________EID157290 - EID157293_________________ _________________EID157578 - EID157583_________________ _________________ EID157631-EID157655_________________ _________________EID157785 - EID157790________________ ______________________ EID157940______________________ ______________________ EID157940______________________ _________________EID157942 - EID157944________________ ______________________ EID157950______________________ ______________________ EID157950______________________ ______________________ EID158015______________________ _________________EID158024 - EID158028________________ _________________EID158029 - EID158030________________ _________________EID158031 - EID158034________________ _________________EID158041 - EID158042________________ ______________________ EID158046______________________ _________________EID158076 - EID158078________________ _________________EID158623 - EID158627________________ _________________EID158830 - EID158834________________ ______________________ EID159344______________________ _________________EID159350 - EID159359________________ EID160006 - EID160007 Page 69 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 100 of 232 PAGEID #: 40864 _____Bates Numbered Documents_____ _____________ EID160301-EID160304_____________ EID161612 - EID161628; EID160320 - 160321 ___________________EID161692___________________ _____________ EID161725 - EID161727_____________ ___________________EID161775___________________ _____________ EID164389 - EID164390_____________ _____________EID165462; HDR002697_____________ EID166245 - EID166247; DGW000038 - DGW000040 _____________ EID166449; GK004600_____________ EID166596 - EID166598; GK004794 - GK004796 EID166599 - EID166608; GK004797 - GK004806 EID166859 - EID166868; HDR002182 - HDR002191 EID166921 - EID166925; HDR002256 - HDR002260 EID166991 - EID166992; HDR002357 - HDR002358 EID167138; EID167286; HDR00235; HDR002700 _______ EID167416; RLR002983; HDR002860_______ _______ EID167437; RLR003302; HDR002881_______ EID167716 - EID167717; JHW000004 - JHW000005 EID167963 - EID167964; JJP000735 - JPP000736 _____________ EID168414; NSR000024_____________ EID170094 - EID170096; GK003302 - GK003304 EID170703 - EID170712; KHF000032 - KHF000042 ___________________EID170763___________________ _____________ EID170795 - EID170798_____________ EID170810 - EID170811; KHF000151 - KHF000152 EID171605 - EID171634; RK000567 - RK000596 _____________ EID173849 - EID173853_____________ EID173958 - EID173967; RP006052 - RP006061 _____________ EID173968; RP006062_____________ EID181074 - EID181076; CF018865 - CFO18867 _____________ EID182129; CF018868_____________ EID189826 - EID189835; RJA000688 - RJA000698 EID189826 - EID189835; RJA000688 - RJA000698 _____________ EID190467; RJC003907_____________ EID192481 - EID192482; ASH014611 - ASH014612 EID192523 - EID192524; ASH014653 - ASH014654 EID193608 - EID193610; CF020518- CF020520 EID193611 - EID193612; CF020522 - CF020523 _____________ EID193613; CF020524_____________ EID193614 - EID193618; CF020541- CF020545 EID194771 - EID194781; DDJ002371 - DDJ002381 EID194854 - EID194858; DDJ002454 - DDJ002458 EID195325 - EID195326; GAA000139 - GAA000140 _____________ EID195362; IAL000024_____________ EID195364 - EID195370; IAL000029 - IAL000035 Page 70 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 101 of 232 PAGEID #: 40865 ________ Bates Numbered Documents________ _______EID195387 - EID195394; IAL000087 - IAL000094 EID196124 - EID196138; PJB000224 - PJB000238 EID196182 - EID196183; PJB000298 - PJB000299 EID196260 - EID196263; PJB000378 - PJB000381 __________________EID196652 - EID196654_________________ __________________EID197765 - EID197768_________________ __________________EID197786 - EID197804_________________ __________________EID198132; TSB001599_________________ _______________________ EID209467_______________________ EID209550 - EID209561; BLD000180 - BLD000186; BLD000086 _______________________ BLD000093_______________________ __________________ EID209554; BR000086__________________ __________________ EID215079; BJR000284_________________ _________________ EID216812; LWB000249_________________ EID217103 - EID217104; LWB000757 - LWB000758 EID217103 - EID217104; LWB000757 - LWB000758 _________________ EID217105; LWB000759_________________ _________________ EID217109; LWB000766_________________ _________________ EID217109; LWB000766_________________ _________________ EID217282; MAK001197_________________ _________________ EID217291; MAK001208_________________ __________________EID219491 - EID219492_________________ _______________________ EID221326_______________________ __________________EID221352 - EID221353_________________ __________________EID221376 - EID221384_________________ __________________EID221402 - EID221403_________________ __________________EID221416 - EID221417_________________ ____________ EID221446; EID290786; EID570922____________ __________________ EID221523; EID157411_________________ __________________EID221589 - EID221591_________________ __________________EID221744 - EID221750_________________ _______________________ EID221837_______________________ __________________EID221879 - EID221883_________________ __________________EID221950 - EID221954_________________ _______________________ EID221967_______________________ __________________EID222474 - EID222485_________________ __________________EID222474 - EID222485_________________ _______________________ EID222894_______________________ __________________EID223429 - EID223430_________________ __________________EID223453 - EID223454_________________ _______________________ EID223479_______________________ __________________EID223496 - EID223497_________________ _______________________ EID223536_______________________ _______________________ EID223546_______________________ EID223645 Page 71 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 102 of 232 PAGEID #: 40866 ______ Bates Numbered Documents______ EID229345 - EID229348; CF025193 - CF025196 _______________ EID230663; RCB000992_______________ _______________ EID230665; RCB000994_______________ _______________ EID230666; RCB000995_______________ EID232293 - EID232300; RCB001012 - RCB001019 EID232452; RL002176; EID232453; RL002177; EID232454; ___________ RL002178;EID232455; RL002179___________ ________________ EID232463; RL002187________________ EID252785 - EID252786; MAK002242 - MAK002243 _______________ EID252791 - EID252799_______________ _________ EID252815 - EID252816; MAK002280_________ EID254620 - EID254621; MAK002216 - MAK002217 EID256133 - EID256137; RJZ007652 - RJZ007656 _______________ EID262048 - EID262052_______________ _______________ EID262198 - EID262199_______________ ________________EID262341; EID262343________________ _____________________ EID267734_____________________ _____________________ EID271549_____________________ _______________ EID271679 - EID271680_______________ _______________ EID271743 - EID271749_______________ _______________ EID271817 - EID271818_______________ _______________ EID272031 - EID272032_______________ _____________________ EID272252_____________________ _______________ EID272585 - EID272586_______________ _______________ EID272877 - EID272912_______________ _______________ EID273441 - EID273442_______________ _______________ EID273505 - EID273507_______________ _______________ EID277891 - EID277892_______________ _______________ EID278951 - EID278953_______________ _____________________ EID286119_____________________ _______________ EID286132 - EID286134_______________ _______________ EID286156 - EID286173_______________ _______________ EID288787 - EID288820_______________ _____________________ EID290336_____________________ _______________ EID290349 - EID290350_______________ _______________ EID292610 - EID292620_______________ _______________ EID292650 - EID292652_______________ _______________ EID292684 - EID292691_______________ _____________________ EID292795_____________________ _______________ EID292937 - EID292939_______________ _______________ EID292994 - EID292995_______________ ___________ E ID 2 9 4 5 6 8 ;E ID 3 9 9 5 2 7 ;E ID 3 9 8 3 7 2 ___________ _____________________ EID302070_____________________ _______________ EID302092 - EID302093_______________ EID303541 - EID3033670 Page 72 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 103 of 232 PAGEID #: 40867 Bates Numbered Documents ____________ EID303759____________ EID303759 - EID303760 EID304435 - EID304441 ____________ EID310516____________ EID310517 - EID310519 ____________ EID310520____________ EID310521 - EID310522 ____________ EID310523____________ ____________ EID310525____________ EID314184; EID314204 ____________ EID314710____________ EID317203 - EID317204 ____________ EID317726____________ EID317730 - EID317731 EID317879 - EID317880 EID317937 - EID317939 EID317940 - EID317941 EID318050 - EID318051 ____________ EID318066____________ EID318097 - EID318098 EID318140 - EID318143 ____________ EID318753____________ ____________ EID318753____________ EID324221 - EID324222 EID324243 - EID324245 EID324333 - EID324235 ____________ EID392253____________ EID392962 - EID392964 EID395145 - EID395147 ____________ EID395370____________ ____________ EID397484____________ ____________ EID397484____________ EID398288 - EID398324 ____________ EID398372____________ ____________ EID398372____________ EID416481 - EID416484 EID417693 - EID417694 ____________ EID418715____________ EID421854 - EID421859 EID434833 - EID434834 ____________ EID434841____________ EID434926 - EID434927 EID435272 - EID435273 EID435272 - EID435273 EID435508 - EID435510 Page 73 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 104 of 232 PAGEID #: 40868 _______Bates Numbered Documents_______ ______________________EID436286______________________ ________________ EID437504 - EID437507________________ ________________ EID437504 - EID437507________________ ________________ EID437504 EID437507________________ ________________ EID437686 - EID437687________________ ________________ EID437686 - EID437687________________ ________________ EID443206 - EID443207________________ ________________ EID447531 - EID447532________________ ________________ EID451631 - EID451641________________ ________________ EID462825; DRS001591________________ EID463553 - EID463555; FH000081 - FH000083 ________________ EID463564; FH000100________________ ______________________EID463724______________________ EID467393 - EID467401; GWJ013064 - GWJ013072 EID468890 - EID468892; LJB000015 - LJB000017 EID468899 - EID468900; LJB000024 - LJB000025 EID476862 - EID476877; RP025834 - RP025849 EID476878 - EID476884; RP025850 - RP025856 _______________ EID477097; RWR000804_______________ EID477100 - EID477105; RWR000807 - RWR000812 EID477124 - EID477135; RWR000881 - RWR000892 ________________ EID477912; BJR000455________________ ________________ EID477912; BJR000455________________ EID483876 - EID484019; GWJ010275 - GWJ010418 ________________ EID488910; LJB000002________________ EID495285 - EID495286; RP026263 - RPO26264; GK001381 EID495811 - EID495821; RWR000584 - RWR000594 EID495822 - EID495828; RWR000595 - RWR000601 EID495829 - EID495875; RWR000602 - RWR000648 EID496070- EID496114; STB002285 - STB002329 EID497142 - EID497143; STB003454 - STB003455 ________________ EID497353; STB003769________________ ________________ EID497423; STB003839________________ EID497487-EID497488; STB003904 - STB003905 EID502722 - EID502723; DJM000563 - DJM000564 ________________ EID509412 - EID509414________________ ________________ EID509977 - EID510001________________ ________________ EID510188 - EID510190________________ EID510221 - EID510226; DDJ001689 - DDJ001694 EID510227 - EID510232; DDJ001695 - DDJ001700 EID510258 - EID510260; DDJ001726 - DDJ001728 EID510258 - EID510260; DDJ001726 - DDJ001728 EID510258 - EID510260; DDJ001726 - DDJ001728 EID510261 - EID510263; DDJ001729 - DDJ001731 EID510279 - EID10289 Page 74 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 105 of 232 PAGEID #: 40869 _______Bates Numbered Documents_______ ________________EID510379 - EID510393________________ _____________________ EID517471_____________________ _____________________ EID517538_____________________ ________________EID517551 - EID517565________________ _____________________ EID517606_____________________ EID521382 - EID521392; AJP009986- AJP009996 EID521382 - EID521392; AJP009986- AJP009996 EID523009; SL001108; EID523010; SL001109; EID523011; SL001110; EID523012; SL001111; EID523013; SL001112; EID523014; SL001113; EID523015; SL001114; EID523016; SL001115; EID523017; SL001116; EID523018; SL001117; EID523019; SL001118; EID523020; SL001119; EID523021; ______________________SL001120;______________________ ________________ EID531323 -EID531328________________ _____________________ EID532321_____________________ _____________________ EID532423______________________ ________________EID533200 - EID533201________________ ________________EID534852 - EID534855________________ _____________________ EID537534_____________________ _____________________ EID537535______________________ ________________EID545545 - EID545548________________ _____________________ EID545709_____________________ _____________________ EID546942_____________________ ________________EID546974 - EID546980________________ ________________EID553737 - EID553847________________ _____________________ EID555491_____________________ _____________________ EID556286_____________________ ________________EID556287 - EID556289________________ ________________EID556290 - EID556294________________ _____________________ EID556295______________________ ________________EID556297 - EID556298________________ _____________________ EID556301_____________________ _____________________ EID556308_____________________ _____________________ EID556309_____________________ _____________________ EID556310_____________________ ________________EID562917 - EID562927________________ ________________EID566392 - EID566412________________ ________________EID566536 - EID566553________________ ________________EID566603 - EID566606________________ ________________EID566704 - EID566708________________ _____________________ EID566717_____________________ ________________EID567066 - EID567071________________ ________________EID567669 - EID567804________________ ________________EID567805 - EID567970________________ EID568823 - EID568826 Page 75 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 106 of 232 PAGEID #: 40870 Bates Numbered Documents EID568827 - EID568830 ____________ EID568932____________ EID569962 - EID569966 EID569962 - EID569966 EID570740 - EID570750 EID570857 - EID570860 EID570880 - EID570881 EID570882 - EID570883 EID570884 - EID570892 EID570893 - EID570894 EID570895 - EID570913 EID570923 - EID570925 EID570926 - EID570928 EID570935 - EID570946 _______ EID570988 - EID0998_______ _______ EID570988 - EID0998_______ EID571080 - EID571101 ____________ EID571103____________ ____________ EID571104____________ EID571129 - EID571132 EID571148 - EID571153 ____________ EID571154____________ _______EID571156 - EID71168 EID571181 - EID571232 EID571233 - EID571295 EID571347 - EID571357 EID571572 - EID571573 EID571576 - EID571577 EID571578 - EID571579 EID571594 - EID571595 EID571598 - EID571599 EID571600 - EID571601 EID571633 - EID571635 ____________ EID572559____________ ____________ EID572607____________ ____________ EID573572____________ EID573988 - EID573985 EID573989 - EID573991 EID574231; EID574233 EID574563 - EID574566 EID575362 - EID575381 EID575387 - EID575414 EID575418 - EID575419 EID575420 - EID575421 EID575426 - EID75429 Page 76 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 107 of 232 PAGEID #: 40871 Bates Numbered Documents ___________ EID579767 - EID579785___________ ___________ EID581284 - EID581289___________ ___________ EID582874 - EID582877___________ ___________ EID583563 - EID583569___________ EID584137 - EID584152; EID192136; AJP007299 ___________ EID584158 - EID584204___________ ___________ EID584159 - EID584204___________ ___________ EID584160 - EID584204___________ ___________ EID584206 - EID584219___________ ___________ EID584220 - EID584230___________ ___________ EID584312 - EID584314___________ ___________ EID584312 - EID584314___________ ___________ EID584316 - EID584319___________ _________________ EID584333_________________ ___________ EID584341 - EID584350___________ ____________EID584373 EID584374____________ ___________ EID584375 - EID584380___________ _________________ EID584381_________________ ___________ EID584775 - EID584777___________ ___________ EID586423 - EID586426___________ ___________ EID586993 - EID586994___________ _________________ EID587727_________________ _________________ EID588162_________________ ___________ EID588601 - EID588602___________ _________________ EID589366_________________ ___________ EID589567 - EID589569___________ ___________ EID597061 - EID597062___________ _________________ EID598296_________________ ___________ EID599660 - EID599662___________ ___________ EID599668 - EID599670___________ ___________ EID599673 - EID599674___________ ___________ EID599757 - EID599759___________ ___________ EID600127 - EID600129___________ _________________ EID600208_________________ _________________ EID600954_________________ _________________ EID600955_________________ _________________ EID601077_________________ ___________ EID601234 - EID601236___________ ___________ EID601314 - EID601320___________ ___________ EID601427 - EID601428___________ _________________ EID602210_________________ ___________ EID602956; RJZ009431___________ ___________ EID602989; RJZ009515___________ EID602990 - EID602992; RJZ009957 - RJZ009959 EID602999 - EID603010; RJZ009986 - RJZ009997 Page 77 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 108 of 232 PAGEID #: 40872 _____ Bates Numbered Documents_____ ___________________ EID603077___________________ EID604383 - EID604386; DDJ008613 - DDJ008616 EID608981 - EID609012; GK011655 - GK011686 EID613593 - EID613594; PJB003901 - PJB003902 _____________ EID657164 - EID657170_____________ _____________ EID657660 - EID657667_____________ _____________ EID665651 - EID665792_____________ ___________________ EID666585___________________ ___________________ EID667449___________________ _____________ EID667472 - EID667474_____________ _____________ EID667480 - EID667483_____________ ________EID667492; EID667494 - EID667498________ ___________________ EID667500___________________ ___________________ EID667508___________________ _____________ EID667523 - EID667524_____________ _____________ EID667534 - EID667537_____________ ___________________ EID667550___________________ _____________ EID667557; EID667561_____________ ______ EID667578- EID6677579___________________ ___________________ EID667585___________________ _____________ EID667598 - EID667599_____________ _____________ EID667627; EID667632_____________ _____________ EID667686 - EID667687_____________ ___________________ EID667743___________________ _____________ EID667767 - EID667768_____________ _____________ EID667795 - EID667797_____________ _____________ EID668620 - EID668709_____________ _____________ EID668810 - EID668812_____________ _____________ EID668852 - EID668853_____________ _____________ EID673847 - EID673852_____________ _____________ EID673917 - EID673942_____________ _____________ EID675933 - EID675977_____________ _____________ EID692574 - EID692583_____________ _____________ EID713127 - EID713135_____________ _____________ EID713127 - EID713135_____________ _____________ EID713136 - EID713143_____________ EID713144 - EID713213; EID713215 - EID713234 ________ EID713307; AJP001412; EID80227________ EID713309 - EID713310; RL001773 - RL001774 EID713350 -EID713360; RL001729 - RL001739 EID713361 - WEID713369; WEF000643 - WEF000651 ___________________ EID713388___________________ ___________________ EID713389___________________ _____________ EID713390 - EID713401_____________ EID713536 - EID713557; CHW000011 - CHW00032 Page 78 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 109 of 232 PAGEID #: 40873 Bates Numbered Documents EID715277 - EID715289; SPR001406 - SPR001418 EID715945 -EID715948; AC011022 - AC011025 EID716645 - EID716649; AEL000392 - AEL000396 EID716929 - EID716930; AEL000676 - AEL000677 EID716931 - EID716932; AEL000678 - AEL000679 _____________ EID71716; DUP000813_____________ EID717723 - EID717735; AVM010040 - AVM010052 EID717795 - EID717796; AVM010113 - AVM010114 EID717855 - EID717857; AVM010174 - AVM010176 EID718838 - EID718861; AVM011183 - AVM011206 _____________EID719068; BLH000367_____________ EID720358 - EID720359; DDJ009413 - DDJ009414 EID723650 - EID723652; GHS007213 - GHS007215 EID723898 - EID723900; GHS007461 - GHS007463 EID723912 - EID723914; GHS007475 - GHS007477 EID723915 - EID723917; GHS007478 - GHS007480 EID723934 - EID723939; GHS007497 - GHS007502 ____________ EID725332; GHS008965____________ EID726997 - EID727003; GK012104 - GK012110 EID727004 - EID727005; GK012111 - GK012112 EID729618 - EID729708; EID729897 - EID729905 EID738989 - EID738990; RWR004880 - RWR004881 EID742523 - EID742524; TSB002780- TSB002781 __________________ EID751241__________________ ____________ EID760361 - EID760371_____________ ____________ EID761317 - EID761405_____________ ____________ EID761533 - EID761624____________ __________________ EID761785__________________ __________________ EID761786__________________ __________________ EID761787__________________ ____________ EID761788 - EID761878____________ ____________ EID761879 - EID761952_____________ ____________ EID761953 - EID761971_____________ ____________ EID762684 - EID762908____________ ____________ EID768106 - EID768107_____________ __________________ EID768298__________________ ____________ EID768299 - EID768306_____________ ____________ EID768307 - EID768307_____________ ____________ EID769106 - EID769127_____________ ____________ EID769128 - EID769151_____________ ____________ EID769159 - EID769162_____________ ____________ EID769186 - EID769192_____________ __________________ EID769193__________________ ____________ EID769194 - EID769197_____________ EID769198 - EID769204 Page 79 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 110 of 232 PAGEID #: 40874 _______ Bates Numbered Documents_______ ________________ EID769205 - EID769223________________ ________________ EID769227 - EID769229________________ ______________________ EID769230______________________ ______________________ EID769230______________________ ________________ EID769231 - EID769232________________ ________________ EID769233 - EID769234________________ ________________ EID769233 - EID769234________________ ________________ EID769235 - EID769237________________ ________________ EID769238 - EID769241________________ ________________ EID769242 - EID769243________________ ________________ EID769244 - EID769245________________ ________________ EID769246 - EID769253________________ ________________ EID769254 - EID769257________________ ________________ EID769254 - EID769257________________ ______________________ EID769258______________________ ______________________ EID769258______________________ ______________________ EID769259______________________ ______________________ EID769260______________________ _________________ EID769318 - EID76938_________________ ________________ EID769339 - EID769340________________ _________________ EID76979 - EID769185_________________ ________________ EID769871 - EID769872________________ ________________ EID769882 - EID769884________________ ________________ EID769885 - EID769887________________ ______________________ EID769889______________________ ________________ EID769894 - EID769901________________ ______________________ EID769923______________________ ________________ EID769939 - EID769950________________ ________________ EID769958 - EID769959________________ ________________ EID769960 - EID769965________________ ________________ EID769960 - EID769965________________ EID769966; EID770067; EID769874; EID770065; EID770622; DFA006721; EID720456; AJP010154; EID603669 EID769967 - EID769968 EID769969 - EID769971 EID769972 - EID769976 EID770051 - EID770053 EID770054 - EID770064 EID770614 EID770628 - EID770631 EID770633 - EID770660 EID770683 EID770871 - EID770872 EID770873 - EID770876 Page 80 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 111 of 232 PAGEID #: 40875 Bates Numbered Documents ___________ EID771069 - EID771072___________ ___________ EID771256 - EID771257___________ ___________ EID771256 - EID771257___________ ___________ EID771431 - EID771435___________ ___________ EID771455 - EID771457___________ ___________ EID771458 - EID771483___________ _____________E ID 7 7 1 5 1 0 -771512_____________ ___________ EID772014 - EID772018___________ ___________ EID772101 - EID772103___________ ___________ EID772102 - EID772103___________ ___________ EID772127 - EID772139___________ ___________ EID772151 - EID772156___________ ___________ EID772354 - EID772360___________ ___________ EID772390 - EID772398___________ ___________ EID772449 - EID772456___________ ___________ EID772547 - EID772549___________ _________________ EID772550_________________ ____________ EID772551 - EID77252____________ _________________ EID772553_________________ EID772745 - EID772757; EID713387 ___________ EID774545 - EID774638___________ ___________ EID774639 - EID774752___________ EID775225 - EID775242; GK031812 - GK031829 ___________ EID775258 - EID775275___________ _________________ EID775276_________________ ___________ EID775276 - EID775277___________ ___________ EID775276 - EID775277___________ ___________ EID775278 - EID775400___________ ___________ EID775401 - EID775459___________ ___________ EID778797 - EID778889___________ ___________ EID778797 - EID778889___________ EID778800 - EID778801; AJP010371 - AJP010372 _________________ EID781977_________________ _________________ EID781980_________________ _________________ EID781981_________________ _________________ EID781982_________________ _________________ EID781983_________________ _________________ EID781983_________________ _________________ EID781984_________________ _________________ EID781985_________________ _________________ EID781986_________________ _________________ EID781987_________________ _________________ EID781988_________________ _________________ EID781988_________________ EID781989 Page 81 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 112 of 232 PAGEID #: 40876 ____ Bates Numbered Documents____ __________________ EID781990__________________ __________________ EID781990__________________ __________________ EID781991__________________ __________________ EID781992__________________ __________________ EID781992__________________ __________________ EID781993__________________ ______________EID78312 - EID78313______________ _____________ EID79034; RJZ009054_____________ _____________ EID79506; AJP002833_____________ EID800056 - EID800057; MLR002326 - MLR002327 EID800823 - EID800833; PEG000032 - PEG000042 EID806588 - EID806593; UMC002262 - UMC002267 EID806995 - EID806996; UMC002692 - UMC002693 EID806998 - EID806999; UMC002695 - UMC002696 _____________EID811846 - EID811852_____________ _____________EID812420 - EID812447_____________ _____________EID813781 - EID813804____________ _____________EID813781 - EID813804____________ _____________EID813781 - EID813804____________ _____________EID820883 - EID820886_____________ _____________EID820894 - EID820896_____________ _____________EID820897 - EID820899_____________ _____________EID820976 - EID820977_____________ EID820978 - EID820979; EID825366 - EID825367 _____________EID821019 - EID821020_____________ _____________EID821088 - EID821089_____________ _____________EID821115 - EID821116_____________ __________________ EID821144__________________ _____________EID821189 - EID821190_____________ __________________ EID821192__________________ _____________EID821237 - EID821239_____________ _____________EID821266 - EID821268____________ _____________EID821278 - EIS821281_____________ _____________EID821287 - EID821288____________ _____________EID821300 - EID821302_____________ _____________EID821309 - EID821310_____________ _____________EID821329 - EID821330_____________ _____________EID821331 - EID821332_____________ _____________EID821352 - EID821353_____________ _____________EID821368 - EID821369_____________ _____________EID821581 - EID821608____________ _____________EID821627 - EID821630_____________ _____________EID821826 - EID821828____________ __________________ EID821906__________________ EID821907 - EID821908 Page 82 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 113 of 232 PAGEID #: 40877 Bates Numbered Documents EID821977 - EID821991 EID822000 - EID822007 EID822052 - EID822054 EID822171 - EID822175 EID822283 - EID822284 ____________ EID822300____________ EID822315 - EID822316 EID822374 - EID822395 EID822462 - EID822463 EID822762 - EID822764 EID822765 - EID822768 EID822798 - EID822801 EID822842 - EID822867 EID822922 - EID822924 EID823009 - EID823037 EID823107 - EID823110 EID823209 - EID823211 ____________ EID823323____________ EID823324 - EID823325 EID823332 - EID823336 ____________ EID823518____________ ____________ EID823519____________ EID823605 - EID823614 EID823965 - EID823987 EID823994 - EID823996 ____________ EID824042____________ EID824421-EID824425 EID825031 - EID825042 ____________ EID825043____________ EID825044 - EID825045 EID825374 - EID825382 EID825815 - EID825816 ____________ EID825984____________ EID825985 - EID826082 EID826210 - EID826252 EID826313 - EID826316 ____________ EID826333____________ ____________ EID826367____________ EID826769 - EID826795 EID827405 - EID827408 EID827520 - EID827521 EID827863 - EID827874 EID828309 - EID828312 EID828309 - EID828312 EID828838 - EID828839 Page 83 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 114 of 232 PAGEID #: 40878 Bates Numbered Documents _________ EID829452 - EID829468_________ _________ EID830213 - EID830214_________ _________ EID834586 - EID834587_________ _______________ EID834695_______________ _________ EID835953 - EID835955_________ _________ EID836214 - EID836215_________ _________ EID837186 - EID837187_________ _________ EID837427 - EID837433_________ _________ EID837496 - EID837499_________ _________ EID837717 - EID837721_________ _________ EID838278 - EID838322_________ _________ EID838377 - EID838388_________ _________ EID838390 - EID838391_________ _________ EID838673 - EID838761_________ _________ EID838823 - EID838911_________ _________ EID841632 - EID841723_________ _________ EID842229 - EID842234_________ _________ EID843813 - EID843843_________ _________ EID845149 - EID845150_________ _________ EID845341 - EID845381_________ _________ EID845606 - EID845611_________ _________ EID845612 - EID845705_________ _________ EID845766 - EID845873_________ _________ EID846104 - EID846212_________ _________ EID861597 - EID861599_________ _________ EID861634 - EID861639_________ _______________ EID861641_______________ _________ EID863858 - EID863860_________ _________ EID863945 - EID863946_________ __________EID863948 - EID63952_________ _________ EID864544 - EID864545_________ _________ EID864684 - EID864710_________ EID864732 - EID864733; 001-0135-0011615 _________ EID865305 - EID865306_________ _________ EID865653 - EID865654_________ __________EID865695 - EID65698_________ _________ EID865701 - EID865704_________ _________ EID866512 - EID866514_________ _________ EID866597 - EID866601_________ _________ EID866597 - EID866601_________ _________ EID866666 - EID866670_________ _________ EID866666 - EID866670_________ _______________ EID866989_______________ _________ EID867041 - EID867043_________ EID867380 - EID867381 Page 84 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 115 of 232 PAGEID #: 40879 _____Bates Numbered Documents_____ ___________________ EID 867386___________________ _____________ EID867673 - EID867678_____________ _____________ EID867688 - EID867689_____________ ___________________ EID 867733___________________ _____________ EID867733 - EID867840_____________ _____________ EID867734 - EID867840_____________ _____________ EID870204 - EID870206_____________ _____________ EID871674 - EID871977_____________ EID900308 - EID900313; RJA000374 - RJA000379 EID900586 - EID900704; WJB000072 - WJB000190 EID903496 - EID903497; CF001391- CF001392 EID903496 - EID903497; CF001391- CF001392 EID909790 - EID909809; DE000245 - DE000264 EID909812 - EID909818; DE000268 - DE000268 ______________EID909865; DE000321_____________ EID914338 - EID914339; ASH010221 - ASH010222 EID914722 - EID914725; LKI001266 - LKI001269 EID914730 - EID914733; LMK001319 - LMK001322 EID914744 - EID914745; LKI001338 - LKI001339 EID914909 - EID914913; LKI001762 - LKI001766 _____________ EID914998; DDJ000386_____________ _____________ EID914999; DDJ000388_____________ EID915033 - EID915035; DDJ000667 - DDJ000669 EID915061 - EID915062; DDJ000701 - DDJ000702 EID915269 - EID915271; DDJ001043 - DDJ001048 EID915591 - EID915593; BWK000006 - BWK000008 EID915597 - EID915609; BWK000029 - BWK000041 EID915673 - EID915674; BWK000169 - BWK000170 _____________ EID916604 - EID916609_____________ EID917493 - EID917494; MEM000452 - MEM000453 EID917773 - EID917774; GLK000037 - GLK000038 EID917954 - EID917959; GLK000699 - GLK000704 EID917954 - EID917959; GLK000699 - GLK000704 EID917954 - EID917959; GLK000699 - GLK000704 EID918337 - EID918397; GLK002093 - GLK002153 _____________ EID918667; GLK002513_____________ EID918739 - EID918749; AVM000415 - AVM000425 EID920083 - EID920085; JMM000659 - JMM000661 ____________ EID920176; JMM001068____________ EID920663 - EID920668; JMM002528 - JMM002533 EID920673 - EID920674; JMM002667 - JMM002668 ___________________ EID 921553___________________ EID921593 - EID921594; JMM008216 - JMM008217 EID921834 - EID921855; JCQC000060 - JCQC000081 EID921856 - EID921860; JCOC000082 - JCOC000086 Page 85 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 116 of 232 PAGEID #: 40880 ________ Bates Numbered Documents________ _______EID923989 - EID923990; RP002196 - RP002197_______ EID923989 - EID923990; RP002196 - RPP002197 _______EID924014 - EID924016; RP002316 - RP002318_______ EID924170 - EID924172; AJP001488 - AJP001490 EID924173 - EID924175; AJP001491 - AJP001493 EID924218 - EID924221; AJP001611 - AJP001614 EID924222 - EID924225; AJP001615 - AJP001618 __________________EID924234; AJP001629__________________ EID924240 - EID924259; AJP001659- AJP001663; AJP001669_______________________ AJP001683_______________________ EID924260- EID924265; AJP001689 - AJP001694 EID924268 - EID924273; AJP001698 - AJP001703 EID924274 - EID924275; AJP001704 - AJP001705 _______________________ EID924294_______________________ EID924418 - EID924419; AJP002114 - AJP002115 __________________EID924420; AJP002116__________________ EID924421 - EID924426; AJP002117 - AJP002122 EID924451 - EID924479; AJP002211 - AJP002214; AJP002216 ____________AJP002218; AJP002226 - AJP002247____________ EID924458 - EID924460; AJP002226 - AJP002228 EID924509 - EID924512; AJP002548 - AJP002551 EID924513 - EID924521; AJP002572 - AJP002580 EID924526 - EID924538; AJP002672 - AJP002684 EID924540 - EID924545; AJP002916 - AJP002930 _______________________ EID924546_______________________ EID924547 - EID924549; AJP002932 - AJP002934 EID924550 - EID924557; AJP002984 - AJP002991 ____________ EID924558 - EID924560; AJP002994____________ ____________ EID924561; AJP002995; EID924562____________ _________________ EID924593 - EID924596_________________ EID924636 - EID924638; AJP003076; EID924639; AJP003077; EID924640; AJP003078; EID924641; AJP003079 EID924642 - EID924644; AJP003080 - AJP003082 EID924645 - EID924646; AJP003083 - AJP003084 EID924654 - EID924655; AJP003092 - AJP003094 EID924674 - EID924675; AJP003111 - AJP003112 EID924676; EID924677; AJP003167; EID924678; AJP003168; ______________________ EID924679______________________ EID924680; AJP003172; EID924681; AJP003173; EID924682; EID924683; AJP003174; EID924684; AJP003175; EID924685; AJP003176; EID924686 - EID924688; AJP003178 EID924689 EID924690; AJP003180 Page 86 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 117 of 232 PAGEID #: 40881 ________ Bates Numbered Documents________ EID924691 - EID924694; AJP003181 - AJP003183 EID924697 - EID924712; AJP003266 - AJP003281 EID924744 - EID924747; AJP003357 - AJP003760 EID924766 - EID924768; AJP003468 - AJP003470 EID924769 - EID924775; AJP003471 - AJP003472; AJP003481 _______________________ AJP003485_______________________ EID924790 - EID924791; AJP003535 - AJP003536 _______ EID925024 - EID925051; JS000097 - JS000124_______ EID925463 - EID925467; TAS000199 - TAS000203 EID926315 - EID926327; RLR000172 - RLR000184 EID926857 - EID926859; RLR001758 - RLR001760 _________________ EID927217; RLR002762_________________ EID927281 - EID927284; RLR002919 - RLR002922 EID927380 - EID927381; HDR000317 - HDR000318 EID927410 - EID927414; HDR000485 - HDR000489 _________________ EID927451; HDR001261_________________ _______EID927609 - EID927610; RV000480 - RV000481_______ EID932089 - EID932090; RJZ004157 - RJZ004158 EID932730 - EID932731; RJZ004924 - RJZ004927 _______________________ EID932733_______________________ EID932735 - EID932742; RJZ005055 - RJZ005062 _______________________ EID932971_______________________ EID933681 - EID933687; RJZ2007414 - RJZ007420 EID933689 - EID933690; RJZ007422 - RJZ007423 EID935007 - EID935009; RJZ008920 - RJZ008922 EID935007 - EID935009; RJZ008920 - RJZ008922 EID935010 - EID935011; RJZ008923 - RJZ008924 __________________EID935012; RJZ008925__________________ _________________ EID935152 - EID935157_________________ EID935370 - EID935376; RJZ009653 - RJZ009659 EID935383 - EID935385; RJZ009666 - RJZ009667 __________________EID935451; RJZ009798__________________ __________________EID935452; RJZ009799__________________ EID935477 - EID935479; RJZ010010 - RJZ010012 EID935529 - EID935534; RJZ010077 - RJZ010082 _______EID935596 - EID935599; RJZ10146 - RJZ010149_______ EID935611 - EID935618; RJZ010161 - RJZ010168 __________________EID936770; RJZ011772__________________ __________________EID937562; RJZ013154__________________ __________________EID938073; RJZ014434__________________ EID942335 - EID942336; RJZ027075 - RJZ027076 __________________EID942337; RJZ027077__________________ EID943616 - EID943627; RJZ020387 - RJZ020398 _________________ EID943631 - EID943690_________________ EID943691 - EID943717; RJZ020538 - RJZ020564 Page 87 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 118 of 232 PAGEID #: 40882 _______ Bates Numbered Documents_______ ________________ EID948790 - RAK004373________________ EID948837 - EID948838; GPS000586 - GPS000587 EID948850 - EID948851; ASH000020 - ASH000021 EID948901 - EID948905; ASH000069 - ASH000073 EID948979 - EID948980; LKI001686 - LKI001687 EID949005 - EID949006; RP000177 - RP000178 _________________ EID949449; AC003618_________________ EID949490 - EID949491; AC003590 - AC003591 _________________ EID949492; AC003592_________________ ________________ EID949713; WEF000041________________ ________________ EID949714; WEF000042________________ ________________ EID949715; WEF000043________________ EID949716 - EID949721; WEF000542 - WEF000547 EID950217 - EID950218; GLK001289 - GLK001290 _________________EID950227; GLK001925_________________ EID950228 - EID950242; GLK002519 - GLK02533 _________________EID950250; GLK002575_________________ EID950267 - EID950271; RL001954 - RL001958 EID950527 - EID950530; AJP001983 - AJP001986 EID950543; BR000002; EID950544 - EID950549; BR000003 BR000008; EID950550 - EID950554; BR000009 - BR000013; EID950555; BR000014; EID950556 - EID950560; BR000015 BR000019; EID950561 - EID950575; BR000020 - BR000034; EID950576 - EID950580; BR000035 - BR000039; EID950581 EID950582 - BR000040 - BR000041; EID950583 - EID950584; BR000042 - BR000043; EID950585 - EID950596; BR000044 BR000055; EID950597 - EID950598; BR000056 - BR000057; _________________ EID950599; BR000058_________________ ________________ EID950616; HDR001952________________ _________________ EID951144; RJZ005413_________________ _________________ EID951144; RJZ005413_________________ EID951145 - EID951147; RJZ005416 - RJZ005418 EID951145 - EID951147; RJZ005416 - RJZ005418 EID951469 - EID951470; RJZ009513 - RJZ009514 EID951480 - EID951481; RJZ009525 - RJZ009526 EID951505 - EID951506; RJZ009903 - RJZ9904 EID951507 - EID951511; RJZ009905 - RJZ009909 _________________ EID951517; RJZ009916_________________ EID951520 - EID951522; RJZ009919 - RJZ009921 EID951548 - EID951549; RJZ009949 - RJZ009950 EID951550 - EID951551; RJZ009951 - RJZ009952 EID951554 - EID951555; RJZ009955 - RJZ009955.01 _________________ EID951556; RJZ009956_________________ EID951560 - EID951564; RJZ009974 - RJZ009978 EID951565 - EID951567; RJZ009980 - RJZ009982 Page 88 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 119 of 232 PAGEID #: 40883 ______ Bates Numbered Documents______ EID951568 - EID951570; RJZ009980 - RJZ009985 EID951571 - EID951580; RJZ009988 - RJZ009997 EID951584 - EID951591; RJZ010002 - RJZ010009 EID951584 - EID951591; RJZ010002 - RJZ010009 _______________ EID951607; RJZ010454_______________ EID951966 - EID951973; RJZ020580 - RJZ020587 EID952019 - EID952024; RJZ020668 - RJZ020673 EID952076 - EID952084; RJZ020999 - RJZ021007 ___________________EID-CL0010415___________________ __________ EID-CL-0010542 - EID-CL-0010544__________ __________________ EID-CL-0037083__________________ __________ EID-CL-0038046 - EID-CL-0038048__________ __________ EID-CL-003-8091 - EID-CL-0038094__________ _______________ EIE009891 - EIE009893_______________ _______________ EIE009892 - EIE009893_______________ _______________ EIE009893 - EIE009892_______________ _______________ EIE009893; EIE009892_______________ _______________ EIE012637 - EIE012643_______________ ________________EIE012653 - EIE12658________________ _____________________ EIE012660_____________________ _____________ ENV0004746 - ENV0004752_____________ ENV0006601 - ENV0006606; T2459 - T2463 ____________________ E N V 0 0 0 6 6 3 2 ____________________ ____________________ E N V 0 0 0 6 6 5 0 ____________________ ____________________ E N V 0 0 0 6 6 8 2 ____________________ ____________________ENV0006685____________________ ____________________ E N V 0 0 0 6 6 8 6 ____________________ ENV001 - ENV027; ANA001 - ANA043; TOX001 - TOX025; __________________RAP001 - RAP005__________________ _______________ EPA175; ROWE000982_______________ EPL000040 - EPL000041; EID713595 - EID713596 ______________ EXP017498- EXP017499______________ ______________ EXP017506 - EXP017507______________ _________ EXP017508; EXP017501 - EXP017502_________ ______________ EXP017510 - EXP017518______________ ______________ EXP018377- EXP018377______________ __________ EXP019664.078 - EXP019664.0081__________ ______________ EXP279539 - EXP279594______________ ______________ EXP279595 - EXP279613______________ ______________ GAA001596 - GAA001595______________ ______________ GAA001684 - GAA001687______________ GHA012776 - GHS012777; EID796495 - EID796496 GHS005502 - GHS005504; EID605181 - EID605183 GHS006034 - GHS006036; EID605711 - EID605713 GHS006230 - GHS006234; EID605907 - EID605911 Page 89 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 120 of 232 PAGEID #: 40884 ________ Bates Numbered Documents________ GHS006242 - GHS006244; EID605919 - EID605921 GHS006369 - GHS006371; EID722822 - EID722824 GHS006489 - GHS006493; EID722942 - EID722946 _________________ GHS006509; EID722962_________________ GHS006530 - GHS006531; EID722983 - EID722984 GHS006549 - GHS006551; EID723002 - EID723004 GHS006559 - GHS006561; EID723012 - EID723014 _________________ GHS006562; EID723015_________________ GHS006563 - GHS006564; EID723016 - EID723017 _________________ GHS007162; EID723599_________________ _________________ GHS007489; EID723926_________________ GHS008008 - GHS008019; EID724444 - EID724455 GHS008065 - GHS008072; EID724501 - EID724508 GHS008401 - GHS008402; EID724837 - EID724838 GHS008472 - GHS8478; EID724908 - EID724914 GHS008474 - GHS008477; EID724910- EID724913 GHS008513 - GHS008518; EID724949 - EID724954 GHS008513 - GHS008518; EID724949 - EID724954 GHS008657 - GHS008658; EID725093 - EID725094 GHS008729 - GHS008731; EID725163 - EID725165 GHS008735 - GHS008738; EID725167 - EID725170 _________________ GHS008883; EID725257_________________ GHS008952 - GHS008955; EID725323 - EID725326 GHS010510; GHS010513 -GHS010518; EID795156; EID795158 _______________________- EID795163_______________________ GHS010554 - GHS010559; EID775988 - EID775993 GHS010565 - GHS010578; EID795204 - EID795217 GHS010565 - GHS010578; EID795204 - EID795217 GHS010595 - GHS010596; EID795234 - EID795235 GHS010597 - GHS010598; EID795236 - EID795237 _________________ GHS010599; EID795238_________________ _________________ GHS010602; EID795241_________________ _________________ GHS011109; EID795599_________________ GHS012288 - GHS012290; EID796043 - EID796045 _________________ GHS012519; EID796243_________________ GHS012576 - GHS012578; EID796298 - EID796300 GHS012607 - GHS012608; EID796327 - EID796328 GHS012779 - GHS012783; EID796498 - EID796502 _________________ GHS012790; EID796509_________________ _________________ GHS012899; EID796585_________________ GHS012900 - GHS012921; EID796586 - EID796607 GHS012922 - GHS012934; EID796608 - EID796620 GHS012922 - GHS012934; EID796608 - EID796620 GHS012936 - GHS 012937; EID796622 - EID796623 GHS013078 - GHS013080; EID796749 - EID796751 Page 90 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 121 of 232 PAGEID #: 40885 Bates Numbered Documents GHS013086 - GHS013089; EID796757 - EID796760 GHS013091 - GHS013092; EID796762 - EID796763 GHS013106 - GHS013107; EID796776 - EID796777 GHS013840 - GHS013846; EID797223 - EID797229 GHS013957 - GHS013958; EID797339 - EID797340 ____________GHS013959; EID797341____________ _________ GK(p)000013 - GK(p)000015__________ __________ GK(P)000013 - GK(p)000015__________ __________GK(p)000020 - GK(p)000021__________ __________GK(p)000069 - GK(p)000070__________ __________GK(P)000766 - GK(P)000769__________ _________________GK(P)001193_________________ __________GK(P)001256 - GK(P)001258__________ __________GK(P)001256 - GK(P)001258__________ __________GK(P)001276 - GK(P)001277__________ _________________GK(P)001278_________________ __________GK(P)001294 - GK(P)001295__________ _________________GK(P)001426_________________ __________GK(p)002041 - GK(p)002084__________ _________________GK(p)002121_________________ __________GK(p)002122 - GK(p)002123__________ __________GK(p)002124 - GK(p)002135__________ __________GK(p)002136 - GK(p)002139__________ __________GK(p)002140 - GK(p)002143__________ __________GK(p)002144 - GK(p)002147__________ __________GK(p)002148 - GK(p)002152__________ __________ GK(p)002153 - GK(p)002168__________ __________GK(p)002169 - GK(p)002175__________ __________GK(p)002176 - GK(p)002178__________ __________GK(p)002179 - GK(p)002180__________ __________GK(p)002181 - GK(p)002193__________ __________GK(p)002194 - GK(p)002196__________ __________ GK(P)002301- GK(P)002303__________ ____________ GK000378 - GK000379____________ ____________ GK000378 - GK000385____________ _____________GK000378; GK000379_____________ ____________ GK000380 - GK000385____________ ____________ GK000665 - GK000666____________ ____________ GK001407 - GK001422____________ ____________ GK001423 - GK001434____________ ____________ GK001435 - GK001439____________ ____________ GK001454 - GK001455____________ ____________ GK001456 - GK001463____________ __________________ GK001533__________________ GK001540 - GK001541 Page 91 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 122 of 232 PAGEID #: 40886 _______ Bates Numbered Documents_______ _________________ GK001600 - GK001601_________________ _________________ GK001607 - GK001613_________________ _________________ GK001607 - GK001613_________________ _________________ GK002007 - GK002009_________________ _________________ GK002017 - GK002018_________________ _________________ GK002049 - GK002067_________________ ______________________ GK002068______________________ _________________ GK002308 - GK002311_________________ _________________ GK002317 - GK002348_________________ ______________________ GK002829______________________ GK003401 - GK003437; EID138315 - EID138351 _________________ GK004724 - GK004743_________________ ______________________ GK005063_______________________ _________________ GK009322; EID606681_________________ _________________ GK009323; EID606682_________________ GK009401 - GK009436; EID606760 - EID606795 GK010681 - GK010721; EID608040 - EID608080 ___________ GK011233 - GK011234; EID608593____________ GK011722 - GK011728; EID609048 - EID609055; HLG002298 GK012123 - GK012130; EID727016 -EID727023 GK012131 - GK012132; EID727024 - EID727025 GK012187 - GK012281; EID727080 - EID727174 GK012493 - GK012501; EID727386 - EID727394 GK012527 - GK012547; EID727420 - EID727440 GK012724 - GK012726; EID797428 - EID797430 ___________ GK012830; EID797532___________ GK012871 - GK012885; EID797573 - EID797587 GK012947 - GK012950; EID797649 - EID797652 GK013082 - GK013098; EID797784 - EID797800 GK013416 - GK013491; EID777095 - EID777170 GK013508 - GK013586; EID777171 - EID777249 GK014108 - GK014110; EID777467 - EID77469 GK014108 - GK014110; EID777467 - EID777469 ___________ G L K 0 0 0 3 2 5 ;E ID 9 1 7 8 5 1 ___________ _______________ GQTTQ00070_______________ _______________ GQTTQ00137_______________ ________ GQTTQ00206 - GQTTQ00208________ ________ GQTTQ00213 - GQTTQ00217________ ________ GQTTQ00245 - GQTTQ00247________ ________ GQTTQ00249 - GQTTQ00250________ ________ GQTTQ00264 - GQTTQ00265________ ________ GQTTQ00280 - GQTTQ00281________ _______________ GQTTQ00592_______________ GQTTQ00601 - GQTTQ00626 Page 92 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 123 of 232 PAGEID #: 40887 _______ Bates Numbered Documents_______ _______________ GOTTO00676 - GOTTO678_______________ ______________GOTTO00726 - GOTTO00735______________ ______________GOTTO00839 - GOTTO00863______________ ______________ GOTTO0251 - GOTTO00253______________ GPS000629 - GPS000629; EID927504 - EID927505 GWS000106 - GWS000107; EID727976 - EID727977 GWS000169 - GWS000170; EID728039 - EID728040 GWS000263 - GWS000265; GHSGWS000270 - GWS000271; ________________ EID728112 - EID728116________________ HDR001193 - HDR001196; EID058072 - EID058075 HDR002553 - HDR002555; EID167154 - EID167156 HDR002553 - HDR002555; EID167154 - EID167156 HDR002553 - HDR002555; EID167154 - EID167156 _______________ HDR005845 - HDR005846_______________ _____________________ HDR005975_____________________ _______________ HDR006057 - HDR006060_______________ _______________ HDR006205 - HDR006206_______________ HDR006346 - HDR006355; EID522239 - EID522248 ________________ HDR006439; EID522332________________ HDR006440 - HDR006445; EID522333 - EID522338 ________________ HDR006763; EID522656________________ HDR007586 - HDR007588; EID728176 - EID728178 ______________ HLAB005391 - HLAB005418______________ _______________ HOLT02895 - HOLT02901_______________ IJZ003496 - IJZ003499; EID728976 - EID728979 _____________________ JAA0003494_____________________ _______________JAA0003497- JAA0003501_______________ _______________JAA0003497- JAA0003501_______________ _______________JAA0011475 -JAA0011514_______________ _______________JAA0016439- JAA0016441_______________ _____________________ JAA0027588_____________________ _______________JAA0027592- JAA0027599_______________ _______________JAA0027600- JAA0027601_______________ _______________JAA0027777- JAA0027781_______________ _______________ JAA0037726-JAA037736_______________ _______________JAA0039242- JAA0039244_______________ _______________JAA0040855 - JAA0040858_______________ JCOC002512 -JCOC002534; EID641460 - EID641482 JHH001274 - JHH001282; EID610077 - EID610085 JHH001476 -JHH001515; EID729771 - EID729810 JHH001539 - JHH001582; EID729834 - EID729877 JHH001669 - JHH001759; EID729964 - EID730054 JHW003306 -JHW003308; EID610137 - EID610139 JMM004049 -JMM004073; USEPA8669 - USEPA8693 JMM008015 -JM M 008016; EID073298; EID073299 Page 93 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 124 of 232 PAGEID #: 40888 ________ Bates Numbered Documents_______ JMM008018 - JMM008020; EID073300 - EID073302 KEL000533 - KEL000537; EID730428 - EID730432 KEL000597 - KEL000598; EID730490 - EID730491 KEL000654 - KEL000660; KEL000664 - KEL000687; KEL000690 ____________ KEL000694; EID730547 - EID730582___________ __________________ K E L 0 0 0 6 9 5 ;E ID 7 3 0 5 8 3 _________________ KEL000702 - KEL000727; EID730586 - EID730611 ____________________ LE 3858 - LE3887____________________ _____________________ LE1750- LE1751____________________ _____________________ LE1750- LE1751____________________ _____________________ LE1752 - LE1789____________________ _____________________ LE5954- LE5955____________________ _____________________ LE5956- LE5957____________________ _________________LE-EX04703 - LE-EX04703________________ LJB000116 - LJB000117; EID610228 - EID610229 ________ LPSD137 - LPSD138; EID112971; DDJ001815________ ___________________ LPSD143 - LPSD144___________________ _________________ LWB004968; EID635572_________________ MAC001957 - MAC001963; EID731474 - EID731480 MAC002001 - MAC002025; EID731518 - EID731542 MAC002207- MAC002309, EID731724 a" EID731826 MAK008040 - MAK008042; EID610518 - EID610520 _________________ MAK008126; EID610600_________________ ________________MEM014045 - MEM014056_______________ MLR002254 - MLR002257; EID799992 - EID799995 MLR002317 - MLR002321; EID800051 - EID800055 MLR002340 - MLR002342; EID800070 - EID800072 MLR002340 - MLR002342; EID800070 - EID800072 MLR002357 - MLR002361; EID800087 - EID800091 MLR002732 - MLR002733; EID800441 - EID800442 _________________MNAG0001 - MNAG0030________________ _____________ M 00RE000017 - M 00RE000019_____________ _____________ M 00RE000028 - M 00RE000032_____________ _____________________ M 00RE000033_____________________ _____________ M 00RE000034 - M 00RE000035_____________ _____________________ M 00RE000036_____________________ ________________M 00RE000037 - M 00RE46_______________ _____________________ M 00RE000052_____________________ _____________ M 00RE000089 - M 00RE000096_____________ _____________________ M 00RE000114_____________________ _____________ M 00RE000241 - M 00RE000268_____________ _________________ M 00RE000288 - M 00RE________________ MPD000058 - MPD000059; EID613190 - EID613191 MR266876; GK013082 - GK013098; EID797784 - EID797800 Page 94 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 125 of 232 PAGEID #: 40889 _____Bates Numbered Documents_____ MR314973; ROWE033130 - ROWE033189 MR314999; ROWE033099 - ROWE033129 MR325063; USEPA30567 - USEPA30623 NKT000001 - NKT000001; EID735221 - EID735222 NKT000003 - NKT000004; EID735223 - EID735224 _____________ NKT000062; EID735282_____________ _____________ NKT000063; EID735283_____________ NSR000300 - NSR000306; EID735328 - EID735334 NSR000307 - NSR000308; EID735335 - EID735336 NSR000309 - NSR000311; EID735337 - EID735339 _____________PBJB003940; EID613632_____________ PEG000001 - PEG000009; EID800795 - EID800803 PEG000010 - PEG000017; EID800804 - EID800811 PEG000027 - PEG000028; EID800821 - EID800822 PEG000043 - PEG000051; EID800834 - EID800842 PEG000052 - PEG000059; EID800843 - EID800850 _____________ PEG000099; EID800851_____________ PEG000100 - PEG000107; EID800852 - EID800859 PJB000371 - PJB000374; EID196253 - EID196256 PJB000378 - PJB000381; EID196260 - EID196263 _____________ PJB001934 - PJB001945_____________ PJB003901 - PJB003902; EID613593 - EID613594 _____________ PJB003937; EID613629_____________ PJB003957 - PJB003967; EID613649 - EID613659 PJB004029 - PJB004043; EID685105 - EID685119 _____________ PJB004082 - PJB004084_____________ ______________ PL000063 - PL000064______________ ___________________ PL000065___________________ PNC000053 - PNC000060; EID736556 - EID736563 PTDB000830 - PTDB000839; EID613678 - EID613687 RAK012623-RAK012624; EID736722-EID736723 _____________ RCB000208;EID217843_____________ RCB002272 - RCB002313; EID638342 - EID6383383 _____________ RCG000331; EID614317_____________ RCG000345 - RCG000439; EID603194 - EID603288 __________________ RCW002019__________________ RGS000005 - RGS000007; EID217933 - EID217935 ____________ RH009049; EDD0072900____________ RH009050 - RH009052; RGS000005 - RGS000007 RJA002101 - RJA002102; EID737588 - EID737589 _____________ RJZ009207; USEPA8850_____________ RJZ009208 - RJZ009208; USEPA14965 - USEPA14966 RJZ009208 - RJZ009211; USEPA14965 - USEPA14968 RL001580 - RL001582; EID107130 - EID107132 RL003145 - RL003163; EID645647 - EID645665 Page 95 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 126 of 232 PAGEID #: 40890 _______ Bates Numbered Documents_______ RLR001349 - RLR001449; EXP002362 - EXP002462 _________________ R L R 0 0 2 7 8 7 ;E ID 9 2 7 2 4 2 _________________ RLR002788 - RLR002792; EID927243 - EID927247 _____________ RLR002806; 011-0002-0000204_____________ RLR002807 - RLR002808; 011-0001-0000205 - 011-0002 _______________________ 0000206_______________________ RLR002899 - RLR002902; EID076927 - EID076930 _________________ R L R 0 1 4 8 2 6 ;E ID 6 1 4 7 2 3 _________________ _________________ R L R 0 1 5 7 4 6 ;E ID 7 3 7 9 0 5 _________________ RLR016790 - RLR016792; EID802644 - EID802646 RLR016790 - RLR016792; EID802644 - EID802646 ______________ROWE 000467 - ROWE000468_____________ ______________ RQWE000001 - ROWE000004______________ _____________________ RQWE000005_____________________ _____________________ RQWE000006_____________________ ______________ RQWE000007 - RQWE000011______________ ______________ RQWE000012 - RQWE000026______________ ______________ RQWE000027 - RQWE000135______________ ______________ RQWE000136 - RQWE000139______________ ______________ RQWE000140 - RQWE000203______________ ______________ RQWE000204 - RQWE000245______________ ______________ RQWE000246 - RQWE000308______________ RQWE000309 - RQWE000385; WVDEP17747- WVDEP17754; USEPA18994 - USEPA18996; USEPA18931 - USEPA18993 _____________________ RQ W E0003777_____________________ RQWE000386 - RQWE000462; WVDEP17747 - WVDEP17754; USEPA18994 - USEPA18996; USEPA18931 - USEPA18993 RQWE000400 - RQWE000462 _______ RQWE000463_______ RQWE000464 - RQWE000466 RQWE000469 - RQWE000487 RQWE000488 - RQWE000489 RQWE000490 - RQWE000501 RQWE000659 - RQWE000660 RQWE000661 - RQWE000662 RQWE000663 - RQWE000665 RQWE000666 -RQWE000677 RQWE000678 - RQWE000679 RQWE000682 - RQWE000683 RQWE000684 - RQWE000685 RQWE000686 - RQWE000687 RQWE000690 - RQWE000693 RQWE000694 - RQWE000695 Page 96 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 127 of 232 PAGEID #: 40891 Bates Numbered Documents ROWE000696 - ROWE000698 ROWE000699 - ROWE000700 ROWE000701 - ROWE000705 ROWE000706 - ROWE000712 ROWE000713 - ROWE000729 ROWE000730 - ROWE000731 ROWE000732 - ROWE000734 ROWE000735 - ROWE000741 ROWE000742 - ROWE000744 ROWE000745 - ROWE000768 __________ ROWE000769__________ ROWE000770 - ROWE000813 ROWE000814 - ROWE000819 ROWE000820 - ROWE000821 ROWE000822 - ROWE000825 __________ ROWE000826__________ ROWE000827 - ROWE000830 ROWE000831 - ROWE000836 ROWE000840 - ROWE000843 ROWE000844 - ROWE000847 ROWE000848 - ROWE000859 ROWE000860 - ROWE000882 ROWE000883 - ROWE000884 ROWE000885 - ROWE000886 ROWE000887 -ROWE000889 ROWE000890 - ROWE000891 ROWE000892 - ROWE000896 ROWE000897 - ROWE000901 ROWE000902 - ROWE000915 ROWE000916 - ROWE000919 ROWE000920 - ROWE000921 ROWE000922 - ROWE000923 ROWE000924 - ROWE000925 ROWE000926 - ROWE000956 __________ ROWE000957__________ ROWE000958 - ROWE000960 __________ ROWE000961__________ ROWE000962 - ROWE000972 ROWE000973 - ROWE000978 ROWE000979 - ROWE000981 ROWE000983 - ROWE001019 ROWE001020 - ROWE001021 __________ ROWE001022__________ ROWE001023 - ROWE001026 ROWE001027 - ROWE001041 Page 97 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 128 of 232 PAGEID #: 40892 Bates Numbered Documents __________ ROWE001042__________ ROWE001043 - ROWE001050 ROWE001051 - ROWE001052 ROWE001055 - ROWE001058 ROWE001059 - RQWE001060 ROWE001061 - ROWE001062 ROWE001063 - ROWE001101 ROWE001102 -ROWE001128 ROWE001129 - ROWE001130 ROWE001131 - ROWE001134 ROWE001135 - ROWE001145 ROWE001146 - ROWE001150 ROWE001151 - ROWE001152 ROWE001153 - ROWE001154 ROWE001155 - ROWE001156 ROWE001157 - ROWE001162 ROWE001163 - ROWE00001170 ROWE001171 - ROWE001172 ROWE001173 - ROWE001177 ROWE001178 - ROWE001179 ROWE001182 - ROWE001184 ROWE001185 - ROWE001186 ROWE001192 - ROWE001198 ROWE001199 - ROWE001237 ROWE001238 - ROWE001241 ROWE001242 - ROWE001245 __________ ROWE001246__________ ROWE001247 - ROWE001250 ROWE001251 - ROWE001256 __________ ROWE001257__________ ROWE001258 - ROWE001260 ROWE001261 - ROWE001264 ROWE001265 - ROWE001269 ROWE001270 - ROWE001332 ROWE001333 - ROWE001341 ROWE001342 - ROWE001467 ROWE001468 - ROWE001504 ROWE001508 - ROWE001510 ROWE001511 - ROWE001513 ROWE001514 - ROWE1525 ROWE001526 - ROWE001530 ROWE001531 - ROWE001546 ROWE001547 - ROWE001605 ROWE001606 - ROWE001612 ROWE001613 - ROWE001616 Page 98 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 129 of 232 PAGEID #: 40893 Bates Numbered Documents ROWE001617 - ROWE001618 ROWE003424 - ROWE003425 __________ ROWE003582__________ ROWE003583 - ROWE003590 ROWE003591 - ROWE003592 ROWE003593 - ROWE003594 ROWE003597 - ROWE003598 ROWE003612 - ROWE003613 ROWE003614 - ROWE003627 ROWE003661 - ROWE003662 __________ ROWE003663__________ __________ ROWE003664__________ ROWE003668 - ROWE003691 ROWE003692 - ROWE003693 ROWE003698 - ROWE003699 ROWE003700 - ROWE003701 ROWE003704 - ROWE003705 ROWE003706 - ROWE003709 ROWE003710 - ROWE003715 ROWE003716 - ROWE003753 ROWE003769 - ROWE003773 ROWE003778 - ROWE003779 ROWE003782 - ROWE003783 ROWE003784 - ROWE003785 ROWE003788 - ROWE003789 __________ ROWE003790__________ ROWE003791 - ROWE003792 ROWE003795 - ROWE003822 ROWE003826 - ROWE003827 __________ ROWE003828__________ ROWE003829 - ROWE003836 ROWE003837 - ROWE003838 ROWE003839 - ROWE003842 ROWE003843 - ROWE003844 ROWE003845 - ROWE003846 ROWE003847 - ROWE003848 ROWE003849 - ROWE003851 ROWE003852 - ROWE003853 ROWE003854 - ROWE003855 ROWE003856 - ROWE003861 ROWE003865 - ROWE003868 __________ ROWE003869__________ ROWE003874 - ROWE003877 __________ ROWE003878__________ ROWE003885 - ROWE003886 Page 99 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 130 of 232 PAGEID #: 40894 Bates Numbered Documents __________ ROWE003887__________ ROWE003888 - ROWE003907 __________ ROWE003909__________ ROWE003913 - ROWE003914 ROWE003926 - ROWE003927 __________ ROWE003929__________ __________ ROWE003930__________ __________ ROWE003933__________ ROWE003934 - ROWE003936 __________ ROWE003937__________ ROWE003938 - ROWE003939 RQWE003940-RQWE003942 __________ ROWE004000__________ __________ ROWE004027__________ __________ ROWE004028__________ ROWE004029 - ROWE004035 ROWE004036 - ROWE004045 ROWE004046 - ROWE004095 ROWE004096 - ROWE004097 ROWE004098 - ROWE004251 ROWE004252 ROWE004253 ROWE004943 - ROWE004953 __________ ROWE005061__________ __________ ROWE005062__________ ROWE005496 - ROWE005516 ROWE005517 - ROWE005519 ROWE005520 - ROWE005527 ROWE005528 ROWE005571 ROWE005572 - ROWE005573 ROWE005596 - ROWE005602 __________ ROWE005603__________ ROWE005604 - ROWE005606 ROWE005607 - ROWE005608 ROWE005659 - ROWE005663 ROWE005664 - ROWE005666 ROWE005667 - ROWE005671 ROWE005672 - ROWE005676 __________ ROWE005677__________ ROWE005678 - ROWE005681 ROWE005682 - ROWE005683 ROWE006115 - ROWE006117 ROWE006696 - ROWE006701 __________ ROWE006831__________ __________ ROWE006846__________ ROWE007936 - ROWE007937 Page 100 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 131 of 232 PAGEID #: 40895 Bates Numbered Documents ROWE007938 - ROW007951 ROWE007952 - ROWE007964 ROWE007967 - ROWE007969 ROWE007970 - ROWE007978 ROWE007979 - ROWE007981 ROWE007982 - ROWE007985 __________ ROWE007986__________ ROWE007987 - ROWE007990 ROWE007991 - ROWE007996 ROWE007997 - ROWE007998 ROWE008008 - ROWE008010 ROWE008011 - ROWE008026 ROWE008027 - ROWE008149 ROWE008150 - ROWE008151 ROWE008152 - ROWE008157 ROWE008158 - ROWE008159 ROWE008167 - ROWE008169 ROWE008170 - ROWE008176 ROWE008177 - ROWE008179 __________ ROWE008181__________ ROWE008181 - ROWE008187 ROWE008181 - ROWE8182 __________ ROWE008183__________ ROWE008188 - ROWE008190 __________ ROWE008191__________ __________ ROWE0081920__________ ROWE008194 - ROWE008195 ROWE008196 - ROWE008233 ROWE008234 - ROWE008235 ROWE008738 - ROWE008745 ROWE008746 - ROWE008750 ROWE008751 - ROWE008786 ROWE008787 - ROWE008829 ROWE008830 - ROWE008838 ROWE008839 - ROWE008847 ROWE008848 - ROWE008857 ROWE008858 - ROWE008876 ROWE008877 - ROWE008879 ROWE008880 - ROWE008890 ROWE008891 - ROWE008900 ROWE008901 - ROWE008910 ROWE008911 - ROWE008916 __________ ROWE008917__________ ROWE008918 - ROWE008920 ROWE008921 - ROWE008922 Page 101 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 132 of 232 PAGEID #: 40896 _______ Bates Numbered Documents_______ _____________ROWE008923 - ROWE0089232_____________ _____________ ROWE008953 - ROWE008956_____________ _____________ ROWE008957 - ROWE008976_____________ _____________ ROWE008977 - ROWE008995_____________ _____________ROWE009068 - ROWE0009069_____________ _____________ ROWE010468 - ROWE010499_____________ _____________ ROWE010501 - ROWE010524_____________ _____________ ROWE010530 - ROWE010538_____________ ____________________ ROWE010539____________________ _____________ ROWE010842 - ROWE010877_____________ _____________ ROWE010880 - ROWE010890_____________ ____________________ ROWE010891____________________ _____________ ROWE010892 - ROWE010893_____________ ____________________ ROWE010894____________________ _____________ ROWE010895 - ROWE010896_____________ _____________ ROWE010897 - ROWE010910_____________ _____________ ROWE010911 - ROWE010925_____________ _____________ ROWE010952 - ROWE010953_____________ _____________ ROWE010954 - ROWE010955_____________ _____________ ROWE011110 - ROWE011120_____________ _____________ ROWE011121 - ROWE011123_____________ _____________ ROWE011127 - ROWE011138_____________ _____________ ROWE011139 - ROWE011143_____________ ____________________ ROWE011144____________________ ____________________ ROWE011145_____________________ _____________ ROWE011146 - ROWE011148_____________ _____________ ROWE011149 - ROWE011150_____________ _____________ ROWE011158 - ROWE011159_____________ ____________________ ROWE011160____________________ ______________ ROWE011163 - ROWE11171______________ ____________________ ROWE011172____________________ _____________ ROWE011173 - ROWE011184_____________ ROWE011173 - ROWE011184; LE 5954 - LE5957; 003-0218 _______________________0003631_______________________ ____________________ ROWE011185_____________________ ____________________ ROWE011186____________________ _____________ ROWE011187 - ROWE011187_____________ _____________ ROWE011195 - ROWE011271_____________ _____________ ROWE011272 - ROWE011274_____________ _____________ ROWE011275 - ROWE011276_____________ _____________ ROWE011277 - ROWE011279_____________ _____________ ROWE011288 - ROWE011289_____________ _____________ ROWE011290 - ROWE011299_____________ _____________ ROWE011300 - ROWE011342_____________ ROWE011345 - ROWE011346 Page 102 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 133 of 232 PAGEID #: 40897 ______ Bates Numbered Documents______ ____________ ROWE011348 - ROWE011349____________ ____________ ROWE011350 - ROWE011371____________ ___________________ ROWE011357___________________ ____________ ROWE011373 - ROWE011381____________ ____________ ROWE011373 - ROWE011381____________ ___________________ ROWE011382___________________ ____________ ROWE011383 - ROWE011894____________ ____________ ROWE011395 - ROWE011396____________ ___________________ ROWE011658___________________ ___________________ ROWE011661___________________ ____________ ROWE015303 - ROWE015334____________ ___________________ ROWE016464___________________ ____________ ROWE016465 - ROWE016467____________ ____________ ROWE016468 - ROWE016481____________ ____________ ROWE016482 - ROWE016486____________ ____________ ROWE016487 - ROWE016505____________ ____________ ROWE016535 -ROWE016536____________ ____________________ ROWE01662____________________ ___________________ ROWE019704___________________ ___________________ ROWE019705___________________ ____________ ROWE019963 - ROWE019964____________ ___________________ ROWE019965___________________ ____________ ROWE019995 - ROWE020000____________ ____________ ROWE020036 - ROWE020079____________ ___________________ ROWE020089___________________ ___________________ ROWE020603___________________ ____________ ROWE020612 - ROWE020613____________ ____________ ROWE020614 - ROWE020615____________ _____________ROWE020718 - ROWE02730_____________ ____________ ROWE021058 - ROWE021059____________ ____________ ROWE021294 - ROWE021300____________ ___________________ ROWE021307___________________ ____________ ROWE021311 - ROWE021312____________ ____________ ROWE021351 - ROWE023152____________ ___________________ ROWE021790___________________ ____________ ROWE021826 - ROWE021828____________ ROWE021916 - ROWE021927; AR226-3743; AR226-3744 ____________ ROWE022158 - ROWE022165____________ ____________ ROWE022168 - ROWE022172____________ ____________ ROWE022353 - ROWE022360____________ ____________ ROWE022510 - ROWE022513____________ ____________ ROWE022514 - ROWE022515____________ ____________ ROWE022580 - ROWE022603____________ ____________ ROWE022646 - ROWE022653____________ ROWE022646 - ROWE022653 Page 103 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 134 of 232 PAGEID #: 40898 _______ Bates Numbered Documents_______ _____________ ROWE022654 - ROWE022690_____________ _____________ ROWE022654 - ROWE022690_____________ _____________ ROWE022691 - ROWE022692_____________ _____________ ROWE022693 - ROWE022708_____________ _____________ ROWE022693 - ROWE022708_____________ _____________ ROWE022709 - ROWE022756_____________ ____________________ ROWE022760____________________ _____________ ROWE022773 - ROWE022868_____________ _____________ ROWE022869 - ROWE022991_____________ _____________ ROWE023197 - ROWE023229_____________ _____________ ROWE023230 - ROWE023248_____________ _____________ ROWE023249 - ROWE023267_____________ _____________ ROWE023536 - ROWE023537_____________ ROWE023536 - ROWE02357; ROWE031925 - ROWE031926 ROWE023538 - ROWE023585 ROWE0235538 - ROWE023585 ________R O W E 0 2 3 6 2 7 ________ ROWE023729 - ROWE023730 ROWE023769 - ROWE023777 ROWE023778 - ROWE023779 ROWE023780 - ROWE023781 ________RO W E 0 2 3 7 8 2 _______ _______ ROWE023783________ ROWE023784 - ROWE023801 ROWE023810 - ROWE023815 ROWE023815 - ROWE023822 ROWE023869 - ROWE023870 _______ ROWE024225________ ROWE024231 - ROWE024232 ROWE024234 - ROWE024239 ________RO W E 0 2 4 2 4 7 _______ ROWE024337 - ROWE0024360 ________RO W E 0 2 4 3 6 1 _______ ________RO W E 0 2 4 3 6 2 _______ ROWE024363 - ROWE024374 ________RO W E 0 2 4 5 4 0 _______ ________RO W E 0 2 4 5 4 1 _______ ROWE024542 - ROWE024550 ROWE024551 - ROWE024561 ROWE024562 - ROWE024563 ROWE024564 - ROWE024574 ROWE024610 - ROWE024611 ROWE024612 - ROWE024613 ROWE024614 - ROWE024617 Page 104 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 135 of 232 PAGEID #: 40899 _____ Bates Numbered Documents_____ __________________ ROWE024619__________________ ___________ ROWE024620 - ROWE024621___________ ___________ ROWE024625 - ROWE024628___________ ___________ ROWE024629 - ROWE024630___________ ___________ ROWE024642 - ROWE024643___________ ___________ ROWE024644 - ROWE024651___________ ___________ ROWE024652 - ROWE024656___________ ___________ ROWE024796 - ROWE024820___________ ___________ ROWE024821 - ROWE024836___________ ___________ ROWE024837 - ROWE024838___________ ___________ ROWE024839 - ROWE024871___________ ___________ ROWE024887 - ROWE024891___________ ___________ ROWE024892 - ROWE024894___________ ___________ ROWE024946 - ROWE024952___________ ___________ ROWE024953 - ROWE024960___________ ___________ ROWE024961 - ROWE024988___________ ___________ ROWE024989 - ROWE024990___________ __________________ ROWE025558__________________ __________________ ROWE025559__________________ ___________ ROWE026023 - ROWE026029___________ ___________ ROWE026030 - ROWE026050___________ ___________ ROWE026276 - ROWE026279___________ ___________ ROWE026386 - ROWE026432___________ ___________ ROWE026436 - ROWE026453___________ __________________ ROWE026488__________________ __________________ ROWE026489__________________ ___________ ROWE026490 - ROWE026497___________ ___________ ROWE026564 - ROWE026565___________ ___________ ROWE026566 - ROWE026567___________ ___________ ROWE026611 - ROWE026612___________ ___________ ROWE026613 - ROWE026614___________ ___________ ROWE026654 - ROWE026655___________ ___________ ROWE026656 - ROWE026657___________ ___________ ROWE026658 - ROWE026659___________ ___________ ROWE027843 - ROWE027905___________ ___________ ROWE029318 - ROWE029319___________ ___________ ROWE029341 - ROWE029342___________ ___________ ROWE029362 - ROWE029422___________ ___________ ROWE029423 - ROWE029437___________ ___________ ROWE029423 - ROWE029437___________ ___________ ROWE029456 - ROWE029484___________ __________________ ROWE029819__________________ ROWE029888 - ROWE029914; EID713244 - EID713270 ___________ ROWE029965 - ROWE030011___________ ROWE029985 - ROWE029887 Page 105 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 136 of 232 PAGEID #: 40900 Bates Numbered Documents ROWE030064 - ROWE030075 ROWE030076 - ROWE030080 __________ RQWE030100__________ ROWE030125 - ROWE030130 ROWE030237 - ROWE030238 ROWE030266 - ROWE030273 ROWE030274 - ROWE030275 ROWE030278 - ROWE030279 ROWE030309 - ROWE030310 ROWE030313 - ROWE030315 ROWE030316 - ROWE030317 ROWE030349 - ROWE030351 ROWE030367 - ROWE030368 ROWE030408 - ROWE030410 ROWE030411- ROWE030412 ROWE030419 - ROWE030421 ROWE030422 - ROWE030423 __________ ROWE030424__________ ROWE030425 - ROWE030427 ROWE030428 - ROWE030429 ROWE030445 - ROWE030446 ROWE030447 - ROWE030448 __________ ROWE030490__________ ROWE030491 - ROWE030492 __________ ROWE030493__________ __________ ROWE030494__________ __________ ROWE030495__________ ROWE030497 - ROWE030499 ROWE030503 - ROWE030507 __________ ROWE030508__________ ROWE030509 - ROWE030511 ROWE030512 - ROWE030513 ROWE030514 - ROWE030515 ROWE030607 - ROWE030608 ROWE030609 - ROWE030610 ROWE030754; 307271 ROWE030789 - ROWE030841 ROWE030862 - ROWE030869 ROWE030881 - ROWE030893 ROWE030894 - ROWE030925 ROWE030968 - ROWE030981 ROWE031166 - ROWE031169 ROWE031176 - ROWE031180 ROWE031363 - ROWE031365 ROWE031446 - ROWE031447 Page 106 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 137 of 232 PAGEID #: 40901 Bates Numbered Documents __________ ROWE031485__________ ROWE031486 - ROWE031487 ROWE031509 - ROWE031514 ROWE031515 - ROWE031559 ROWE031606 - ROWE031614 ROWE031615 - ROWE031656 ROWE031657 - ROWE031661 ROWE031662 - ROWE031664 ROWE031665 - ROWE031678 __________ ROWE031679__________ ROWE031875 - ROWE031876 ROWE031884 - ROWE031885 ROWE031895 - ROWE031896 __________ ROWE031924__________ ROWE031925 - ROWE031926 ROWE031942 - ROWE031943 ROWE031944 - ROWE031945 ROWE031946 - ROWE031955 ROWE031956 - ROWE032000 ROWE032001 - ROWE032010 ROWE032029 - ROWE032030 ROWE032071 - ROWE032077 ROWE032078 - ROWE032105 ROWE032106 - ROWE032148 ROWE032587 - ROWE032625 ROWE032703 - ROWE03705 ROWE032939 - ROWE033019 ROWE033020 - ROWE033031 ROWE033020 - ROWE033031 ROWE033040 - ROWE033053 ROWE033064 - ROWE033071 ROWE033075 - ROWE033076 ROWE033077 - ROWE033098 __________ ROWE033322__________ ROWE033329 - ROWE033330 ROWE033397 - ROWE033412 ROWE033465 - ROWE033497 ROWE033503 - ROWE033507 ROWE033503 - ROWE033507 __________ ROWE033508__________ ROWE033509 - ROWE033510 ROWE033530 - ROWE033565 ROWE033530 - ROWE033565 __________ ROWE033650__________ ROWE033682 Page 107 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 138 of 232 PAGEID #: 40902 Bates Numbered Documents ROWE033683 - ROWE033686 ROWE033781 - ROWE033782 ROWE033786 - ROWE033788 ROWE034159 - ROWE034164 ROWE034165 - ROWE034166 __________ ROWE034167__________ ROWE034168 - ROWE034169 ROWE034170 -034171 ROWE034172 - ROWE034174 __________ ROWE034176__________ ROWE034177 - ROWE034182 ROWE034183 - ROWE034184 ROWE034185 - ROWE034199 __________ ROWE034645__________ ROWE034648 - ROWE034649 ROWE034673 - ROWE034674 __________ ROWE034694__________ ROWE034695 - ROWE034706 ROWE034715 - ROWE034795 ROWE035813 - ROWE035818 ROWE035864 - ROWE035873 ROWE035894 - ROWE035899 ROWE035900 - ROWE035906 ROWE035968 - ROWE036007 ROWE036140 - ROWE036143 ROWE036271 - ROWE036273 ROWE036342 - ROWE036355 ROWE036461 - ROWE036469 ROWE036470 - ROWE036478 ROWE036534 - ROWE036536 ROWE036560 - ROWE036586 ROWE036679 - ROWE036681 ROWE036682 - ROWE036686 ROWE036682 - ROWE036686 ROWE036687 - ROWE036703 __________ ROWE036735__________ __________ ROWE036738__________ ROWE037124 - ROWE037127 ROWE037128 - ROWE037129 __________ ROWE037135__________ ROWE037136 - ROWE037138 __________ ROWE037148__________ ROWE037149 - ROWE037152 ROWE037166 - ROWE037168 ROWE037169 - ROWE037171 Page 108 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 139 of 232 PAGEID #: 40903 Bates Numbered Documents ROWE037247 - ROWE037249 ROWE037254 - ROWE037256 ROWE037257 - ROWE037301 ROWE037332 - ROWE037334 ROWE037351 - ROWE037353 ROWE037356 - ROWE037361 ROWE037371 - ROWE037374 ROWE037411 - ROWE037416 ROWE037417 - ROWE037437 ROWE037457 - ROWE037459 ROWE037467 - ROWE037472 ROWE037473 - ROWE037476 ROWE037477 - ROWE037479 ROWE037483 - ROWE037512 ROWE037558 - ROWE037618 ROWE037626 - ROWE037681 ROWE037728 - ROWE037730 __________ ROWE037790__________ ROWE038025 - ROWE038033 ROWE038247 - ROWE038286 ROWE038289 - ROWE038315 ROWE038289 - ROWE038315 ROWE038341 - ROWE038342 ROWE038343 - ROWE038351 ROWE038393 - ROWE038394 ROWE038469 - ROWE038548 ROWE038549 - ROWE038553 ROWE038699 - ROWE038701 ROWE038720 - ROWE038727 ROWE038939 - ROWE038948 __________ ROWE038949__________ ROWE038978 - ROWE039005 ROWE039098 - ROWE039100 ROWE039164 - ROWE039174 ROWE039186 - ROWE039189 ROWE039253 - ROWE039255 __________ ROWE039260__________ ROWE039264 - ROWE039265 ROWE039266 - ROWE039274 ROWE039275 - ROWE039300 ROWE039321 - ROWE039324 ROWE039380 - ROWE039381 ROWE039382 - ROWE039393 __________ ROWE039418__________ ROWE039419 - ROWE039423 Page 109 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 140 of 232 PAGEID #: 40904 _______ Bates Numbered Documents_______ ______________ ROWE039425 - ROWE039427______________ ______________ ROWE039431 - ROWE039432______________ ______________ ROWE039431 - ROWE039432______________ ______________ ROWE039433 - ROWE039435______________ _____________________ ROWE039438_____________________ ______________ ROWE039591 - ROWE039593______________ _____________________ ROWE039594_____________________ ______________ ROWE039598 - ROWE039609______________ ______________ ROWE039637 - ROWE039639______________ ______________ ROWE039752 - ROWE039759______________ ______________ ROWE039752 - ROWE039759______________ ______________ ROWE040184 - ROWE040192______________ ______________ ROWE040305 - ROWE040306______________ ______________ ROWE040341 - ROWE040353______________ _____________________ ROWE040354_____________________ ______________ ROWE040363 - ROWE040366______________ ______________ ROWE040367 - ROWE040379______________ ______________ ROWE040388 - ROWE040389______________ ______________ ROWE040476 - ROWE040477______________ ROWE040483 - ROWE040489; ROWE040491 - ROWE040499 ROWE040483 - ROWE040499 ________R O W E 0 4 0 5 8 6 ________ ROWE040592 - ROWE040603 ROWE040604 - ROWE040624 ROWE040707 - ROWE040708 ROWE040725 - ROWE040726 ROWE040760 - ROWE040798 ROWE040799 - ROWE040804 _______ ROWE040875________ ROWE040882 - ROWE040898 ROWE040899 - ROWE040922 ________RO W E 0 4 0 9 7 0 _______ ROWE040994 - ROWE040995 ROWE0409977 - ROWE040980 ROWE041177 - ROWE041178 ROWE041180 - ROWE041181 ________RO W E 0 4 1 1 9 1 _______ ROWE041201 - ROWE041233 ________RO W E 0 4 1 2 5 0 _______ ________RO W E 0 4 1 2 5 1 _______ _______ ROWE041344_______ ________RO W E 0 4 1 3 5 2 _______ ________RO W E 0 4 1 4 5 9 _______ ROWE041462 Page 110 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 141 of 232 PAGEID #: 40905 Bates Numbered Documents ROWE041469 - ROWE041471; ROWE041193 _______ROWE041753 - ROWE041764 _______ROWE041765 - ROWE041766_______ ______________ ROWE041791______________ _______ROWE041924 - ROWE041926_______ ______________ ROWE041972______________ _______ROWE042023 - ROWE042032_______ _______ROWE042023 - ROWE042032_______ _______ROWE042033 - ROWE042065_______ ______________ ROWE042106______________ ______________ ROWE042107______________ ______________ ROWE042205______________ ______________ ROWE042206______________ ______________ ROWE042207______________ _______ROWE042222 - ROWE042223_______ _______ROWE042224 - ROWE042289_______ _______ROWE042290 - ROWE042296_______ _______ROWE042297 - ROWE042302_______ _______ROWE042297 - ROWE042302_______ _______ROWE042336 - ROWE042353_______ ______________ ROWE042354______________ ______________ ROWE042355______________ _______ROWE042357 - ROWE042394 ______________ ROWE042397______________ ______________ ROWE042398______________ _______ROWE042405 - ROWE042417_______ ______________ ROWE042418______________ _______ROWE042665 - ROWE042712_______ _______ROWE042742 - ROWE042748 _______ROWE042742 - ROWE042748 _______ROWE042763 - ROWE042765_______ _______ROWE042766 - ROWE042773_______ _______ROWE042803 - ROWE042804 _______ROWE042805 - ROWE042806_______ _______ROWE042836 - ROWE042848 _______ROWE042850 - ROWE042855_______ _______ROWE042856 - ROWE042863_______ _______ROWE042908 - ROWE042914 _______ROWE042947 - ROWE042992_______ ______________ ROWE042993______________ _______ROWE043006 - ROWE043015_______ _______ROWE043018 - ROWE043024 _______ROWE043025 - ROWE043026_______ _______ROWE043042 - ROWE043097_______ ROWE043268 Page 111 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 142 of 232 PAGEID #: 40906 Bates Numbered Documents ROWE043378 - ROWE043382 ROWE043378 - ROWE043382 ROWE043378 - ROWE043382 ROWE043530 - ROWE043531A __________ ROWE043532__________ __________ ROWE043534__________ __________ ROWE043539__________ ROWE043545 - ROWE043551 __________ ROWE043552__________ __________ ROWE043553__________ __________ ROWE043554__________ __________ ROWE043555__________ __________ ROWE043557__________ ROWE043598 - ROWE043599 ROWE043610 - ROWE043618 ROWE043610 - ROWE043618 ROWE043632 - ROWE043641 __________ ROWE043679__________ __________ ROWE043680__________ ROWE043889 - ROWE043896 ROWE043902 - ROWE043904 ROWE043905 - ROWE043923 ROWE043924 - ROWE043925 ROWE043926 - ROWE043928 ROWE043929 - ROWE043931 ROWE043932 - ROWE043933 ROWE043934 - ROWE043943 ROWE043944 - ROWE043947 ROWE043948 - ROWE043950 ROWE043951 - ROWE043953 ROWE043954 - ROWE043968 ROWE043969 - ROWE043970 ROWE043971 - ROWE043976 ROWE043977 - ROWE043978 __________ ROWE043979__________ ROWE043980 - ROWE043987 ROWE043988 - ROWE043990 ROWE043991 - ROWE043992 ROWE043993 - ROWE043994 ROWE043995 - ROWE043996 ROWE043997 - ROWE043999 ROWE044000 - ROWE044002 ROWE044003 - ROWE044006 ROWE044007 - ROWE044008 ROWE044009 - ROWE044016 Page 112 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 143 of 232 PAGEID #: 40907 Bates Numbered Documents ROWE044017 - ROWE044024 ROWE044025 - ROWE044028 ROWE044029 - ROWE044037 ROWE044038 - ROWE044041 ROWE044042 - ROWE044044 ROWE044045 - ROWE044047 ROWE044048 - ROWE044049 ROWE044050 - ROWE044051 ROWE044052 - ROWE044063 ROWE044064 - ROWE044066 ROWE044067 - ROWE044068 ROWE044069 - ROWE044070 ROWE044071 - ROWE044073 ROWE044074 - ROWE044077 ROWE044078 - ROWE044084 ROWE044085 -ROWE044086 ROWE044087 - ROWE044088 ROWE044100 - ROWE044107 ROWE044213 - ROWE044232 ROWE044609 - ROWE044664 ROWE044839 - ROWE044840 ROWE044841 - ROWE044842 ROWE044891 - ROWE044893 ROWE044894 - ROWE044902 ROWE044903 - ROWE044905 ROWE044907 - ROWE044920 __________ ROWE044921__________ ROWE044925 - ROWE044927 ROWE044931 - ROWE044933 ROWE045006 - ROWE045010 ROWE045011 - ROWE045020 ROWE045021 - ROWE045024 ROWE045027 - ROWE045052 ROWE045053 - ROWE045055 ROWE045056 - ROWE045139 ROWE045183 - ROWE045211 ROWE045183 - ROWE045211 ROWE045214 - ROWE045215 ROWE045216 - ROWE045218 ROWE045305 - ROWE045306 ROWE045307 - ROWE045314 ROWE045317 - ROWE045326 ROWE045317 - ROWE045326 ROWE045359 - ROWE045371 ROWE045410 - ROWE045426 Page 113 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 144 of 232 PAGEID #: 40908 Bates Numbered Documents ROWE045427 - ROWE045430 ROWE045431 - ROWE045433 ROWE045437 - ROWE045438 ROWE045464 - ROWE045465 ROWE045470 - ROWE045522 ROWE045534 - ROWE045535 ROWE045569 - ROWE045600 ROWE045608 - ROWE045612 __________ ROWE045661__________ ROWE045765 - ROWE045768 ROWE045769 - ROWE045773 ROWE045774 - ROWE045776 ROWE045777 - ROWE045811 __________ ROWE045812__________ ROWE045813 - ROWE045846 ROWE045847 - ROWE045849 ROWE045850 - ROWE045859 ROWE045860 - ROWE0 45909 ROWE045910 - ROWE045953 ROWE045962 - ROWE045973 ROWE045974 - ROWE046008 ROWE046018 - ROWE046045 ROWE046046 - ROWE046088 ROWE046089 - ROWE046129 ROWE046130 - ROWE046163 ROWE046164 - ROWE046308 ROWE046309 - ROWE046336 ROWE046337 - ROWE046391 ROWE046392 - ROWE046417 ROWE046475 - ROWE046476 ROWE046477 - ROWE046760 ROWE046761 - ROWE046970 ROWE046971 - ROWE046973 ROWE046974 - ROWE046979 ROWE046980 - ROWE046982 ROWE047006 - ROWE047020 ROWE047048 - ROWE047083 ROWE047091 - ROWE047096 __________ ROWE047148__________ ROWE047160 - ROWE047161 ROWE047183 - ROWE047194 ROWE047248 - ROWE047252 ROWE047253 - ROWE047255 __________ ROWE047256__________ ROWE047257 - ROWE047291 Page 114 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 145 of 232 PAGEID #: 40909 _______Bates Numbered Documents_______ _____________ ROWE047292 - ROWE047341_____________ _____________ ROWE047342 - ROWE047385_____________ _____________ ROWE047386 - ROWE047389_____________ _____________ ROWE047390 - ROWE047399_____________ _____________ ROWE047400 - ROWE047433_____________ _____________ ROWE047434 - ROWE047436_____________ _____________ ROWE047437 - ROWE047456_____________ _____________ ROWE047750 - ROWE047761_____________ ROWE047787 - ROWE047789; USEPA23171 - USEPA23173 ROWE047790 - ROWE047791; USEPA23174 - USEPA23175 ______________ ROWE047792;USEPA23176______________ ______________ROWE047793; USEPA23177______________ ______________ROWE047794; USEPA23178______________ ROWE047795 - ROWE047796; USEPA23179 - USEPA23180 ROWE047797 - ROWE047798; USEPA23181 - USEPA23182 ROWE047799 - ROWE047804; USEPA23183 - USEPA23188 ______________ROWE047805; USEPA23189______________ ROWE047806 - ROWE047808; USEPA23190 - USEPA23192 ROWE047809 - ROWE047811; USEPA23193 - USEPA23195 ROWE047812 - ROWE047815; USEPA23196 - USEPA23199 ROWE047816 - ROWE04819; USEPA23200 - USEPA23203 ______________ROWE047820; USEPA23204______________ ROWE047821 - ROWE047822; USEPA23205 - USEPA23206 ROWE047823 - ROWE047825; USEPA23207 - USEPA23209 ______________ROWE047826; USEPA23210______________ ______________ROWE047827; USEPA23211______________ ______________ROWE047828; USEPA23212______________ ROWE047829 - ROWE047830; USEPA23213 - USEPA23214 ROWE047831 - ROWE047832; USEPA23215 - USEPA23216 ROWE047833 - ROWE047834; USEPA23217 - USEPA23218 ROWE047835 - ROWE047836; USEPA23219 - USEPA23220 Page 115 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 146 of 232 PAGEID #: 40910 _______Bates Numbered Documents_______ ______________ROWE047837; USEPA23221______________ ______________ROWE047838; USEPA23222______________ ROWE047839 - ROWE047841; USEPA23223 - USEPA23225 ROWE047842 - ROWE047843; USEPA23226 - USEPA23227 ROWE047844 - ROWE047846; USEPA23228 - USEPA23230 ROWE047847 - ROWE047848; USEPA23231 - USEPA23232 ______________ROWE047849; USEPA23233______________ ______________ROWE047850; USEPA23234______________ ______________ROWE047851; USEPA23235______________ ROWE047852 - ROWE047855; USEPA23236 - USEPA23239 ROWE047856 - ROWE047859; USEPA23240 - USEPA23243 ROWE047860 - ROWE047864; USEPA23244 - USEPA23248 ______________ROWE047865; USEPA23249______________ ______________ROWE047867; USEPA23251______________ ______________ROWE047868; USEPA23252______________ ______________ROWE047869; USEPA23253______________ ______________ROWE047870; USEPA23254______________ ______________ROWE047871; USEPA23255______________ ROWE047872 - ROWE047873; USEPA23256 - USEPA23257 ROWE047874; USEPA23258 ROWE047875; USEPA23259 ROWE047890 - ROWE047915 ROWE047920 - ROWE047921 ROWE047989 - ROWE047990 _______ ROWE048064_______ ROWE048079 - ROWE048080 ROWE048143 - ROWE048162 ROWE048181 - ROWE048184 ROWE048185 - ROWE048189 _______ ROWE048191_______ ROWE048197 - ROWE048198 ROWE048224 - ROWE048235 _______ ROWE048326_______ ROWE048331 - ROWE048333 ROWE048343 - ROWE048345 ROWE048372 - ROWE048374 ROWE048403 - ROWE048420 Page 116 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 147 of 232 PAGEID #: 40911 _______Bates Numbered Documents_______ _____________ ROWE048475 - ROWE048485_____________ _____________ ROWE048632 - ROWE048672_____________ ROWE048673 - ROWE049140; USEPA23260 - USEPA23728 ROWE049299 - ROWE049301 ROWE049306 - ROWE049310 ROWE049312 - ROWE049314 _______ ROWE049316_______ ROWE049318 - ROWE049352 ROWE049354 - ROWE049387 ROWE049389 - ROWE049392 ROWE049394 - ROWE049403 ROWE049405 - ROWE049407 ROWE049409 - ROWE049514 ROWE049516 - ROWE049551 ROWE049608 - ROWE049620 ROWE050065 - ROWE050068 ROWE050071 - ROWE050073 ROWE050074 - ROWE050077 ROWE050080 - ROWE050102 ROWE050151 - ROWE050152 ROWE050153 - ROWE050155 _______ ROWE050206_______ ROWE050207 - ROWE050209 ROWE050211 - ROWE050214 ROWE050215 - ROWE050223 ROWE050224 - ROWE050225 ROWE050227 - ROWE050228 ROWE050229 - ROWE050230 ROWE050231 - ROWE021825 ROWE050232; ROWE011372 _______ ROWE050233_______ ROWE050234 - ROWE050238 ROWE050300 - ROWE050301 ROWE050329 - ROWE050330 _______ ROWE050448_______ ROWE050516 - ROWE050526 _______ ROWE050554_______ ROWE050621 - ROWE050622 _______ ROWE050686_______ _______ ROWE050688_______ ROWE050690 - ROWE050691 ROWE050714 - ROWE050715 ROWE050716 - ROWE050758 ROWE050759 - ROWE050763 Page 117 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 148 of 232 PAGEID #: 40912 _______Bates Numbered Documents_______ _____________ ROWE050851 - ROWE050887_____________ _____________ ROWE051039 - ROWE051040_____________ _____________ ROWE051041 - ROWE051042_____________ _____________ ROWE051173 - ROWE051203_____________ _____________ ROWE051285 - ROWE051297_____________ _____________ ROWE051307 - ROWE051316_____________ _____________ ROWE051333 - ROWE051338_____________ _____________ ROWE051339 - ROWE051345_____________ _____________ ROWE051346 - ROWE051353_____________ _____________ ROWE051354 - ROWE051365_____________ _____________ ROWE051438 - ROWE051441_____________ _____________ ROWE051566 - ROWE051568_____________ ____________________ ROWE051604____________________ _____________ ROWE051634 - ROWE051642_____________ _____________ ROWE051665 - ROWE051676_____________ _____________ ROWE051688 - ROWE051695_____________ _____________ ROWE051696 - ROWE051701_____________ _____________ ROWE051702 - ROWE051705_____________ _____________ ROWE051706 - ROWE051710_____________ _____________ ROWE051711 - ROWE051714_____________ _____________ ROWE051715 - ROWE051719_____________ _____________ ROWE051720 - ROWE051731_____________ _____________ ROWE051732 - ROWE051734_____________ _____________ ROWE051735 - ROWE051743_____________ _____________ ROWE051744 - ROWE051749_____________ _____________ ROWE051750 - ROWE051756_____________ _____________ ROWE051773 - ROWE051774_____________ _____________ ROWE051776 - ROWE051786_____________ _____________ ROWE051788 - ROWE051791_____________ _____________ ROWE051793 - ROWE051795_____________ _____________ ROWE051797 - ROWE051799_____________ _____________ ROWE051801 - ROWE051803_____________ _____________ ROWE051812 - ROWE051860_____________ _____________ ROWE051814 - ROWE051852_____________ _____________ ROWE051863 - ROWE051901_____________ _____________ ROWE052035 - ROWE052042_____________ _____________ ROWE052050 - ROWE052088_____________ _____________ ROWE052330 - ROWE052364_____________ _____________ ROWE052442 - ROWE052449_____________ _____________ ROWE052450 - ROWE052460_____________ _____________ ROWE052461 - ROWE052469_____________ _____________ ROWE052471 - ROWE052489_____________ _____________ ROWE052490 - ROWE052498_____________ ROWE052816 - ROWE052818; USEPA23817 - USEPA23819 Page 118 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 149 of 232 PAGEID #: 40913 _______Bates Numbered Documents_______ ROWE052819 - ROWE052820; USEPA23820 - USEPA23821 ______________ROWE052821; USEPA23822______________ ______________ROWE052822; USEPA23823______________ ______________ROWE052823; USEPA23824______________ ______________ROWE052824; USEPA23825______________ ROWE052825 - ROWE052826; USEPA23826 - USEPA23827 ______________ROWE052827; USEPA23828______________ ______________ROWE052828; USEPA23829______________ ______________ROWE052829; USEPA23830______________ ______________ROWE052830; USEPA23831______________ ROWE052831 - ROWE052836; USEPA23832 - USEPA23837 ROWE052837 - ROWE052838; USEPA23838 - USEPA23839 ROWE052839 - ROWE052841; USEPA23840 - USEPA23842 ROWE052842 - ROWE052843; USEPA23843 - USEPA23844 ______________ROWE052844; USEPA23845______________ ROWE052845 - ROWE052852; USEPA23846 - USEPA23853 ROWE053034 - ROWE053072 ROWE053196 - ROWE053197 _______ ROWE053210_______ ROWE053212 - ROWE053213 _______ ROWE053246_______ ROWE053260 - ROWE053283 ROWE053373 - ROWE053374 _______ ROWE053386_______ _______ ROWE053388_______ ROWE053396; ROWE053014 ROWE053401 - ROWE053407 ROWE053451 - ROWE053455 _______ ROWE053456_______ _______ ROWE053457_______ _______ ROWE053458_______ _______ ROWE053471_______ ROWE053476 - ROWE053483 _______ ROWE053484_______ ROWE053547 - ROWE053548 ROWE053553 - ROWE053556 ROWE053590 - ROWE053593 ROWE053674 -053680 Page 119 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 150 of 232 PAGEID #: 40914 Bates Numbered Documents ROWE053681 - ROWE053686 ROWE054176 -ROWE054157 ROWE054187 - ROWE054192A ROWE054202 - ROWE054203 ROWE054219 - ROWE054220 ROWE054263 - ROWE054266 ROWE054267 - ROWE054270 ROWE054271 - ROWE054280 ROWE054607 - ROWE054641 ROWE054607 - ROWE054641 ROWE054685 - ROWE054686 ROWE054687 - ROWE054756 __________ ROWE055065__________ __________ ROWE055068__________ __________ ROWE055069__________ ROWE055072 - ROWE055073 __________ ROWE055074__________ __________ ROWE055075__________ ROWE055133 - ROWE055133 __________ ROWE055140__________ ROWE055163 - ROWE055164 ROWE056419 - ROWE056420 ROWE056585 - ROWE056586 ROWE056601 - ROWE056606 ROWE056751 - ROWE056756 ROWE056766 - ROWE056778 ROWE056799 - ROWE056800 __________ ROWE056822__________ __________ ROWE056833__________ ROWE056845 - ROWE056853 ROWE056854 - ROWE056861 __________ ROWE056902__________ ROWE056903 - ROWE056904 __________ ROWE056908__________ __________ ROWE057294__________ __________ ROWE057295__________ ROWE057396 - ROWE057397 ROWE057404 - ROWE057472 ROWE057565 - ROWE057577 ROWE057581 - ROWE057582 __________ ROWE057744__________ ROWE057747 - ROWE057748 ROWE057758 - ROWE057759 ROWE057760 - ROWE057828 ROWE057891 - ROWE057935 Page 120 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 151 of 232 PAGEID #: 40915 _______Bates Numbered Documents_______ ____________________ ROWE057968____________________ ROWE057969 - ROWE057979; USEPA24014 - USEPA24024 ROWE057980 - ROWE058065; USEPA24025 - USEPA24110 ______________ROWE058066; USEPA24111______________ ROWE058067 - ROWE058079; USEPA24112 - USEPA24124 ROWE058080 - ROWE058113; USEPA24125 - USEPA24158 ROWE058114 - ROWE058157; USEPA24159 - USEPA24202 ROWE058158 - ROWE058187; USEPA24203 - USEPA24232 ROWE058188 - ROWE058194; USEPA24233 - USEPA24239 ROWE058195 - ROWE058203; USEPA24240 - USEPA24248 ROWE058204 - ROWE058241; USEPA24249 - USEPA24286 ROWE058242 - ROWE058264; USEPA24287 - USEPA24309 _________________ ROWE058265_________________ __________ ROWE058266 - ROWE058268__________ __________ ROWE058269 - ROWE058270__________ _________________ ROWE058271_________________ RP027965 - RP027969; EID638384 - EID638388 _________ RTOWE000688 - ROWE000689_________ RV000914 - RV000921; EID088521 - EID088528 RWR003982 - RWR003991; EID615440 - EID615449 ____________ RWR003992; EID615450____________ RWR004880 - RWR004881; EID738989 - EID738990 RWR004980 - RWR004988; EID739089 - EID739097 RWR005034 - RWR005036; EID739143 - EID739145 RWR005045 - RWR005137; EID744607 - EID744699 RWR005138 - RWR005145; EID744700 - EID744707 RWR010736 - RWR010738; EID802749 - EID802751 RWR010739 - RWR010741; EID802752 - EID802754 RWR010742 - RWR010744; EID802755 - EID802757 RWR010786 - RWR010788; EID802794 - EID802796 RWR010874 - RWR010875; EID802880 - EID802881 ____________ RWR010877; EID802883____________ RWR010957 - RWR010964; EID778059 - EID778066 RWR011044 -RWR011135; EID803042 -EID803133 RWR011136 - RWR011140; EID803134 - EID803138 Page 121 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 152 of 232 PAGEID #: 40916 _____Bates Numbered Documents____ RWR011142 - RWR011145; EID803139 - EID803142; _____________ PEG000325; EID801051_____________ RWR011142 - RWR11145; EID803139 - EID803142 RWR011185 - RWR011186; EID803182 - EID803183 ____________ RWR011360; EID803357____________ __________ SAMET00053 - SAMET00057__________ __________ SAMET01846 - SAMET01848__________ __________ SAMET01846 - SAMET01848__________ __________ SAMET01849 - SAMET01850__________ _________________ SAMET02004_________________ _________________ SAMET02005_________________ SAPPHIRE-000079 - SAPPHIRE-000080 SAPPHIRE-000079 - SAPPHIRE-000080 SAPPHIRE-000081 - SAPPHIRE-000082 SAPPHIRE-000094 - SAPPHIRE-000095 SAPPHIRE-000122 - SAPPHIRE-000123 SAPPHIRE-000135 - SAPPHIRE-000136 SAPPHIRE-000139 - SAPPHIRE-000140 SAPPHIRE-000141 - SAPPHIRE-000142 SAPPHIRE-000143 - SAPPHIRE-000144 ________ SAPPHIRE00137 - SAPPHIRE00138________ SAPPHIRE-009799 - SAPPHIRE-009800 SAPPHIRE-010009 - SAPPHIRE-010078 SAPPHIRE-010361 - SAPPHIRE-010372 SAPPHIRE-010373 - SAPPHIRE-010390 ___________SEIXAS00031 - SEIXAS00044___________ ___________SEIXAS00048 - SEIXAS00061___________ ___________SEIXAS00162 - SEIXAS00199___________ _________________ SEIXAS00442_________________ ___________SEIXAS00470 - SEIXAS00471___________ ___________SEIXAS00473 - SEIXAS00474___________ ___________SEIXAS00473 - SEIXAS00474___________ ___________SEIXAS00495 - SEIXAS00508___________ ___________SEIXAS00600 - SEIXAS00601___________ ___________SEIXAS00602 - SEXIAS00604___________ ___________SEIXAS00639 - SEIXAS00645___________ ___________ SEIXAS0065 - SEIXAS00071___________ SEIXAS00706 - SEIXAS0070 SEIXAS00855 - SEIXAS00860 SEIXAS01006 - SEIXAS01008 SEIXAS01033_______ SEIXAS01035_______ SEIXAS01036_______ SEIXAS01177 - SEIXAS01189 Page 122 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 153 of 232 PAGEID #: 40917 _______ Bates Numbered Documents_______ ______________ SEIXAS01212 - SEIXAS01213_______________ ______________ SEIXAS01354 - SEIXAS01358______________ ______________ SEIXAS01545 - SEIXAS01552______________ ______________ SEIXAS01688 - SEIXAS01691______________ _____________________ SEIXAS01692_____________________ _____________________ SEIXAS01693_____________________ ______________ SEIXAS01699 - SEIXAS01706______________ ______________ SEIXAS01720 - SEIXAS01723_______________ ______________ SEIXAS01724 - SEIXAS01725_______________ ______________ SEIXAS01726 - SEIXAS01740______________ SHK000115 - SHK000117; EID152077 - EID152079 SL001069 - SL001071; EID522970 - EID522972; 063-0169 ______________0005487 - 063-0169-0005489______________ SL001069 - SL001074; EID522970 - EID522975 SL001075 - SL001076; EID522976 - EID522977 SL001077 - SL001078; EID522978 - EID522979 SL001080 - SL001082; EID522981 - EID522983; BLD003353 ______________________ BLD003360______________________ SL001091 - SL001095; EID522992 - EID522996 SL001096 - SL001098; EID522997 - EID522999; YLP000136 ______________________ YLP000139______________________ SL001099 - SL001101; EID523000 - EID523002 _________________ SL001102;EID523003_________________ _______ SL001103 - SL1104; EID523004 - EID523005_______ SL001105 - SL001106; EID523006 - EID523007 _________________ SL001107; EID523008_________________ SL001108 - SL001110; EID523009 - EID523011. SL001108 - SL001120; EID523009 - EID523021 SL001111 - SL001112; EID523012 - EID523013 SL001111 - SL001112; EID523012 - EID523013 SL001113 - SL001114; EID523014 - EID523015 _________________ SL001115;EID523016_________________ _________________ SL001116; EID523017_________________ SL001117 - SL001120; EID523018 - EID523021 SMK002122 - SMK002129; EID741080 - EID741087 ________________ SPD002068- SP002154_________________ ______________________ SPD002326______________________ ________________ SPD002327 - SPD002357________________ _________________ SPD 01534- SPD01540_________________ _________________ SPD 01534- SPD01646_________________ __________________S P D 0 1 5 4 1 S P D 0 1 6 4 6 __________________ SPD01788 - SPD01799; SPD01809 - SPD01810; SPD01837 ______________________ SPD01838______________________ SPR000232 - SPR000233; EID714149 - EID714150 SPR000237 - SPR000240; EID714154 - EID714157 Page 123 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 154 of 232 PAGEID #: 40918 ______ Bates Numbered Documents______ SPR000310 - SPR000338; EID714222 - EID714250 SPR001359 - SPR001361; EID715230 - EID715232 SPR00297 - SPR000299; EID714209 - EID714211 ______________________ T3758_______________________ ______________________ T3759_______________________ ______________________ T3760_______________________ ______________________ T3761_______________________ ______________________ T3762_______________________ ______________________ T3763_______________________ ______________________ T3764_______________________ ___________________T3774 - T3777___________________ ___________________T3778 - T3780___________________ ______________________ T3781_______________________ TPM001824 - TPM001828; EID742473 - EID742477 TSB002753 -TSB002758; EID742496 - EID742501 TSB002899 -TSB002943; EID806348 - EID806392 TSB002899 -TSB002943; EID806348 - EID806392 TSB002944 - TSB002997; EID806393 - EID806446 TSB002944 -TSB002997; EID806393 - EID806446 UMC000169 - UMC000173; EID742829 - EID2833 UMC002541 - UMC002551; EID806844 - EID806854 UMC002644 - UMC002649; EID806947 - EID806952 UMC002659 - UMC002664; EID806962 - EID806967 USEPA14926 - USEPA14931; CF009524 - CF009529 USEPA15165 - USEPA15167; RL001770 - RL001772 _____________ USEPA15189; BWK000016_____________ _____________ USEPA15189; BWK000026_____________ _____________ USEPA15190; BWK000027_____________ USEPA15191 - USEPA15204; RCG000001 - RCG000002; ______________ AJP002919- AJP002930_______________ USEPA15205 - USEPA15207; RL000181 - RL000183 USEPA15609 - USEPA15616; RCG000141 - RCG000148 USEPA15609 - USEPA15616; RCG000141 - RCG000148 USEPA15640 - USEPA15648; RCG000172 - RCG000180 USEPA15649 - USEPA15658; RCG000181 - RCG000190 USEPA15649 - USEPA15658; RCG000181 - RCG000190 ______________USEPA15659; RCG000191______________ USEPA15699 - USEPA15707; RCG000231 - RCG000239 USEPA15699 - USEPA15707; RCG000231 - RCG000239 USEPA15743 - USEPA15812; WJB000002 - WJB000071 USEPA16148 - USEPA16191; HLAB000231 - HLAB000274 USEPA16690; GWJ000170; EID192138; AJP007301 USEPA16788 - USEPA16805; RL000910 - RL000927 USEPA16842 - USEPA16849; RKI000005 - RKI000011 USEPA16941 - USEPA16958; HLAB000003 - HLAB000020 Page 124 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 155 of 232 PAGEID #: 40919 _______ Bates Numbered Documents_______ _____________ USEPA8844-45; JRW000022-23_____________ ____________WEGMAN00110 - WEGMAN00114____________ ____________WEGMAN00294 - WEGMAN00302____________ ____________________ WEGMAN00385____________________ ____________________ WEGMAN00386____________________ ____________________ WEGMAN00436____________________ ____________________ WEGMAN00437____________________ ____________WEGMAN00438 - WEGMAN00444____________ ____________WEGMAN00456 - WEGMAN00478____________ ____________________ WEGMAN00561____________________ ____________WEGMAN00564 - WEGMAN00566____________ ____________WEGMAN00567 - WEGMAN00588____________ ____________WEGMAN00589 - WEGMAN00592____________ ____________WEGMAN00593 - WEGMAN00735____________ ____________WEGMAN00736 - WEGMAN00795____________ WVDHHR000098 - WVDHHR000099; EID648314 - EID648315 WVDHHR000103; EID648319; WVDHHR000096; EID648312 WVDHHR000106 - WVDHHR000107; EID648322 - EID648323 WVDHHR000118 - WVDHHR000119; EID648334 - EID648335 ______________ WVDHHR000207; EID648423______________ WVDHHR000222 - WVDHHR000225; EID648438 - EID648441 WVDHHR000289; EID648505 YAA000030 - YAA000052 YAA000134 - YAA000142 YAA000389 - YAA000390 YAA000393 - YAA000394 YAA000423 - YAA000435 Page 125 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 156 of 232 PAGEID #: 40920 Descriptions of Documents Without Bates Numbers Amended Class Action Complaint filed in Ja ck Leach, et al. v. D u P o n t on 8/30/01 Second Amended Class Action Complaint filed in W illiam Rhodes, e ta l. v. D u P o n t on 1/8/09 Fourth Amended Civil Action Complaint - Class Action filed in R ich a rd Row e, et al., v. D u P o n t on 5/13/10 First Amended Complaint filed in The Little H o ckin g W ater A sso cia tio n v. D u P o n t on 3/15/10 DuPont's Answer to Amended Class Action Complaint in the Leach v. D u P on t case, filed on 10/15/01 DuPont's Answer to Amended Complaint in the R hodes v. D u P o n t case, filed on 7/5/06 DuPont's Answer to Complaint in the R o w e v. D u P o n t case, filed on 5/31/06 DuPont's Answer to Complaint in The Little H o ckin g W ater A sso cia tio n v. D u P o n t case, filed on 1/29/10 DuPont's Answers to Plaintiffs' First Set of Requests for Admissions in the Leach v. D u P on t case, served on DuPont's Answers to Plaintiffs' Second Set of Requests for Admissions in the Leach v. D u P on t case, served on DuPont's Answers to Plaintiffs' Third Set of Requests for Admissions in the Leach v. D u P on t case, served on DuPont's Responses to Plaintiffs' First Set of Interrogatories in the Leach v. D u P on t case, served on 2/18/02 DuPont's Supplemental Response to Plaintiffs' Second Set of Interrogatories in the R hodes v. D u P on t case, served on 7/11/07 DuPont's Responses to Coles Plaintiffs' First Set of Requests for Admissions in the R ow e v. D u P on t case, served on 2/14/07 DuPont's Supplemental Responses to Rowe Plaintiffs' Interrogatory Nos. 3-10 in the R ow e v. D u P on t case, served on 6/6/07 DuPont's Responses to Plaintiffs' First Set of Requests for Admissions in The Little H o ckin g W ater A sso cia tio n v. D uPont case, served on 1/4/13 DuPont's Responses to Plaintiffs' Second Requests for Admissions in The Little H o ckin g W ater A sso cia tio n v. D uPont case, served on 1/9/13 DuPont's Responses to Plaintiffs' Initial Master Sets of Requests for Admissions, Requests for Production, Interrogatories, and Requests for Stipulations in the DuPont/C-8 Personal Injury MDL case, served on 12/9/13 DuPont's Responses to Plaintiffs' Fourth Master Set of Interrogatories, Document Requests and Requests for Admissions in the DuPont/C-8 Personal Injury MDL case, served on 3/5/2014 DuPont's Counter-Statement of Undisputed Material Facts Pursuant to Local Rule 56.1, filed in the R ow e v. D uPont case on 9/24/10 DuPont's Counter-Statement to Plaintiffs' Joint Supplemental Statement of Disputed Material Facts, filed in the R ow e v. D u P o n t case on 10/1/10 Book: Stain -Resistant, Nonstick, Waterproof and Lethal: The Hidden Dangers of C-8, authored by Callie Lyons Grandjean, P., Clapp, R., "Changing Interpretation of Human Health Risks from Perfluorinated Compounds", Public Health Reports, vol. 129, 482-485 Plaintiffs' Memorandum in Support of Motion for partial Summary Judgment under Rule 56 for Determination of Issues under Rule 16c, filed on 9/3/14 in the DuPont C-8 Personal Injury Litigation MDL Defendant's Opposition to Plaintiffs' Motion for Partial Summary Judgment under Rule 56 or for Determination of Issues under Rule 16C, filed on 9/29/14 in the DuPont C-8 Personal Injury Litigation MDL Plaintiffs' Reply in Support of Motion for Partial Summary Judgment under Rule 56 or for Determination of Issues under Rule 16C, filed on 10/13/14 in the DuPont C-8 Personal Injury Litigation MDL Post, Gloria, et al., "Perfluorooctanoic Acid (PFOA), An Emerging Drinking Water Contaminant: A Critical Review of Recent Literature", Environ. Res., doi.org/10.1016/j.envres.2012.03.007 April 1981 articles from various newspapers nationwide regarding DuPont reassigning female employees who worked with FC-143 at Washington Works plant (10 pages) Extracted pages from, " Hearings before the Subcommittee on Investigations and Oversight of the Committee on Science and Technology U.S House of Representatives ", Ninety Seventh Congress First Session, Statement of Bruce Karrh, 10/14/1981 and 10/15/1981, No.53 Page 126 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 157 of 232 PAGEID #: 40921 Descriptions of Documents Without Bates Numbers Parkersburg Community Opinion Survey dated December 1991 authored by Stephen Schmidt of DuPont (39 pages) (from Charles Ryan & Associates' third-party production in Rowe/Rhodes cases) From United Nations Environment Program web page: Statement from Dr. Paul Tebo, DuPont World Environment Day 1997, 6/5/1997 DuPont contract with Charles Ryan Associates dated 8/27/1998 (13 pages) (from Charles Ryan & Associates' third-party production in Rowe/Rhodes cases) Letter from USEPAto Paul Bossert- DuPont, re Request for Information,7/24/2001 Fax, 11/29/01 to Larry Winter from EPA Region III, Janet E. Sharke, transmitting DuPont's Response to Request for Information, 8/31/2001 Fax, 11/29/01 to Larry Winter from Janet Sharke, EPA Region III, transmitting DuPont's First Response to July 24,2001 Request for Information, 9/28/2001 Email dated 1/1/2002 from Patrick Gallagher of Charles Ryan to Clifton Webb (1 page) (from Charles Ryan & Associates' third-party production in Rowe/Rhodes cases) Draft Letter of Agreement between Spilman, Thomas and Charles Ryan Associates dated February 2002 (2 pages) (from Charles Ryan & Associates' third-party production in Rowe/Rhodes cases) DuPont Press Release, "DuPont Statement on Ammonium Perfluorooctanoate (C-8) Human Health Protective Level", 5/15/2002______________________________________________________________________________________ 1/3/2003 Email from Dawn D. Jackson, DuPont to Andrea Hannon, Marietta Times, "Info from DuPont Washington Works",1/3/2003 DuPont news release: "DuPont Statement on December 20, 2002 Environmental Working Group Article on Past Surveillance of C8 Fax to Andrea Hannon from Dawn Jackson transmitting DuPont Statement on December 20,2002 Environmental Working Group Article on Past Surveillance of C 8 ,1/3/2003 DuPont information sheet: "DuPont Caution Regarding Medical Applications of DuPont Materials, 2/1/2003 Calendar Entry screenshot for Clif Webb, Re: News Journal Interview request re: C8, 2/27/2003 DuPont News Release, " DuPont Refutes Health Effects Claims About PFOA Confirms Safety of Cookware Sold Under Teflon Brand", 3/31/2003 DuPont news release: "DuPont Counters Allegations on Safety of Teflon, Stainmaster Company Affirms Safety of Products", 4/8/2003 Letter from Environmental Working Group to Christine Todd Whitman of USEPA re DuPont's failure to submit key health studies under the requirements of TSCA 8e, 4/11/2003 News Article from Delawareonline News Journal: "DuPont chief defends C-8", 5/1/2003 DuPont news release, " DuPont to Appeal Court Order in Case Involving C-8", 5/7/2003 AR226-1318___________________________________________________________________________________________ Letter from USEPA to Kenneth A. C o o k, EWG re:Environmental Working Group concerns about PFOA and possible DuPont violations of reporting under Section 8 of the Toxic Substance Control A c t, 5/28/203 AR226-1408; AR226-1409; AR226-1410; AR226-1411; AR226-1412; AR226-1413; AR226-1414_________________ DuPont email from G Irvin Lipp, to Chad Holliday, et al., re: "News Journal Coverage of CPSC", 7/12/2003 Website Article, China, People's Daily Online, " DuPont non -stick cookware completely safe: Interview" ,7/19/2004____________________________________________________________________________________________ Plastic News Website Page, Opinion: " DuPont respectful of human rights, desires", Richard J. Angiullo of DuPont, 8/6/2003_____________________________________________________________________________________ EWG letter to EPA Richard H. Heftner, re: DuPont's failure to submit key health studies under the requirements of TSCA 8e, ,8/15/2003_________________________________________________________________________________ Website Article re PFOA from Plastics Technology, "Hard Choices", Matt Naitove, Editor, 9/2003 Page 127 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 158 of 232 PAGEID #: 40922 Descriptions of Documents Without Bates Numbers DuPont news release, "DuPont Statement on ABC "20/20 Segment on Teflon", 12/8/2003 DuPont brochure: Societal Benefits of Fluoropolymers and Fluorotelomers (not dated) (2 pages) (from thirdparty production of Dezenall Resources in Rowe/Rhodes cases) Website page Earnings.com News, "DuPont Reports Second Quarter 2004 Earnings", 7/27/2004 DuPont SEC Report, Form 8-K, 7/27/2004 AR226-1879; AR226-1880______________________________________________________________________________ DuPont news release, "DuPont Reports First Phase Results of Health Study Examining PFOA Exposure on Washington Works Employees", 1/11/2005 Letter from Paul Bossert of DuPont to Washington Works Employees re: Results of Phase I PFOA health survey, 1/11/2005___________________________________________________________________________________________ DuPont PowerPoint Presentation given to USEPA, "Product Stewardship Advancements and Direction" ,4/2005 DuPont Daily News website page, "Study Says Consumer Articles with DuPont Materials are Safe for Consumer Use", 4/21/2005______________________________________________________________________________________ Website page, PFOAfacts.com: SPI Statements on PFOA, 11/21/2005 DuPont News Release, "DuPont Settles With USEPA on PFOA Reporting Matter, 12/14/2005 Website page, www.fibre2fashion.com: "USW warns carpet industry on stain repellent PFOA", 12/22/2005 DuPont website PFOA page: PFOA Product Safety, 5/6/2005 DuPont website PFOA page: Important Facts about Teflon, 11/4/2006 DuPont website PFOA page: "About PFOA", 5/6/2005 DuPont website PFOA page: "About Teflon", 5/6/2005 DuPont News Release, "DuPont Disagrees With Science Advisory Board Draft on PFOA", 1/30/2006 DuPont Form 10-K SEC report for 2005 fiscal year, filed on 2/28/2006 DuPont email dated 4/25/05 from Silvio DeCarli to Daniel Turner re: Communications Report (3 pages) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). Email dated 4/27/06 from Daniel Turner of DuPont to Core Team re: Communications Report - Statement of Health Effects (1 page) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont SEC 10-Q report, filed 5/4/2006 for period up to 3/31/2006 Email dated 7/21/06 from Noah Seixas to Robin Leonard of DuPont and David Wegman re: Phase 1 report (2 pages) (from David Wegman's third-party production in Rowe/Rhodes cases). DuPont New Release, "DuPont Concludes Washington Works Employee PFOA Study", 10/17/2006 Email dated 10/18/06 from Tom Beauchamp to David Wegman and Jonathan Samet re: Press Release (3 pages) (from David Wegman's third-party production in Rowe/Rhodes cases). DuPont News Release, "DuPont Signs Agreement with USEPA on Interim Drinking Water Standard for PFOA in West Virginia and Ohio Communities", 11/21/2006 DuPont statement: DuPont Activities on the Reduction of PFOA Emissions, Exposure, undated Fact Sheet on DuPont Zonyl, undated DuPont News Release, "DuPont Installs Final Two Water Filtration Systems", 1/15/2009 DuPont website page, "About PFOA", undated The Sapphire Group news release, "New Study Finds PFOA Levels in Drinking Water Are Safe", 3/3/2009 and Sapphire Group abstract: Derivation of a Drinking Water Equivalent Concentration and Maximum Contaminant Level for PFOA"_______________________________________________________________________________________ DuPont letter from William Hopkins to Washington Works employees re: EIB on C8 Science Panel Status Reports, 3/26/2009 Article, "Textile Fluorochemicals, What Users Need to Know" by Robert C. Buck and Kai -Volker Schubert, ATTC Review, pp. 32-35, May 2009 Page 128 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 159 of 232 PAGEID #: 40923 Descriptions of Documents Without Bates Numbers List of Information for Residents re:PFOA, undated USEPA email from Daniel Gerasimowicz to Mathy Stanislaus, et al., re: , 6/8/2009 Schedule for Lisa P. Jackson, 6/8/2009 Information for DuPont Blog/ Web response on PFOA and Birth Outcomes, 8/7/2009 Letter from Michael W. Steinberg, counsel for DuPont, to David Altman,Esq. re: Little Hocking Water Association Notice of Intent to File RCRA Citizen Suit, 8/27/2009 Letter from DuPont to Bob Martin, Commissioner New Jersey DEP, Re: "NJDEP Actions Relating to Perfluorooctanoic Acid (PFOA), 12/1/2010 DuPont Website Home page, Occupational & Public Health, undated DuPont news release: "DuPont Statement on July 30,2012 Reports by the C8 Science Panel", 7/30/2012 DuPont letter from Andrea V. Malinowski Corporate Counsel to USEPA Document Processing Center, Re: C-8 Science Panel, 2/28/2013 Letter from Robert A. Bilott to Paula Durst Gillis, Esq. Re: Wilbur E. Tennant, et al. v DuPont, re: C-8, 8/15/2000 Letter from Lubeck Public Service District, James Cox Manager to PSD Customers re: C-8, 10/31/2000 DuPont calendar entry appointment, "Expect call from George Senkler re: C8 update", 10/08/2001 Bernard Reilly email to Bern re: drinking water results, 10/20/2001 The Little Hocking Water Association news release re C-8, 1/15/2002 DuPont Calendar Entry Appointment ",Expecting a call from George Senkler re: C8", 2/26/2002 DuPont email from G Irvin Lipp, to Chad Holliday, et al., re: Daily Communications Report, 3/20/2002 WVDEP email from Dave Watkins to Allyn Turner, Dee Ann Staats re: EPA Laboratory,5/6/2002 DuPont email from Anthony R. Farina to Chad Holliday, et al., re: Daily Communications Report, 5/13/2002 DuPont Email from Anthony R. Farina to Chad Holliday, et al., re: Daily Communications Report, 5/16/2002 DuPont email from Clifton Webb to Chad Holliday, et al., re: Daily Communications Report, 10/9/2002 DuPont email from Irv Lipp to Chad Holliday, et al., re: Daily Communications Report, 10/11/2002 DuPont email from G Irvin Lipp to Chad Holliday, et al., re: Daily Communications Report, 10/28/2002 Pages from transcript of George H. Senkler in Leach v. DuPont case, 11/21/2002 DuPont email from Anthony R. Farina to Chad Holliday, et al. re Daily Communications Report, 12/20/2002 DuPont email from Clifton Webb to Chad Holliday, et al. re: Weekend Report Feb.16,2/16/2003 DuPont email from Anthony R. Farina to Chad O. Holliday, et al., Re: Daily Communications Report, 2/26/2003 DuPont email from Clifton Webb to Chad Holliday, et al., re: Daily Communications Report, 2/16/2003 DuPont email from G Irvin Lipp to Chad Holliday, et al. re: Daily Communications Report, 3/17/2003 DuPont email from G Irvin Lipp to Chad Holliday, et al., re: Daily Communications Report, 3/28/2003 DuPont email from G Irvin Lipp to Chad Holliday, et al., re: Stories on C8 Picked up across US, 3/30/2003 DuPont email from R Clifton Webb to Chad Holliday, et al., re: Daily Communications Report, 4/2/2003 April 2003 DuPont information re: USEPA released a preliminary risk assessment for C-8 ; also DuPont Calendar entry "Call from George Senkler re C8", 4/3/2003 DuPont email from Scott F. Nelson to Chad Holliday, et al. re: Daily Communications Report, 4/4/2003 DuPont email from Scott F. Nelson to Chad Holliday, et al., re: Weekend Communications Report, 4/5/2003 DuPont email from Anthony R. Farina to Chad Holliday, et al., re: Daily Communications Report,, 4/7/2003 DuPont email from Anthony R. Farina to Chad Holliday, et al., re Daily Communications Report, 4/8/2003 Letter to Christine Todd Whitman of USEPA from EWG re: DuPont's failure to submit key health studies under the requirements of TSCA 8e, 15 U.S.C 2607, 4/11/2003 EWG website pages: PFCs Global Contaminants - DuPont's Spin About PFOA, undated DuPont email from Chad Holliday to Richard J. Angiullo, re:Daily Communications Report, 4/11/2003 DuPont email from Anthony R. Farina to Chad Holliday, et al., Re: Weekend Communications Report, 4/12/2003 Page 129 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 160 of 232 PAGEID #: 40924 Descriptions of Documents Without Bates Numbers DuPont email from R. Clifton Webb to Chad Holliday, et al., Re: Daily Communications Report, 4/16/2003 DuPont Calendar Entry appointment: " George Senkler will call (C8), 4/22/2003 Letter from "A Concerned Citizen" to Christine T. Whitman EPA Administrator re DuPont, 4/22/2003 DuPont email from Chad Holliday to Nandakumar Rao re: Daily Communications Report, 4/28/2003 DuPont email from Chad Holliday to Lois Juliber re: Contact with Gore, 4/29/2003 DuPont email from Anthony R. Farina to Chad Holliday, et al., re: Daily Communications Report, 4/30/2003 Order Granting Plaintiff's Second Motion for Sanctions Against DuPont, in Leach v. DuPont case, 5/1/2003 DuPont email from R. Clifton Webb to Chad Holliday, et al. Re: Daily Communications Report, 5/8/2003 DuPont email from Chad O. Holliday to Thomas M. Connelly, DuPont re Weekend Communications Report, 5/11/2003___________________________________________________________________________________________ DuPont email from Alexa L Girardi to Donna Saunders forwarding Daily Communications Report, 5/13/2003 AR226-1318__________________________________________________________________________________________ DuPont email from Chad O. Holliday to Louise B. Lancaster re Agenda for Board Meeting , 5/26/2003 From USEPA Dockets website: Document #OPPT-2003-0012-0124, dated 6/20/2003 DuPont email from G Irvin Lipp to Chad O. Holliday, et al. re; Weekend Communications Report, 6/21/2003 Latham & Watkins presentation slides: "Chemicals in the Body," dated 6/24/03 (68 pages) DuPont email from Anthony Farina to Chad O. Holliday, et al., re: Daily Communications Report, 6/25/2003 DuPont email from Anthony R. Farina to ChadO. Holliday, et al., Re: Daily Communications Report, 7/7/2003 DuPont email from Anthony R, Farina to ChadO. Holliday, et al., Re: Daily Communications Report7/9/2003 DuPont email from Anthony R. Farina to Chad O. Holliday, et al. re: Daily Communications Report, 7/10/2003 DuPont email from G Irvin Lipp to Chad O. Holliday, et al. Re: News Journal Coverage of CPSC, 7/12/2003 DuPont email from Anthony R. Farina to ChadO. Holliday, et al. Re: Daily Communications Report, 7/28/2003 DuPont email from Anthony R. Farina to ChadO. Holliday, et al., re: Daily Communications Report, 7/29/2003 DuPont email from Clifton Webb to Chad Holliday, et al., re: Daily Communications Report, 8/6/2003 DuPont email from Anthony R. Farina to Chad Holliday, et al., re: Daily Communications Report, 8/18/2003 DuPont email from R. Clifton Webb to Chad Holliday, et al., re; Daily Communications Report, 8/22/2003 DuPont email from R. Clifton Webb to Chad O. Holliday, et al., re: Weekend Report, 8/23/2003 DuPont email from Anthony R. Farina to Chad O. Holliday, et al., re: Daily Communications Report, 9/23/2003 DuPont email from G. Irwin Lipp to Chad O. Holliday, et al., re: Daily Communication Report, 9/30/2003 DuPont email from Anthony R. Farina to Chad O. Holliday, et al., re: Daily Communication Report, 10/24/2003 DuPont email from G. Irwin Lipp to Chad Holliday, et al., Re: Daily Communications Report, 10/28/2003 DuPont email from Catherine L. Andriadis to Chad O. Holliday, et al., re: Daily Communications Report, 10/31/2003__________________________________________________________________________________________ DuPont email from Chad O. Holliday to Lois Juliber forwarding Communication Report, 11/15/2003 Email from Louise B. Lancaster of DuPont to Alain Belda of Alcoa, et al., re DuPont's to Statement on ABC's 20/20 Segment, 11/15/2003___________________________________________________________________________ DuPont email from G Irvin Lipp to Chad O. Holliday, et al., re Weekend Communications Report, 11/16/2003 DuPont email from R Clifton Webb to Chad Holliday, et al., re: Daily Communications Report, 11/22/2003 DuPont email from R Clifton Webb to Chad O. Holliday, et al., Re: Weekend Report- November 23, 11/23/2003 DuPont email from G Irwin Lipp to Chad O Holliday, et al., re: Daily Communications Report, 11/24/2003 DuPont email from G Irvin Lipp to Chad O. Holliday, et al., Re: Daily Communications Report, 11/26/2003 DuPont Email from Kathleen H. Forte to Chad O. Holliday, et al., re: Possible Questions and Topics for Community Leaders Meeting,12/2/2003 DuPont email from Scott Nelson to Chad Holliday, et al., re: Daily Communications Report, 12/5/2003 Page 130 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 161 of 232 PAGEID #: 40925 Descriptions of Documents Without Bates Numbers DuPont email from Scott F. Nelson to Chad O. Holliday, et al., re: Weekend Communications Report, 12/6/2003 DuPont email from Chad O Holliday to W Donald Johnson, forwarding Communications Report, 1/3/2004 DuPont email from Lori A. Captain to Chad Holliday, et al., re: Daily Communications Report, 1/6/2004 DuPont email from Chad O. Holliday to Francine C. Shaw, re: 2003 Yr In Review, 1/10/2004 DuPont email from Catherine L. Andriadis to Chad Holliday, et al., re: Daily Communications Report, 1/16/2004 DuPont email from G. Irwin Lipp to Chad O. Holliday, et al., re: Daily Communication Report, 2/11/2004 DuPont email from G Irwin Lipp to Chad O. Holliday, et al., Re: Daily Communications Report, 2/14/2004 DuPont email from Chad Holiday to Scot Holliday, et al., forwarding Daily Communications Report, 2/12/2004 DuPont email from Anthony R. Farina to Chad O. Holliday, et al., re: Daily Communications Report, 2/27/2004 DuPont email from G. Irvin Lipp to Chad Holliday, et al., re: Daily Communications Report, 3/3/2004 DuPont email from G. Irvin Lipp to Chad Holliday, et al., re: Daily Communications Report, 3/4/2004 Bullet-point list dated 3/15-3/16/05 titled: Global Regulatory Meeting (6 pages) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). Email dated 2/22/2006 from David Wegman to Tom Beauchamp re: questions for ERB re the Community Study (5 pages) (from Ellen Eisen's third-party production in Rowe/Rhodes cases). DuPont email dated 5/1/06 from Susan Silencer to Robert Rickard, et al., re: Core Team Meeting (1 page) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont email dated 5/23/06 from Susan Stalnecker to Robert Rickard, et al., re: Core Team Meeting (1 page) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont email dated 6/13/06 from Susan Stalnecker to Robert Rickard, et al., re: Core Team Meeting (1 page) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont email dated 7/10/06 from Susan Stalnecker to Robert Rickard, et al., re: Core Team Meeting Agenda (1 page) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont email dated 7/18/06 from Susan Stalnecker to Susan Stalnecker, with numerous copyholders, re: Agenda (3 pages) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont email dated 8/11/06 from Susan Stalnecker to Robert Rickard, et al., re: John Hopkins Update (1 page) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). Email dated 11/9/06 from Michael McCabe to David Boothe, et al., re: Dalton Study (1 page) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont undated PowerPoint slides titled: Global Regulatory Strategy. (4 pages) (from McCabe & Associates' third-party production in Rowe/Rhodes cases). DuPont slides: "Clean Hardball", 9/20/2007 Company Profile dated 12/11/01 authored by Charles Ryan Associates (40 pages). (From third-party production of Charles Ryan Associates in Rowe/Rhodes cases.) Charles Ryan Associates Job Code Request Form dated 2/8/02 (1 page). (From third-party production of Charles Ryan Associates in Rowe/Rhodes cases.) Undated 2-page document authored by Charles Ryan Associates titled: Questions (From third-party production of Charles Ryan Associates in Rowe/Rhodes cases.) Memo dated 9/18/03 from Joe Gollehon of Charles Ryan Associates to Kelli Kukura re: Regional Public Affairs Specialist Position (2 pages) (From third-party production of Charles Ryan Associates in Rowe/Rhodes cases.) J. Wesley Clayton, Jr.chapter from book: "Fluorocarbon Toxicity and Biological Action" Undated DuPont report: Study of Myocardial Infarction at Washington Works Plant authored by Maureen T. O'Berg (8 pages) (non-Bates numbered document produced by DuPont in the Leach case) Page 131 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 162 of 232 PAGEID #: 40926 Descriptions of Documents Without Bates Numbers Don Fuqua, et al: "Genetic Screening and the Handling of High-Risk Groups in the Workplace", Hearings Before the Subcommitte on Investigations and Oversight of the Committee on Science and Technology U.S. House of Representatives, 10/14/1981 AR226-00467__________________________________________________________________________________________ 6/5/2001 Fax from Robin C. Leonard to R.W. Rickard regarding Epidemiology Surveillance at Washington Works Letter dated 9/16/03 from Charles Holliday of DuPont to Alan Greene, M.D. re: DuPont Health Advisory Board; attaches meeting details for 10/12-10/14/03 meeting (2 pages) (from Dr. Greene's third-party production in Rowe/Rhodes cases). Draft DuPont Health Advisory Board information dated 10/3/03 (3 pages) (from Dr. Greene's third-party production in Rowe/Rhodes cases). Letter dated 10/12/03 from Charles Holliday of DuPont to Alan Greene, M.D. re Health Advisory Board (1 page) (from Dr. Greene's third-party production in Rowe/Rhodes cases). List of DuPont Health Advisory Board Members attending 10/12-10/14/03 meeting (11 pages) (from Dr. Greene's third-party production in Rowe/Rhodes cases). Draft summary of DuPont Health Advisory Board meeting 10/12-10/14/03 (8 pages) (from Dr. Greene's thirdparty production in Rowe/Rhodes cases). Memo dated 12/12/03 from Dick Bingham to Johanna Dwyer, Erica Frank, Alan Greene, Dervilla McCann, Donnica Moore and Mary Lake Polan re conference call; attaches 11/6/03 leadership principles (3 pages) (from Dr. Greene's third-party production in Rowe/Rhodes cases). USEPA Dockets, Document Detail, "Suspected Scientific Link Between Enamel Degradation and the Presence of C8 in Drinking Water" submitted by Debra Cochran, Citizen, 2003 Undated proposed position regarding chemicals in the body prepared by Janesse Brewer of The Keystone Center (1 page) (from Dr. Greene's third-party production in Rowe/Rhodes cases). Agenda of DuPont Health Advisory Board meeting 4/4-4/5/04 with attached Health Advisory Board information and Overview (6 pages) (from Dr. Greene's third-party production in Rowe/Rhodes cases). Draft summary of DuPont Health Advisory Board meeting 4/4-4/5/04 prepared by The Keystone Center (6 pages) (from Dr. Greene's third-party production in Rowe/Rhodes cases). Email dated 4/27/04 from Robin Leonard of DuPont to David Wegman Re: Proposal; also email dated 4/25/04 from David Wegman to Robin Leonard re: Proposal (2 pages) (from David Wegman's third-party production in Rowe/Rhodes cases). 4/29/20047 DuPont Letter from Paul Bossert, to Washington Works Employees regarding Washington Works Health Survey by Haskell Laboratory for Health and Environmental Sciences 5/5/2004 Statement Issued regarding DuPont Reiterates Position PFOA, Refutes Claim that PFOA Causes Human Health Effects Email dated 5/18/04 from Mark Cullen to Ellen Eisen and Robin Leonard (1 page) (from Mark Cullen's third-party production in Rowe/Rhodes cases). Email dated 5/25/04 from Jonathan Samet to David Wegman re: Statement on PFOA Study, in response to email on same page dated 5/25/04 from David Wegman to All (1 page) (from David Wegman's third-party production in Rowe/Rhodes cases). Report prepared by Sapphire Group dated 6/2/04: Ammonium Perfluorooctanoate: Cross-Sectional Surveillance in a Community Sample of Clinical Measures of General Health Status Related to a Serum Biomarker of Exposure: A Study Protocol (45 pages) (Non-Bates numbered document produced by DuPont in the Leach case). November 2003 Confidential General Health Questionnaire prepared by Health Examinetics (12 pages) (NonBates numbered document produced by DuPont in the Leach case). Page 132 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 163 of 232 PAGEID #: 40927 Descriptions of Documents Without Bates Numbers Exygen Research report: Implementation Plan: May 1, 2003 Injunction Order: Appendix No. 2 - - Study-Specific Standard Operating Procedure: Documentation, Accountability and Sample Chain of Custody Requirements for the Shipping of Serum Samples (8 pages) (non-Bates numbered document produced by DuPont in the Leach case). 6/23/2004 Letter from Robert A. Bilott to Laurence F. Janssen re Leach case, concerning DuPont proposed community study 7/20/2004 Letter from Robert A. Bilott to Laurence F. Janssen reJack W. Leach case, concerning DuPont proposed community study AR226-1869, AR226-1865, AR226-1866___________________________________________________________________ Email dated 10/1/04 from Robin Leonard of DuPont to Mark Cullen re: An Opportunity/Request in response to email on same page dated 10/1/04 from Mark Cullen to Robin Leonard (2 pages) (from Mark Cullen's third-party production in Rowe/Rhodes cases). DuPont Health Advisory Board agenda for 10/12-10/14/04 meeting (from Alan Greene's third-party production in Rowe/Rhodes cases). DuPont Health Advisory Board meeting materials for 10/17-10/18/04 meeting (6 pages) (from Alan Greene's third-party production in Rowe/Rhodes cases). 2/2/2005 USEPA Email from Mary Dominiak to Robert A. Bilott regarding DuPont Worker Study Slides Email dated 1/3/05 from Robin Leonard to Thomas Beauchamp, David Wegman, Jonathan Samet, Mark Cullen and Noah Seixas re: Your Note of December 22, in response to email on same page dated 12/29/04 from Jonathan Samet to Robin Leonard (from Mark Cullen's third-party production in Rowe/Rhodes cases). 1/8/2005 Email from Kathleen Forte to Robert W. Rickard regarding Comment from Linda Fisher on News Release - Need Input AR226-1899 ~ 1/11/2005 Letter from Paul J. Bossert, Jr., to Washington Works Employees regarding Results of our Phase I PFOA Health Survey Robin C. Leonard, PhD: "Results to Date from the PFOA Worker Study, Ammonium Perfluorooctonoate: Cross Sectional Surveillance of Clinical Measures of General Health Status Related to a Serum Biomarker of Exposure and Retrospective Cohort Analyses in a Polymer Production Plant", 1/10/2005 1/11/2005 Release, "DuPont Reports First-Phase Results of Health Study Examining PFOA Exposure, To Date, No Human Health Effects Known to be Caused by PFOA; Several Statistical Observations Merit Further Study" DuPont 1/11/2005 Slides, Results to Date from the PFOA Worker Health Study 1/14/2005 Email from Robert W. Rickard to USEPA Charles Auer and Oscar Hernandez regarding Presentation Email dated 1/20/05 from Noah Seixas to David Wegman re: PFOA publicity and email dated 1/19/05 from David Wegman to Noah Seixas re PFOA publicity (from third-party production by David Wegman in the Rhodes/Rowe cases Email dated 2/8/05 from Tom Beauchamp to David Wegman and Ellen Eisen re: Summary of Conference Call, in response to email on same page dated 2/4/05 from David Wegman to Ellen Eisen and Tom Beauchamp (from David Wegman's third-party production in Rowe/Rhodes cases). Email dated 5/23/05 from Amelia Kittredge to Thomas Beauchamp, David Wegman, Ellen Eisen, Jonathan Samet, Mark Cullen and Noah Seixas re: U.S. Dept. of Justice Grand Jury Subpoena to DuPont (from Mark Cullen's thirdparty production in Rowe/Rhodes cases). AR226-3542___________________________________________________________________________________________ Email dated 12/6/05 from Jonathan Samet to Robin Leonard, Ellen Eisen, David Wegman, Thomas Beauchamp, Mark Cullen and Noah Seixas re: Parkersburg Data Request (first page of 7-page email string). (From David Wegman's third-party production in Rowe/Rhodes cases). Page 133 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 164 of 232 PAGEID #: 40928 Descriptions of Documents Without Bates Numbers Email dated 2/10/06 from Jonathan Samet to David Wegman re: IRB Issue (first email in email string) (4 pages). (From David Wegman's third-party production in Rowe/Rhodes cases). Letter dated 2/22/06 from Robin Leonard to David Wegman; also email dated 2/22/06 from Tom Beauchamp to David Wegman, Jon Samet, Mark Cullen, Noah Seixas and Ellen Eisen re: The Weinberg Proposal (3 pages) (from Ellen Eisen's third-party production in Rowe/Rhodes cases). Letter dated 2/22/06 from DuPont's Epidemiology Advisory Board (addressee not listed) re: comments on DuPont's research program on potential health risks of PFOA (3 pages) (from Thomas Beauchamp's third-party production in Rowe/Rhodes cases). Email dated 2/22/06 from Jonathan Samet to Ellen Eisen re: Draft Letter (top email in 2-page email string). (From Ellen Eisen's third-party production in Rowe/Rhodes cases). Email (1 page) dated 2/23/06 from Mark Cullen to Carine Sakr re: Question, in response to email from Carine Sakr to Mark Cullen on the same page. (From Mark Cullen's third-party production in Rowe/Rhodes cases). Memo dated 2/26/06 from DuPont's Epidemiology Review Board to Michael Kaplan re: comments on DuPont's research program on potential health risks of PFOA (2 pages) (from Ellen Eisen's third-party production in Rowe/Rhodes cases). Email dated 2/27/06 from Robin Leonard to Thomas Beauchamp, David Wegman, Ellen Eisen, Jonathan Samet, Mark Cullen and Noah Seixas re: Memo (1 page) (from Mark Cullen's third-party production in Rowe/Rhodes cases). Email dated 3/8/06 from Carine Sakr to Ellen Eisen re: Cox Different Exposures (top email in 2-page email string). (From Ellen Eisen's third-party production in Rowe/Rhodes cases). Curriculum Vitae of Erica Frank, M.D. dated 4/17/06 (20 pages)(from Mark Cullen's third-party production in Rowe/Rhodes cases). CH Lee, et al: Fatal Acute Pulmonary Oedema after Inhalation of Fumes from Polytetrafluoroethylene (PTFE)", European Respiratory Journal, Vol. 10, pp. 1408-11, 1997 Email dated 5/3/06 from Mark Cullen to Jonathan Samet Re: Regarding Erica (top email in 3-page email string) (From Mark Cullen's third-party production in Rowe/Rhodes cases). Email dated 5/4/06 from Mark Cullen to Carine Sakr re: Update (1 page) (from Mark Cullen's third-party production in Rowe/Rhodes cases). AR226-3658, AR226-3659 ~ DuPont email dated 5/18/06 from Robin Leonard to Mike Kaplan re: Completed Data: What's Next? (top email in 2-page email string) (From David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 6/8/06 from Noah Seixas to Kim Kreckmann of DuPont re: Methods Section-Exposure (in response to email on same page from Kim Kreckmann) (2 pages) (From Ellen Eisen's third-party production in Rowe/Rhodes cases). Email dated 6/9/06 from Kim Kreckmann of DuPont to Noah Seixas (top email in 3-page email string). (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Email dated 7/10/06 from Robin Leonard of DuPont to Ellen Eisen, David Wegman, Thomas Beauchamp, Mark Cullen, Jonathan Samet and Noah Seixas re: Science Panel Protocols. (1 page) (From David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 7/17/06 from Mark Cullen to Robin Leonard, Ellen Eisen, Noah Seixas and Thomas Beauchamp re: Protocols. (1 page) (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Email dated 7/17/06 from Mark Cullen to Robin Leonard, Ellen Eisen, Noah Seixas and Thomas Beauchamp re: Protocols. (1 page) (From David Wegman's third-party production in Rowe/Rhodes cases.) Page 134 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 165 of 232 PAGEID #: 40929 Descriptions of Documents Without Bates Numbers Email dated 7/17/06 from Ellen Eisen to Robin Leonard of DuPont re: Different Views (in response to Robin Leonard's 7/17/06 email on the same page). (From David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 7/17/06 from Robin Leonard of DuPont to David Wegman and Ellen Eisen re: Different Views. (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Email dated 7/20/06 from Mark Cullen to Robin Leonard, Ellen Eisen, David Wegman, Thomas Beauchamp, Jonathan Samet and Noah Seixas re: Manuscript in Preparation. (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Email dated 7/24/06 from Ellen Eisen to David Wegman re: DuPont (in response to 7/24/06 email from David Wegman on same page). (From David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 8/1/06 from Robin Leonard of DuPont to David Wegman re: Diabetes Discussion. (From David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 9/10/06 from Noah Seixas to Robin Leonard re: Rate Ratios for Cumulative Exposure (top email in 2page email string). (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Email dated 9/10/06 from Noah Seixas to Robin Leonard re: Rate Ratios for Cumulative Exposure (top email in 2page email string). (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Robin C. Leonard, PhD: Study "Ammonium Perfluorooctanoate: Phase II. Retrospective Cohort Mortality Analyses Related to a Serum Biomarker of Exposure in a Polymer Production Plant", 9/15/2006 Email dated 9/20/06 from Mark Cullen to Robin Leonard, Ellen Eisen and David Wegman re: New Table, in response to 9/20/06 email from Robin Leonard (on the same page). (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Email dated 9/21/06 from Nancy Selzer of DuPont to Barbara Dawson, Thomas Beauchamp, et al. re: Renaming of ERB to EAB top email in 2-page email string). (From Mark Cullen's third-party production in Rowe/Rhodes cases.) Email dated 9/21/06 from Noah Seixas to David Wegman re New Table (top email in 3-page email string). (From Ellen Eisen's third-party production in Rowe/Rhodes cases.) Email dated 9/26/06 from Noah Seixas to Robin Leonard re: Input (in response to email on same page from Robin Leonard). (From David Wegman's third-party production in Rowe/Rhodes cases.) Minutes of 10/3/06 Lipid Review Panel meeting (from Mark Cullen's third-party production in Rowe/Rhodes cases.) PowerPoint presentation slides dated 10/3/06 re LRP teleconference headed "Teleconference Agenda" (from Mark Cullen's third-party production in Rowe/Rhodes cases.) Email dated 10/17/06 from Jonathan Samet to David Wegman re: Press Release (top email in 2-page email string). (From David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 11/8/06 from Ellen Eisen to Sol Sax, et al. re: Letter to Science Panel (from David Wegman's thirdparty production in Rowe/Rhodes cases.) Email dated 11/20/06 from Robin Leonard to Kim Kreckmann, John Green, et al. re: First Draft of Phase I Manuscript (from David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 12/6/06 from Ellen Eisen to Noah Seixas, David Wegman, Robin Leonard and Mark Cullen re: First of Two Phase II Manuscripts (top email in 2-page email string). (From David Wegman's third-party production in Rowe/Rhodes cases.) Undated 1-page document titled: Review of Final Draft of Phase II Report (from Ellen Eisen's third-party production in Rowe/Rhodes cases.) Undated 3-page document titled: Review of Final Draft of Phase II Report Ellen Eisen (from Ellen Eisen's thirdparty production in Rowe/Rhodes cases.) Page 135 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 166 of 232 PAGEID #: 40930 Descriptions of Documents Without Bates Numbers Undated 3-page draft letter to Science Advisory Panel (from Ellen Eisen's third-party production in Rowe/Rhodes cases.) Article manuscript: Carine Sakr, MD, MPH, et al: "Twenty-five Year Longitudinal Study of Serum Total Cholesterol Related to a Serum Biomarker of Exposure (Serum Perfluorooctanoate or PFOA) in a Polymer Production Plant", Undated Undated 27-page article from the American Journal of Epidemiology titled: Repeated Measures Study of Serum Lipids and Liver Enzymes in Workers with Occupational Exposure to Ammonium Perfluorooctanoate (APFO). (From Mark Cullen's third-party production in Rowe/Rhodes cases.) Undated 2-page draft document authored by Janesse Brewer of The Keystone Center headed: Four Point Body Burden Position Proposed. (From Alan Greene's third-party production in Rowe/Rhodes cases.) 1/11/2007 Minutes from Dr. Emmett's Little Hocking C8 Study Community Meeting Email dated 1/19/07 from Mark Cullen to Carine Sakr re: AJE-01232-2006 (Decision) Repeated Measures Study of Serum Lipids and Liver Enzymes in Workers with Occupational Exposure to Ammonium Perfluorooctanoate (APFO). (Top email of 4-page email string.) (From Mark Cullen's third-party production in Rowe/Rhodes cases.) Email (2 pages) dated 1/19/07 from Nancy Selzer of DuPont to Barbara Dawson, et al. re: Organization Notice Sol Sax, forwarding email dated 1/19/07 from Sol Sax. (From Mark Cullen's third-party production in Rowe/Rhodes cases.) Email dated 2/27/07 from J. Morel Symons to David Wegman, Thomas Beauchamp, Mark Cullen, Ellen Eisen, Jonathan Samet and Noah Seixas re: DuPont Epi Manuscript for Review. (2 pages) (From David Wegman's thirdparty production in Rowe/Rhodes cases.) Email (1 page) dated 3/30/07 from Sol Sax to Carine Sakr, Erica Frank, Ernst Schaefer, Mark Cullen, Peter Gillies, Robert Rickard and Robin Leonard re: Lipid Review Panel - - Progress Report. (From Mark Cullen's third-party production in Rowe/Rhodes cases.) Two-page document dated 3/22/07: Review of manuscript: Retrospective Cohort Mortality Study of Workers in a Polymer Production Plant Including a Reference Population of Regional Workers (from Ellen Eisen's thirdparty production in Rowe/Rhodes cases.) Sidney Pell, PhD, et al: "Cancer Epidemiological Surveillance in the Du Pont Company", Journal of Occupational Medicine, Vol. 20, No. 11, 11/1978______________________________________________________________________ Bruce W. Karrh, M.D.: "A Company's Duty to Report Health Hazards", Buff. NY Acad Med., Vol. 54, No. 8, CJ Sakr, et al: "Cross-Sectional Study of Lipids and Liver Enzymes Related to a Serum Biomarker of Exposure (Ammonium Perfluorooctanoate or APFO) as Part of a General Health Survey in a Cohort of Occupationally Exposed Workers",JOEM (10), 1086-96, Oct. 2007________________________________________________________ Carine J. Sakr, MD, MPH, et al: "Cross-Sectional Study of Lipids and Liver Enzymes Related to a Serum Biomarker of Exposure (ammonium perfluorooctanoate or APFO) as Part of a General Health Survey in a Cohort of Occupationally Exposed Workers", JOEM, Vol. 49, No. 10, 10/2007 CJ Sakr, et al: "Cross-Sectional Study of Lipids and Liver Enzymes Related to a Serum Biomarker of Exposure (Ammonium Perfluorooctanoate or APFO) as Part of a General Health Survey in a Cohort of Occupationally Exposed Workers", PubMed, 10/2007 4/6/2009 Letter from Barbara J. Dawson to Michael S. Morgan, ScD, CIH, regarding JOEH 149 Revision Kim H. Kreckmann, et al: "Estimation and Validation of Biomarker-Based Exposures for Historical Ammonium Perfluorooctanoate", Journal of Occupational and Enviromental Hygiene, doi: 10.1080/15459620903025483, 9/2009_______________________________________________________________________________________________ Presentation abstract: J. Morel Symons, et al: "Results from Sequential Analysis of Thyroid Hormone and Disease Measures from the National Health and Nutrition Examination Survey, 1999-2010", Undated Page 136 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 167 of 232 PAGEID #: 40931 Descriptions of Documents Without Bates Numbers Email (1 page) dated 4/9/07 from Ellen Eisen to Mark Cullen, Noah Seixas and David Wegman re: SAB "Review" responding to email dated 4/8/07 on same page from Mark Cullen. (From David Wegman's third-party production in Rowe/Rhodes cases.) Email dated 5/8/07 from Mark Cullen to Carine Sakr re: 15 Minutes for Reviews, responding to email on same page from Carine Sakr. (From Mark Cullen's third-party production in Rowe/Rhodes cases.) Two-page email dated 6/18/07 from Robin Leonard to Thomas Beauchamp, David Wegman, Ellen Eisen, Mark Cullen and Noah Seixas re: 07-04R1: Final Decision; forwards email on same page dated 6/18/07 from Annals of Epidemiology. (From Mark Cullen's third-party production in Rowe/Rhodes cases.) Draft document dated 8/15/2007 authored by Robin Leonard titled: DuPont Epidemiology Program: Status of Program, and Research Strategy. (From Mark Cullen's third-party production in Rowe/Rhodes cases.) One-page undated email from Dawn Rittenhouse of DuPont to HAB Members, forwarding email on same page dated 9/6/07 from Silvio DeCarli of DuPont to Dawn Rittenhouse re: HAB Subpoenas. (From Kevin Stephen's third-party production in Rowe/Rhodes cases.) Letter dated 10/3/07 from Noah Seixas to Robin Leonard re: meeting. (From Noah Seixas' third-party production in Rowe/Rhodes cases.) Undated PowerPoint presentation slides titled: Exposure Categorization for the Washington Works Mortality Analysis (40 pages). (From Noah Seixas' third-party production in Rowe/Rhodes cases.) Undated 4-page document titled: Draft text for EAB statement on importance of exposure assessment module of Medgate data system. (4 pages) (From Noah Seixas' third-party production in Rowe/Rhodes cases.) Undated draft letter from the EAB to the SAB Panel (6 pages). (From Mark Cullen's third-party production in Rowe/Rhodes cases.) 8/2008 Slides from DuPont, "Chambers Works IH Update for PFOA" 11/3/2008 Summary "Concerns and Responses for APFO Area" Draft letter from Bill Hopkins to Washington Works Employees regarding New Birth Weight Epidemiology Study that DuPont will be Starting", Undated 11/9/10 DuPont Epidemiology Program Protocol Withdrawal for Study Title "Birth Weight Outcomes for Children of Female Washington Works Employees" ISEE Abstract, J. Morel Symons: Abstract #: S-139, "Potential Outcomes Analyses Applied to Hazard Identification", Undated AR226-0480___________________________________________________________________________________________ 4/29/1982 Letter from Leonard M. Schuman, M.D., to Dr. Frank Ubel regarding Data from the Studies on Fluorochemical Exposure AR226-0035___________________________________________________________________________________________ AR226-0032___________________________________________________________________________________________ 3M Report on "An Epidemiologic Investigation of Clinical Chemistries, Hematology and Hormones in Relation to Serum Levels of Perfluorooctane Sulfonate in Male Fluorochemical Production Employees", Undated AR226-0022___________________________________________________________________________________________ AR226-0548___________________________________________________________________________________________ AR226-0076___________________________________________________________________________________________ AR226-0611___________________________________________________________________________________________ Geary W. Olsen, DVM, PhD: 3M Study "An Epidemiologic Analysis of Episodes of Care of 3M Decatur Chemical and Film Plant Employees, 1993-1998", 6/25/2001 AR226-1350___________________________________________________________________________________________ AR226-1087___________________________________________________________________________________________ AR226-1088 Page 137 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 168 of 232 PAGEID #: 40932 Descriptions of Documents Without Bates Numbers Jean M. Burris, RN, MPH: Interim Report #2 "Determination of Serum Half-Lives of Several Fluorochemicals", 1/11/2002____________________________________________________________________________________________ 3M Epidemiology Medical Department Final Report dated 6/9/03: Assessment of Lipid, Hepatic and Thyroid Function in Relation to an Occupational Biologic Limit Value for Perfluorooctanoate (41 pages) AR226-1954 ~ AR226-1908___________________________________________________________________________________________ AR226-1963___________________________________________________________________________________________ 6/29/2005 Letter from Larry Zobel, MD, MPH, of 3M to Sue Shallal, PhD, regarding PFOA Review Panel - Draft Report Geary W. Olsen, DVM, PhD, et al of 3M: Final Report, "An Analysis of the 2000 Fluorochemical (Perfluorooctanoate, PFOA) Medical Surveillance Program at 3M Company's Antwerp (Belgium), Cottage Grove (Minnesota), and Decatur (Alabama) Facilities", 5/16/2006 6/16/2006 Letter from Michael A. Santoro of 3M to Mary Dominiak, EPA, regarding Information on Perfluorooctane Sulfonate, Perfluorooctanoic Acid, and Related Compounds Jessical I. Lundin, MPH, et al. of 3M: Final Report "Mortality of Employees of an Ammonium Perfluorooctanoate Production Facility", 8/22/2007 B.H. Alexander, et al: "Abstracts...Oral Session 8 - Mortality Studies: Cancer and Cardiovascular, Mortality of Employees of an Ammonium Perfluorooctanoate Production Facility", Occup Environ Med 2004 Downloaded on 1/24/2008____________________________________________________________________________________________ 6/30/2009 Letter from Larry R. Zobel and Geary W. Olsen of 3M to Tony Fletcher, David A. Savitz and Kyle Steenland regarding Health Related Research Efforts Pertaining to Perfluorooctanoate (PFOA) Presentation poster: David J. Ehresman, et al: Abstract 395 "A Longitudinal Occupational Assessment of the Potential Association of Changes Between Serum Concentrations of Perfluorooctanoate and Perfluorooctanesulfonate and Non-High-Denisity-Lipoprotein Cholesterol", Undated Geary Olsen, et al: ISEE Abstract #: P-205, "PFOA, PFOS, and Chronic Kidney Disease: Clearance Comes Before Causation", 2012 BH Alexander, et al: "Mortality of Employees of a Perfluorooctanesulphonyl Fluoride Manufacturing Facility, Occup Environ Med 2003; 60:722-729 Geary W. Olsen, et al: "An Occupational Exposure Assessment of a Perfluorooctanesulfonyl Fluoride Production Site: Biomonitoring", AIHA Journal 64:651-659 (2003), 9/2003 GW Olsen, et al: "Analysis of Episodes of Care in a Perfluorooctanesulfonyl Fluoride Production Facility", Occup Environ Med., 8/2004__________________________________________________________________________________ Geary W. Olsen, DVM, PhD, et al: Analysis of Episodes of Care in a Perfluorooctanesulfonyl Fluoride Production Facility", Journal of Occupational and Environmental Medicine, Vol. 46, No. 8, 8/2004 John L. Butenhoff, et al: "Response to Letter to the Editor", Reg. Toxicol. & Pharmacol, 42. pp. 146-47 (2005), doi: 10.1016/j.yrtph.2005.01.006, 2/24/2005_____________________________________________________________ Presentation poster: G. Olsen, et al: "Urinary Bladder Endpoints in Workers and Rats Exposed to Perfluorooctanesulfonyl Fluoride (POSF)" Abstract, Undated 3M presentation abstract: G. Olsen, et al: "Urinary Bladder Endpoints in Workers and Rats Exposed to Perfluorooctanesulfonyl Fluoride (POSF)" Summary, Undated 3M presentation poster: D. Ehresman, et al: "Evaluation of the Half-life (T %) of Elimination of Perfluorooctanoate (PFOA) from Human Serum" Abstract, Undated Abstract: JH Raymer, et al: "Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) and Their Associations with Human Semen Quality Measurements", Reprod. Toxicol. ,epub 6/29/2011 Page 138 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 169 of 232 PAGEID #: 40933 Descriptions of Documents Without Bates Numbers JH Raymer, et al: "Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) and Their Associations with Human Semen Quality Measurements", Reproductive Toxicology, doi: 10.1016/j.reprotox2011.05.024, 2011____________________________________________________________________ 3M poster abstract:J.L. Butenhoff, et al: "Perfluorooctanoate, Perfluorooctanesulfonate, and Chronic Kidney Disease: Clearance Comes Before Causation", Abstract, Undated 3M poster abstract: D. J. Ehresman, et al: "A Longitudinal Occupational Assessment of the Potential Association of Changes Between Serum Concentrations of Perfluorooctanoate and Perfluorooctanesulfonate and Non HighDenisity-Lipoprotein Cholesterol", Abstract, Undated Poster abstract:A.E. Loccisano, et al: "Use of PBPK Models to Evaluate Associations in Epidemiological Studies of Reproductive Outcomes with PFOA and PFOS Concentrations", Abstract, Undated Presentation abstract: Larry R. Zobel, MD, MPH, et al: "Perfluorinated Compounds and Immunotoxicity in Children", Article JAMA, Vol. 307, No. 18, 5/9/2012________________________________________________________ Geary Olsen, et al: "PFOA, PFOS, and Chronic Kidney Disease: Clearance Comes Before Causation", Article Epidemiology, Vol. 23, Issue 5S, doi: 10.1097.01.ede.0000417208.38915.26, 9/2012__________________________ Geary W. Solsen, et al: "A Causation Role for Clearance with Epidemiologic Associations Related to Serum Concentrations of PFOA and PFOS?", Abstract, Undated Olsen, G., et al., "Half-Life of Serum Elimination of Perfluorooctanesulfonate, Perfluorohexanesulfonate, and Perfluorooctanoate in Retired Fluorochemical Production Workers", Env. Health Perspectives (September 2007) (2 pages)______________________________________________________________________________________________ AR226-1866___________________________________________________________________________________________ 9/7/2004 Letter from Edward E. Shea to USEPA regarding Submitting a Report Describing a Meeting with 3M and DuPont to Discuss Biological Monitoring of Miteni Workers Exposed to Perfluorooctanoic Acid (PFOA), dated 8/23/2004____________________________________________________________________________________________ AR226-1867___________________________________________________________________________________________ USEPA Docket: Letter to Mary Ellen Weber, USEPA from Robert A. Bilott, regarding PFOA Human Health Effects for AR-226 and OPPT-2003-0012, 9/22/2004______________________________________________________________ Eleven-page document dated 5/21/07 titled: Issue Brief: PFOA and Breast Cancer Activism (from Dezenhall Resource's third-party production in Rowe/Rhodes cases.) Brent D. Kerger, et al: "Tenuous Dose-Response Correlations for Common Disease States: Case Study of Cholesterol and Perfluorooctanoate/Sulfonate (PFOA/PFOS) in the C8 Health Project", Drug and Chemical Toxicology, doi: 10.3109/01480545.2011.582502, 2011____________________________________________________ I.R. MacPherson, et al: "A First-in-Human Phase I Clinical Trial of CXR1002 in Patients (pts) with Advanced Cancer", American Society of Clinical Oncology, 2011 I.R. MacPherson, et al: "A First-in-Human Phase I Clinical Trial of CXR1002 in Patients (pts) with Advanced Cancer", American Society of Clinical Oncology, 2011 Undated 3-page document authored by Harvey Checkoway entitled: Peer Review Comments on: An International Collaborative Cohort Mortality Study of Workers with Potential Exposure to TFE (from Harvey Checkoway's third-party production in Rowe/Rhodes cases.) Document dated 6/19/06 authored by David Coggon and Harvey Checkoway titled: Peer Review Comments on: An International Collaborative Cohort Mortality Study of Workers with Potential Exposure to TFE (4 pages). (From Harvey Checkoway's third-party production in Rowe/Rhodes cases.) 13-page document titled: Fluoropolymers Committee Working Group on the Multi-Centre Epidemiology Study on TFE - June 19, 2006 (from Harvey Checkoway's third-party production in Rowe/Rhodes cases.) 1-page draft letter dated 6/23/06 from Harvey Checkoway to Prof. Pier A. Bertazzi (from Harvey Checkoway's third-party production in Rowe/Rhodes cases.) Page 139 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 170 of 232 PAGEID #: 40934 Descriptions of Documents Without Bates Numbers Report: Dario Consonni, MD, PhD, et al: "TFE Multicentre Mortality Study" Summary and Full Report, 3/6/2012 Royal Society of Chemistry Study of "Exposure Assessment Methodology for Tetrafluoroethylene (TFE) and Ammonium Perfluorooctanoate Acid (APFO)", for Journal of Environmental Monitoring, 2012 Dario Consonni, et al: "Cancer Risk Among Tetrafluoroethylene Synthesis and Polymerization Workers", American Journal of Epidemiology, doi: 10.1093/aje/kws588, 7/4/2013 Dario Consonni, et al: "Cancer Risk Among Tetrafluoroethylene Synthesis and Polymerization Workers", American Journal of Epidemiology, doi: 10.1093/aje/kws588, 7/4/2013 A. Sleeuwenhoek, et al: "Exposure Assessment of Tetrafluoroethylene and Ammonium Perfluorooctanoic Acid 1951-2002", Abstract, Undated Christopher Lau: "Perfluoroalkyl Acids: Recent Research Highlights", Elsevier, doi: 10.1016/j.reprotox.2012.03.002, 2012___________________________________________________________________ WVDHHR Table "Wood County Selected Causes of Deaths, 1989-1998, Number of Deaths", 2000 Community Health Status Report, Washington County Ohio, US Department of Health and Human Services, 7/2000_______________________________________________________________________________________________ Scot Long: "Cancer in Area Above Average", Parkersburg News Article, 9/9/2001 West Virginia Health Statistics Center, Statistical Brief No. 6, "Birth Defects Surveillance System, 1990-1999 West Virginia Residents", Number 6, 4/2002 West Virginia Health Statistics Center, Statistical Brief No. 9, "Cleft Palate and/or Lip Birth Defects, 1990-1999 West Virginia Residents", Number 9, 9/2002 West Virginia Health Statistics Center, Statistical Brief, No. 7, "Infant Mortality Statistics by Race West Virgina Residents", Number 7, 4/2002 West Virginia Bureau for Public Health Rates for Heart Disease by County, 2000 West Virginia Division of Surveillance and Disease Control Website Page regarding "Cancer in WV Incidence and Mortality, 1993-1999", 2002____________________________________________________________________________ Beverly Kenner, et al: "Cancer in West Virginia Incidence and Mortality 1993-1999", West Virginia Cancer Registry, 3/2002 Beverly Kenner, et al: "Cancer in West Virginia Incidence and Mortality 1993-1999", West Virginia Cancer Registry, 3/2002 Patricia Colsher, PhD: "Cancer in West Virginia Incidence and Mortality 1993-2000", West Virginia Cancer Registry, 5/2003 Vicki Smith: "W.Va. Fifth-Worst State for Asthma, Study Finds", Charleston Gazette Article, 10/2/2003 Kate York: "Cutting Risks of Cancer", The Marietta Times Article, 11/21/2003 Michelle Saxton: "Report: W.Va. Has Highest Mortality Rate", The Charleston Gazette Article, 11/24/2003 American Cancer Society Report, "Ohio Cancer Facts & Figures 2003, Focus: Appalachia, 2003 Ohio EPA News Release "Ohio EPA Recommends Bottled Water in Areas Where C8 Has Been Detected", 10/4/2005____________________________________________________________________________________________ 7/1/2007 Ohio Department of Health Report on C8 Perfluorooctanoic Acid, Commonly known as C8, is also Called PFOA and/or APFO: A 2006 C8 Physician Reference, What we know..., What we don't know..., What is taking p lace . Kathryn Z. Guyton, et al: "A Reexamination of the PPAR-a Activation Mode of Action as a Basis for Assessing Himan Cancer Risks of Environmental Contaminants", Environmental Health Perspectives, doi: 10.1289/ehp.0900758, 5/15/2009_______________________________________________________________________ 8/31/2009 Letter from Henry A. Spiller, Kentucky Regional Poison Center, to Dr. Frumpkin, Agency for Toxic Substances and Disease Registry, regarding Comments on Toxicological Profile for Perfluoroalkyls Page 140 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 171 of 232 PAGEID #: 40935 Descriptions of Documents Without Bates Numbers Environmental Working Group, "Toxic to Animals & People. Persistent Forever. Pervasive in Human Blood", 2003 Biography of Edward A. Emmett, MD, Ms, Undated David Gray, et al: "Liver Toxicity in Fluorochemical Workers", Tetra Tech, Inc., 11/2003 JA Zapp, Jr., et al: "Toxicity of Pyrolysis Products of "Teflon" Tetrafluoroethylene Resin", Am. Ind. Hygience Association: Abstract of Annual Meeting, 4/26/55 Fact Sheet regarding "Community Exposure to C8 In The Little Hocking Area", 12/3/2003 Environmental Working Group Web Article "DuPont's Spin About PFOA", 2/16/2004 4/21/2004 Letter from Bilott to Charles M. Auer, Oscar Hernandez, and USEPA regarding PFOA Human Health Effects Study: Cancer Data XJ Jian, et al: "Experiences in Emergency Treatment for 38 Cases with Organofluorine", PubMed Abstract, Zhonggyo Wei Zhong Bing Ji Jiu Yi Xve, 5/16/2004 DuPont C8 Questionnaire (Blank), Defendant's Exhibit 4, 8/31/2004 AR226-1866___________________________________________________________________________________________ Daniel T. Smith, MD: "CBRNE - Lung-Damaging Agents, Toxic Smokes: Nox, Hc, Rp, Fs, Fm, Sgf2, Teflon", EMedicine Article, 11/1/2004 DuPont C8 Questionnaire (Blank), Defendant's Exhibit 4, 8/31/2004 James Dahlgren, MD, et al: "Prevalence and Incidence of Cancer in Populations, Exposed to Perfluorooctanoate (PFOA)", Report, Undated Pamela Anderson-Mahoney, PhD, et al: "Self-Reported Health Effects Among Community Resident Exposed to Perfluorooctanoate (PFOA)", Report, Undated C8 Questionnaire Study Protocol, Undated 3/15/2010 Letter from Bilott to USEPA regarding Submission to TSCA 8(e) FYI Database Re: PFOA/PFOS 2/7/2005 Letter from Bilott to USEPA Auer, Hernandex, Seed, Weber, Dominiak regarding PFOA Human Health Effects Study: Cancer Data 1/7/2005 Letter from Bilott to USEPA Auer, Hernandex, Seed, Weber, Dominiak regarding PFOA Human Health Effects Study: Cancer Data 2/7/2005 Letter from Bilott to USEPA Auer, Hernandex, Seed, Weber, Dominiak regarding PFOA Human Health Effects Study: Cancer Data Little Hocking Water System C8 Study Fact Sheet, 4/11/2005 7/22/2005 Letter from Edward A. Emmett, MD, to Mary Dominiak regarding Community Exposure to C8 University of Pennsylvania press release 8/15/2005 : "Penn Study Finds No Relationship Between Elevated C8 Levels and Liver or Thyroid Abnormalities, Highest C8 Levels Found in the Very Young and Eldest" Tony Fletcher, et al: Slides "The Science Panel Health Study" Draft Outline, 10/29/2005 1/26/2006 Email from Cathy Lewis to USEPA regarding EPA-HQ-OPPT-2003-0012_____________________________ 2/2006 Little Hocking Water C8 Study Community Newsletter #8 Letter dated 6/1/06 from Robert Bilott of Taft to Dr. Charles Auer of USEPA, et al. re: PFOA Human Health Effects Study, transmitting attached research studies (40 pages) 6/6/2006 Letter from Bilott to USEPA Auer, Dominiak, Seed, Goeden, Krueger, Kriens, Seymour and Post regarding Perfluorochemical Human Health Data Michael Smith: "Waterproofing Sprays Booted Off Market Over Illness, MedPageToday.com Article, 5/8/2006 Edward A. Emmett, MD, MS, et al: Manuscript Daft, "Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters", Journal of Occupational and Environmental Medicine, 2006 Page 141 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 172 of 232 PAGEID #: 40936 Descriptions of Documents Without Bates Numbers Edward A. Emmett, MD, MS, et al: Manuscript Daft, "Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters", Journal of Occupational and Environmental Medicine, 2006_________________________________________________________________________________________________ University of Cincinnati News Release, "Firefighters Face Increased Risk for Certain Cancers", 11/10/2006 Grace K. LeMasters, PhD., et al: "Cancer Risk Among Firefighters: A Review and Meta-Analysis of 32 Studies", JOEM, Volume 48, Number 11, 11/2006__________________________________________________________________ 2/2007 Little Hocking Water C8 Study Community Newsletter #11 Society of Toxicology, "Perfluoroalkyl Acids and Related Chemistries: Toxicokinetics and Mode of Action", Speaker Abstract 13, 2/14/2007 KJ Fairley, et al: "Exposure to the Immunosuppresant, Perfluorooctanoic Acid, Enhances the murine Ige and Airway Hyperreactivity Response to Ovalbumin, PFOA Enhances OVA Induced Allergic Response", ToxSci Article, doi: 10.1093/toxsci/kfm053, 3/15/2007__________________________________________________________________ Selected References: Polymer Fume Fever, 9/5/2007 David Gray, PhD, et al: "A Review and Critique of Four Recent PFOA Papers", Report, 11/2/2007 11/29/2007 Articles (10) from The C8 Science Panel Website The C8 Science Panel Website Community Study Summary, The Studies at a Glance, Undated Media Release, European Congress on Obesity, "New Evidence Links Hormone-Mimic Chemicals to Obesity", Geneva Switzerland, 5/14/2008 Letter-in-Press, Environ Health Perspect., from R. Slama regarding "How to Control for Gestational Age in Studies Involving Environmental Effects on Fetal Group", doi: 10.1289/ehp.11105, 6/24/2008 C8 Science Panel C8 Study Results, 10/15/2008 Kyle Steenland, et al: Status Report, "Association of Perfluorooctanic Acid (PFOA) and Perfluoroctanesulfonate (PFOS) with Lipids Among Adults in a Community with High Exposure to (PFOA)", 10/8/2008 Veronica Vieira, et al: "PFOA Community Health Studies: Exposure via Drinking Water Contaminated by a Teflon Manufacturing Facility", Organohalogen Compounds, Vol. 7, p. 000732, 2008 Jessica L. Reiner, et al, Abstract, Reproductive Toxicology 27, p. 422-423, doi: 10.1016/j.reprotox.2008.11.071, 2009_________________________________________________________________________________________________ WV University School of Medicine Chart, "Summary of Population C8 Decile Groups", 2008 WV University School of Medicine C8 Health Project Results (Webpage), 2010 WV University School of Medicine Chart, "Population Results for C8 and C8 Sulfonate Plasma Concentrations", 2008_________________________________________________________________________________________________ WV University School of Medicine Chart, "First Pregnancy with Single Live Birth: Diagnosis of Birth Complications Stratified by Mother's Age-Group at Time of Birth", 2008 WV University School of Medicine Chart, "First Pregnancy with Single Live Birth: Birth Defects Stratified by Mother's Age-Group at Time of Birth", 2008 WV University School of Medicine Chart, "First Pregnancy with Single Live Birth: Downs Syndrome Stratified by Mother's Age-Group at Time of Birth", 2008 WV University School of Medicine Chart, "First Pregnancy with Single Live Birth: Birth Defects Stratified by Mother's Age-Group at Time of Birth", 2008 WV University School of Medicine Chart, "First Pregnancy with Single Live Birth: Diagnosis of Birth Complications Stratified by Mother's Age-Group at Time of Birth", 2008 WV University School of Medicine Chart, "First Pregnancy with Single Live Birth: Downs Syndrome Stratified by Mother's Age-Group at Time of Birth", 2008 1/25/2009 Email from Libretta Porta Stennes to David W. Boothe and John R. Flynn regarding Meeting with DuPont at WW Page 142 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 173 of 232 PAGEID #: 40937 Descriptions of Documents Without Bates Numbers 1/27/2009 C8 Science Panel, C8 Study Results, Status Report: "Association of Perfluorooctanic Acid (PFOA) and Perfluoroctanesulfonate (PFOS) with Uric Acid Among Adults with Elevated Community Exposure to PFOA" Kyle Steenland, et al: 1/23/2009 C8 Science Panel, C8 Study Results, Status Report: "Association of Perfluorooctanic Acid (PFOA) and Perfluoroctanesulfonate (PFOS) with Uric Acid Among Adults with Elevated Community Exposure to PFOA" Kyle Steenland, et al: Status Report: "A Cross-Sectional Analysis of Type II Diabetes in a Community with Exposure to Perfluorooctanoic Acid (PFOA)", 11/17/2008 Kyle Steenland, et al: Status Report: "Factors Associates with PFOA Levels in a Community Surrounding a Chemical Plant", 10/7/2008 1/27/2009 C8 Science Panel, C8 Study Results, Status Report: "Association of Perfluorooctanic Acid (PFOA) and Perfluoroctanesulfonate (PFOS) with Lipids Among Adults in a Community with High Exposure to (PFOA)", 10/8/2008____________________________________________________________________________________________ C8 Science Panel C8 Study Results, The Studies At A Glance, Undated C8 Science Panel Summary of the C8 Science Panel Studies, 2009 Samuel Yamin, MPH: "Non-Occupational Perfluorochemical (PFC) Biomonitoring in Minnesota: Interpretation of Results and Discussion of Potential Health Indicators", Study Results, 7/14/2009 Kyle Steenland, et al: "Association of Perfluorooctanoic Acid and Perfluorooctane Sulfonate with Serum Lipids Among Adults Living Near a Chemical Plant", Article, American Journal of Epidemiology, doi: 10.1093/aje/kwp279 10/21/2009________________________________________________________________________ 10/27/2009 Letter from David G. Gray, PhD, to Agency for Toxic Substances and Disease Registry regarding Comments on Draft Toxicological Profile for Perfluoroalkyls, Docket Control Number ATSDR-253 10/30/2009 Environmental Working Group, Draft for Public Comment, "Toxicological Profile for Perfluoroalkyls", Comments of Olga V. Naidenko, PhD Kathryn Z. Guyton, et al: "A Reexamination of the PPAR-a Activation Mode of Action as a Basis for Assessing Himan Cancer Risks of Environmental Contaminants", Environmental Health Perspectives, Vol. 117, No. 11, doi: 10.1289/ehp.0900758, 11/2009_________________________________________________________________________ Susan M. Pinney, et al: "Perfluorooctanoic Acid (PFOA) and Pubertal Maturation in Young Girls", Epidemiology, Vol. 20, Issue 6, p S8o, doi: 10.1097/01.ede.0000362949.30847.cb, 11/2009_________________________________ Susan M. Pinney, et al: "Perfluorooctanoic Acid (PFOA) and Pubertal Maturation in Young Girls", Epidemiology, Vol. 20, Issue 6, p S8o, doi: 10.1097/01.ede.0000362949.30847.cb, 11/2009_________________________________ Kate Hoffman, et al: "Exposure to Polyfluoroalkyl Chemicals and Attention Deficit Hyperactivity Disorder in U.S. Children Aged 12-15 Years, Epidemiology, Vol. 20, Issue 6, p S70, doi: 10.1097/01.ede.0000362918.40325.e9, 11/2009______________________________________________________________________________________________ Declaration of Kathleen Burns, PhD, Emerald Coast Utilities v. 3M Company, DuPont, et al, USDC ND FL, Case No. 3:09CV361/MCR/MD, 2/2/2010_________________________________________________________________________ 3/15/2010 Letter from Bilott to USEPA regarding Submission to TSCA 8(e) FYI Database Re: PFOA/PFOS Collaborative on Health and the Environment Fact Sheet, "PFCs Perfluorinated Chemicals, Including PFOA/C8", 4/2010________________________________________________________________________________________________ H. Fromme, et al: "Pre- and Postnatal Exposure to Perfluorinated Compounds (PFCs)", Environ Sci Technol. Article, 8/19/2001______________________________________________________________________________________ C. Fei, et al: "Prenatal Exposure to PFOA and PFOS and Risk of Hospitalization for Infectious Diseases in Early Childhood", Environ Res. Article, 8/26/2010 C. Fei, et al: "Prenatal Exposure to PFOA and PFOS and Risk of Hospitalization for Infectious Diseases in Early Childhood", Environ Res. Article, 8/26/2010 Page 143 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 174 of 232 PAGEID #: 40938 Descriptions of Documents Without Bates Numbers Chunyuan Fei, et al: "Prenatal exposure to PFPA and PFOS and risk of hospitalization for infectious diseases in early childhood" Environmental Research, doi:10.1016/j.envres.2010.08.004, 8/30/2010 Tony Fletcher, et al: Slides "Monitoring the Health of Populations with Polluted Drinking Water: The C8 Science Panel Study of Perfluorinated Compounds and Health", 9/2010 SJ Frisbee, et al: "Perfluorooctanoic Acid, Perfluorooctanesulfonae, and Serum Lipids in Children and Adolescents: Results from the C8 Health Project", Arch Pediatr Adolesc Med, 9/2010 SJ Frisbee, et al: "Perfluorooctanoic Acid, Perfluorooctanesulfonae, and Serum Lipids in Children and Adolescents: Results from the C8 Health Project", Archives of Pediatrics & Adolescent Medicine, Vol. 164, No., 9, dio: 10.1001/archpediatrics.2010.163, 9/2010 Stephanie J. J Frisbee, et al: "Perfluorooctanoic Acid, Perfluorooctanesulfonae, and Serum Lipids in Children and Adolescents: Results from the C8 Health Project", Arch Pediatr Adolesc Med, 10/2010 Kyle Steenland, et al: "Status Report: Association of Perfluorooctanic Acid (C8/PFOA) and Perfluoroctanesulfonate (PFOS) with Lipids Among Children in the Mid-Ohio Valley", 9/3/2010 U.K. Health Protection Agency: GS Leonardi, et al: "Association of Fluorocarbons and Immune Biomarkers in the Adult Mid-Ohio Valley Population", Slides, 9/10/2010 KY Christensen, et al: "Exposure to Polyfluoroalkyl Chemicals During Pregnancy is not Associated with Offspring Age at Menarche in a Contemporary British Cohort", Environ Int., 9/13/2010 Kyle Steenland: "Is Teflon Bad?, The Epidemiology of PFOA", Slides, 9/13/2010 Veronica Vieira, et al: "PFOA-Contaminated Site Surrounding a Teflon Manufacturing Facility", Slides, Undated Bethan Davies: "PFOS: Potential Impacts on Public Health", Abstract, 9/14/2010 Abstract of presentation: Tony Fletcher: "Monitoring the Health of Populations with Polluted Drinking Water: The C8 Science Panel Study of Perfluorinated Compounds and Health", Abstract, 9/15/2010 Abstract of presentation: Giovanni Leonard: "Association of Fluorocarbons and Immune Biomarkers in the Adult Mid-Ohio Valley Population", Abstract, 9/15/2010 Krista Yorita Christensen, et al: Env. International, "Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort", doi:10.1016/j.envint.2010.08.007, 9/16/2010_____________________________________________________________________________________________ Ryan Seals, et al: "Accumulation and Clearance of PFOA in Current and Former Residents of an Exposed Community", Environmental Health Perspectives Article, doi: 10.1289/ehp.1002346, Undated Edward A. Emmett, et al: "Community First Communication: Reversing Information Disparities to Achieve Environmental Justice", Environmental Justice, Vol. 3, Issue 3, 9/24/2010 AD Hernick, et al: "Sharing Unexpected Biomarker Results with Study Participants", Environ Health Perspect Article, 9/29/2010______________________________________________________________________________________ Ann D. Hernick, et al: "Sharing Unexpected Biomarker Results with Study Participants", Environ Health Perspect Article, doi: 10.1289/ehp.1001988, 9/29/2010____________________________________________________________ Ann D. Hernick, et al: "Sharing Unexpected Biomarker Results with Study Participants", Environ Health Perspectives Article, doi: 10.1289/ehp.1001988, 9/29/2010 Tony Fletcher: "Patterns of Age of Puberty Among Children in the Mid-Ohio Valley in Relation to Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS)" Briefing Notes, 9/30/2010 C-8 Science Panel Status Report: "Patterns of Age of Puberty Among Children in the Mid-Ohio Valley in Relation to Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS)", 9/30/2010 K. Hoffman, et al: "Private Drinking Water Wells as a Source of Exposure to PFOA in Communities Suirrounding a Fluoropolymer Production Facility", Environ Health Perspect. Article, epub date 10/4/2010 K. Hoffman, et al: "Private Drinking Water Wells as a Source of Exposure to PFOA in Communities Suirrounding a Fluoropolymer Production Facility", Environ Health Perspect. Article, doi: 10.1289/ehp.1002503, 10/4/2010 Page 144 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 175 of 232 PAGEID #: 40939 Descriptions of Documents Without Bates Numbers K. Hoffman, et al: "Private Drinking Water Wells as a Source of Exposure to PFOA in Communities Suirrounding a Fluoropolymer Production Facility", Environ Health Perspect. Article, doi: 10.1289/ehp.1002503, 10/4/2010 UC Berkley Seminar presentation by Tony Fletcher: "Perfluorinated Compounds PFOA and PFOS, Immune Markers and Age of Puberty: Findings from Cross Sectional Analyses of an Exposed Population in the Mid-Ohio Valley; The Brian and Jennifer Maxwell Chair Seminar Series in Children's Environmental Health Research", School of Public Health Article, 10/6/2010 CS Andersen, et al: "Prenatal Exposures to Perfluorinated Chemicals and Anthropometric Measures in Infancy", PubMed Abstract, Am. J. Epidemiol. epub 10/12/2010 Camilla Schou Andersen, et al: "Prenatal Exposures to Perfluorinated Chemicals and Anthropometric Measures in Infancy", American Journal of Epidemiology, Vol. 172, No. 11, doi: 10.1093/aje/kwq289, 10/12/2010 Camilla Schou Andersen, et al: "Prenatal Exposures to Perfluorinated Chemicals and Anthropometric Measures in Infancy", American Journal of Epidemiology, Vol. 172, No. 11, doi: 10.1093/aje/kwq289, 10/12/2010 10/15/2010 Email from Bilott to C8 Science Panel regarding C8 Science Panel Quarterly Newsletter October 2010 MA Kaiser, et al: "Understanding Potential Exposure Sources of Perfluorinated Carboxylic Acids in the Workplace", PubMed abstract, Ann. Occup. Hyg., Epub date 10/25/2010 Chunyuan Fei, et al: "Prenatal Exposure to Perfluorinated Chemicals and Behavioral or Coordination Problems at Age 7", Environmental Health Perspectives, doi: 10.1289/ehp.1002026, 11/9/2010 Chunyuan Fei, et al: "Prenatal Exposure to Perfluorinated Chemicals and Behavioral or Coordination Problems at Age 7", Draft, Undated C-8 Science Panel: "Status Report: Association of Perfluorinated Compounds with Attention Deficit/Attention Deficit Hyperactivity Disorder and Learning Disorder Among Children Aged 5 - 1 8 Years with Elevated Community Exposure to PFOA", 1/31/2011__________________________________________________________________________ Maria-Jose Lopez-Espinosa, et al: "Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Age of Puberty amont Children Living near a Chemical Plant", Abstract of Article, 11/17/2010 Abstract regarding Animal Studies Suggest that Perfluorocarbons May Alter Sexual Maturation, Undated News Release, "C8 Science Panel Reports on Half-Life, Pregnancy Outcomes and Immune Markers", 11/29/2010 Kimberly B. Blake, et al: "Associations Among Cardiometabolic Risk Factor Clustering, Weight Status, and Cardiovascular Disease in an Appalachian Population", The Journal of Clinical Hypertension, Vol. 12, No. 12, doi: 10.1111/j.1751-7141.2010.00078.x, 12/2010_____________________________________________________________ Abstract regarding Comparison Between Free Serum Thyroxiine Levels, 12/15/2010 Abstract regarding Animal Studies Have Shown that Negative Associations Between Serum Levels of Free Thyroxine and Perfluorooctane Sulfonate, Undated Emma Rae Goosey: "Towards Understanding the Fate of Perfluoroalkyl Compounds (PFCs) within Urban Environments: Implications for Human Exposure", Abstract, 2010 Boston University Dissertation/Thesis from ProQuest website: Jessica Webb Nelson: "Analyzing Biomonitoring Surveillance Data on Endocrine-Disrupting Chemicals for Population Exposure Patterns and Health Outcomes", Abstract, 2010 Bio-Network.org Article "Exposure to Polyfluoroalkyl Chemicals During Pregnancy is Not Associated with Offspring Age at Menarche in a Contemporary British Cohort", 2010 Edward A. Emmett, et al: "Community First Communication: Reversing Information Disparities to Achieve Environmental Justice", Environmental Justice, Vol. 3, Issue 3, 2010 Scott M. Bartell, et al: "Decline of Perfluorooctanoic Acid in Human Serum Over Two Years Before and After Granular Activated Carbon Filtration in Two Public Water Supplies, and Implications for Half-Live Estimation", C8 Panel Abstract, Undated Page 145 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 176 of 232 PAGEID #: 40940 Descriptions of Documents Without Bates Numbers Rafael Guerrero-Preston, et al: "Global DNA Hypomethylation is Associated with in Utero Exposure to Cotinine and Perfluorinated Alkyl Compounds", Article Epigenetics, Vol. 5, Issue 6, doi: 10.4161/epi.5.6.12378, Undated Fardin Oliaei, et al: "Update on PFC Investigation and Health Risks", Report, 2010 Hyeong-Moo Shin, et al: "Environmental Fate and Transport Modeling for Perfluorooctanoic Acid Emitted from the Washington Works Facility in West Virgina", Environmental Science & Technology Article, doi: 10.1021/es102769t, 1/2011_____________________________________________________________________________ Chunyuan Fei, et al: "Prenatal Exposure to PFOA and PFOS and Risk of Hospitalization for infectious Diseases in Early Childhood", Environmental Research Article, 2010 Marianne Kraugerud, et al, Norweigian School of Vet. Medicine: "Perfluorinated Compounds Differentially Affect Steroidogenesis in the Human Adrenocortical Carcinoma (H295R) in Vitro Cell Assay", Manuscript, Abstract, Undated Krista Yorita Christensen, et al: Env. International, "Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort", doi:10.1016/j.envint.2010.08.007, 9/16/2010_____________________________________________________________________________________________ Kate Hoffman, et al: "Private Drinking Water Wells as a Source of Exposure to Perfluorooctanoic Acid (PFOA) in Communities Surrounding a Fluoropolymer Production Facility", Article Environmental Health Perspectives, Vol. 119, No. 1, doi: 10.1289/ehp.1002503, 1/2011____________________________________________________________ 1/18/2011 Email from C8 Science Panel to Bilott regarding C8 Science Panel Quarterly Newsletter January 2011 Kellyn S. Betts: "A Measure of Community Exposure: PFOA in Well Water Correlates with Serum Levels", Article Science Selections, doi: 10.1289/ehp.119-a35a, 1/1/2011 Michele La Merrill, PhD, MPH, et al: "Childhood Obesity and Environmental Chemicals", Article in Mount Sinai Journal of Medicine, doi: 10.1002/msj.20229, 1/2011 Emily Chan, et al: "Perfluorinated acids and hypothyroxinemia in pregnant women", Environ Research (2011), doi:10.1016/j.envres.2011,1/2011_______________________________________________________________________ Hyeong-Moo Shin, et al: "Environmental Fate and Transport Modeling for Perfluorooctanoic Acid Emitted from the Washington Works Facility in West Virgina", Environmental Science & Technology Article, doi: 10.1021/es102769t, 1/12/2011__________________________________________________________________________ Abstract from FindAPhD.com website: "Exploiting Chirality to Further Understanding of the Contribution of Precursor Compounds to Human Body Burdens of Perfluorooctanesulfonate (PFOS)", 1/31/2011 From C-8 Science Panel website: Summary of the C8 Science Panel Studies, Quarterly Report, 1/2011 E. Chan, et al: "Perfluorinated Acids and Hypothyroxinemia in Pregnant Women", Env. Res., ePub 2/8/2011 LS Haug, et al: "Characterization of Human Exposure Pathways to Perfluorinated Compounds - Comparing Exposure Estimates with Biomarkers of Exposure", PubMed Article, Environ. Int., 2/17/2011 SS White, et al: "Endocrine Disrupting Properties of Perfluorooctanoic Acid", PubMed Article, J. Steroid Biochem. Mol. B iol.,, 3/10/2011__________________________________________________________________________________ Salley S. White, et al: "Endocrine Disrupting Properties of Perfluorooctanoic Acid", Accepted Manuscript to appear in Journal of Steroid Biochemistry & Molecular Biology, doi: 10.1016/j.jsbmb.2011.03.11, 2010 A. Brieger, et al: "Impact of Perfluorooctanesulfonate and Perfluorooctanoic Acid on Human Peripheral Leukocytes", Toxicology In Vitro Article, 3/10/2011 Anne Brieger, et al: "Impact of Perfluorooctanesulfonate and Perfluorooctanoic Acid on Human Peripheral Leukocytes", Accepted Manuscript to Appear in Toxicology In Vitro Article, 3/7/2011 Outline for Conference of Environmental Epidemiology Professionals, Undated SS Knox, et al: "Implications of Early Menopause in Women Exposed to Perfluorocarbons", Clin Endocrinol Meta., Abstract, 3/16/2011 Page 146 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 177 of 232 PAGEID #: 40941 Descriptions of Documents Without Bates Numbers Sarah S. Knox, et al: "Implications of Early Menopause in Women Exposed to Perfluorocarbons", Article Clinical Endocrinology & Metabolism, 3/16/2011 Sarah S. Knox, et al: "Implications of Early Menopause in Women Exposed to Perfluorocarbons", Article Clinical Endocrinology & Metabolism, doi: 10.1210/jc.2010-2401, 3/16/2011 Tony Fletcher, PhD: "Epidemiological Studies of Perfluorinated Compounds - New Findings on Age of Puberty", Slides, 4/13/2011_____________________________________________________________________________________ Maria-Jose Lopez-Espinosa, et al: "Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Age of Puberty among Children Living near a Chemical Plant", Article manuscript, 11/17/2010 Abstract of dissertation/thesis from ProQuest website: Jessica Webb Nelson: "Analyzing Biomonitoring Surveillance Data on Endocrine-Disrupting Chemicals for Population Exposure Patterns and Health Outcomes", 2010_________________________________________________________________________________________________ MJ Lopez-Espinosa, et al: "Comparison Between free Serum Thyroxine Levels, Measured by Analog and Dialysis Methods, in the Presence of Perfluorooctane Sulfonate and Perfluorooctanoate", Abstract Reprod Toxicol, 4/17/2011____________________________________________________________________________________________ Maria-Jose Lopez-Espinosa, et al: "Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Age of Puberty among Children Living near a Chemical Plant", Environmental Science & Technology Article, doi: 10.1021/es1038694, 5/2/2011_______________________________________________________________ Maria-Jose Lopez-Espinosa, et al: "Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Age of Puberty among Children Living near a Chemical Plant", Environmental Science & Technology Article, doi: 10.1021/es1038694, 5/2/2011_______________________________________________________________ 5/9/2011 Email from C8 Science Panel to Bilott regarding C8 Science Panel Quarterly Newsletter May 2011 IJ Wang, et al: "The Effect of Prenatal Perfluorinated Chemicals Exposures on Pediatric Atopy", Environmental Research Abstract, 5/20/2011 IJ Wang, et al: "The Effect of Prenatal Perfluorinated Chemicals Exposures on Pediatric Atopy", Environmental Research Article, doi: 10.1016/j.envres.2011.04.006, 5/20/2011 C8 Science Panel Newsletter, 5/18/2011 M. Kraugerub, et al: "Perfluorinated Compounds Differentially Affect Steroidogenesis and Viability in the Human Andrenocortical Carcinoma (H295R) in Vitro Cell Assay", Toxicol Lett. Abstract, 5/27/2011 Cheryl R. Stein, et al: "Serum Perfluorinated Compound Concentration and Attention Deficit/Hyperactivity Disorder in Children Aged 5 to 18 Years", Environmental Health Perspectives Article, doi: 10.1289/ehp.1003538, 6/10/2011____________________________________________________________________________________________ Poster abstract: Debapriya Mondal, et al: "Temporal Trends in Perfluoronate Exposure in A US Population Exposed to Raised Levels of PFOA rough Drinking Water", C8 Science Panel Summary, 2004 T. Fletcher, et al: "Patterns of Age of Purberty in Relation to Exposure to PFOA and PFOS Among Children Living an an Area with PFOA-Contaminated Drinking Water", C8 Science Panel Abstract, 2004 Tony Fletcher, PhD: "Epidemiology of PFOA and PFOS - New Findings", Slides, 6/17/2011 Brooks B. Gump, et al: "Perfluorochemical (PFC) Exposure in Children: Associations with Impaired Response Inhibition", Environmental Science Technology Article, 6/17/2011 Brooks B. Gump, et al: "Perfluorochemical (PFC) Exposure in Children: Associations with Impaired Response Inhibition", Environmental Science Technology, American Chemical Society Article, doi: 10.1021/es103712g, 2011_________________________________________________________________________________________________ David A. Savitz, "PFOA Contamination in the Mid-Ohio Valley and Reproductive Outcomes", C8 Science Panel Slides, 6/17/2011_____________________________________________________________________________________ Julia Green Brody, et al: "Testing Chemicals for Effects on Breast Development, Lactation, and Cancer", Environmental Health Perspect., doi: 10.1289/ehp.1104077, 6/22/2011 Page 147 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 178 of 232 PAGEID #: 40942 Descriptions of Documents Without Bates Numbers Ruthann A. Rudel, et al: "Environmental Exposure and Mammary Gland Development: State of the Science, Public Health Implications, and Research Recommendations", Abstract, doi: 101289, ehp.1002864, 6/22/2011 Ruthann A. Rudel, et al: "Environmental Exposure and Mammary Gland Development: State of the Science, Public Health Implications, and Research Recommendations", Environmental Health Perspectives, doi: 101289, ehp.1002864, 6/22/2011______________________________________________________________________________ Kim E. Innes, et al: "Association of Osteoarthritis With Serum Levels of the Environmental Contaminants Perfluorooctanoate and Perfluorooctane Sulfonate in a Large Appalachian Population", American Journal of Epidemiology, doi: 10.1093/aje/kwr107, 6/27/2011 James H. Raymer, et al: "Concentrations of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoate (PFOA) and Their Associations with Human Semen Quality Measurements", Reproductive Toxicology Article, doi: 10.1016/j.reprotox.2011.05.24, 5/30/2011______________________________________________________________ List of symposium presentations re: "Prenatal Exposure to POPs and Age of Puberty," Undated List of symposium presentations re: "New Health and Exposure Findings from a Large US Population Exposed to High Levels of PFOA, Undated The C8 Science Panel Status Report "The Mortality of DuPont Workers in Relation to Exposure to PFOA (C8), 7/15/2011___________________________________________________________________________________________ The C8 Science Panel Status Report "Serum PFOA and Liver Function Markers in the Blood of Adults in the MidOhio Valley", 7/15/2011_______________________________________________________________________________ The C8 Science Panel status Report "PFOA (C8) Exposure and Pregnancy Outcome Among Participants in the C8 Health Project", 7/15/2011____________________________________________________________________________ Stipulation Regarding Science Panel Status Reports, Leach v. E.I. DuPont De Nemours and Company, 7/19/2011 News Release, "C8 Science Panel Submits Three Reports to Court", 7/19/2011 Brent D. Kerger, et al: "Tenuous Dose-Response Correlations for Common Disease States: Case Study of Cholesterol and Perfluorooctanoate/Sulfonate (PFOA/PFOS) in the C8 Health Project", Drug and Chemical Toxicology, doi: 10.3109/01480545.2011.582502, 2011___________________________________________________ Julia Green Brody, et al: "Testing Chemicals for Effects on Breast Development, Lactation, and Cancer", Environmental Health Perspective, doi: 10.1289/ehp.1104077, 8/1/2011 SS Knox, et al: "Perfluorocarbon Exposure, Gender and Thyroid Function in the C8 Health Project", Abstract, Toxicol Sci., 2011 Sunmi Kim, et al: "Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones", Environmental Science & Technology, American Chemical Society, doi: 10.1021/ex202408a 8/1/2011____________________________________________________________________________________________ Sarah S. Knox, et al: "Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project", Article The Journal of Toxicology Sciences, Vol. 36, No. 4, 403-410, 2011 K.W. Weirecht, et al: "Acute Respiratory Distress Associated with Inhaled Hydrocarbon", Article Am J Ind Med, doi: 10.1002/ajim.20989, 7/27/2011____________________________________________________________________ Sunmi Kim, et al: "Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones", Environmental Science & Technology, Manuscript, 8/2/2011 8/12/2011 Email from C8 Science Panel to Bilott regarding C8 Science Panel Quarterly Newsletter August 2011 The C8 Science Panel Status Report "Serum PFOA and Liver Function Markers in the Blood of Adults in the MidOhio Valley", 8/11/2011_______________________________________________________________________________ The C8 Science Panel Status Report "Serum PFOA and Liver Function Markers in the Blood of Adults in the MidOhio Valley", 8/11/2011_______________________________________________________________________________ A. Shankar, et al: "Perfluoroalkyl Chemicals and Chronic Kidney Disease in US Adults", PubMed abstract, American Journal Epidemiology, 8/26/2011 Page 148 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 179 of 232 PAGEID #: 40943 Descriptions of Documents Without Bates Numbers A. Shankar, et al: "Perfluoroalkyl Chemicals and Chronic Kidney Disease in US Adults", Article American Journal Epidemiology, doi: 10.1093/aje/kwr171, 8/26/2011 Natasha D. Henry, et al: "Comparison of in Vitro Cytotoxicity, Estrogenicity and Anti-Estrogenicity of Triclosan, Perfluorooctane Sulfonate and Perfluorooctanoic Acid", Article, Journal of Applied Toxicology, doi: 10.1002/jat.1736, 8/8/2011_____________________________________________________________________________ USEPA web page: Extramural Research, "PFOA Concentration in Serum Collected 1991-2008 and Related Health Effects", 12/16/2011___________________________________________________________________________________ The C8 Science Panel Quarterly Report regarding Data Assembled, 9/2011 Kyle Steenland, et al: "Cohort Mortality Study of Workers Exposed to PFOA", Slides, 9/14/2011 The International Society for Environmental Epidemiology Research Article: Abstracts of the 23rd Annual Conference of the International Society of Environmental Epidemiology (ISEE), 9/13/2011, Barcelona, Spain List: The International Society for Environmental Epidemiology Research Symposia, 8/23/2011 K.B. Gutzkow, et al: "Placental Transfer of Perfluorinated Compounds is Selective - A Norwegian Mother and Child Sub-Cohort Study", Abstract Int J Hyg Environ Health, 9/19/2011 N.D. Henry, et al: "Comparison of in Vitro Cytotoxicity, Estrogenicity and Anti-Estrogenicity of Triclosan, Perfluorooctane Sulfonate and Perfluorooctanoic Acid", Article Journal Applied Toxicology, doi: 10.1002/jat.1736, 9/21/2011___________________________________________________________________________ Status Report: C8 (PFOA) Exposure and Pregnancy Outcome Based on Ohio and West Virginia Birth Records and Linkage to C8 Health Project Participants, 9/23/2011 Amir Miodovnik, MD: "Environmental Neurotoxicants and Developing Brain", Mount Sinai Journal of Medicine 78:58-77, doi: 10.1002/msj.20237, 2011_________________________________________________________________ MJ Lopez-Espinosa, et al: "Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Age of Puberty Among Children Living Near a Chemical Plant", Environ Sci Technol., Abstract, 10/1/2011 BB Gump, et al: "Perfluorochemical (PFC) Exposure in Children: Associations with Impaired Response Inhibition", Abstract Environ Sci Technol, 10/1/2011 EC Bonefeld-Jorgensen, et al: "Perfluorinated Compounds Are Related to Breast Cancer Risk in Greenlandic Inuit: A Case Control Study", Abstract Environ Health, 10/6/2011 Eva C. Bonefeld-Jorgensen, et al: "Perfluorinated Compounds Are Related to Breast Cancer Risk in Greenlandic Inuit: A Case Control Study", Environmental Health, doi: 10.1186/1476-069X-10-88, 10/6/2011 Anoop Shankar, et al: "Perfluoroalkyl Chemicals and Elevated Serum Uric Acid in US Adults", Clinical Epidemiology, Dove Press, 3 251-258, 2011 E. Okada, et al: "Prenatal Exposure to Perfluorinated Chemicals and Relationship with Allergies and Infectious Diseases in Infants", PubMed Abstract Environ Res., 10/24/2011 Emiko Okada, et al: "Prenatal Exposure to Perfluorinated Chemicals and Relationship with Allergies and Infectious Diseases in Infants", Article Environmental Research, doi: 10.1016/j.envres.2011.10.003, 10/24/2011 Jennifer Franko, et al: "Dermal Penetration Potential of Perfluorooctanoic Acid (PFOA) in Human and Mouse Skin", PubMed Abstract, J. Toxicol. Environ. Health doi: 10.1080/15287394.2011.615108, 2012________________ Chien-Yu Lin, et al: "Associations Between Levels of Serum Perfluorinated Chemicals and Adiponectin in a Young Hypertension Cohort in Taiwan", Environ. Sci. Technol., dx.doi.org/10.1021/es201964x, 11/2/2011 Jennifer Franko, et al: "Dermal Penetration Potential of Perfluorooctanoic Acid (PFOA) in Human and Mouse Skin", Journal of Toxicology and Environmental Health, Part A. 75:50-62, doi: 10.1080/15287394.2011.615108, 2011_________________________________________________________________________________________________ Cynthia J. Wolf, et al: "Activation of Mouse and Human Peroxisome Proliferator-Activated Receptor-Alpha (PPARa) by Perfluoroalkyl Acids (PFAAs): Further Investigation of C4-C12 Compounds", Abstract Reproductive Toxicology, doi: 10.1016/reprotox.2011.09.009, 11/15/2011 Page 149 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 180 of 232 PAGEID #: 40944 Descriptions of Documents Without Bates Numbers J. E. Klaunig, et al: "Mode of Action Analysis of Perfluorooctanoic Acid (PFOA) Tumorigenicity and Human Relevance", Abstract Reprod Toxicol., 11/22/2011 Jamie C. DeWitt, et al: "Immunotoxicity of Perfluorinated Compounds: Recent Developments", Article Toxicologic Pathology, doi: 10.1177/0192623311428473, 2011_____________________________________________ K. J. Silk, et al: "Investigating the Impact of Message Format, Involvement, Scientific Literacy, and Education on Attitude Toward Reducing Cancer Risk Through Regulation", Abstract Journal Cancer Educ., 11/29/2011 Jamie DeWitt of East Carolina University: Report prepared for U.S. Army: Final Report "Immunopathogenesis in Autism: Regulatory T-Cells and Autoimmunity in Neurodevelopement", 12/2011 Institute of Medicine Report Brief, "Breast Cancer and The Environment, A Life Course Approach", 12/2011 Institute of Medicine Prepublication Copy: Uncorrected Proofs, "Breast Cancer and The Environment, A Life Course Approach", 2012 The C8 Science Panel Status Report "PFOA and Adult Thyroid Disease in the Mid-Ohio Valley", 12/5/2011 C8 Science Panel Reports and Findings, "Probable Link Findings, Pregnancy Induced Hypertension", 12/5/2011 C8 Science Panel Reports and Findings, "Probable Link Findings, Pregnancy Induced Hypertension", Slides, 12/5/2011_____________________________________________________________________________________________ 12/5/2011 Letter from Clifford F. Kinney, Jr., to Carole Jones, Clerk Wood County Circuit Court, regarding Leach, et al v. E.I. Du Point de Nemours and Company, Civil Action No. 01-C-608, enclosing Stipulation Regarding Science Panel Status Reports The C8 Science Panel Status Report "Changes in Serum PFOA/PFOS and Serum Lipids Between 2005 and 2010 in the Mid-Ohio Valley, 12/5/2011_________________________________________________________________________ The C8 Science Panel Status Report "PFOA and Adult Thyroid Disease in the Mid-Ohio Valley", 12/5/2011 The C8 Science Panel Status Report "Prospective Study of Reproductive Health Outcomes in the Mid-Ohio Valley, 12/5/2011_____________________________________________________________________________________________ Article by Julia Brody Of Silent Spring Institute: "Opinion: News Stories Miss Important Points of Breast Cancer Report", Environmental Health News, 12/13/2011 Institute of Medicine Report: "Breast Cancer and The Environment, A Life Course Approach", 12/13/2010 C. La Rocca, et al: "Exposure and Effective Dose Biomarkers for Perfluorooctane Sulfonic Acid (PFOS) and Perfluorooctanoic Acid (PFOA) in Infertile Subjects: Preliminary Results of the Previeni Project", Abstract Int J Hyg Environ Health, 12/23/2011 U.C. Nygaard, et al: "Perfluorinated Compounds and Immune Health Outcomes in 3-year-old Children", Division of Environmental Medicine, Norwegian Institute of Public Health, Abstract, 2012 James E. Klaunig, et al: "Mode of Action Analysis of Perfluorooctanoic Acid (PFOA) Tumorigenicity and Human Relevance", Article Reproductive Toxicology, doi: 10.1016/j.reprotox.2011.10.14, 10/2011 Cynthia J. Wolf, et al: "Activation of Mouse and Human Peroxisome Proliferator-Activated Receptor-Alpha (PPARa) by Perfluoroalkyl Acids (PFAAs): Further Investigation of C4-C12 Compounds", Article Reproductive Toxicology, doi: 10.1016/reprotox.2011.09.009, 9/2011 Chien-Yu Lin, et al: "Associations Between Levels of Serum Perfluorinated Chemicals and Adiponectin in a Young Hypertension Cohort in Taiwan", American Chemical Society, dx.doi.org/10.1021/es201964x, 11/2/2011 Emily Chan, et al: "Perfluorinated acids and hypothyroxinemia in pregnant women", Environ Research (2011), doi:10.1016/j.envres.2011,1/2011_______________________________________________________________________ Ian T. Cousins, et al: Letter to the Editor regarding, "Polyfluorinated Compounds: Past, Present, and Future", American Chemical Society Article, 10/28/2011 USEPA web page: Extramural Research: 'Susan M. Pinney, et al: USEPA Extramural Research 2011 Progress Report: PFOA Concentration in Serum Collected 1991-2008 and Related Health Effects, 8/22/2011 Page 150 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 181 of 232 PAGEID #: 40945 Descriptions of Documents Without Bates Numbers MJ Lopez-Espinosa, et al: "Thyroid Function, PFOA and PFOS in Children Living Near a Chemical Plant", C8 Science Panel Fact Sheet, Undated Marlene Boas, et al: "Thyroid Effects of Endocrine Disrupting Chemicals", Molecular and Cellular Endocrinology Article, doi: 10.1016/j.mce.2011.09.005, 9/10/2011_______________________________________________________ Qixiao Jiang, et al: "Perflurooctanoic Acid Induces Development Cardiotxicity in Chicken Embryos and Hatchlings", Toxicology Article, doi: 10.1016/j.tox.2012.01.005, 1/18/2012 Philippe Grandjean, et al: "Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds", JAMA, Vol. 307, No. 4, 1/25/2012___________________________________________________________ Philippe Grandjean, et al: "PFCs: Countless Applications, New Health Risks", JAMA, Vol. 307, pgs. 291-7, 1/24/2012_____________________________________________________________________________________________ Anne Sleeuwenhoek, et al: "Exposure Assessment of Tetrafluoroethylene and Ammonium Perfluorooctanoic Acid 1951-2002, Journal of Environmental Monitoring, doi: 10.1039/C2EM10930A, 1/27/2012 Valentina Gallo, et al: "Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure", Abstract Research Article, 1/30/2012_____________________________________________________________________________________________ Valentina Gallo, et al: "Serum Perfluorooctanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure", Article Environmental Health Perspectives, doi: 10.1289/eph.1104436, 1/30/2012_______________________________________________________ Philippe Grandjean, et al: "Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds", JAMA Abstract, doi: 10.1001.jamia.2011.2034, 2011 S. Peng, et al: "Hepatotoxicity of Perfluorooctanoic Acid in Human Hepatocytes Using Metabolomics", Se Pu Feb. 30(2):123-7, PubMed Abstract, 2/2012___________________________________________________________________ Thorhallur I. Halldorsson, et al: "Prenatal Exposure to Perfluorooctanoate and Risk of Overweight at 20 Years of Age: A Prospective Cohort Study", National Institute of Environmental Health Sciences, dx.doi.org/10.1289/ehp.1104034, 2/3/2012______________________________________________________________ Slides "Non-Malignant Thyroid Disease Status Report", C-8 Science Panel, Undated Scott M. Bartell: "Bias in Half-Life Estimates Using Log Concentration Regression in the Presence of Background Exposures, and Potential Solutions", Journal of Exposure Science and Environmental Epidemiology, doi: 10.1038/jes.2012.2, 2/15/2012__________________________________________________________________________ David A. Savitz, et al: "Perfluorooctanoic Acid Exposure and Pregnancy Outcome in a Highly Exposed Community", Epidemiology Article, doi: 10.1097/EDE.0b013e31824cb93b, 2/24/2012 Chunyuan Fei, et al: "Commentary: Perfluorinated Chemicals and Time to Pregnancy: A Link Based on Reverse Causation?, Epidemiology Article, Vol. 23, Issue 2, p 264-266, doi: 10.1097/EDE.0b013e3182467608, 3/2012 Kristina W. Whitworth, et al: "Perfluorinated Compounds and Subfecundity in Pregnant Women", Epidemiology Article, Volume 23, Number 2, doi: 10.1097/EDE.0b013e31823b5031, 3/2012________________________________ The C8 Science Panel Quarterly Report Jan to Mar 2012 regarding Sufficient Results to Start the First of a Series of Probable Link Determinations 7th Space Interactive Article "Social Disparities in Exposures to Bisphenol A and Polyfluoroalkyl Chemicals; A Cross-Sectional Study Within NHANES 2003-2006" Env. Health 2012 11:10, 3/6/2012_________________________ Jessica W. Nelson et al: "Social Disparities in Exposures to Bisphenol A and Polyfluoroalkyl Chemicals; A Cross Sectional Study Within NHANES 2003-2006", Environmental Health Article, doi: 10.1086/1476-069X-11-10 03.06.12______________________________________________________________________________________________ Morten Sondergaard Jensen, et al: "Phthalates and Perfluorooctanesulfonic Acid in Human Amniotic Fluid: Temporal Trends and Timing of Amniocentesis in Pregnancy", Abstract Article, Environmental Health Perspective, doi: 10.1289/ehp.1104522, 3/7/2012 Page 151 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 182 of 232 PAGEID #: 40946 Descriptions of Documents Without Bates Numbers Christopher Lau: "Perfluoroalkyl Acids: Recent Research Highlights", Reproductive Toxicology, doi: 10.1016/j.reprotox.2012.03.002, 3/9/2012_______________________________________________________________ Qixiao Jiang, et al: "Perflurooctanoic Acid Induces Development Cardiotxicity in Chicken Embryos and Hatchlings", Toxicology Abstract,, doi: 10.1016/j.tox.2012.01.005, 3/11/2012 Laura n. Vandenberg, et al: "Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotoic Dose Responses", The Endocrine Society, doi: 10.1210/er.2011, 6/2012 IO Specht, et al: "Sperm DNA Integrity in Relation to Exposure to Environmental Perfluoroalkyl Substances - A Study of Spouses of Pregnant Women in Three Geographical Regions", Reprod Toxicology Abstract, ePub 3/15/2012____________________________________________________________________________________________ Maria-Jose Lopez-Espinosa, et al: "Thyroid Function and Perfluoroalkyl Acids in Children Living Near a Chemical Plant", Environmental Health Perspectives, dx.doi.org/10.1289/ehp.1104370, 3/27/2012 Michael Bloom, et al: "Exposure to Persistent Organohalogen Pollutants is Associated with Thyroid Function Among Older Residents of Upper Hudson River Communities", ISEE Abstract #:S-042, 2012 C. Lau: "Perfluoroalkyl Acids: Recent Research Highlights", Repro Toxicology, doi: 10.1016/j.reprotox.2012.03.002, 2012___________________________________________________________________ Linda S. Birnbaum: "Environmental Chemicals: Evaluating Low-Dose Effects", Environmental Health Perspectives, Vol. 120, No. 4, doi: 10.1289/ehp.1205179, 4/2012________________________________________________________ D. J. Ehresman, et al: "A Longitudinal Occupational Assessment of the Potential Association of Changes Between Serum Concentrations of Perfluorooctanoate and Perfluorooctanesulfonate and Non High-Denisity-Lipoprotein Cholesterol", Poster Board Abstract, Undated J. L. Butenhoff, et al: "Perfluorooctanoate, Perfluorooctanesulfonate, and Chronic Kidney Disease: Clearance Comes Before Causation", Poster Board Abstract, Undated U.C. Nygaard, et al: "Perfluorinated Compounds and Immune Health Outcomes in 3-year-old Children", Division of Environmental Medicine, Norwegian Institute of Public Health, Presentation Poster,, 2012 The C8 Science Panel Report "Probable Link Evaluation of Diabetes, 4/13/2012 The C8 Science Panel Report "Probable Link Evaluation of Cancer, 4/15/2012 The C8 Science Panel Press Release "C8 Science Panel Announces Probable Links Between C8 and Testicular, Kidney Cancers", 4/16/2012 The C8 Science Panel Press Release "C8 Science Panel Announces Probable Links Between C8 and Testicular, Kidney Cancers", 4/16/2012 The C8 Science Panel Press Release "C8 Science Panel Announces Probable Links Between C8 and Testicular, Kidney Cancers", Slides, Undated K. W. Whitworth, et al: "Perfluorinated Compounds in Relation to Birth Weight in the Norwegian Mother and Child Cohort Study", American Journal Epidemiology Abstract, 4/19/2012 Susan R. Woskle, et al: "Retrospective Exposure Assessment of Perfluorooctanoic Acid Serum Concentrations at a Fluoropolymer Manufacturing Plant, Annals of Occupational Hygiene Article, doi: 10.1093/annhyg/mes023, 4/26/2012____________________________________________________________________________________________ S.R. Woskie, et al: "Retrospective Exposure Assessment of Perfluorooctanoic Acid Serum Concentrations at a Fluoropolymer Manufacturing Plant, Annals of Occupational Hygiene Article, doi: 10.1093/annhyg/mes023, 4/26/2012____________________________________________________________________________________________ Susan R. Woskle, et al: "Retrospective Exposure Assessment of Perfluorooctanoic Acid Serum Concentrations at a Fluoropolymer Manufacturing Plant, Annals of Occupational Hygiene Article, doi: 10.1093/annhyg/mes023, 4/26/2012____________________________________________________________________________________________ Tony Fletcher, et al: The C8 Science Panel "Endocrine Effects of Perfluoroalkyl Acids - Delay in Puberty in Relation to PFOA and PFOS", Slides, Undated Page 152 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 183 of 232 PAGEID #: 40947 Descriptions of Documents Without Bates Numbers David A. Savitz, et al: "Perfluorooctanoic Acid Exposure and Pregnancy Outcome in a Highly Exposed Community", Epidemiology Article, doi: 10.1097/EDE.0b013e31824cb93b, 2/24/2012 Valentia Gallo, et al: "Serum Perfluoroocatanoate (PFOA) and Perfluorooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure", Environmental Health Perspectives Abstract, ePub 5/25/2012 Larry R. Zobel, MD, MPH, et al: "Perfluorinated Compounds and Immunotoxicity in Children", Article JAMA, Vol. 307, No. 18, 5/9/2012__________________________________________________________________________________ Larry R. Zobel, MD, MPH, et al: "Perfluorinated Compounds and Immunotoxicity in Children", Article JAMA, Vol. 307, No. 18, 5/9/2012__________________________________________________________________________________ K. Ji, et al: "Serum Concentrations of Major Perfluorinated Compounds Among the Geral Population in Korea: Dietary Sources and Potential impact on Thyroid Hormones", Environ Int. Abstract, 5/9/2012 K. Ji, et al: "Serum Concentrations of Major Perfluorinated Compounds Among the Geral Population in Korea: Dietary Sources and Potential impact on Thyroid Hormones", Environment International Article, doi: 10.1016/j.envint.2012.03.007 5/9/2012__________________________________________________________________ E. Scharmach, et al: "Perfluorooctanoic Acid Affects the Activity of the Hepatocyte Nuclear Factor 4 Alpha (NHF4a)", Toxicol Lett Abstract, 5/15/2012________________________________________________________________ E. Scharmach, et al: "Perfluorooctanoic Acid Affects the Activity of the Hepatocyte Nuclear Factor 4 Alpha (NHF4a)", Toxicology Letters Article, 5/15/2012 Omayma Alshaarawy, et al: "Perfluoralkyl Chemicals and Prediabetes in US Adults", Society for Epidemiologic Research Abstract #: 197-Sfor presentation, Undated G. Toft, et al: "Exposure to Perfluorinated Compounds and Human Semen Quality in Arctic and European Populations", Hum Reprod Abstract, ePub 5/30/2012 Jin-Young Min, et al: "Perfluorooctanoic Acid Exposure is Associated with Elevated Homocysteine and Hypertension in US Adults", Occup. Environ. Med., doi: 10.1136/oemed-2011-100288, 5/31/2012 Jin-Young Min, et al: "Perfluorooctanoic Acid Exposure is Associated with Elevated Homocysteine and Hypertension in US Adults", Occup. Environ. Med.., doi: 10.1136/oemed-2011-100288, 5/31/2012 M. Song, et al: "Changes in Thyroid Peroxidase Activity in Response to Various Chemicals", Journal of Environmental Monitoring Abstract, 6/15/2012 M. Song, et al: "Changes in Thyroid Peroxidase Activity in Response to Various Chemicals", Journal of Environmental Monitoring Article, doi: 10.1039/c2em30106g, 6/15/2012 The C8 Science Panel Report "Infections, Obesity and Clinical Markers in Children in Relation to PFOA Serum Level During Pregnancy in Mothers in the Mid-Ohio Valley", 5/10/2012 Germain Luis, et al: "Persistent Environmental Pollutants and Couple Fecundity, Life Study, 2005-2009", ISEE Abstract #:O-054, 2012_________________________________________________________________________________ Vaughn Barry, et al: "Breast Cancer Incidence Among Women with Substantial PFOA Exposure", ISEE Abstract #: O-062, 2012___________________________________________________________________________________________ Andrea Winquist, et al: "Association Between Cumulative PFOA Exposure and Thyroid Disease in Community and Worker Cohorts", ISEE Abstract#: O-063, Undated Tony Fletcher, et al: "Longitudinal Changes in Biomarkers in Relation to Declining Trends in PFOA and PFOS in Adults in the Mid-Ohio Valley", ISEE Abstract #: O-064, Undated Kyle Steenland, et al: "Cancer Incidence in a Population with Substantial PFOA Exposure", ISEE Abstract #: O065, Undated Veronica Vieira, et al: "Geographic Patterns of Cancer in a Community Surrounding a Teflon-Manufacturing Facility", ISEE Abstract #: O-066, Undated Page 153 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 184 of 232 PAGEID #: 40948 Descriptions of Documents Without Bates Numbers Conny Karnes, et al: "Diabetes Incidence in a Cohort with Substantial Exposure to PFOA", ISEE Abstract #: O-098, Undated Lyndsey Darrow, et al: "Serum Perfluorooctanoic Acid Concentrations and Pregnancy Outcome in the Mid-Ohio Valley, 2005-2010", ISEE Abstract #: O-099, Undated_______________________________________________________ Rosana Hernandez Weldon, et al: "In Utero Exposure to PFOA: Associations with Clinical Markers, BMI and Metabolic Syndrome in Children Born in the Mid-Ohio Valley", ISEE Abstract #: O-101, Undated Tony Fletcher, et al: "Infectious Disease Risk in Children and In Utero Exposure of Children to PFAAs in the MidOhio Valley", ISEE Abstract #: O-102, Undated Chien-Yu Lin, et al: "The Role of Gene Polymorphisms as Modifiers of the Effect of Perfluorinated Chemicals on Carotid Intima-Media Thickness", ISEE Abstract#: P-207, Undated Pau-Chung Chen: "Introduction and Findings of the Taiwan Birth Panel study (TBPS) on Children's Environmental Health", ISEE Abstract #: S-015, Undated Michael Bloom, et al: "Exposure to Persistent Organohalogen Pollutants is Associated with Thyroid Function Among Older Residents of Upper Hudson River Communities", ISEE Abstract #:S-042, 2012 Kusheng Wu, et al: "Association Between Maternal Exposure to Perfluorooctanoic Acid (PFOA) from Electronic Waste Recycling and Neonatal Health Outcomes", Environmental International, Vol. 48, pgs 1-8, doi: 10.1016/j.envint.2012.06.018, 11/1/2012________________________________________________________________ Kusheng Wu, et al: "Association Between Maternal Exposure to Perfluorooctanoic Acid (PFOA) from Electronic Waste Recycling and Neonatal Health Outcomes", Environmental International, Vol. 48, pgs 1-8, doi: 10.1016/j.envint.2012.06.018, 11/1/2012________________________________________________________________ The C8 Science Panel Status Report "Exposure to Perfluoroalkyl Acids and Markers of Kidney Function in Children and Adolescents", 7/25/2012 The C8 Science Panel Press Release "Exposure to Perfluoroalkyl Acids and Markers of Kidney Function in Children and Adolescents", 7/30/2012 The C8 Science Panel Press Release "C8 Science Panel Announces Probable Links Between C8 and Ulcerative Colitis, Thyroid Disease", 7/30/2012 The C8 Science Panel Report "Probable Link Evaluation of Infectious Disease", 7/30/2012 The C8 Science Panel Report "Probable Link Evaluation of Stroke", 7/30/2012 The C8 Science Panel Report "Probable Link Evaluation for Non-Infectious Lung Disease Asthma and Chronic Obstructive Pulmonary Disease - COPD", 7/30/2012 The C8 Science Panel Report "Probable Link Evaluation for Neurodevelopmental Disorders in Children", 7/30/2012____________________________________________________________________________________________ The C8 Science Panel Report "Probable Link Evaluation of Autoimmune Disease", 7/30/2012 The C8 Science Panel Report "Probable Link Evaluation of Thyroid Disease", 7/30/2012 Geary W. Olsen, et al: "Longitudinal Assessment of Lipid and Hepatic Clinical Parameters in Workers Involved with the Demolition of Perfluoroalkyl Manufacturing Facilities", JOEM, Vol. 54, NO. 8, doi: 10.1097/JOM.0b013e31825461d2, 8/2012_______________________________________________________________ Tony Fletcher, et al: "Associations Between PFOA or PFOS and Changes in the Expression of Genes Involved in Cholesterol Metabolism in Humans", C8 Science Panel Abstract, 8/2012 Jiansche Wang, et al: "Association of Perfluorooctanoic Acid with HDL Cholesterol and Circulating miR-26b and miR-199-3p in Workers of a Fluorochemical Plant and Nearby Residents", Environmental Science & Technology, American Chemical Society Article, doi: 10.1021/es300906q, 8/3/2012 M.H. Chen, et al: "Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes", PLoS One Abstract, 2012, 7(8), e42474, 8/3/2012 Page 154 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 185 of 232 PAGEID #: 40949 Descriptions of Documents Without Bates Numbers Jiansche Wang, et al: "Association of Perfluorooctanoic Acid with HDL Cholesterol and Circulating miR-26b and miR-199-3p in Workers of a Fluorochemical Plant and Nearby Residents", Environmental Science & Technology, American Chemical Society Article, doi: 10.1021/es300906q, 8/3/2012 Andrea Winquist, et al: "Association Between Cumulative PFOA Exposure and Thyroid Disease in Community and Worker Cohorts", for ISEE conference presentation, Abstract #: O-063, Undated Vaughn Barry, et al: "Breast Cancer Incidence Among Women with Substantial PFOA Exposure", Epidemiology, Vol. 23, Issue 5X, doi: 10.1097/01.ede.0000416720.72173.c5, 8/26/2012____________________________________ Vaughn Barry, et al: "Breast Cancer Incidence Among Women with Substantial PFOA Exposure", Epidemiology, Vol. 23, Issue 5X, doi: 10.1097/01.ede.0000416720.72173.c5, 8/26/2012____________________________________ Veronica Vieira, et al: "Geographic Patterns of Cancer in a Community Surrounding a Teflon-Manufacturing Facility", Epidemiology, Vol. 23, Issue 5X, doi: 10.1097/o1.ede.0000416724.95044.6d, 9/2012_________________ Conny Karnes, et al: "Diabetes Incidence in a Cohort with Substantial Exposure to PFOA", Epidemiology, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416756.49234.82, 9/2012______________________________________________ Lyndsey Darrow, et al: "Serum Perfluorooctanoic Acid Concentrations and Pregnancy Outcome in the Mid-Ohio Valley, 2005-2010", Epidemiology, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416757.49234.cb, 9/2012________ Cheryl R. Stein, et al: "Perfluorooctanoate Exposure and Neurobehavioral Development in Children Aged 6-12", Epidemiology, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416758.26363.d3, 9/2012__________________________ Rosana Hernandez Weldon, et al: "In Utero Exposure to PFOA: Associations with Clinical Markers, BMI and Metabolic Syndrome in Children Born in the Mid-Ohio Valley", Epidemiology, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416759.33987.6e, 9/2012___________________________________________________________ Tony Fletcher, et al: "Infectious Disease Risk in Children and In Utero Exposure of Children to PFAAs in the MidOhio Valley", Epidemiology, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416760.33987.e3, 9/2012______________ Krista Christensen, et al: "Method to Assess Multiple Classes of Environmental Chemicals and Liver Disease: NHANES 2003-2006, Epidemiology, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416890.04536.cf, 9/2012_______ Deborah J. Watkins, et al: "Serum Perfluorooctanoic Acid (PFOA) and Markers of Kidney Function: Are Both Affected by Kidney Disease or by PFOA Exposure?", Epidemiology Article, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416930.17998.31, 9/2012___________________________________________________________ Sanjay Beesoon, et al: High Serum Levels of PFHxS In A Canadian Family Linked to Multiple Scotchgard Applications - A Case Study, Epidemiology Article, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000417067.13465.05, 9/2012_______________________________________________________________________________________________ Tony Fletcher: "Potential Bias in Studies of Biomarkers from Drinking Water Contaminants, Epidemiology Article, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416933.63739.5e, 9/2012_______________________________________ Tony Fletcher: "Longitudinal Changes in Biomarkers in Relation to Declining Trends in PFOA and PFOS in Adults in the Mid-Ohio Valley", Epidemiology Article, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416722.17915.bb, 9/2012_______________________________________________________________________________________________ Mildred Maisonet, et al: "Maternal Concentrations of Polyfluoroalkyl Compounds During Pregnancy and Fetal and Postnatal Growth in British Girls", Environmental Health Perspectives, dx.doi.org/10.1289/ehp.1003096, 8/30/2012____________________________________________________________________________________________ Kyle Steenland: "PFOA and Studies by the C8 Science Panel in the Mid-Ohio Valley", Slides, Undated Anoop Shankar, et al: "Perfluorooctanoic Acid and Cardiovascular Disease in US Adults", Arch Intern Med Article, doi: 10.1001/archinternmed.2012.3393, 9/3/2012________________________________________________________ Debabrata Mukherjee: "Perfluorooctanoic Acid Exposure and Cardiovascular Disease", Arch Intern Med, ePub Article, 9/3/2012______________________________________________________________________________________ Anoop Shankar, et al: "Perfluorooctanoic Acid and Cardiovascular Disease in US Adults", Arch Intern Med Article, doi: 10.1001/archinternmed.2012.3393, 9/3/2012 Page 155 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 186 of 232 PAGEID #: 40950 Descriptions of Documents Without Bates Numbers Y.J. Lee, et al: "Concentrations of Perfluoroalkyl Compounds in Maternal and Umbilical Cord Sera and Birth Outcomes in Korea", Chemosphere abstract, doi: 10.1016/j.chemosphere.2012.08.035, 9/15/2012 Youn Ju Lee, et al: "Concentrations of Perfluoroalkyl Compounds in Maternal and Umbilical Cord Sera and Birth Outcomes in Korea", Chemosphere Article, doi: 10.1016/j.chemosphere.2012.08.035, 9/15/2012 Linus Kvist, et al: "Serum Levels of Perfluorinated Compounds and Sperm Y:X Chromosome Ratio in Two European Populations and in Inuitfrom Greenland", Reproductive Toxicology Article, doi: 10.1016/reprotox.2012.09.007, 10/5/2012_______________________________________________________________ Germain M. Buck Louis, et al: "Perfluorochemicals and Endometriosis, The ENDO Study", epidemiology Article, Volume 23, No. 6, doi: 10.1097.EDE.0b013e31826cc0cf, 11/2012___________________________________________ Kyle Steenland, et al: "Cohort Mortality Study of Workers Exposed to Perflurooctanoic Acid "American Journal of Epidemiology, doi:10.1093/aje/kws171, 10/18/2012 Kyle Steenland, et al: "Cohort Mortality Study of Workers Exposed to Perfluorooctanoic Acid" American Journal of Epidemiology Abstract, doi:10.1093/aje/kws171, 10/18/2012 Kyle Steenland, et al: "Cohort Mortality Study of Workers Exposed to Perfluorooctanoic Acid", American Journal of Epidemiology Abstract, doi:10.1093/aje/kws171, 10/18/2012 M.C. Power, et al: "Cross-Sectional Association Between Polyfluoroalkyl Chemicals and Cognitive Limitation in the National Health and Nutrition Examination Survey", Neuroepidemiology Abstract, 10/24/2012 C8 Science Panel Report "Probable Link Evaluation for Heart Disease (including high blood pressure, high cholesterol, coronary artery disease), 10/26/2012 C8 Science Panel Report "Probable Link Evaluation for Chronic Kidney Disease, 10/26/2012 C8 Science Panel Report "Probable Link Evaluation of Osteoarthritis", 10/29/2012 C8 Science Panel Report "Probable Link Evaluation for Liver Diseases", 10/29/2012 C8 Science Panel Report "Probable Link Evaluation for Parkinson's Disease", 10/29/2012 C8 Science Panel News Release "Science Panel Completes Studies; Finds Probable Link Between C8, High Cholesterol", 10/29/2012_______________________________________________________________________________ Melinda C. Power, et al: "Cross-Sectional Association Between Polyfluoroalkyl Chemicals and Cognitive Limitation in the National Health and Nutrition Examination Survey", Neuroepidemiology, Vol. 40, No. 2, doi: 10.1159/000342310,11/8/2012_________________________________________________________________________ C. Kunacheva, et al: "Worldwide Surveys of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA) in Water Environment in Recent Years", Water Sci Technol Abstract, doi: 10.2166/wst.2012.518, 2012 Chinagarn Kunacheva, et al: "Worldwide Surveys of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA) in Water Environment in Recent Years", Water Science & Technology Abstract, doi: 10.2166/wst.2012.518, 2012____________________________________________________________________________ C.Y. Lin, et al: "The Associations Between Serum Perfluorinated Chemicals and Thyroid Function in Adolescents and Young Adults", JHM Abstract, doi: 10.1016/j.jhazmat.2012.10.019, 11/2/2012 Sohel Saikat, et al: "The Impact of PFOS on Health in the General Population: A Review", Environmental Science Article, doi: 10.1039/C3EM30698K, 11/29/2012___________________________________________________________ Yu Gao, et al: "Assessment of Estrogenic Activity of Perfluoroalkyl Acids Based on Ligand-Induced Conformation State of Human Estrogen Receptors", Environmental Science & Technology Article, doi: 10.1021/es304030x, 12/7/2012____________________________________________________________________________________________ Ulla Nordstrom, et al: "PFOS (perfluorooctanesulfonate) in Serum is Negatively Associated with Testosterone Levels, but Not with Semen Quality, in Healthy Men", Human Reproduction Abstract, doi: 10.1093/humrep/des425, 12/18/2012___________________________________________________________________ B. Javins, et al: "Circulating Maternal Perfluoroalkly Substances During Pregnancy in the C8 Health Study", Environmental Science & Technology Abstract, 12/28/2012 Page 156 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 187 of 232 PAGEID #: 40951 Descriptions of Documents Without Bates Numbers B. Javins, et al: "Circulating Maternal Perfluoroalkly Substances During Pregnancy in the C8 Health Study", Environmental Science & Technology Abstract, doi: 10.1021/es3028082, 12/28/2012 H. Viberg, et al: "Adult Dose-Dependent Behavioral and Cognitive Disturbances After a Single Neonatal PFHxS Dose", Toxicology Abstract, doi: 10.1016/j.tox.2012.12.013, 12/31/2012 Veronica Vieier, et al: "Geographic Patters of Cancer Study", Slides, Undated Maria-Jose Lopez-Espinosa, et al: "Comparison Between Free Serum Thyroxine Levels, Measured by Analog and Dialysis Methods, in the Presence of Perfluorooctane Sulfonate and Perfluorooctanoate", Reproductive Toxicology Article, doi: 10.1016/j.reprotox.2011.04.002, 4/17/2011 Andrea Winquist, Kyle Steenland: "Association Between Cumulative PFOA Exposure and Thyroid Disease in Community and Worker Cohorts", Slides, Undated Beth Javins, et al: "Circulating Maternal Perfluoroalkly Substances During Pregnancy in the C8 Health Study", Environmental Science & Technology Article, doi: 10.1021/es3028082, 12/28/2012 Guang-Hui Dong, et al: "Serum Polyfluoroalkyl Concentrations, Asthma Outcomes, and Immunological Markers in a Case-Control Study of Taiwanese Children", Environmental Health Perspectives, doi: 10.1289/ehp.1205351, 1/8/2013______________________________________________________________________________________________ Veronica M. Vieira, et al: "Perfluorooctanoic Acid Exposure and Cancer Outcomes in a Contaminated Community: A Geographic Analysis", Environmental Health Perspectives, doi: 10.1289/ehp.1205829, 1/8/2013 B. Granum, et al: "Pre-Natal Exposure to Perfluoroalkyl Substances May be Associated with Altered Vaccine Antibody Levels and Immune-Related Health Outcomes in Early Childhood", J Immunotoxicol Abstract, 1/25/2013____________________________________________________________________________________________ Berit Granum, et al: "Pre-Natal Exposure to Perfluoroalkyl Substances May be Associated with Altered Vaccine Antibody Levels and Immune-Related Health Outcomes in Early Childhood", Journal of Immunotoxicology Article, doi: 10.3109/1547691X.2012.755580, 1/25/2013__________________________________________________________ Anne Vested, et al: "Associations of in Utero Exposure to Perfluorinated Alkyl Acids with Human Semen Quality and Reproductive Hormones in Adult Men", Environmental Health Perspectives, doi: 10.1289.ehp.1205118, 1/28/2013____________________________________________________________________________________________ USEPA Extramural Research web page , "PFOA Concentration in Serum Collected 1991-2008 and Related Health Effects", 12/16/2011___________________________________________________________________________________ USEPA Extramural Research web page, "2011 Progress Report: PFOA Concentration in Serum Collected 1991 2008 and Related Health Effects", 2011 Sarah A. Uhl, et al: "Association of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2009", Environmental Health Perspectives, doi: 10.1289/ehp.1205673, 2/8/2013________________ Kirsten T. Eriksen, et al: "Association Between Plasma PFOA and PFOS Levels and Total Cholesterol in a MiddleAged Danish Population", PLOSONE, doi: 10.1371/journal.pone.0056969, 2/18/2013 H. Nilsson, et al: "Professional Ski Waxers' Exposure to PFAS and Aerosol Concentrations in Gas Phase and Different Particle Size Fractions", Environ Sci Process Impacts Abstract, 2/21/2013 Helena Nilsson, et al: "Professional Ski Waxers' Exposure to PFAS and Aerosol Concentrations in Gas Phase and Different Particle Size Fractions", Environmental Science Processes & Impacts Article, doi: 10.1039/c3em30739e, 2013__________________________________________________________________________________________________ USEPA web page - Grants Awards Database: "Project Title: PFOA Serum Concentration & Related Health Effects", 2/28/2013____________________________________________________________________________________ USEPA Extramural Research web page: "PFOA Concentration in Serum Collected 1991-2008 and Related Health Effects", Susan M. Pinney, Investigator, 8/22/2011 USEPA Extramural Research web page: "PFOA Concentration in Serum Collected 1991-2008 and Related Health Effects", Susan M. Pinney, Investigator, 8/22/2011 Page 157 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 188 of 232 PAGEID #: 40952 Descriptions of Documents Without Bates Numbers J.P. Antignac, et al: "Occurrence of Perfluorinated Alkylated Substances in Breast Milk of French Women and Relation with Socio-Demographical and Clinical Parameters: Results of the ELFE Pilot Study", Chemosphere Abstract, doi: 10.1016/j.chemospher.2013.01.088, 3/6/2013 R. B. Jain: "Contribution of Diet and Other Factors to the Levels of Selected Polyfluorinated Compounds: Data from NHANES 2003-2008", Int J Hyg Environ Health, doi: 10.1016/j.ijheh.2013.03.008, 3/27/2013_____________ David C. Bellinger: "Prenatal Exposures to Environmental Chemicals and Children's Neurodevelopment: An Update", Safety and Health at Work Article, doi: 10.5491/shaw.2013.4.1.1, 2013 S. D. Geiger, et al: "Positive Association Between Perfluoroalkyl Chemicals and Hyperuricemia in Children", American Journal of Epidemiology Abstract, 4/3/2013 Sarah Dee Geiger, et al: "Positive Association Between Perfluoroalkyl Chemicals and Hyperuricemia in Children", American Journal of Epidemiology Article, doi: 10/1093/1je/kws392, 4/3/2013 Richard DeGrandchamp, PhD of University of Colorado, Denver: "Perfluorinated Chemicals: Toxicology and Public Health Perspective", Slides, 4/23/2013 R.B. Jain: "Effect of Pregnancy on the Levels of Selected Perfluoroalkyl Compounds for Females Aged 17-39 Years: Data from National Health and Nutrition Examination Survey 2003-2008", J Toxicol Environ Health Abstract, doi: 10.1080/15287394.2013.771547, 2013_____________________________________________________ Mei-Huei Chen, et al: "Perfluorinated Compounds in Umbilical Cord Blood and Adverse Birth Outcomes", PLOS One Abstract, doi: 10.1371/journal.pone.0042474, 8/3/2012 R.B. Jain: "Effect of Pregnancy on the Levels of Selected Perfluoroalkyl Compounds for Females Aged 17-39 Years: Data from National Health and Nutrition Examination Survey 2003-2008", J Toxicol Environ Health Abstract, doi: 10.1080/15287394.2013.771547, 2013_____________________________________________________ C8 Medical Panel Report, 5/24/2013 C.Y. Lin, et al: "The Associations Between Levels of Serum Perfluorooctane Sulfate and Carotid Artery Intima Media Thickness in Adolescents and Young Adults", Int J Cardiol Abstract, doi: 10.1016/j.ijcard.2013.04.042, 5/7/2013_____________________________________________________________________________________________ Cheryl R. Stein, et al: "Perfluorooctanoate and Neuropsychological Outcomes in Children", Epidemiology Abstract, Vol. 24, No. 4, doi: 10.1097/EDE.0b013e3182944432, 7/2013_____________________________________ Andrea Winquist, et al: "Design, Methods and Population for a Study of PFOA Health Effects Among Highly Exposed Mid-Ohio Valley Community Residents and Workers", Environmental Health Perspectives Article, doi: 10.1289/ehp.1206450, 6/4/2013_______________________________________________________________________ Kyle Steenland, et al: "Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley", Environmental Health Perspectives Article, doi: 10.1289/ehp.1206449, 6/4/2013_______________________________________________________________________ V. Gallo, et al: "Serum Perfluoroalkyl Acids Concentrations and Memory Impairment in a Large Cross-Sectional Study", BMJ Open Abstract, doi: 101136/bmjopen-2012-002414, 6/20/2013_________________________________ Igor Burstyn: "Commentary: Country Doctor Versus Epidemiologist: How Uncertainty Analysis Can Help See What is in Plain View", Epidemiology Article, Vol. 24, Issue 4, doi: 10.1097/EDE.0b013e3182953272, 7/2013 Nicola Fitz-Simon, et al: "Rejoinder: Understanding Uncertainties in a Change Versus Change Study", Epidemiology Article, Vol. 24, Issue 4, doi: 10.1097/EDE.0b013e3182961926, 7/2013_________________________ Cheryl R. Stein, et al: "Perfluorooctanoate and Neuropsychological Outcomes in Children", Epidemiology Article, doi: 10.1097/EDE.0b013e3182944432, 7/2013___________________________________________________________ Nicola Fitz-Simon, et al: "Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid", Epidemiology, Volume 24, Number 4, doi: 10.1097/EDE.0b013e318294443ee, 7/2013 Page 158 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 189 of 232 PAGEID #: 40953 Descriptions of Documents Without Bates Numbers C.S. Andersen, et al: "Prenatal Exposures to Perfluorinated Chemicals and Anthropometry at 7 Years of Age", American Journal of Epidemiology Abstract, 7/3/2013 Camilla Schou Andersen, et al: "Prenatal Exposures to Perfluorinated Chemicals and Anthropometry at 7 Years of Age", American Journal of Epidemiology Article, doi: 10.1093/aje/kwt057, 7/3/2013 Lyndsey A. Darrow, et al: "Serum Perfluorooctanoic Acid and Perfluorooctane Sulfonate Concentrations in Relation to Birth Outcomes in the Mid-Ohio Valley, 2005-2010", Environmental Health Perspectives, doi: 10.1289/ehp.1206372, 12/6/2012_______________________________________________________________________ Li Li Wen, et al: "Association Between Serum Perfluorinated Chemicals and Thyroid Function in U.S. Adults: The National Health and Nutrition Examination Survey 2007-2010", J. Clin. Endocrin. M etab., doi: 10.1210/jc.20131282, 7/17/2013_______________________________________________________________________________________ Kashino Ikuka, et al: "Prenatal Exposure to 11 Perfluorinated Compounds (PFCs) and Infant Weight in the Hokkaido Study on Environmental and Children's Health", Environment and Health Conference, Basel, Switzerland Abstract, 8/19/2013 Kristian Tore Jorgensen, et al: "Perfluorinated Compounds and Time to Pregnancy in Couples from Greenland, Poland and Ukraine", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Joseph Braun, et al: "Gestational Endocrine Disrupting Chemical Exposure and Autistic Behaviors in 4 to 5 Year Old Children from Cincinnati OH", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013____________________________________________________________________________________________ Anne Starling, et al: "Perfluoroalkyl Substances in Mid-Pregnancy and Preeclampsia in the Norwegian Mother and Child Cohort Study", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Jia-Shian Shiu, et al: "Prenatal Exposure to Perfluorinated Chemicals and Attention Deficit/Hyperactivity Symptoms in Children at 7 Years of Age", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Philippe Grandjean, et al: "Decreased Serum Vaccine Antibody Concentrations as Critical Outcome of Exposure to Perfluorinated Compounds", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Cheryl Stein, et al: "Perfluorooctanoate Exposure and Maternal Report of Birth Defects", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Vaughn Barry, et al: "Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers Among Adults Living Near a Chemical Plant", Environmental Health Perspectives Article, doi: 10.1289/ehp.1306615, 9/5/2013 M.H. Chen, et al: "Perfluorinated Compound Levels in Cord Blood and Neurodevelopment at 2 Years of Age", Epidemiology Abstract, ePub 9/12/2013 Susan M. Pinney, et al: "Exposure to Polyfluroalkyl Compounds in the Mid Ohio River Valley and Associations with Consumption of Ohio River Water", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013____________________________________________________________________________________________ Srishti Srestha, et al: "Perfluorinated Compounds and Thyroid Function in Older Adults", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Andrea Winquist, et al: "Association Between Cumulative PFOA Exposure and Coronary Artery Disease, Hypertension and High Cholesterol in Community and Worker Cohorts", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Paula Johnson, et al: "The Navigation Guide - Evidence-Based Medicine Meets Environmental Health: PFOA and Fetal Growth", Abstract fro Environment and Health conference, Basel, Switzerland, 8/19/2013 Xia Huo, et al: "Human Developmental Toxicity by Exposure to Mixture Chemicals of E-Waste Recycling", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Page 159 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 190 of 232 PAGEID #: 40954 Descriptions of Documents Without Bates Numbers Glenys Webster, et al: "Perfluoroalkyl Acids (PFASs) and Thyroid Disruption in US Adults (NHANES 2007-2008)", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 Rosana Weldon, et al: "In Utero PFOA and High Blood Pressure Among Pre-Adolescent Children in West Virginia", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 E.C. Bonefeld-Jorgensen, et al: "Effects of Perfluorinate Compounds in Vitro/Ex Vivo and the Risk of Human Breast Cancer", Abstract for conference presentation, Undated Chris Simpson, et al: "Relation Between Perfluorooctanoic Acid Exposure and Strokes in a Large Cohort Living Near a Chemical Plant", Environmental Research Article, doi: 10.1016/j.envres.2013.10.002, 10/2013 S.L. Kristensen, et al: "Long-Term Effects of Prenatal Exposure to Perfluoroalkyl Substances on Female Reproduction", Human Reproduction Article, Vol. 0, No. 0, doi: 10.1093/humrep/det382, 10/15/2013 J. Lyngso, et al: "Menstrual Cycle Characteristics in Fertile Women from Greenland, Poland and Ukraine Exposed to Perfluorinated Chemicals: A Cross-Sectional Study", Human Reproduction Article, Vol. 0, No. 0, doi: 10.1093/humrep/det390, 10/25/2013____________________________________________________________________ E. Hardell, et al: "Case-Control Study on Perfluorinated Alkyl Acids (PFAAs) and the Risk of Prostate Cancer", Environ Int Abstract, doi: 10.1016/j.envint.2013.10.005, 11/15/2013 Barbara J. Keller, et al: "Inhibition of Mitochondrial Respiration and Oxygen-Dependent Hepatotoxicity by Six Structurally Dissimilar Peroxiaomal Proliferating Agents"; Toxicology, 71, pp. 49-61,1992 Gary E. Marchant: "Genetic Susceptibility and Biomarkers in Toxic Injury Litigation", Article, 41 Jurimetrics, 67 109, 2000_____________________________________________________________________________________________ Yibin Kang, et al: "A Multigenic Program Mediating Breast Cancer Metastasis to Bone", Article, Cancer Cell Vol. 3, 6/2003________________________________________________________________________________________________ Wenyue Hu, et al: "Identification of Genes Responsive to PFOS Using Gene Expression Profiling", Environmental Toxicology and Pharmacology Abstract, doi: 10.1016/j.etap.2004.04.008, 2004 K. S. Guruge, et al: "Gene Expression Profiles in Rat Liver Treated with Perfluorooctanoic Acid (PFOA)", Toxicology Sci Abstract, 89(1): 93-107, 2006________________________________________________________________________ C Le Page, et al: "Gene Expression Profiling of Primary Cultures of Ovarian Epithelial Cells identifies Novel Modecular Classifiers of Ovarian Cancer", British Journal of Cancer Article, doi: 10.1038/sj.bjc.6602933, 1/17/2006____________________________________________________________________________________________ Gary E. Marchant: "Genetic Data in Toxic Tort Litigation", Journal of Law and Policy, 14 J.L. & Policy 7, 2006 Bruce Gillis, et al: "Identification of Human Cell Responses to Benzene and Benzene Metabolites", Abstract, Geonomics, doi: 10.1016/j.ygeno.2007.05.003, 2/2/2007 James A. Bjork, et al: "Perfluorooctane Sulfonate-Induced Changes in Fetal Rat Liver Gene Expression", Toxicology Accepted Manuscript, doi: 10.1016/j.tox.2008.06.007, 2007 M.B. Rosen, et al: "Gene Expression Profiling in Wild-Type and PPARa-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARa-Independent Effects", Abstract, PPAR Res., 9/27/2010 V. Vongphachan, et al: "Effects of Perfluoroalkyl Compounds (PFCs) on mRNA Expression Levels of Thyroid Hormone-Responsive Genes in Primary Cultures of Avian Neuronal Cells", Toxicol Sci Abstract, 1/6/2011 W. Xia, et al: "PFOS Prenatal Exposure induce Mitochondrial injury and Gene Expression Change in Hearts of Weaned SD Rats", Toxicology Abstract, 1/18/2011 Rebecca E. Bathke, Oregon State University: "Effects of Perfluorinated Compounds on GnRH Gene Expression in Vitro", Slides, Undated J.A. Bjork, et al: "Multiplicity of Nuclear Receptor Activation by PFOA and PFOS in Primary Human and Rodent Hepatocytes", Toxicology Abstract, ePub 6/23/2011 C. Rylander, et al: "Using Blood Gene Signatures for Assessing Effects of Exposure to Perfluoroalkyl Acids (PFAAs) in Humans: The NOWAC Postgenome Study", Int J Mol Epidemiology Genet Abstract, 8/30/2011 Page 160 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 191 of 232 PAGEID #: 40955 Descriptions of Documents Without Bates Numbers Charlotta Rylander, et al: "Using Blood Gene Signatures for Assessing Effects of Exposure to Perfluoroalkyl Acids (PFAAs) in Humans: The NOWAC Postgenome Study", Int J Mol Epidemiology Genet Abstract, 8/30/2011 J. E. Naile, et al: "Transcriptional Effects of Perfluorinated Compounds in Rat Hepatoma Cells", Chemosphere Abstract, 11/7/2011____________________________________________________________________________________ D. Salter, et al: "Short Term PFOA Administration Does Not Markedly Affect Key Lipogenic and Antioxicant Gene Expression in Adipose Tissue", Poster Board Abstract, Undated K. Midgett, et al: "Effects of Perfluorooctane Sulfonate (PFOS) and Perfluorooctanoic Acid (PFOA) on IL-2 Production in the Human JurkatT-cell Line", Poster Board Abstract, Undated T. Signh, et al: "Perfluorooctanoic Acid Induces Mast Cell-Mediated Allergic Inflammation: Release of Histamine, Involvement of Calcium, Caspase-1, COX-2 and Nuclear Factor-kB", Poster Board Abstract, Undated S. Peng, et al: "Hepatotoxicity of Perfluorooctanoic Acid in Human Hepatocytes Using Meabonomics", PubMed Abstract, Se Pu, 30(2): 123-7, 2/2012____________________________________________________________________ H.G. Lee, et al: "Perfluorooctane Sulfonate Induces Apoptosis of Cerebellar Granule Cells via a ROS-Dependent Protein Kinase C Signaling Pathway", Neurotoxicology Abstract, 6/2012 Tony Fletcher, et al: "Genetic Variations in Kidney Transporter Proteins and Serum Half-Lives of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonic Acid (PFOS)", Epidemiology Article, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000417207.31291.7e, 9/2012_______________________________________________________ Tony Fletcher, et al: "Gene Expressiona and Epigenetic Modification in Lipid Regulating Genes in Relation to PFOA and PFOS", Epidemiology Article, Vol. 23, Issue 5S, doi: 10.1097/01.ede.0000416791.76157.2f, 9/2012 Feng Tan, et al: "Global Liver Proteome Analysis Using iTRAQ Labeling Quantitative Proteomic Technology to Reveal Biomarkers in Mice Exposed to Perfluorooctane Sulfonate (PFOS)", Environmental Science & Technology Article, doi: 10.1021/es3027715, 10/9/2012______________________________________________________________ A. Watkins, et al: "Effects of Gestational Exposure to PFOA on PPAR Protein and mRNA Expression in Vital Organs of Fetal and Postnatal Mice", Abstract, USEPA web page, 10/22/2010 A . K. Rosenmai, et al: "Fluorochemicals Used in Food Packaging inhibit Male Sex Hormone Synthesis", Toxicol Appl Pharmacol Abstract, doi: 10.1016/j.taap.2012.10.022, 11/7/2012 B. Wens, et al: "Cultured Human Peripheral Blood Mononuclear Cells Alter Their Gene Expression When Challenged with Endocrine-Disrupting Chemicals", Toxicology, doi: 10.1016/j.tox.2012.10.019, 11/9/2012 J.H. Oh, et al: "Alternations in Differentially Expressed Genes After Repeated Exposure to Perfluorooctanoate and Perfluorooctanesulfonate in Liver of Oryzias Latipes", Arch Envron Contam Toxicol Abstract, 12/6/2012 L. M. Eldasher, et al: "Hepatic and Renal Bcrp Transporter Expression in Mice Treated with Perfluorooctanoic Acid", Toxicology Abstract, doi: 10.1016/j.tox.2013.02.009, 2/19/2013 M. B. Rosen, et al: "Evaluation of Perfluoroalkyl Acid Activity Using Primary Mouse and Human Hepatocytes", Toxicology Abstract, doi: 10.1016/j.tox.2013.03.011, 4/5/2013 Tony Fletcher, et al: "Associations Between PFOA or PFOS and Changes in the Expression of Genes Involved in Cholesterol Metabolism in Humans", Environ Int Abstract, doi: 10.1016/j.envint.2013.03.008, 4/24/2013 Tony Fletcher, et al: "Associations Between PFOA or PFOS and Changes in the Expression of Genes Involved in Cholesterol Metabolism in Humans", Environment International Abstract, doi: 10.1016/j.envint.2013.03.008,2013______________________________________________________________________ H. Tsang, et al: "Perfluorooctanoate Suppresses Spheroid Attachment on Endometrial Epithelial Cells Through Peroxisome Proliferator-Activated Receptor Alpha and Down-Regulation of Wnt Signaling", Reprod Toxicol Abstract, doi: 10.16/j.reprotox.2013.08.001, 8/23/2013 A.C. Dankers, et al: "Endocrine Disruptors Differentially Target ATP-binding Cassette Transporters in the BloodTestis Barrier and Affect Leydig Cell Testosterone Secretion in Vitro", Toxicol Sci Abstract, 9/6/2013 Page 161 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 192 of 232 PAGEID #: 40956 Descriptions of Documents Without Bates Numbers Tony Fletcher, et al: "Genetic and Transcriptiomic Studies of PF"OA and PFOS: Thyroid Hormones, Lipid Metabolism and Transporter Proteins", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013_____________________________________________________________________________________________ Deborah Watkins, et al: "Associations Between Serum Perfluoroalkyl Acids and LINE-1 DNA Methylation in a Highly Exposed Population", Abstract for Environment and Health conference, Basel, Switzerland, 8/19/2013 John P. Vanden Heuvel Letter to the Editor, Environment International, "Comment on "Associations Between PFOA, PFOS and Changes in the Expression of Genes Involved in Cholesterol Metabolism in Humans" by Fletcher, et al, Environment Internation 57-58 (2013) 2-10", doi: 10.1016/j.envint.2013.09.004, 2013 Manhai Long, et al: "Effects of Perfluoroalkyl Acids on the Function of the Thyroid Hormone and the Aryl Hydrocarbon Receptor", Abstract for conference presentation, Undated John P. Vanden Heuvel: "Effects of PFOA and PFOS on Cholesterol Efflux in Macrophage-Derived Foam Cells", Abstract for conference presentation, Undated D.J. Watkins, et al: "Associations Between Serum Perfluoroalkyl Acids and LINE-1 DNA Methylation", Environ Int Abstract, doi: 10.1016/j.envint.2013.10.018, 11/18/2013___________________________________________________ 9/17/2009 USEPA Consent Agreement and Final Order 3/6/2001 Bilott letter to USEPA re request for immediate governmental action 12/6/2004 USEPA Complaint re DuPont United States District Court Southern District of Ohio Eastern Division, Complaint, Earl Edgar Frum v. E.I. DuPont De Nemours and Company, 2/7/2013 7/8/2004 USEPA Complaint re DuPont Hongxiang Teng: "Overview of the Development of the Fluoropolymer Industry", Appl. Sci. 2012, 2, 496-512; doi: 10.3390, 5/29/2012____________________________________________________________________________________ Paul D. Thacker: "The Weinberg Proposal", Environmental Science & Technology, 05/01/2006; and AR226-1693 04/29/2003 Correspondence Richard W. Clapp, et al: "Environmental and Health: Vital Intersection or Contested Territory?", American Journal of Law and Medicine; 2004, 30, 2/3; Health Module David Michaels, PhD, MPH, et al: "Manufacturing Uncertainty: Contested Science and the Protection of the Public's Health and Environment", American Journal of Public Health, Supplement 1, Vol. 95, No. S1, 2005 James Huff, PhD: "Industry Influence on Occupational and Environmental Public Health", INT J Occup Environ Health, Vol. 12/No 1, JAN/Mar 2007______________________________________________________________________ Roni A. Neff, ScM, et al: "Regulatory Parallels to Daubert: Stakeholder Influence, "Sound Science," and the Delayed Adoption of Health-Protective Standards", American Journal of Public Health, Supplement 1, Vol. 95, No. S1, 2005______________________________________________________________________________________________ David Michaels: "Doubt Is Their Product"; Scientific American, Inc.; June 2005 David Michaels: "Doubt How Industry's Assault on Science is Their Threatens Your Health Product", Oxford University Press 2008 Kyle Steenland, et al: "Commentary: Class Action Lawsuits: Can They Advance Epidemiologic Research?", Epidemiology, Volume 25, Issue 2 - p 167-169, doi: 10.1097/EDE.0000000000000067, 3/2014__________________ Rena Steinzor, et al: "Cozying Up: How the Manufacturers of Toxic Chemicals Seek to Co-opt Their Regulators", Center for Progressive Reform, White Paper #1211, September 2012 WVU report - Kevin M. Leyden, PhD., et al: "Chronicle of the C8 Health Project" Ubel, F.A., et al., "Health Status of Plant Workers Exposed to Fluorochemicals - A Preliminary Report," American Industrial Hygiene Association Journal, August 1980 3M memo dated 5/25/82 from D.E. Roach to F.A. Ubel re: Fluorochemical Control Study (8 pages) 3M memo dated 5/25/82 from D.E. Roach to F.A. Ubel re: Fluorochemical Control Study (8 pages) Page 162 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 193 of 232 PAGEID #: 40957 Descriptions of Documents Without Bates Numbers Doctoral Thesis submitted to the University of Minnesota by Frank Gilliland: "Fluorocarbons and Human health: Studies in an Occupational Cohort", October 1992 Gilliland, F.D., Mandel, J.S., "Mortality Among Employees of a Perfluorooctanoic Acid Production Plant," JOM, Vol. 35, No. 9, September 1993 Geary W. Olsen, et al: "Plasma Cholecystokinin and Hepatic Enzymes, Cholesterol and Lipoproteins in Ammonium Perfluorooctanoate Production Workers", Marcel Dekker, Inc., Drug and Chemical Toxicology, 23(4), 603-620, 2000_________________________________________________________________________________________ Bruce H. Alexander, PhD: "Final Report, Mortality Study of Workers Employed at the 3M Cottage Grove Facility", Division of Environmental and Occupational Health, School of Public Health, University of Minnesota, 04/26/2001___________________________________________________________________________________________ Geary W. Olsen, DVM, PhD, et al: "Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations", JOEM, Volume 45, Number 3, 3/2003 B. H. Alexander, PhD: "Mortality of Employees of a Perfluorooctanesulphonyl Fluoride Manufacturing Facility", Occup Environ Med; 60:722-729, 2003 Geary W. Olsen, DVM, PhD, et al: "Analysis of Episodes of Care in a Perfluorooctanesulfonyl Fluoride Production Facility", Journal of Occupational and Environmental Medicine, Volume 46, Number 8, 8/2004 AR226-1865, AR226-1866, AR226-1869__________________________________________________________________ Study authored by Patricia Colsher of WV Caner Registry, et al. "Examination of Community Concerns about Water Contamination with Perfluorooctanoic Acid and Related Chemicals Using Population-Based Cancer Registry Data", 3/1/06 Grace K. LeMasters, PhD., et al: "Cancer Risk Among Firefighters: A Review and Meta-Analysis of 32 Studies", JOEM, Volume 48, Number 11, 11/2006__________________________________________________________________ Robin C. Leonard, PhD, et al: Retrospective Cohort Mortality Study of Workers in a Polymer Production Plant Including a Reference Population of Regional Workers", Elsevier, Inc., Article in Press, doi: 10.1016/j.annepidem.2007.06.011, 2007_________________________________________________________________ Carine J. Sakr, MD, MPH, et al: "Cross-Sectional Study of Lipids and Liver Enzymes Related to a Serum Biomarker of Exposure (ammonium perfluorooctanoate or APFO) as Part of a General Health Survey in a Cohort of Occupationally Exposed Workers", JOEM, Volume 49, Number 10, doi: 10.1097/JOM.0b013e318156eca3, 2008 WVU School of Medicine, The C 8 Health Project: How a Class Action Lawsuit Can Interact with Public Health-History of Events Dr. Kyle Steenland, et al: "Association of Perfluorooctanoic Acid and Perfluorooctane Sulfonate with Serum Lipids Among Living Near a Chemical Plant". American Journal of Epidemiology DOI:10.1093/AJE/KWP279 Page 1 of 11, 10/21/2009_____________________________________________________________________________________ Kyle Steenland, et al:" Association Of PFOA and PFOS with Uric Acid among Adults with Elevated Community Exposure to PFOA", DOI:10.1289/EHP.0900940 10/22/2009_______________________________________________ Pinney, Susan M, et al: "Perfluorooctanoic Acid (PFOA) and Pubertal Maturation in Young Girls", Epidemiology, November 2009, Vol. 20 (6)pS80, doi:10.1097/01.ede.0000362949.30847.cb page 1 of p1_____________________ Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight and Insulin Resistance in the General U.S Population, Jessica Nelson, doi 10.1289/ehp.0901165 online 11/2/2009 Chein-Yu Lin MD,MPH, al: The American Journal of Gastroenterology, online publication 15, 12/2009; doi:10.1038/ajg-2009.707, "Investigation of the Associations Between Low-Dose Serum Perfluorinated Chemicals and Liver Enzymes in US Adults" David Melzer, et al; Environmental Health Perspectives," Association Between Serum Perfluorooctanoic Acid (PFOA) and Thyroid Disease in the NHANES Study", doi:10.1289/ehp.0901584, 01/10/2010 Page 163 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 194 of 232 PAGEID #: 40958 Descriptions of Documents Without Bates Numbers Chunyuan Fei, et al: "Prenatal exposure to PFPA and PFOS and risk of hospitalization for infectious diseases in early childhood" Environmental Research, doi:10.1016/j.envres.2010.08.004 Stephanie J. Frisbee, MSc, et al: "Perfluorooctanoic Acid,Perfluorooctanesulfonate,and Serum Lipids in Children and Adolescents" Results from the C8 Health Project, American Medical Association, VOL 164 (NO 9) 10/7/2010 Krista Yorita Christensen, et al: Env. International, "Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort", doi:10.1016/j.envint.2010.08.007 Maria-Jose Lopez-Espinosa, et al: "Association of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonate (PFOS) with Age of Puberty among Children Living near a Chemical Plant", Environmental Science & Technology, doi: 10.1021/es1038694________________________________________________________________________________ Camilla Schou Anderson, et al: "Prenatal Exposures to Perfluorinated Chemicals and Anthropometic Measures in Infancy", American Journal of Epidemiology,Vol. 172 NO.11,doi:10.1093/aje/kwq289, 10.12.2010 Chunyuan Fei,et al:" Prenatal Exposure to Perfluorinated Chemicals and Behavior or Coordination Problems at Age 7", Env. Health Perspectives, doi:10.1289/ehpo.1002026, 11/9/2010 Cheryl R. Stein et al: "Serum Perfluorinated Compound Concentration and Attention Deficit/Hyperactivity Disorder in Children 5-18 Years of Age, Env. Health Perspectives, Vol 119, No 10, 10/2011 Emily Chan, et al: "Perfluorinated acids and hypothyroxinemia in pregnant women", Environ Research (2011), doi:10.1016/j.envres.2011,1/2011_______________________________________________________________________ Sarah Knox, et al: "Implications of Early Menopause in Women Exposed to Perflurocarbons", The Endocrine Society, doi:10.1210/jc.2010-2401,6/2011________________________________________________________________ I-Jen Wang, et al: "The effect of prenatal perfluorinated chemicals exposures on pediatric atopy", Env. Research (2011), doi:10.1016/j.envres. 4/6/2011___________________________________________________________________ Kim E. Innes, et at: "Association of Osteoarthritis With Serum Levels of the Environmental Contaminants Perfluorooctanoate and Perfluorooctane Sulfonate in a Large Appalachian Population", American Journal of Epidemiology, doi: 10.1093/aje/kwr107, 06/27/2011 James H. Raymer, et al: " Concentrations of perfluorooctane sulfonate (PFOS)and perfluorooctanoate (PFOA) and their associations with human semen quality measurements", Reproductive Toxicology, doi:10.1016/j.reprotox 05/24/2011___________________________________________________________________________________________ Kyle Steenland, et al: "Cohort Mortality Study of Workers Exposed to Perflurooctanoic Acid "American Journal of Epidemiology, doi:10.1093/aje/kws171,10.18.2012 Valentina Gallo, et al: " Serum Perfluorooctanoate (PFOA) and Perflurooctane Sulfonate (PFOS) Concentrations and Liver Function Biomarkers in a Population with Elevated PFOA Exposure", Env. Health Perspectives, dx.doi.org/10.1289/ehp.1104436, 1/30/2012_____________________________________________________________ David A. Savitz, et al: "Perfluorooctanoic Acid Exposure and Pregnancy Outcome in a Highly Exposed Community", Epidemiology Vol. 23, No 3/ 5/2012 Sarah S. Knox, et al: "Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project", The Journal of Toxicology Sciences, VOL.36,No.4,403-410,2011 Sunmi Kim, et al: "Trans-Placental Transfer of Thirteen Perfluorinated Compounds and Relations with Fetal Thyroid Hormones", Environmental Science & Technology, 8/1/2011 Maria-Jose Lopez-Espinosa, et al: "Thyroid Function and Perfluoroalkyl Acids in Children Living Near a Chemical Plant", Environmental Health Perspectives, dx.doi.org/10.1289/ehp.1104370, 3/27/2012 Anoop Shankar, et al: "Perfluoroalkyl Chemicals and Chronic Kidney Disease in US Adults", American Journal of Epidemiology Advance Access, doi: 10.1093/aje/kwr171, 8/26/2011 Page 164 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 195 of 232 PAGEID #: 40959 Descriptions of Documents Without Bates Numbers David A. Savitz, et al: "Relationship of Perfluorooctanoic Acid Exposure to Pregnancy Outcome Based on Birth Records in the Mid-Ohio Valley", Environmental Health Perspectives, dx.doi.org/10.1289/ehp.1104752, 3/26/2012____________________________________________________________________________________________ Anoop Shankar, et al: "Perfluoroalkyl Chemicals and Elevated Serum Uric Acid in US Adults", Clinical Epidemiology, Dove Press, 3 251-258, 2011 Eva C. Bonefeld-Jorgensen: "Perfluorinated Compounds are Related to Breast Cancer Risk in Greenlandic Inuit: A Case Control Study", Environmental Health, BioMed Central, doi: 10.1186/1476-069X-10-88, 10/6/2011 Emilo Okada, et al: "Prenatal Exposure to Perfluorinated Chemicals and Relationship with Allergies and Infectious Diseases in Infants", Elsevier Environmental Research, doi: 10.1016/j.envres.2011.10.003, 2011 Kristina W. Whitworth, et al: "Perfluorinated Compounds and Subfecundity in Pregnant Women", Epidemiology, Volume 23, Number 2, doi: 10.1097/EDE.0b013e31823b5031, 3/2012_______________________________________ Chien-Yu Lin, et al: "Associations Between Levels of Serum Perfluorinated Chemicals and Adiponectin in a Young Hypertension Cohort in Taiwan", American Chemical Society, dx.doi.org/10.1021/es201964x, 2011 "Probable Link Evaluation of Pregnancy Induced Hypertension and Preeclampsia", 12/5/2011 "Probable Link Evaluation of Miscarriage and Stillbirths", 12/5/2011 "Probable Link Evaluation of Preterm Birth and Low Birthweight", 12/5/2011 "Probable Link Evaluation of Birth Defects", 12/5/2011 Kyle Steenland, et al: Status Report "PFOA and Adult Thyroid Disease in the Mid-Ohio Valley", 12/5/2011 Kyle Steenland, et al: Status Report "Prospective Study of Reproductive Health outcomes in the Mid-Ohio Valley", 12/5/2011_____________________________________________________________________________________ Nicola Fitz-Simon, et al: "Reductions in Serum Lipids with a 4-year Decline in Serum Perfluorooctanoic Acid and Perfluorooctanesulfonic Acid", Epidemiology, Volume 24, Number 4, doi: 10.1097/EDE.0b013e318294443ee, 7/2013________________________________________________________________________________________________ 3/15/2010 Correspondence from Bilott to USEPA: Submission to TSCA 8e database re PFOA/PFOS Philippe Grandjean, MD, DMSc, et al: "Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds", Journal American Medical Association, Vol. 307. No. 4, 1/25/2012 Thorhallur I. Halldorsson, et al: "Prenatal Exposure to Perfluorooctanoate and Risk of Overweight at 20 Years of Age: A Prospective Cohort Study", National Institute of Environmental Health Sciences, dx.doi.org/10.1289/ehp.1104034, 2/3/2012______________________________________________________________ John L. Butenhoff, et al: "Distribution of Perfluorooctanesulfonate and Perfluorooctanoate into Human Plasma Lipoprotein Fractions", Elsevier Ireland, Ltd., doi: 10.1016/j.toxlet.2012.02.013, 2012 Specht IO, et al: "Sperm DNA Integrity in Relation to Exposure to Environmental Perfluoroalkyl Substances - A Study of Spouses of Pregnant Women in Three Geographical Regions", PubMed, 03/15/2012 Abstract: J.L. Butenhoff, et al: "Perfluorooctanoate, Perfluorooctanesulfonate, and Chronic Kidney Disease: Clearance Comes Before Causation" Geary W. Olsen, DVM, PhD, et al: "Longitudinal Assessment of Lipid and Hepatic Clinical Parameters in Workers Involved With the Demolition of Perfluoroalkyl Manufacturing Facilities", JOEM, Volume 54, Number 8, doi: 10.1097/JOM.0b013e31825461d2, 8/2012_______________________________________________________________ U.C. Nygaard, et al: "Perfluorinated Compounds and Immune Health Outcomes in 3-year-old Children", Division of Environmental Medicine, Norwegian Institute of Public Health, 2012 Study by the C8 Science Panel: "Probable Link Evaluation of Diabetes", 4/13/2012 Study by the C8 Science Panel: "Probable Link Evaluation of Cancer", 4/15/2012 Tony Fletcher, et al, The C8 Science Panel: "Infections, Obesity and Clinical Markers in Children in Relation to PFOA Serum Level During Pregnancy in Mothers in the Mid-Ohio Valley", 5/10/2012 Page 165 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 196 of 232 PAGEID #: 40960 Descriptions of Documents Without Bates Numbers Jin-Young Min, et al: "Perfluorooctanoic Acid Exposure is Associated with Elevated Homocysteine and Hypertension in US Adults", BMJ Publishing Group Ltd., doi: 10.1136/oemed-2011-100288, 5/31/2012 Michael Bloom, et al: "Exposure to Persistent Organohalogen Pollutants is Associated with Thyroid Function Among Older Residents of Upper Hudson River Communities", ISEE Abstract #:S-042, 2012 Krista Christensen, et al: "Method to Assess Multiple Classes of Environmental Chemicals and Liver Disease: NHANES 2003-2006, ISEE Abstract #: S-036, 2012 Kusheng Wu, et al: "Association Between Maternal Exposure to Perfluorooctanoic Acid (PFOA) from Electronic Waste Recycling and Neonatal Health Outcomes", Elsevier Ltd., doi: 10.1016/j.envint.2012.06.018, 2012 Deborah J. Watkins, et al: "Exposure to Perfluoroalkyl Acids and Markers of Kidney Function Among Children and Adolescents Living Near a Chemical Plant", Environmental Health Perspectives, dx.doi.org/10.1289/ehp.1205838, 3/11/2013 Study by the C8 Science Panel: "Probable Link Evaluation of Thyroid Disease", 7/30/2012 Study by the C8 Science Panel: "Probable Link Evaluation of Autoimmune Disease", 7/30/2012 Study by the C8 Science Panel: "Probable Link Evaluation of Neurodevelopmental Disorders in Children", 7/30/2012 Study by the C8 Science Panel: "Probable Link Evaluation for Non-infectious Lung Disease (Asthma and Chronic Obstructive Pulmonary Disease - COPD)", 7/30/2012 Study by the C8 Science Panel: "Probable Link Evaluation of Stroke", 7/30/2012 Study by the C8 Science Panel: "Probable Link Evaluation of Infectious Disease", 7/30/2012 Jianshe Wang, et al: "Association of Pefluorooctanoic Acid with HDL Cholesterol and Circulating miR-26b and miR199-3p in Workers of a Fluorochemical Plant and Nearby Residents", Environmental Science & Technology, doi: 10.1021/es300906q, 8/3/2012 Mildred Maisonet, et al: "Maternal Concentrations of Polyfluoroalkyl Compounds During Pregnancy and Fetal and Postnatal Growth in British Girls", Environmental Health Perspectives, dx.doi.org/10.1289/ehp.1003096, 8/30/2012 Anoop Shankar, MD, PhD, et al: "Perfluorooctanoic Acid and Cardiovascular Disease in US Adults", American Medical Association, doi: 10.1001/archinternmed.2012.3393, 9/3/2012 Tony Fletcher, et al: "Associations Between PFOA or PFOS and Changes in the Expression of Genes Involved in Cholesterol Metabolism in Humans", C8 Science Panel, 8/2012 Youn Ju Lee, et al: "Concentrations of Perfluoroalkyl Compounds in Maternal and Umbilical Cord Sera and Birth Outcomes in Korea", Elsevier ltd., dx.doi.org/10.1016/j.chmosphere.2012.08.035, 2012 Germaine M. Buck Louis, et al: "Perfluorochemicals and Endometriosis, The ENDO Study", Epidemiology, Volume 23, Number 6, doi: 10.1097/EDE.0b013e31826cc8cf, 11/2012 Study by the C8 Science Panel: "Probable Link Evaluation for Heart Disease (including High Blood Pressure, High Cholesterol, Coronary Artery Disease)", 10/26/2012 Study by the C8 Science Panel: "Probable Link Evaluation for Chronic Kidney Disease", 10/29/2012 Study by the C8 Science Panel: "Probable Link Evaluation for Liver Diseases", 10/29/2012 Study by the C8 Science Panel: "Probable Link Evaluation for Osteoarthritis", 10/29/2012 Study by the C8 Science Panel: "Probable Link Evaluation for Parkinson's Disease", 10/29/2012 Melinda C. Power, et al: "Cross-Sectional Association Between Polyfluoroalkyl Chemicals and Cognitive Limitation in the National Health and Nutrition Examination Survey", Neuroepidemiology, Vol. 40, No. 2, doi: 10.1159/000342310,11/8/2012 Guang-Hui Dong, et al: "Serum Polyfluoroalkyl Concentrations, Asthma Outcomes, and Immunological Markers in a Case-Control Study of Taiwanese Children", Environmental Health Perspectives, doi: 10.1289/ehp.1205351, 1/8/2013 Page 166 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 197 of 232 PAGEID #: 40961 Descriptions of Documents Without Bates Numbers Veronica M. Vieira, et al: "Perfluorooctanoic Acid Exposure and Cancer Outcomes in a Contaminated Community: A Geographic Analysis", Environmental Health Perspectives, doi: 10.1289/ehp.1205829, 1/8/2013 Berit Grahum, et al: "Pre-Natal Exposure to Perfluoroalkyl Substances May be Associated with Altered Vaccine Antibody Levels and Immune-Related Health Outcomes in Early Childhood", Journal of Immunotoxicology, doi: 10.3109/1547691X, 1/25/2013__________________________________________________________________________ Anne Vested, et al: "Associations of in U tero Exposure to Perfluorinated Alkyl Acids with Human Semen Quality and Reproductive Hormones in Adult Men", Environmental Health Perspectives, doi: 10.1289.ehp.1205118, 1/28/2013____________________________________________________________________________________________ Sarah A. Uhl, et al: "Association of Osteoarthritis with Perfluorooctanoate and Perfluorooctane Sulfonate in NHANES 2003-2009", Environmental Health Perspectives, doi: 10.1289/ehp.1205673, 2/8/2013________________ Kirsten T. Eriksen, et al: "Association Between Plasma PFOA and PFOS Levels and Total Cholesterol in a MiddleAged Danish Population", PLOSONE, doi: 10.1371/journal.pone.0056969, 2/18/2013 Sarah Dee Geiger, et al: "Positive Association Between Perfluoroalkyl Chemicals and Hyeruricemia in Children", American Journal of Epidemiology Advance Access, doi: 10.1093/aje/kws392, 4/3/2013 Cheryl R. Stein, et al: "Perfluorooctanoate and Neuropsychological Outcomes in Children", Epidemiology, Vol. 24, No. 4, doi: 10.1097/EDE.0b013e3182944432, 7/2013______________________________________________________ Kyle Steenland, et al: "Ulcerative Colitis and Perfluorooctanoic Acid (PFOA) in Highly Exposed Population of Community Residents and Workers in the Mid-Ohio Valley", Environmental Health Perspectives, doi: 10.1289/ehp.1206449, 6/4/2013________________________________________________________________________ Lyndsey A. Darrow, et al: "Serum Perfluorooctanoic Acid and Perfluorooctane Sulfonate Concentrations in Relation to Birth Outcomes in the Mid-Ohio Valley, 2005-2010", Environmental Health Perspectives, doi: 10.1289/ehp.1206372, 12/6/2012_______________________________________________________________________ Li-Li Wen, et al: "Association Between Serum Perfluorinated Chemicals and Thyroid Function in U.S. Adults: The National Health and Nutrition Examination Survey 2007-2010", The Endocrine Society, doi: 10.1210/jc.20131282, 7/17/2013_______________________________________________________________________________________ Dario Consonni, et al: "Cancer Risk Among Tetrafluoroethylene Synthesis and Polymerization Workers", American Journal of Epidemiology, doi: 10.1093/aje/kws588, 7/4/2013 Vaughn Barry, et al: "Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers Among Adults living near a Chemical Plant", Environmental Health Perspectives, Vol. 121, Nos. 11-12, doi: 10.1289/ehp.1306615, 11/2013 Vaughn Barry, et al: "Perfluorooctanoic Acid (PFOA) Exposures and Incident Cancers Among Adults living near a Chemical Plant", Environmental Health Perspectives,, doi: 10.1289/ehp.1306615, 9/5/2013 Chris Simpson, et al: "Relation Between Perfluorooctanoic Acid Exposure and Strokes in a Large Cohort Living Near a Chemical Plant", Environmental Research Article, doi: 10.1016/j.envres.2013.10.002, 10/2013 S.L. Kristensen, et al: "Long-Term Effects of Prenatal Exposure to Perfluoroalkyl Substances on Female Reproduction", Human Reproduction Article, Vol. 0, No. 0, doi: 10.1093/humrep/det382, 10/15/2013 J. Lyngso, et al: "Menstrual Cycle Characteristics in Fertile Women from Greenland, Poland and Ukraine Exposed to Perfluorinated Chemicals: A Cross-Sectional Study", Human Reproduction Article, Vol. 0, No. 0, doi: 10.1093/humrep/det390, 10/25/2013___________________________________________________________________ Sarah Dee Geiger, et al: "The Association Between PFOA, PFOS and Serum Lipid Levels in Adolescents", Chemosphere Article, 2013 Kyla W. Taylor et al: "Polyfluoroalkyl Chemicals and Menopause among Women 20-65 Years of Age (NHANES) Environmental Health Perspectives Article, doi: 10.1289/ehp.1306707, 11/26/2013 Conny Karnes, et al: "Incidence of Type II Diabetes in a Cohort With Substantial Exposure to Perfluorooctanoic Acid", Environmental Research Article, doi: 10.1016/j.envres.2013.11.003, 11.11.2013 Page 167 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 198 of 232 PAGEID #: 40962 Descriptions of Documents Without Bates Numbers Lars Lind, et al: "Circulating Levels of Perfluoroalkyl Substances and Prevalent Diabetes in the Elder", Diabetologia Article, doi: 10.1007/s00125-013-3126-3, 8/29/2013_________________________________________ Andrea Winquist et al,: "Perfluorooctanoic Acid Exposure and Thyroid Disease in Community and Worker Cohorts", Article, Epidemiology, Volume 25, No.2, 3/2014 Kim Innes, et a.:"Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population", Article, BMC Cancer 2014, doi:10.1186/1471-2407-14-45,1/27/2014_______________________________________________________________ Kyla W. Taylor et al: "Polyfluoroalkyl Chemicals and Menopause among Women 20-65 Years of Age (NHANES)", Article, Environmental Health Perspectives, Vol. 122, No.2, 2/2014 From UK Clinical Research Network web site: Portfolio Database: "Phase I Clinical Trial of CXR 1002 in Patients with Advanced Cancer", Undated Presentation abstract: Anna L. Barnett, et al: "Anti-Tumor Activity of CXR1002, A Novel Anti-Cancer Compound that Induces ER Stress: Human Tumor Xengraft Efficacy and In Vitro Mode of Action", American Association for Cancer Research, 4/17/2010 US District Court for the Southern District of West Virginia at Parkersburg, Wilber Earl Tennant, et al v. E.I. DuPont De Nemours and Company, DuPont's Supplemental Response to Plaintiffs' Fourth Set of Interrogatories and Responses to Fifth Set of Document Requests, 2/1/2001 AR226_1011; MR47027________________________________________________________________________________ ENVIRON International Corporation: "A Hazard Narrative for Perfluorooctanoate (PFOA) Final", 1/24/2002 M. Ann Bradley Email, 1/31/2002 to J. Bowman and B. Reilly re draft monograph USEPA Fax to R. Bilott 3/12/2002 transmitting News Release and Consent Order re DuPont Washington Works AR226-1146__________________________________________________________________________________________ AR226; 63030000001; MR64426; ML64776; AR226_1146 - AR226_1148____________________________________ DuPont Nov. 2003 memo from Seshu Dharmavaram, PhD, P.E.,to David Van Bramer, et al attaching draft "Quantitative Risk Assessment, Fluoroproduct Operations DuPont: "The Tale of Teflon", DuPont (1 Page) AR226-1879__________________________________________________________________________________________ Scott E. Loveless, PhD et al: "An Internal Approach to the Risk Assessment of PFOA - A Biopersistent Chemical", Michigan State University, 1/31/2008 Gerald L. Kennedy, Jr., et al: "The Toxicology of Perfluorooctanoate", Taylor & Francis Health Sciences, doi: 10.1080/10408440490464705_________________________________________________________________________ S.T. Washburn, et al: "Exposure Assessment and Risk Characterization for Perfluorooctanoate in Selected Consumer Articles", PubMed, Environ Sci Technol, 6/1/2005 John L. Butenhoff, etal: "Response to Letter to the Editor", Elsevier, Inc., doi: 10.1016/j.yrtph.2005.01.006, 2/24/2005___________________________________________________________________________________________ 3M memo dated from John Butenhoff and Robert Roy to Larry Zobel re: 3M Drinking Water Health Advisory APFO transmitting attached report: Derivation of a 3M Lifetime Drinking Water Health Advisory for Ammonium Perfluorooctanoate (APFO) (8 pages) 3M memo dated from John Butenhoff and Robert Roy to Larry Zobel re: 3M Drinking Water Health Advisory APFO transmitting attached report: Derivation of a 3M Lifetime Drinking Water Health Advisory for Ammonium Perfluorooctanoate (APFO) (8 pages) 3M document dated 1/28/02: Lifetime Drinking Water Health Advisory for Perfluorooctanoate (14 pages) 3M Lifetime Drinking Water Health Advisory for Perflurooctanoate dated 1/28/02, authored by John Butenhoff and Robert Roy (14 pages) Page 168 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 199 of 232 PAGEID #: 40963 Descriptions of Documents Without Bates Numbers Letter dated 4/12/04 from Michael Santoro of 3M to Mary Dominiak of USEPA re: 3M monitoring programs; encloses data (17 pages). John L. Butenhoff, et al: "Characterization of Risk for General Population Exposure to Perfluorooctanoate", Elsevier, Inc., doi: 10.1016/j.yrtph.2004.03.003, 4/16/2004_____________________________________________ Whelan, Elizabeth, "Our 'Stolen Future' and the Precautionary Principle", American Council on Science and Health, Vol 8, No. 3, 1996 (2 pages) AR226-1055 AR226-1727 Letter dated 2/20/03 from John Heinze of Environmental Health Research Foundation to Donald Duncan, of The Society of the Plastics Industry transmitting attached Summary and Analysis of Health Data on perfluorooctanoic Acid (PFOA) dated 2/20/03 (3 pages). (Non-Bates numbered document produced by DuPont in the Leach case.) Portion of Environmental Health Research Foundation Summary and Analysis of Health Data on perfluorooctanoic Acid (PFOA) dated 2/20/03 (7 pages) (Non-Bates numbered document produced by DuPont in Leach case.) Trevor Butterworth: "Teflon Pan Scare Comes with Sales Pitch": Statistical Assessment Service, 3/15/2007 Recipients of Grants from 3M for PFOS or PFOA Research, 3/2007 Robert G. Tardiff, et al: "Derivation of a Drinking Water Equivalent Concentration and Maximum Contaminant Level Goal (MCLG) for Perfluorooctanoic Acid (PFOA), a Persistent Water Soluble Compound", Journal of Regulatory Toxicology and Pharmacology, 11/18/2008 Robert G. Tardiff email to Rickard, 7/20/2009 re Tox Forum slides Robert G. Tardiff, PhD, ATS: "Update: PFOA Drinking Water Equivalent Levels", Presented at Toxicology Forum, 7/15/2009____________________________________________________________________________________________ Robert G. Tardiff email to Rickard, 7/28/2009 re Sapphire Group presentation Jeffrey M. Peters, et al: "Why Toxic Equivalency Factors Are Not Suitable for Perfluoroalkyl Chemicals", American Chemical Society Publications, doi: 101021/tx200616x Tables 1 through 10 of PFOA Studies (no other identifiers) Pat Ware: "Drinking Water OMB Reviewing EPA's Determinations On Regulating Contaminants of Concern" Bloomberg BNA Daily Environmental Report, 9/12/2013 The HED Toxicology Science Advisory Council: "Hepatocellular Hypertrophy", HED Guidance Document #G0201, 10/21/2002___________________________________________________________________________________________ Christopher Lau, et al: "Embryonic and Fetal Programming of Physiological Disorders in Adulthood", Whiley-Liss, Inc., doi: 10.1002/bdrc.20029, 2004_____________________________________________________________________ John B. Stephenson, et al: "Low Productivity and New Interagency Review Process Limit the Usefulness and Credibility of EPA's Integrated Risk Information System", U.S. Government Accountability Office, 3/2008 Timothy Donaghy, et al: "Interference at the EPA, Science and Politics at the U.S. Environmental Protection Agency", Union of Concerned Scientists, 4/2008 Chip Reid: "Politics Keeping EPA from Toxin Warnings?", CBS Evening News, 4/28/2008 USEPA Strategic Plan Fiscal Year 2011-2015, 9/30/2010 ~ USEPA News Release, 01/18/2011 announcing Water Technology Innovation Cluster David C. Trimble, et al: "Safe Drinking Water Act, EPA Should Improve Implementation of Requirements on Whether to Regulate Additional Contaminants", United States Government Accountability Office, 5/2011 Pages from Water Technology Innovation Cluster website: Bill McCann: "Cincinnati Water Technology Cluster to Support Economic Growth", IWA Publishing, 4/2011 USEPA Scientific Integrity Policy Draft, 8/5/2011 Page 169 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 200 of 232 PAGEID #: 40964 Descriptions of Documents Without Bates Numbers Safe Chemicals Act of 2011, Summary of Proposed Legislative Changes Avery Fellow: "Toxic Substances, EPA Seeking Greater Regulatory Authority Over Chemicals, Official Tells Lawmakers", The Bureau of National Affairs, Inc., 7/25/2012 Memorandum authored by Lori Weigle of Public Opinion Strategies, 07/16/2012 re: key findings from survey re regulation of chemicals United States Senate Letter to The Honorable Frank Lautenberg, 7/23/2012 American Alliance for Innovation Letter to The Honorable Barbara Boxer and The Honorable Frank Lautenberg, 7/23/2012____________________________________________________________________________________________ Pat Rizzuto: "Toxic Substances, Senate Committee Passes TSCA Reform Bill; Republicans Call for Further Negotiations", The Bureau of National Affairs, Inc., 7/26/2012 David C. Trimble: "EPA Has Increased Efforts to Assess and Control Chemicals but Could Strengthen Its Approach", United States Government Accountability Office, 3/2013 AR226-0938 ~ USEPA Fax to Bilott, 3/12/2002, transmitting USEPA news release and DuPont Consent Order AR226-1093 ~ AR226-1112__________________________________________________________________________________________ AR226-1114__________________________________________________________________________________________ AR226-1117__________________________________________________________________________________________ AR226-1116__________________________________________________________________________________________ AR226-1121__________________________________________________________________________________________ AR226-1120__________________________________________________________________________________________ AR226-1122__________________________________________________________________________________________ AR226-1127__________________________________________________________________________________________ AR226-1129__________________________________________________________________________________________ AR226-1134__________________________________________________________________________________________ AR226-1130__________________________________________________________________________________________ AR226-1311__________________________________________________________________________________________ PowerPoint presentation authored by Rich Purdy: "Screening Level Cumulative Risk Assessment Perfluorinated Alkyl Acids on Human Health" OPPT-2003-0012-0071_________________________________________________________________________________ OPPT-2003-0012-0086_________________________________________________________________________________ AR226-1528__________________________________________________________________________________________ USEPA Draft Risk Assessment for PFOA, 1/4/2005 USEPA Memorandum from Sue Shallal to Vanessa Vu, 1/13/2005 re USEPA risk assessment Geary Olsen, DVM, PhD, et al: "Comments of 3M Company to the EPA Science Advisory Board PFOA Review Panel", 2/10/2005_____________________________________________________________________________________ John A. Moore, D.V.M. of Hollyhouse, Inc. correspondence to EPA re PFOA risk assessment, 2/20/2005 Bilott Letter to USEPA, 2/11/2005 re SAB Risk Assessment for PFOA Timothy Kropp, PhD, Letter to Board Members, USEPA's Draft Risk Assessment on PFOA, 2/11/2005 David Gray, PhD, Letter to USEPA, 2/11/2005 re comments on PFOA risk assessment Joseph V. Rodricks, PhD., Letter to USEPA, Science Advisory Board, 2/11/2005 re comments on risk assessment James A. Popp, DVM, PhD: "Comments on Rodent Tumor Sections, EPA Draft Risk Assessment of PFOA" Robin C. Leonard, PhD, Letter to USEPA, 2/15/2005 re limitations of DuPont surveillance data USEPA Draft Agenda, 2/22/2005 re SAB meeting Joseph V. Rodricks, PhD, DABT PowerPoint presentation: "Comments on EPA's Draft PFOA Risk Assessment" Page 170 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 201 of 232 PAGEID #: 40965 Descriptions of Documents Without Bates Numbers Bob Griffin, Little Hocking Water Association, Inc., Comments regarding USEPA Public Science Advisory Panel Perfluorooctanoic Acid (PFOA) Risk Assessment Review Panel, 02/22/2005 Environmental Working Group PowerPoint presentation: Human Health Risks from Exposure to PFOA Robert W. Rickard, PhD., Letter to USEPA, 3/9/2005_______________________________________________________ Staff: "Agency Contradicted Internal Agency Guidelines in Health Assessment for Toxic Teflon Chemical", Environmental Working Group, 3/15/2005 Bilott Letter to USEPA, 3/22/2005: Supplemental comments re SAB PFOA risk assessment John L. Butenhoff, PhD, et al: "Additional Comments of 3M Company to the EPA Science Advisory Board PFOA Review Panel", 3M Company, 4/18/2005 AR226-2722___________________________________________________________________________________________ Kathleen M. Roberts, American Chemistry Council letter to NCIC OPPT EPA, 12/19/2005 submitting comments to EPA on TSCA 8e reporting. Email dated 1/26/06 from Cathy Lewis to NCIC OPPT@EPA re: EPA-HQ-OPPT-2003-0012 ~ EPA: "Premanufacture Notification Exemption for Polymers; Amendment of Polymer Exemption Rule to Exclude Certain Perfluorinated Polymers", Federal Register, Vol. 71, No. 44, 3/7/2006 Lynne R. Harris, Science and Technology, Letter to EPA, 4/21/2006 re proposed rule on premanufacture notification for polymers Anne Meininger 5/9/2006 Email to Geraldine Hilton of USEPA regarding Comments from the Peoples Republic of China on docket OPPT-2002-0051 Letter dated 5/5/06 from International Imaging Industry Association to OPPT for docket EPA-HQ-OPPT-2002- 0051 (4 pages) Email dated 5/8/06 from Society of Plastics Industry to EPA OPPT re: EPA-HQ-OPPT-2002-0051 Andrea V. Malinowski Letter to USEPA, 5/12/2006 re well sampling results Correspondence to USEPA from Dr. M. Granger Morgan and Dr. Deborah Cory-Slechta, 5/30/2006 re comments on EPA draft PFOA risk assessment USEPA Memorandum from Christopher P. Weis, PhD, DABT, to Walker Smith, 11/17/2006 C. Lau, et al: "Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings", Toxicol Sci., PubMed, 5/22/2007____________________________________________________________________________________________ Christopher Lau, et al: "Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings", Toxicological Sciences, 5/22/2007 USEPA email to Bilott, 8/2/2007 announcing ToxCast Phase I chemicals Email from Charles M. Auer to Robert W. Rickard, 11/2/2007 Superfund Report, Industry asks Rationale for EPA PFOA Risk Research, Citing Phase-Out, 11/19/2007 Email from David W. Boothe to Alan Roberson, 3/27/2008 Correspondence from Bilott to USEPA, 5/29/2008 re documents for AR226 docket DuPont PowerPoint presentation: Chemical Safety Assessment PFOA Under Reach, EPA Meeting, 7/9/2008 USEPA Correspondence from Dr. Deborah Swackhamer and Dr. Joan B. Rose to Stephen Johnson of USEPA re SAB Advisory on EPA's draft CCL 3, Undated USEPA PFC News Report, Vol. 1, Issue 1, 10/2008 USEPA Provisional Health Advisory for PFOA and PFOS 1/8/2009 Email chain from Daniel A. Turner and Ken Ward, Jr., 1/14/2009 re Health Advisory for PFOA Alan Kovski, "EPA Issues Advisories on Safe Levels of Exposure to Two Perfluorinated Chemicals", Daily Environment Report, 1/21/2009 Correspondence from Kathryn K. McCord to James Jones and Wendy Cleland-Hamnett of USEPA re PFOA, 3/25/2009 ~ Page 171 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 202 of 232 PAGEID #: 40966 Descriptions of Documents Without Bates Numbers Letter from David W. Booth to USEPA re meeting with USEPA regarding perfluorinated compounds 7/22/2009 USEPA Email from Priscilla Flattery to Robert W. Rickard re PFOA risk assessm ent, 7/31/2009 Jane Kay, "EPA Unveils Plan to Review 6 Controversial Chemicals, Reform US Toxics Policy", Environmental Health News, 9/29/2009________________________________________________________________________________ Agenda for Perfluorinated Chemicals (PFOA, PFOS, PFHxA, PFBA) Science Presentation for EPA Office of Water, 11/5/2009____________________________________________________________________________________________ Email from David W. Boothe to Joyce Donohue re meeting, 10/21/2009 Email from Joyce Donohue to David W. Boothe re meeting, 10/20/2009 PowerPoint presentation: Provisional Health Advisories for PFOA and PFOS, Fish Forum, Portland, Oregon, 11/3/2009____________________________________________________________________________________________ Jerrold J. Heindel, PhD, National Institute of Environmental Health Sciences, "Chemicals in the Environment: What Doesn't Make Us Sick....Makes us Fatter!, Environmental Chemical (Obesogen) Hypothesis of Obesity, 12/7/2009____________________________________________________________________________________________ Correspondence from Robert A. Bilott to USEPA re PFAA Research, scientific meetings, 2/22/2010 DuPont PowerPoint presentation: Discussion of Short-Chain Alternatives to Long-Chain Perfluorinated Compounds, 3/25/2010 JoeTw itchell PowerPoint presentation: "Merck Advanced Fluorosurfactants, A New Product Line from Merck KGaA, A Presentation to the USEPA", 4/2010 AR226-0550___________________________________________________________________________________________ Federal Register Notice, Vol. 75, No.200, 10/18/2010, pages 63827-30 Federal Register Notice, Vol. 75, No.221, 11/17/2010, pp. 70248-54 ~ Federal Register Notice, Vol. 75, No. 221, 11/17/2010, pp. 70558-68________________________________________ USEPA PowerPoint: Perfluorinated Chemical (PFC) Uses, Issues and Management Techniques in Electroplating Processes, Undated (30 pages) Federal Register Proposed Rules, Vol. 76, No. 42, pp. 11713-11737, 3/3/2011 TAFT website article: EPA's First "Group" Drinking Water Regulations, 3/9/2011 Ohio EPA Correspondence from Scott J. Nally to USEPA Water Docket - Ohio's comments on proposed UCMR 3 Correspondence from Andrew Eaton, PhD, to USEPA Water Docket, comments on proposed UCMR 3, 4/25/2011 Society of the Plastics Industry Meeting Sign-In Sheet, 4/28/2011, New Jersey DEP Correspondence from Gary A. Buchanan, PhD, to USEPA, comments on UCMR3, 5/2/2011 Correspondence from Jessica S. Steinhilber, FluoroCouncil, to USEPA, comments on UCMR3, 5/2/2011 Correspondence from Thomas W. Curtis, American Water Works Association, to USEPA, 5/2/2011 Association of State Drinking Water Administrators, Comments on the Unregulated Contaminant Monitoring Rule - Third Cycle (UCMR3), 5/2/2011____________________________________________________________________ Correspondence from Olga V. Naidenko, PhD, Environmental Working Group, comments on UCMR3, to USEPA, 5/2/2011______________________________________________________________________________________________ Correspondence from Larry R. Zobel, M.D., MPH, 3M, to USEPA, comments on UCMR 3, 5/2/2011 Correspondence from Deborah H. Metz, Greater Cincinnati Water Works, to USEPA, comments on UCMR 3, 5/2/2011______________________________________________________________________________________________ Correspondence from Richard Harrison, PE, Northern Kentucky Water District to USEPA, comments on UCMR 3, 5/2/2011______________________________________________________________________________________________ Correspondence from William L. Kovacs, U.S. Chamber of Commerce to U.S. OMB, Cass Sunstein, re EPA's proposal to list chemicals, 6/7/2011 The Bureau of National Affairs, Inc., Article: EPA Releases 104 Health, Safety Studies Naming Chemicals Tested by Manufacturers, 6/9/2011 Page 172 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 203 of 232 PAGEID #: 40967 Descriptions of Documents Without Bates Numbers PowerPoint presentation: USEPA Regulatory Determinations for the Third Drinking Water Contaminant Candidate List, Stakeholder Meeting, Washington D.C., 6/16/2011 The Bureau of National Affairs, Inc., Article: EPA Expects to Announce in Mid-2012 Contaminants Targeted for Regulation, 6/6/2011 Correspondence from Center for Progressive Reform to Office of Information and Regulatory Affairs re EPA's Proposal to List Chemicals Under the Toxic Substances Control Act (TSCA 5(b)(4), 6/20/2011 PowerPoint presentation: FluoroCouncil Proposed ANPR Approach for Long-Chain Perfluorinated Chemicals Action Plan, 7/13/2011________________________________________________________________________________ USEPA Fact Sheet, TSCA Inventory Update Reporting Modifications; Chemical Data Reporting; Final Rule, 8/2011 Andrew B. Lindstrom, "Polyfluorinated Compounds: Past, Present, and Future", Environmental Science & Technology, doi: 10.1021/es2011622, 8/25/2011_________________________________________________________ Andrew B. Lindstrom, "Polyfluorinated Compounds: Past, Present, and Future", Environmental Science & Technology, doi: 10.1021/es2011622, 8/25/2011_________________________________________________________ Andrew B. Lindstrom, et al: "Guest Comment: Perfluoroalkyl Acid Focus Issue", Environmental Science & Technology, dio: 10.1021/es202963p, 9/29/2011_________________________________________________________ SPI Meeting Sign-In Sheet, 12/8/2011 USEPA Correspondence from David E. Giamporcaro to Robert A. Bilott re work plan chemicals, 3/1/2012 USEPA 2012 Edition of the Drinking Water Standards and Health Advisories, 4/2012 Science Seminar with 3M and USEPA, Sign-In Sheet and Agenda, 4/4/2012 Comments on Grandjean et al, Serum Vaccine Antibody Concentrations in Children Exposed to Perfluorinated Compounds, JAMA, 1/25/2012 PowerPoint presentation: Geary Olsen, et al: "Is Clearance a Common Explanation Across the Epidemiological Associations Reported at "Low" PFOA and PFOS Concentrations?", 4/4/2012 PowerPoint presentation: John Butenhoff, PhD, DABT, "Effect of Dietary Factors on Plasma PFOA and Non-HDL Cholesterol in ApoE*3.Leiden.CETP Mice", Undated Federal Register Rules and Regulations, Vol. 77, No. 85, pp. 26072-26101, 5/2/2012 USEPA External Review Draft, Framework for Human Health Risk Assessment to Inform Decision Making, 7/12/2012____________________________________________________________________________________________ EPAOPPT proposed rule: "Perfluoroalkyl Sulfonates and Long-Chain Perfluoroalkyl Carboxylate Chemical Substances; Proposed Significant New Use Rule [FRL 9358-7]", 8/7/2012 Federal Register Proposed Rules, Vol. 77, No. 158, p. 48924, 8/15/2012 Federal Register Proposed Rules, Vol. 77, No. 158, p. 48858, 8/15/2012 Correspondence from Bilott to USEPA re regulation of PFOA in drinking water, 8/20/2012 USEPA Correspondence from Nancy K. Stoner to Robert A. Bilott re regulation of PFOA in drinking water, 9/18/2012____________________________________________________________________________________________ Correspondence from Marie R. Martinko to Katherine Sleasman, USEPA, 10/15/2012 USEPA, Comments Submitted by The Association of Global Automakers, Inc., regarding the Proposed Significant New Rule for Perfluoroalkyl Sulfonates and Long-Chain Perfluoroalkyle Carboxylate Chemical Substances, Undated USEPA Summary of 12/19/2012 Meeting with the Society of the Plastics Industry (SPI) from Katherine Sleasman Sign-In Sheet for Meeting with the Society of the Plastics industry (SPI), 12/19/2012 USEPA America's Children and the Environment, Third Edition, 1/25/2013, Pre-Publication Copy The Bureau of National Affairs, Inc., Daily Environment Report, "Rule to Target Chemicals Discontinued After 2015, 3/14/2013 Page 173 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 204 of 232 PAGEID #: 40968 Descriptions of Documents Without Bates Numbers PowerPoint presentation: USEPA, Erica Koustas, PhD, Test Driving the Navigation Guide Methodology to Evaluate Human Health Effects of Environmental Contaminants, Undated Correspondence from J. Phillip Berrier, Innovative Chemical Technologies, Inc. to USEPA: comments on proposed SNUR re perfluorochemicals, 5/6/2013 Federal Register Notices, Vol. 78, No. 115, p. 35922, 6/14/2013 Federal Register: USEPA Endocrine Disruptor Screening Program; Final Second List of Chemicals and Substances for Tier 1 Screening, 6/14/2013 Bloomberg BNA, Daily Environment Report, Substances Removed from Draft List, 6/14/2013 PowerPoint presentation: Applying Systematic Review to Assessments of Health Effects of Chemical Exposures, EPA Workshop, 8/26/2013______________________________________________________________________________ USEPA News Release, EPA Takes Steps to Allow Restriction of Imports of Harmful Category of Chemicals Used in Carpets, 9/30/2013 USEPA Perfluoroalkyl Sulfonates and Long-Chain Perfluoralkyl Carboxylate Chemical Substances; Final Significant New Use Rule, 9/30/2013_______________________________________________________________________________ Federal Register Rules and Regulations, Vol. 78, No. 204, p. 62443, 10/22/2013 Undated document titled: Risk Information Update: Overview of Assessment Activities of PFOS and PFOA, authored by Jennifer Seed (1 page) Jennifer Seed, USEPA, PowerPoint presentation: "Risk Information Update: Overview of Assessment Activities of PFOS and PFOA, Undated_______________________________________________________________________________ Undated PowerPoint presentation slides: Overview of Perfluorooctane Sulfonate and Perfluorooctanoic Acid, authored by Jennifer Seed (14 pages) Samuel M. Cohen, et al: "The Human Relevance of Information on Carcinogenic Modes of Action: Overview", Taylor and Francis, Inc., Critical Reviews in Toxicology, doi: 10.1080/10408440390250073, 2003 USEPA memo dated 3/5/2004: Transmittal of Meeting Minutes of the FIFRA Scientific Advisory Panel Meeting Held 12/9/2003________________________________________________________________________________________ National Toxicology Program, Draft NTP Approach for Reaching Conclusions for Literature-Based Evidence Assessments, NTP Board of Scientific Counselors Working Group Meeting, 8/28/2012 Correspondence from Michael P. Walls, American Chemistry Council to Dr. Lori White, EPA NTP re: Approach for Systematic Review and Evidence Integration for Literature-based Health Assessments, 11/27/2012 Comments from the Natural Resources Defense Council to the December 11th NTP Board of Scientific Counselors Meeting on the NTP Approach for Systematic Review and Evidence Integration for Literature-based Health Assessments, 12/7/2012 PowerPoint presentation: Lynn Goldman, NTP BSC Working Group Report on the Draft NTP Report, 12/11/2012 National Toxicology Program, Board of Scientific Counselors, Summary Minutes, 12/11/2012 Lynn Goldman, MD, et al: "Draft Report of the National Toxicology Program Board of Scientific Counselors Working Group on Evaluating NTP's Approach for Reaching Conclusions for Literature-Based Evidence Assessments", 12/11/2012 National Toxicology Program, Revised Draft NTP Approach for Systematic Review and Evidence Integration for Literature-Based Health Assessments, 12/11/2012 Federal Register Notice, Vol. 78, No. 37, p. 12764, 2/25/2013_______________________________________________ National Toxicology Program, Systematic Review to Evaluate the Evidence for an Association Between Perfluorooctanoic Acid (PFOA) or Perflurooctane Sulfonate (PFOS) Exposure and Immunotoxicity, 4/9/2013 Draft National Toxicology Program, Appendix 2: Guidance for Assessing Risk of Bias in the Protocol for Evaluating the Evidence for an Association Between PFOA and PFOS Exposure and Immunotoxicity, 4/9/2013 National Toxicology Program, website document: OHAT Implementation of Systematic Review, 2/25/2013 Page 174 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 205 of 232 PAGEID #: 40969 Descriptions of Documents Without Bates Numbers Tracey J. Woodruff, PhD, MPH, et al: "A Path Forward for Systematic Reviews in Environmental Health: The Navigation Guide Methodology", 8/26/2013 Federal Register Notice, Vol. 78, No. 183, p. 57868, 9/20/2013 Federal Register Notice, Vol. 78, No. 183, p. 57868, 9/20/2013 ATSDR ToxGuide for Perfluoroalkyls, 5/2009 Agency for Toxic Substances and Disease Registry (ATSDR) Correspondence from Lora Siegmann Werner, MPH, to Barbara Taylor of WV Health & Human Resources, 6/24/2009 PowerPoint presentation: Thomas Sinks, PhD, CDC/ATSDR Environmental Public Health Perfluorinated Compounds, Undated Correspondence from Perry Cohn, PhD, MPH, New Jersey Department of Health and Senior Services, to Nickolette Roney, ATSDR re draft perfluoroalkyls toxicology profile, 10/30/2009 Correspondence from Robert A. Bilott to Nickolette Roney, ATSDR, re draft perfluoroalkyls toxicology profile, 9/19/2011___________________________________________________________________________________________ ATSDR Health Consultation, Exposure Investigation Report, Perfluorochemical Serum Sampling in the Vicinity of Decatur, Alabama, 4/1/2013 Federal Register Notice, Vol. 68, No. 189, p. 56296, 9/30/2003 Centers for Disease Control 2009 Fourth National Report on Human Exposure to Environmental Chemicals (10 pages)_______________________________________________________________________________________________ Centers for Disease Control 2009 Fourth National Report on Human Exposure to Environmental Chemicals (p. 247 through 257) Centers for Disease Control and Prevention Fact Sheet, Perfluorooctanoic Acid (PFOA), 4/3/2012 Environmental Working Group Chemical Industry Consultant Runs Federal Reproductive Health Agency, Firm Tied to Dow, R.J. Reynolds Leads Review of Plastics Compound, 2/28/2007 Environmental Working Group Correspondence to David A. Schwartz, M.D., National Institute of Environmental Health Sciences, from Richard Wiles re NTP's CERHR management and review process, 2/28/2007 Marla Cone, Los Angeles Times: "Public Heath Agency Linked to Chemical Industry", 3/4/2007 Dr. Joseph Mercola website article: "Another Pro-Business Federal Agency Plays Favorites and Endangers Your Health Again", 3/4/2007_______________________________________________________________________________ "Editorial: Flawed Oversight on Chemicals' Safety", Minneapolis StarTribune.com, 3/11/2007 Environmental Working Group "Conflict of Interest Still Looms Over NIH Contractor: Independent Investigation into SI's Ties to Chemical industry Needed", 4/3/2007 Marla Cone: "NIH Sidelines Contractor in Conflict Inquiry", Los Angeles Times, 4/4/2007 Marla Cone: "NIH Sidelines Contractor in Conflict Inquiry", Los Angeles Times, 4/4/2007 Marla Cone: "NIH Sidelines Contractor in Conflict Inquiry", Environmental Working Group, 4/4/2007 Environmental Working Group "NIH Suspends Consultant Tied to Industry, Orders Review of All Contractors' Conflicts", 4/4/2007; and Environmental Working Group "Conflict of Interest Still Looms Over NIH Contractor: Independent Investigation into SI's Chemical industry Needed", 4/3/2007 Alliance for Risk Assessment "PFOA-PFOS Interim Risk Assessment for Contaminated Sites", 8/24/2012 National Institute of Environmental Health Sciences report: 2012-2017 Strategic Plan, Advancing Science, Improving Health: A Plan for Environmental Health Research, 8/2012 National Institute of Environmental Health Sciences Fact Sheet, "Perfluorinated Chemicals (PFCs)", Sept. 2012 DuPont PowerPoint presentation: "PFOA Phase Out, Review for DOD", 6/26/2008 Memorandum from Wayne Arny, Office of the Under Secretary of Defense regarding Phase-Out of Perfluorooctanoic Acid (PFOA), 8/7/2008 Page 175 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 206 of 232 PAGEID #: 40970 Descriptions of Documents Without Bates Numbers Email Chain between David W. Booth, DuPont, and Shannon Cunniff regarding DOD Follow up on PFOA, 10/27/2008___________________________________________________________________________________________ Ronald C. Porter, PhD: "AFCEE/TDV Emerging Issue: Perfluorinated Compounds", Noblis, Inc., Undated Linda S. Birnbaum, Ph.D.: "Endocrine Disruption, Where do we go from here?", National Institute of Environmental Health Sciences, 6/11/2012 Consent Order between EPA and DuPont, 11/14/2001 Department of Environmental Protection West Virginia News Release, Multi-Agency Order Entered to Investigate Unregulated Chemical, 11/15/2001 USEPA Region 9 Preliminary Remediation Goals Table, Undated Summary: WVDEP Meeting of C8 Assessment of Toxicity Team (CATT) Toxicologists, 5/6/2002 WVDEP PowerPoint presentation: Public Meeting Regarding C8, 5/15/2002 TERA Internal Deliberative Draft, Pre-Meeting Review of the Human Health and Toxicology Literature on C8 WVDEP Letter from Christopher D. Negley to Robert A. Bilott re CAT team opinion regarding C-8, 5/9/2002 WVDEP News Release, Health Level for C8 Announced by Expert Team; Public Meeting May 15, 5/9/2002 Table: Alternative Derivation of the RfD and RfC Values for C8, 2002 TERA Internal Deliberative Draft, Summaries of Potential Critical Studies for Derivation of Rfd/RfCs for C8 TERA Internal Deliberative Draft Table, Alternative Derivation of the RfD and RfC Values for C8 TERA Internal Deliberative Table, Alternative Derivation of the RfD and RfC Values for C8 Fax cover sheet dated 6/5/02 from Washington Occupational Health Associates to Heather Jones of Spilman firm transmitting attached notes and pages from draft report regarding derivation of RfD/RfCs for C8 (38 pages). (Non-Bates numbered document produced by DuPont in the Leach case.) Letter from Robert A. Bilott regarding C8 Assessment of Toxicity Team Work Under November 14, 2001 Consent Order Between DuPont and State of West Virgina (Order No. GRW-2001-019), 6/10/2002 Letter dated 6/13/02 from Michael Dourson of TERA to Robert Bilott of Taft in response to request for interim deliberative drafts of study (2 pages) Injunction Order Directed to Dee Ann Staats, Ph.D and The WVDEP in Leach case, 6/25/2002 WVDEP Letter from Perry D. McDaniel, 7/1/2002 transmitting TERA notes from CAT team meeting WVDEP Final Ammonium Perfluorooctanoate (C8) Assessment of Toxicity Team (CATT) Report, 8/2002 Sign-in sheet regarding C8 Assessment of Toxicity Toxicologist Panel Meeting, 8/2002 WVDEP Final Draft Ammonium Perfluorooctanoate (C8) Assessment of Toxicity Team (CATT) Report, 8/2002 Final Report C8 Assessment of Toxicity Team (CATT) Report Addendum Aquatic Life Advisory Concentration for C8, 10/2002___________________________________________________________________________________________ Email from Theresa Ellsworth to WVDEP Dee Ann Staats enclosing C8 Assessment of Toxicity Team (CATT) Report Addendum Aquatic Life Advisory Concentration for C8, 10/9/2002 WVDEP News Release re C-8 report, 11/14/2002__________________________________________________________ Table: Alternative Derivation of the RfD and RfC Values for C8, Undated Table: Alternative Derivation of the RfD and RfC Values for C8, Undated National Institute for Chemical Studies, NICS Announces a One-Day Workshop on "Protecting the Public in a Hazardous Matt Emergency" March 25, 2003 in Charleston, W.Va., 1/2/2003 Ken Ward, Jr.: "C8 Study "Tainted," Group Says Governor Urged to Appoint an Indepenedent Panel", Charleston Gazette, 3/13/2003 Ken Ward, Jr.: "Profile: Environment is a Priority for Wise, says New DEP Chielf", Charleston Gazette, 4/14/2003 Order Granting Plaintiffs' Second Motion for Sanctions Against DuPont in Leach case, 4/29/2003 WVDEP Email re C-8 Science Panel, 1/6/2006______________________________________________________________ WVDEP Email from M. Ann Bradley to Randy Huffman, 3/16/2006 Page 176 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 207 of 232 PAGEID #: 40971 Descriptions of Documents Without Bates Numbers GIST Meeting Agenda, 3/28/2006 WVDEP Sign-In Sheet, GIST Meeting, 3/28/2006___________________________________________________________ GIST Questions, Undated GIST Meeting Minutes, Groundwater investigation Steering Team, 3/28/2006 Handwritten notes of GIST meeting Letter from M. Ann Bradley to Perry McDaniel, WVDEP re DuPont MOU, 4/10/2006 7/12/2006 DuPont Letter from Robert L. Ritchey to Cliff D. Whyte regarding Letter, Cliff D. Whyte to R.L. Richey, December 16, 2005 and Letter, Robert L. Ritchey to Cliff D. Whyte, January 12, 2006 WVDEP Consent Order 3/9/2009________________________________________________________________________ Summary of Discussions, 3/19/2009 WVDEP-DuPont Meeting on C8 Issues, 3/23/2009 3/26/2009 Email from David W. Boothe to Bill Toomey, WV Department of Health and Human Services, regarding Water Guidance Levels or Limits From WVDEP website: Division of Water and Waste Management list of C8 Investigation Reports as of 9/3/09 11/21/2011 Letter from Katherine Crockett to Yogesh Pate, WVDEP, regarding Executed Draft Consent Order No. 7418__________________________________________________________________________________________________ Table: Alternative Derivations of the RfD and RfC Values for C8, Undated USEPA Region 9 Preliminary Remediation Goals summary, Undated 1/6/2003 Ohio EPA Inter-Office Communication from Chris Jones to Cindy Hafner regarding CAT Team Report on C8____________________________________________________________________________________________________ 10/4/2005 Ohio EPA News Release to Jim Leach and Kevin Johnson regarding Ohio EPA Recommends Bottled Water in Areas Where C8 Has Been Detected 1/24/2007 Ohio Department of Health Report on C8 Perfluorooctanoic Acid, Commonly known as C8, is also Called PFOA and/or APFO, A 2006 C8 Physician Reference, What we know..., What we don't know..., What is taking p lace . 1/24/2007 Ohio Department of Health Report on C8 Perfluorooctanoic Acid, Commonly known as C8, is also Called PFOA and/or APFO, A 2006 C8 Physician Reference, What we k n o w ., What we don't k n o w ., What is taking p lace . 5/5/2009 PowerPoint presentation: DuPont Briefing to Ohio EPA 6/23/2009Letter from David W. Boothe to Michael Baker, Ohio EPA, regarding DuPont Update Meeting of May 5, 2009_______________________________________________________________________________________________ 8/5/2012 Ohio Department of Health Report on C8 Perfluorooctanoic Acid, Commonly known as C8, is also Called PFOA and/or APFO, A 2006 C8 Physician Reference, What we kn o w . 8/2/2012 Ohio Department of Health, Bureau of Environmental Health, Health Assessment Section, C8, C8 is also Known as Perfluorooctanoic Acid and/or PFOA Fact Sheet 6/2013 Ohio Department of Health, Bureau of Environmental Health, Health Assessment Section, C8, C8 is also Known as Perfluorooctanoic Acid and/or PFOA Fact Sheet 8/6/2013 Internation Agency for Research on Cancer, Upcoming Meetings regarding Perfluoro-octanoic Acid, Tetrafluoroethylene, 1,2-Dichloromethane, and Ambient Air Pollution Environmental Working Group, The Power of Information regarding DuPont Hid Teflon Pollutions for Decades, Undated Environmental Working Group, Toxic to Animals & People. Persistent Forever. Pervasive in Human Blood., Undated 5/14/2003 Environmental Working Group Canaries in the Kitchen: Teflon Toxicosis, EWG Finds Heated Teflon Pans can Turn Toxic Faster than DuPont Claims Jane Houlihan, et al, Environmental Working Group: "Body Burden, The Pollution in Newborns", 7/14/2005 Page 177 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 208 of 232 PAGEID #: 40972 Descriptions of Documents Without Bates Numbers 3/20/2009 Environmental Working Group, EWG "Letter: EPA/DuPont Deal Contradicts Sound Science and EPA Principles", Letter to The Honorable Lisa Jackson from Richard Wiles AR226-1005, Note to File from Karen Lannon regarding 3/26/2001 Perfluoroalkanoic Acids, 3/28/2001 AR226-1532, Screening Level Cumulative Risk Assessment Perfluorinated Alkyl Acids on Human Health, Rich Purdy, 10/9/2003______________________________________________________________________________________ 10/14/2003 Email from USEPA to Robert A. Bilott regarding AR-226 Requests, enclosing AR226-1532, Screening Level Cumulative Risk Assessment Perfluorinated Alkyl Acids on Human Health, Rich Purdy, 10/9/2003 4/28/2009 Letter from Maya van Rossum, Delaware Riverkeeper, to Mark N. Mauriello, NJDEP, regarding PFOA Pollution in the Vicinity of the DuPont Chambers Works Facility, Deepwater, Salem County, New Jersey 4/19/2010 Food and Chemical Toxicology Letter to the Editor regarding Derivation of a Drinking Water Quivalent Level (DWEL) Related to the Maximum Contaminant Level Goal for Perfluorooctanoic Acid (PFOA), a Persistent Water Soluble Compound, Keith R. Cooper, Rutgers University 3/18/2011 News Release from Maya K. van Rossum, Delaware Riverkeeper, regarding Delaware Riverkeeper Network Questions New Jersey Department of Environmental Protection About Public Drinking Water Protections Report: 6/2011 National Conversation on Public Health and Chemical Exposures Report, "Addressing Public Health and Chemical Exposures, An Action Agenda, Leadership Council YG Zhao, et al: PubMed Article, "Risk Assessment for Human Consumption of Perfluorinated CompoundContaminated Freshwater and Marine Fish from Hong Kong and Xiamen", 6/24/2011 From Alliance for Risk Assessment Website: : "PFOA-PFOS Interim Risk Assessment for Contaminated Sites", 2012_________________________________________________________________________________________________ Philippe Grandjean, et al: "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", Environ. Health, doi: 10.1186/1476-069X-12-35, 1/22/2013 Philippe Grandjean, et al: Author's Response to Reviews, "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", 3/26/2013 Glorida Post, Reviewer's Report, "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", 3/19/2013 Philippe Grandjean, et al: Author's Response to Reviews, "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", 3/14/2013 Philippe Grandjean, et al: Author's Response to Reviews, "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", 3/13/2013 Allen Allen Davis, Reviewer's Report, "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", 2/13/2013 Dori R. Germolec, Reviewer's Report, "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", 2/12/2013 Gloria Post, Reviewer's Report, "Immunotoxicity of Perfluorinated Alkylates: Calculation of Benchmark Doses Based on Serum Concentrations in Children", 2/8/2013 abstract: Tony Fletcher: "Risk Assessment and Setting No Adverse Effect Levels for PFOA", Environment and Health, Basel Switzerland, 8/19/2013 PowerPoint presentation authored by Rich Purdy: "Screening Level Cumulative Risk Assessment Perfluorinated Alkyl Acids on Human Health", Undated PowerPoint presentation authored Jennifer Sass, PhD, et al of NRDC: "The Delay Game, How the Chemical Industry Ducks Regulation of the Most Toxic Substances", 10/2011 D. Chimeddulam, et al: "River Water Contaminated with Perfluorinated Compounds Potentially Posing the Greatest Risk to Young Children", doi: 10.1016/j.chemospher.2012.08.039, 9/26/2012 Page 178 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 209 of 232 PAGEID #: 40973 Descriptions of Documents Without Bates Numbers Various publicly-available documents, in addition to those listed above, which were obtained from state or federal agencies pursuant to FOIA/records requests, as well as pages printed from those agencies' websites Page 179 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 210 of 232 PAGEID #: 40974 Deposition Transcripts and Exhibits Darleen Bailey, taken in Leach v. DuPont case on 6/15/04 Glenn Evers, taken in Leach v. DuPont case on 4/30/04 William Fayerweather, taken in Leach v. DuPont case on 6/3/04 Philip Guzelian (2 vols.), taken in Rowe v. DuPont case on 3/13/08 and 12/11/09 Robert Ingalls, taken in Leach v. DuPont case on 5/19/04 Bruce Karrh (2 vols.), taken in Leach v. DuPont case on 4/14/04 and 4/15/04 Gerald Kennedy (2 vols.), taken in Leach v. DuPont case on 7/31/02 and 8/1/02 Robin Leonard, taken in Leach v. DuPont case on 6/25/04 Robin Leonard, taken in Rhodes v. DuPont case on 10/2/07 Anthony Playtis, taken in Tennant v. DuPont case on 1/31/01 (no exhibits marked) DuPont 30(b)(6) witness (Robert Rickard), taken in Rowe v. DuPont case on 12/10/07 Karen Robinson, taken in Leach v. DuPont case on 6/16/04 Howard Smith, taken in Leach v. DuPont case on 5/21/04____________________________ Dee Ann Staats (2 vols.), taken in Leach v. DuPont case on 6/6/02 and 6/7/02 Robert Tardiff, taken in Rowe v. DuPont case on 9/10/10____________________________ Judy Walrath, taken in Leach v. DuPont case on 6/24/04____________________________ Kenneth Wamsley (2 vols.), taken in Leach v. DuPont and Rhodes v. DuPont cases on 2/27/07 (exhibits not included) David Wegman, taken in Rowe v. DuPont case on 10/3/07 DuPont 30(b)(6) witness (Robert Buck), taken on 1/10/13 in the Little Hocking Water Association v. DuPont case (without exhibits) DuPont 30(b)(6) witness (Gerald Kennedy), taken on 7/31/02 in the Leach v. DuPont case Robert Rickard, taken on 1/9/13 in the Little Hocking Water Association v. DuPont case (without exhibits) Page 180 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 211 of 232 PAGEID #: 40975 Deposition Transcripts and Exhibits DuPont 30(b)(6) Witness (Robert Rickard), taken on 1/11/13 in the Little Hocking Water Association v. DuPont case (without exhibits) James Cox (2 vols.), taken in Leach v. DuPont case on 3/30/04 and 3/31/04 DuPont 30(b)(6) witness (Robert Rickard), taken on 8/27/14 in the DuPont/C-8 MDL case James Becker, taken in Rhodes v. DuPont case on 6/1/09 Patricia Buffler (2 vols.), taken in Rowe v. DuPont case on 3/25/08 and 3/26/08 Richard Clapp, taken in Leach v. DuPont case on 8/31/04_____________________________ Barbara Dawson, taken in Leach v. DuPont case on 8/27/04 David Gray, taken in Rhodes v. DuPont case on 1/25/08_____________________________ David Gray, taken in Rhodes v. DuPont case on 1/31/08_____________________________ David Gray, taken in Rhodes v. DuPont case on 6/2/09______________________________ David Gray, taken in Rowe v. DuPont case on 4/3/08________________________________ David Gray, taken in Rowe v. DuPont case on 10/9/09_______________________________ Robert James, taken in Rhodes v. DuPont case on 6/3/09______________________________ Robert James, taken in Rowe v. DuPont case on 1/26/10 Barry Levy (2 vols.), taken taken in Rhodes v. DuPont case on 1/29/08 and 1/30/08 Barry Levy, taken in Rhodes v. DuPont case on 5/28/09_______________________________ Barry Levy (2 vols.), taken in Rowe v. DuPont case on 3/27/08 and 3/28/08 Barry Levy, taken in Rowe v. DuPont case on 10/1/09_______________________________ Barry Levy, taken in Rowe v. DuPont case on 10/26/09______________________________ John Whysner (2 vols.), taken in Rowe v. DuPont case on 3/10/08 and 3/11/08 Page 181 of 181 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 212 of 232 PAGEID #: 40976 APPENDIX B Curriculum Vitae Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 213 of 232 PAGEID #: CURRI 40977 VITAE Michael B. Siegel, M.D., M.P.H. Professor Boston University School of Public Health Department of Community Health Sciences 801 Massachusetts Avenue, 3rdFloor Boston, MA 02118 (617) 638-5167 Education 1. University of California at Berkeley/UCSF General Preventive Medicine Residency Program August, 1991 to June, 1993 M.P.H. completed: May, 1992 (Epidemiology) 2. Berkshire Medical Center, Pittsfield, MA PGY-1 Year in Internal Medicine July, 1990 to June, 1991 3. Yale University School of Medicine M.D. completed: May, 1990 4. Brown University B.A., Environmental Studies: May, 1986 Magna cum laude, Phi Beta Kappa, Sigma Xi Employment Experience June 2006 to present: Boston University School of Public Health Social and Behavioral Sciences Department (now Department of Community Health Sciences) Associate Chair of Academics (now Concentration Director) February 2005 to present: Boston University School of Public Health Social and Behavioral Sciences Department (now Department of Community Health Sciences) Professor September 1999 to February 2005: Boston University School of Public Health Social and Behavioral Sciences Department Associate Professor August, 1995 to September, 1999: Boston University School of Public Health Social and Behavioral Sciences Department Assistant Professor Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 214 of 232 PAGEID #: 40978 July, 1993 to July, 1995: Office on Smoking and Health Centers for Disease Control and Prevention Atlanta, GA Epidemiology fellowship (EIS program) July, 1991 to May, 1993: Santa Clara County Health Department Bureau of Alcohol and Drug Programs San Jose, CA Part-time physician for methadone maintenance program Summers, 1983-1986: Danbury Health Department Section of Environmental and Occupational Health Danbury, CT Memberships in Professional Boards and Associations Board of Scientific and Policy Advisors, American Council on Science and Health Member, American Public Health Association (APHA) Awards and Honors Boston University School of Public Health Excellence in Teaching Award, Fall, 1996 (SB733: Mass Communication and Public Health) Boston University School of Public Health Excellence in Teaching Award, Spring, 1998 (SB815: Program Evaluation Research) Boston University School of Public Health Excellence in Teaching Award, Summer, 1999 (SB815: Program Evaluation Research) Boston University School of Public Health Excellence in Teaching Award, Fall, 1999 (SB733: Mass Communication and Public Health) Norman A. Scotch Award for Excellence in Teaching, 2001 (presented to the outstanding teacher of the year at Boston University School of Public Health) Presented at Commencement exercises, May 20, 2001 Co-author of paper selected by American Marketing Association Advertising Special Interest Group as best advertising article written in 1996 (Pollay RW, Siddarth S, Siegel M, Haddix A, Merritt RK, Giovino GA, Eriksen MP: The last straw? Cigarette advertising and realized market shares among youths and adults, 1979-1993. Journal of Marketing 1996; 60:1-16) Boston University School of Public Health Excellence in Teaching Award, Fall, 2001 (SB733: Mass Communication and Public Health) Recipient of a Flight Attendant Medical Research Institute (FAMRI) Distinguished Professor 2 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 215 of 232 PAGEID #: Award, July 1, 2002 - June 30, 2005 40979 Boston University School of Public Health Excellence in Teaching Award, Fall, 2003 (SB733: Mass Communication and Public Health) Boston University School of Public Health Excellence in Teaching Award, Spring, 2005 (SB860: Strategies for Public Health Advocacy) Boston University School of Public Health Excellence in Teaching Award, Summer, 2005 (SB822: Quantitative Methods for Program Evaluation) Boston University School of Public Health Excellence in Teaching Award, Spring, 2007 (SB860: Strategies for Public Health Advocacy) Boston University School of Public Health Excellence in Teaching Award, Fall, 2007 (SB733: Mass Communication and Public Health) Boston University School of Public Health Excellence in Teaching Award, Spring, 2009 (SB860: Strategies for Public Health Advocacy) Boston University School of Public Health Excellence in Teaching Award, Fall, 2009 (SB733: Mass Communication and Public Health) Boston University School of Public Health Educational Innovation Award, 2010 Presented at the 5thAnnual John McCahan Medical Campus Education Day, June 11, 2010 Boston University School of Public Health Excellence in Teaching Award, Fall, 2010 (SB721: Social and Behavioral Sciences for Public Health) Boston University School of Public Health Excellence in Teaching Award, Spring, 2011 (SB721: Social and Behavioral Sciences for Public Health) Boston University School of Public Health Excellence in Teaching Award, Spring, 2011 (SB860: Strategies for Public Health Advocacy) Books Siegel M, Doner L. Marketing public health: Strategies to promote social change. Gaithersburg, MD: Aspen Publishers, Inc.; 1998. Siegel M, Doner L. Marketing public health: Strategies to promote social change (2ndedition). Sudbury, MA: Jones & Bartlett Publishers, Inc.; 2007. Siegel M, Doner L. Marketing public health: Strategies to promote social change (3ndedition). Sudbury, MA: Jones & Bartlett Learning; 2012. Publications 1. Nakabayashi K, Aronson SC, Siegel M, Stunner WQ, Aronson SM: Traffic fatalities in Rhode Island: Part I -- Descriptive epidemiology. Rhode Island Medical Journal 1984; 67:25-30. 2. Nakabayashi K, Aronson SC, Siegel M, Stumer WQ, Aronson SM: Traffic fatalities in Rhode Island: Part II -- The timing of accidents and the role of marital status, alcohol, and psychoactive drugs. 3 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 216 of 232 PAGEID #: Rhode Island Medical Journal 1984; 67:171- 40980 3. Nakabayashi K, Aronson SC, Siegel M, Stumer WQ, Aronson SM: Traffic fatalities in Rhode Island: Part III -- The role of the motorcycle. Rhode Island Medical Journal 1984; 67:453-459. 4. Aronson SC, Nakabayashi K, Siegel M, Sturner WQ, Aronson SM: Traffic fatalities in Rhode Island: Part IV -- The pedestrian victim. Rhode Island Medical Journal 1984;67:485-489. 5. Siegel M, Forsyth B, Siegel L, Cullen MR: The effect of lead on thyroid function in children. Environ Res 1989; 49:190-196. 6. Yakovlevitch M, Siegel M, Hoch D, Rutlen D: Pulmonary hypertension in a patient with tryptophaninduced eosinophilia-myalgia syndrome. Am J Med 1991; 90:272-3. 7. Siegel M: Smoking and leukemia: Evaluation of a causal hypothesis. Am J Epidemiol 1993; 138:1-9. 8. Siegel M: Involuntary smoking in the restaurant workplace: A review of employee exposure and health effects. JAMA 1993; 270:490-493 9. Siegel M: Re: Smoking and leukemia: evaluation of a causal hypothesis (reply to letter to editor). Am J Epidemiol 1994; 139:852. 10. Siegel M: The hazards of involuntary smoking in the restaurant workplace (reply to letter to editor). JAMA 1994; 271:584-585. 11. Siegel M, Arday DR, Merritt RK, Giovino GA: Re: "Risk attribution and tobacco-related deaths" (letter to editor). Am J Epidemiol 1994; 140:1051. 12. Changes in the cigarette brand preferences of adolescent smokers -- United States, 1989-1993. MMWR 1994; 43:577-581. 13. Conlisk E, Siegel M, Lengerich E, MacKenzie W, Malek S, Eriksen M: The status of local smoking regulations in North Carolina following a state preemption bill. JAMA 1995; 273:805-807. 14. Siegel M, Husten C, Merritt R, Giovino G, Eriksen M: The health effects of separately ventilated smoking lounges on smokers: Is this an appropriate public health policy? Tobacco Control 1995; 4:22-29. 15. Assessment of the impact of a 100% smoke-free ordinance on restaurant sales -- West Lake Hills, Texas, 1992-1994. MMWR 1995; 44:370-372. 16. Trends in smoking initiation among adolescents and young adults -- United States, 1980-1989. MMWR 1995; 44:521-525. 17. Siegel M, Peddicord J, Merritt R, Nelson D, Giovino G, Eriksen M: The extent of cigarette brand switching among current smokers: Data from the 1986 Adult Use of Tobacco Survey. American Journal of Preventive Medicine 1996; 12:14-16. 18. Mannino D, Siegel M, Husten C, Rose D, Etzel R: Environmental tobacco smoke exposure and health effects in children: Results from the 1991 National Health Interview Survey. Tobacco Control 1996; 5:13-18. 19. Pollay RW, Siddarth S, Siegel M, Haddix A, Merritt RK, Giovino GA, Eriksen MP: The last straw? Cigarette advertising and realized market shares among youths and adults, 1979-1993. Journal of Marketing 1996; 60:1-16. 4 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 217 of 232 PAGEID #: 20. Novotny TE, Siegel M: California's tobacco 4 0 9 8 1 aga. Health Affairs 1996; 15:56-72. 21. Siegel M, Biener L. Evaluating the impact of statewide anti-tobacco campaigns: The Massachusetts and California tobacco control programs. Journal of Social Issues 1997;53:147-168. 22. Biener L, Siegel M. Behavior intentions of the public after bans on smoking in restaurants and bars. American Journal of Public Health 1997;87: 2042-2044. 23. Siegel M. Media advocacy and public health: power for prevention (book review). International Quarterly of Community Health Education 1997;16:286-288. 24. Siegel M, Carol J, Jordan J, Hobart R, Schoenmarklin S, DuMelle F, Fisher P. Preemption in tobacco control: review of an emerging public health problem. Journal of the American Medical Association 1997;278:858-863. 25. Mannino DM, Siegel M, Rose D, Nkuchia J, Etzel R. Environmental tobacco smoke exposure in the home and worksite and health effects in adults: results from the 1991 National Health Interview Survey. Tobacco Control 1997;6:296-305. 26. Pucci L, Joseph HM, Siegel M. Outdoor tobacco advertising in six Boston neighborhoods: Evaluating youth exposure. American Journal of Preventive Medicine 1998;15:155-159. 27. King C, Siegel M, Celebucki C, Connolly GN. Adolescent exposure to cigarette advertising in magazines: An evaluation of brand-specific advertising in relation to youth readership. Journal of the American Medical Association 1998; 279:516-520. 28. Siegel M. Mass media antismoking campaigns: A powerful tool for health promotion. Annals of Internal Medicine 1998;129:128-132. 29. Menashe CL, Siegel M. The power of a frame: An analysis of newspaper coverage of tobacco issues - United States, 1985-1996. Journal of Health Communication 1998; 3:307-325. 30. Pucci LG, Siegel M. Features of sales promotion in cigarette magazine advertisements, 1980-1993: An analysis of youth exposure in the United States. Tobacco Control 1999; 8:29-36. 31. Siegel M. Should we compromise on tobacco industry immunity to achieve national comprehensive tobacco legislation? (letter to the editor) Am J Public Health 1999; 89:1273. 32. Lima J, Siegel M. The tobacco settlement: an analysis of newspaper coverage of a national policy debate, 1997-1998. Tobacco Control 1999; 8:247-253. 33. Siegel M, Biener L, Rigotti NA. The effect of local tobacco sales laws on adolescent smoking initiation. Preventive Medicine 1999; 29:334-342. 34. Pucci LG, Siegel M. Exposure to brand-specific cigarette advertising in magazines and its impact on youth smoking. Preventive Medicine 1999; 29:313-320. 35. King C, Siegel M. Brand-specific cigarette advertising in magazines in relation to youth and young adult readership, 1986-1994. Nicotine and Tobacco Research 1999; 1:331-340. 36. Biener L, Siegel M. Tobacco marketing and adolescent smoking: more support for a causal inference. American Journal of Public Health 2000; 90:407-411. 37. Siegel M, Biener L. The impact of an antismoking media campaign on progression to established smoking: results of a longitudinal youth study. American Journal of Public Health 2000; 90:380-386. 5 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 218 of 232 PAGEID #: 38. Siegel M, Mowery PD, Pechacek TP, Straus 40982hooley MW, Merritt RK, Novotny TE, Giovino GA, Eriksen MP. Trends in adult cigarette smoking in California compared with the rest of the United States, 1978-1994. American Journal of Public Health 2000; 90:372-379. 39. King C, Siegel M, Pucci LG. Exposure of black youths to cigarette advertising in magazines. Tobacco Control 2000; 9:64-70. 40. Howland J, Rohsenow DJ, Cote J, Siegel M, Mangione TW. Effects of low-dose alcohol exposure on simulated merchant ship handling power plant operation by maritime cadets. Addiction 2000; 95:719 726. 41. Siegel M. Counteracting tobacco motor sports sponsorship as a promotional tool: is the tobacco settlement enough? American Journal of Public Health 2001; 91:1100-1106. 42. Rosenberg NJ, Siegel M. Use of corporate sponsorship as a tobacco marketing tool: a review of tobacco industry sponsorship in the USA, 1995-99. Tobacco Control 2001; 10:239-246. 43. King C, Siegel M. The Master Settlement Agreement with the tobacco industry and cigarette advertising in magazines. New England Journal of Medicine 2001; 345:504-511. 44. Siegel M. Antismoking advertising: figuring out what works. Journal of Health Communication 2002; 7:157-162. 45. Siegel M. The effectiveness of state-level tobacco control interventions: a review of program implementation and behavioral outcomes. Annual Review of Public Health 2002; 23:45-71. 46. Honjo K, Siegel M. Perceived importance of being thin and smoking initiation among young girls. Tobacco Control 2003; 12:289-295. 47. Skeer M, Siegel M. The descriptive epidemiology of local restaurant smoking regulations in Massachusetts: an analysis of the protection of restaurant customers and workers. Tobacco Control 2003; 12:221-226. 48. Siegel M, Skeer M. Exposure to secondhand smoke and excess lung cancer mortality risk among workers in the "5 B's": bars, bowling alleys, billiard halls, betting establishments, and bingo parlours. Tobacco Control 2003; 12:333-338. 49. Skeer M, George S, Hamilton WL, Cheng DM, Siegel M. Town-level characteristics and smoking policy adoption in Massachusetts: Are local restaurant smoking regulations fostering disparities in health protection? American Journal of Public Health 2004; 94:286-292. 50. Siegel M, Albers AB, Cheng DM, Biener L, Rigotti NA. Effect of local restaurant smoking regulations on environmental tobacco smoke exposure among youths. American Journal of Public Health 2004; 94:321-325. 51. Albers AB, Siegel M, Cheng DM, Rigotti NA, Biener L. Effects of restaurant and bar smoking regulations on exposure to environmental tobacco smoke among Massachusetts adults. American Journal of Public Health 2004;94:1959-1964. 52. Albers AB, Siegel M, Cheng DM, Biener L, Rigotti NA. Relation between local restaurant smoking regulations and attitudes towards the prevalence and social acceptability of smoking: a study of youths and adults who eat out predominantly at restaurants in their town. Tobacco Control 2004; 13:347-55. 53. Skeer M, Land ML, Cheng DM, Siegel M. Smoking in Boston bars before and after a 100% smokefree regulation: an assessment of early compliance. Journal of Public Health Management and 6 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 219 of 232 PAGEID #: Practice 2004; 10:501-507. 40983 54. Stone M, Siegel M. Tobacco industry sponsorship of community-based public health initiatives: why AIDS and domestic violence organizations accept or refuse funds. Journal of Public Health Management and Practice 2004; 10:511-517. 55. Thomson CC, Gokhale M, Biener L, Siegel MB, Rigotti NA. Statewide evaluation of youth access ordinances in practice: effects of the implementation of community-level regulations in Massachusetts. Journal of Public Health Management and Practice 2004; 10:481-489. 56. Siegel M, Jones S. Bar workers have disproportionately high health risks from exposure to tobacco smoke (letter to the editor - rapid response). British Medical Journal Online (bmj .com), July 23, 2004. http://bmj .bmjjournals.com/cgi/eletters/329/7457/70-b#68303. 57. Siegel M. Food and Drug Administration regulation of tobacco: snatching defeat from the jaws of victory (commentary). Tobacco Control 2004;13:439-41. 58. Skeer M, Cheng DM, Rigotti NA, Siegel M. Secondhand smoke exposure in the workplace. American Journal of Preventive Medicine 2005;28:331-337. 59. Thomson CC, Siegel M, Winickoff J, Biener L, Rigotti NA. Household smoking bans and adolescents' perceived prevalence of smoking and social acceptability of smoking. Preventive Medicine 2005;41:349-356. 60. Siegel M, Albers AB, Cheng DM, Biener L, Rigotti NA. Effect of local restaurant smoking regulations on progression to established smoking among youths. Tobacco Control 2005; 14:300-306. 61. Siegel M, Barbeau EM, Osinubi OY. The impact of tobacco use and secondhand smoke on hospitality workers. Clinics in Occupational and Environmental Medicine 2006; 5:31-42. 62. Deverell M, Randolph C, Albers A, Hamilton W, Siegel M. Diffusion of local restaurant smoking regulations in Massachusetts: identifying disparities in health protection for population subgroups. Journal of Public Health Management and Practice 2006; 12:261-268. 63. Siegel M, Blum A. FDA tobacco legislation: reprieve for the Marlboro man? (commentary). Lancet 2006; 368:266-268. 64. Thomson CC, Hamilton WL, Siegel MB, Biener L, Rigotti NA. Effect of local youth-access regulations on progression to established smoking among youths in Massachusetts. Tobacco Control 2007; 16:119-126. 65. Albers AB, Siegel M, Cheng DM, Biener L, Rigotti NA. Effect of smoking regulations in local restaurants on smokers' anti-smoking attitudes and quitting behaviours. Tobacco Control 2007; 16:101-106. 66. Biener L, Garrett CA, Skeer M, Siegel M, Connolly G. The effects on smokers of Boston's smokefree bar ordinance: A longitudinal analysis of changes in compliance, patronage, policy support, and smoking at home. Journal of Public Health Management and Practice 2007; 13:630-636. 67. Siegel M. Is the tobacco control movement misrepresenting the acute cardiovascular health effects of secondhand smoke exposure? An analysis of the scientific evidence and commentary on the implications for tobacco control and public health practice. Epidemiologic Perspectives and Innovations 2007; 4:12. 68. Siegel M, Albers AB, Cheng DM, Hamilton WL, Biener L. Local restaurant smoking regulations and the adolescent smoking initiation process: Results of a multi-level contextual analysis among 7 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 220 of 232 PAGEID #: Massachusetts youth. Archives of Pediatrics a40984lescent Medicine 2008; 162:477-483. 69. Siegel M, King C, Ostroff J, Ross C, Dixon K, Jernigan DH. Comment - Alcohol advertising in magazines and youth readership: Are youths disproportionately exposed? Contemporary Economic Policy 2008; 26:482-492. 70. Albers AB, Siegel MB, Cheng DM, Biener L, Rigotti NA. Household smoking bans and adolescent antismoking attitudes and smoking initiation: Findings from a longitudinal study of a Massachusetts youth cohort. American Journal of Public Health 2008; 98:1886-1893. 71. Biener L, Wakefield M, Shriner CM, Siegel M. How broadcast volume and emotional content affect youth recall of anti-tobacco advertising. American Journal of Preventive Medicine 2008; 35:14-19. 72. Houle B, Siegel M. Smoker-free workplace policies: Developing a model of public health consequences of workplace policies barring employment to smokers. Tobacco Control 2009; 18: 64 69. 73. Siegel M. Nicotine replacement, effective? (letter to the editor and rapid response). BMJ 2009;338:b1730. 74. Albers AB, Biener L, Siegel M, Cheng DM, Rigotti NA. Impact of parental home smoking policies on policy choices of independently living young adults. Tobacco Control 2009; 18:245-248. 75. Nyborn JA, Wukitsch K, Nhean S, Siegel M. Alcohol advertising on Boston's Massachusetts Bay Transit Authority transit system: An assessment of youths' and adults' exposure. American Journal of Public Health 2009; 99(S3):S644-S648. 76. King C, Siegel M, Jernigan DH, Wulach L, Ross C, Dixon K, Ostroff J. Adolescent exposure to alcohol advertising in magazines: An evaluation of advertising placement in relation to underage youth readership. Journal of Adolescent Health 2009; 45:626-633. 77. Biener L, Hamilton WL, Siegel M, Sullivan EM. Individual, social-normative and policy predictors of smoking cessation: A multilevel, longitudinal analysis. American Journal of Public Health 2010; 100:547-554. 78. Siegel M, King C, Jernigan DH, Ross C, Ostroff J. Reply to: Nelson JP. Measurement problems in assessing adolescent exposure to alcohol advertising in magazines (reply to letter to editor). Journal of Adolescent Health 2010; 46:404. 79. Schwartz MB, Ross C, Harris J, Jernigan D, Siegel M, Ostroff J, Brownell KD. Cereal industry pledges to self-regulate advertising to youth: Will they improve the marketing landscape? Journal of Public Health Policy 2010; 31:59-73. 80. Cahn Z, Siegel M. Electronic cigarettes as a harm reduction strategy for tobacco control: A step forward or a repeat of past mistakes? Journal of Public Health Policy 2011; 32:16-31. 81. Siegel M, DiLoreto J, Johnson A, Fortunato EK, DeJong W. Development and pilot testing of an internet-based survey instrument to measure the alcohol brand preferences of U.S. youth. Alcoholism: Clinical and Experimental Research 2011; 35:765-772. 82. Binakonsky J, GigaNM, Ross C, Siegel M. Jello shot consumption among older adolescents: A pilot study of a newly identified public health problem. Substance Use and Misuse 2011; 46(6):828-835. 83. Giga NM, Binakonsky J, Ross C, Siegel M. The nature and extent of flavored alcoholic beverage consumption among underage youth: Results of a national brand-specific survey. American Journal of Drug and Alcohol Abuse 2011; 37:229-234. 8 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 221 of 232 PAGEID #: 40985 84. Siegel M, DeJong W, Naimi TS, Heeren T, Rosenbloom DL, Ross C, Ostroff J, Jemigan DH. Alcohol brand preferences of underage youth: Results from a pilot survey among a national sample. Substance Abuse 2011; 32:191-201. 85. Siegel M, Tanwar KL, Wood KS. Electronic cigarettes as a smoking cessation tool: Results from an online survey. American Journal of Preventive Medicine 2011; 40:472-475. 86. Siegel MB, Naimi TS, Cremeens JL, Nelson DE. Alcoholic beverage preferences and associated drinking patterns and risk behaviors among high school youth. American Journal of Preventive Medicine 2011; 40:419-426. 87. Gentry E, Poirier K, Wilkinson T, Nhean S, Nyborn J, Siegel M. Alcohol advertising at the Boston subway stations: An assessment of exposure based on race and socio-economic status. American Journal of Public Health 2011; 101:1936-1941. 88. Siegel M. A lost opportunity for public health - the FDA Advisory Committee report on menthol (Perspective). New England Journal of Medicine 2011; 364:2177-2179. 89. Abdullah AS, Hua F, Xia X, Hurlburt S, Ng P, MacLeod W, Siegel M, Griffiths S, Zhang Z. Second hand smoke exposure and household smoking bans in Chinese families: A qualitative study. Health & Social Care in the Community 2012; 20:356-364. 90. DiLoreto JT, Siegel M, Hinchey D, Valerio H, Kinzel K, Lee S, Chen K, Shoaff JR, Kenney J, Jernigan DH, DeJong W. Assessment of the average price and ethanol content of alcoholic beverages by brand - United States, 2011. Alcoholism: Clinical and Experimental Research 2012; 36:1288 1297. 91. Wagener TL, Siegel M, Borrelli B. Electronic cigarettes: achieving a balanced perspective. Addiction 2012; 107:1545-1548. 92. Wagener TL, Siegel M, Borrelli B. Let's keep our `eye on the ball': Reducing tobacco-related harm. Addiction 2012; 107:1554-1555. 93. Siegel M, DeJong W, Albers AB, Naimi TS, Jernigan DH. Differences in liquor prices between control state-operated and license-state retail outlets in the U.S. Addiction 2012; 108:339-347. 94. Swenson T, Siegel M. Increasing stair use in an office worksite through an interactive environmental intervention. American Journal of Health Promotion 2013; 27:323-329. 95. Albers AB, DeJong W, Naimi TS, Siegel M, Shoaff JR, Jernigan DH. Minimum financial outlays for purchasing alcohol brands in the U.S. American Journal of Preventive Medicine 2013; 44:67-70. 96. Siegel M, DeJong W, Naimi TS, Fortunato EK, Albers AB, Heeren T, Rosenbloom DL, Ross C, Ostroff J, Rodkin S, King C, Borzekowski DLG, Rimal RN, Padon AA, Eck RH, Jernigan DH. Brand-specific consumption of alcohol among underage youth in the United States. Alcoholism: Clinical & Experimental Research 2013; 37(7): 1195-1203. 97. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapies among successful e-cigarette users: a qualitative approach. Addiction Science and Clinical Practice 2013, 8:5. doi: 10.1186/1940-0640-8-5. 98. Siegel M, Grundman J, DeJong W, Naimi TS, King C, Albers AB, Williams RS, Jernigan DH. Statespecific liquor excise taxes and retail prices in eight U.S. states, 2012. Substance Abuse 2013; 34:415-421. 9 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 222 of 232 PAGEID #: 99. Siegel M, Johnson RM, Tyagi K, Power K, 4 0 9 8 6 C, Ayers AJ, Jemigan DH. Alcohol brand references in U.S. popular music, 2009-2011. Substance Use & Misuse 2013; 48:1475-1484. 100. Siegel M, Ross CS, King C. The relationship between gun ownership and firearm homicide rates in the United States, 1981-2010. American Journal of Public Health 2013; 103:2098-2105. 101. Borzekowski DLG, Ross CS, Jernigan DH, DeJong W, Siegel M. Patterns of media use and alcohol brand consumption among underage drinking youth in the U.S. Journal of Health Communication (in press). 102. Wagener TL, Meier E, Hale JJ, Oliver ER, Warner ML, Quinalty LM, Gillaspy SR, Siegel M, Foster S. A pilot investigation of changes in readiness and confidence to quit smoking after e-cigarette experimentation and 1-week of use. Nicotine & Tobacco Research 2014; 16:108-114. 103. Siegel M, Ross CS, King C. A new proxy measure for state-level gun ownership in studies of firearm injury prevention. Injury Prevention 2014; 20:204-207. 104. Fortunato EK, Siegel M, Ramirez RL, Ross C, DeJong W, Albers AB, Jernigan DH. Brand-specific consumption of flavored alcoholic beverages among underage youth in the United States. American Journal of Drug and Alcohol Abuse 2014; 40:51-57. 105. Kponee K, Siegel M, Jernigan DH. The use of caffeinated alcoholic beverages among underage drinkers: Results of a national survey. Addictive Behaviors 2014; 39:253-258. 106. Nhean S, Nyborn J, Hinchey D, Valerio H, Kinzel K, Siegel M, Jernigan DH. The frequency of company-sponsored alcohol brand-related sites on FacebookTM - 2012. Substance Use & Misuse (in press). 107. Siegel M, Chen K, DeJong W, Naimi TS, Ostroff J, Ross CS, Jernigan DH. Differences in alcohol brand consumption between underage youth and adults - United States, 2012. Substance Abuse (in press). 108. Siegel M, Ross CS, King C. Examining the relationship between the prevalence of guns and homicide rates in the United States using a new and improved state-level gun ownership proxy. Injury Prevention (in press). 109. Siegel M, Negussie Y, Vanture S, Pleskunas J, Ross CS, King C. The relationship between gun ownership and stranger and nonstranger firearm homicide rates in the United States, 1981-2010. American Journal of Public Health 2014; 104: 1912-1919. 110. Naimi TS, O'Doherty CM, DeJong W, Siegel M, Jernigan DH. Beverage- and brand-specific binge alcohol consumption among underage youth in the U.S. Journal of Substance Use (in press). 111. Albers AB, Siegel M, DeJong W, Naimi TS, Jernigan DH. The relationship between alcohol price and brand choice among underage drinkers: Are the most popular alcoholic brands consumed by youth the cheapest? Substance Use & Misuse (in press). 112. Ross, CS, Maple E, Siegel M, DeJong W, Naimi TS, Ostroff J, Padon AA, Borzekowski DLG, Jernigan DH. The relationship between brand-specific alcohol advertising on television and brandspecific consumption among underage youth. Alcoholism: Clinical & Experimental Research 2014; 38: 2234-2242.13 113. Roberts SP, Siegel MB, DeJong W, Naimi TS, Jernigan DH. The relationships between alcohol source, autonomy in brand selection, and brand preference among youth in the U.S. Alcohol & Alcoholism (in press). 10 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 223 of 232 PAGEID #: 114. Siegel M, Ayers AJ, DeJong W, Naimi TS, J40987 DH. Differences in alcohol brand consumption among underage youth by age, gender, and race/ethnicity - United States, 2012. Journal of Substance Use (in press). 115. Roberts SP, Siegel MB, DeJong W, Jernigan DH. How much are adolescents really drinking? A comparison between brand-specific and traditional alcohol surveillance methods to assess underage drinkers' reported alcohol use. American Journal of Drug and Alcohol Abuse (in press). 116. Ross CS, Ostroff J, Siegel MB, DeJong W, Naimi TS, Jernigan DH. Youth alcohol brand consumption and exposure to brand advertising in magazines. Journal of Studies on Alcohol and Drugs 2014; 75: 615-622. 117. Esser M, Siegel M. Alcohol facts labels on Four Loko: Will the Federal Trade Commission's order be effective in reducing hazardous drinking among underage youth? American Journal of Drug and Alcohol Abuse (in press). 118. Belt O, Stamatakos K, Ayers AJ, Fryer VA, Jernigan DH, Siegel M. Alcohol brand sponsorship of events, organizations and causes in the United States, 2010-2013. Addiction (in press). 119. Siegel M, Galloway A, Ross CS, Binakonsky J, Jernigan DH. Jello shot consumption among underage youth in the United States. Journal of Child and Adolescent Substance Abuse (in press). Published Articles, Columns, Book Chapters, and Letters 1. Siegel M. Smoking and Restaurants: A Guide for Policy-Makers. Berkeley, CA: University of California, Berkeley Preventive Medicine Residency Program, Alameda County Tobacco Control Program, American Heart Association, California Affiliate, 1992. 2. Siegel M. Second-hand smoke (letter to editor). The Toronto Globe and Mail 1996;June 10. 3. Siegel M. Secondhand smoke: Fact & fiction. Massachusetts Association of Health Boards Quarterly 1996; 14:1,6,7. 4. Siegel M. Tobacco: The $10 billion dollar debate (op-ed column). The Washington Post 1996;December 22:C7. 5. Siegel M. What sort of tobacco settlement? (op-ed column). The Washington Post 1997;May 4:C7. 6. Siegel M. No deal worth giving tobacco companies immunity from accountability (letter to editor). USA Today 1997;September 26:14A. 7. Siegel M. Too soft on tobacco (letter to the editor). The Nation's Health 1997; November:2. Washington, DC: American Public Health Association. 8. Siegel M. Not too hasty on tobacco (op-ed column). Knight Ridder News Service. February 3, 1998. 9. Siegel M. Outrage of the Month: American Cancer Society and American Heart Association - Failing to oppose atobacco deal. Health Letter 1998 (May), Volume 14, Number 5. Washington, DC: Public Citizen, Health Research Group. 10. Siegel M. Smoking and Bars: A Guide for Policy-Makers. Boston, MA: Boston University School of Public Health, January, 1998. 11. Kendrick JS, Siegel M. Health consequences of tobacco use among four racial/ethnic minority groups: Smoking and pregnancy. In: U.S. Department of Health and Human Services. Tobacco Use 11 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 224 of 232 PAGEID #: among U.S. Racial/Ethnic Minority Groups - 40988 Americans. American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1998:166-171. 12. Siegel M. Secondhand smoke hazards proved. Worcester Telegram & Gazette 1998;September 7:A10. 13. Doner L, Siegel M. Public health marketing. In: Novick LF, Mays GP, eds. Public Health Administration: Principles for Population-Based Management. Gaithersburg, MD: Aspen Publishers, Inc., 2000, pp. 474-509. 14. Siegel M. Tobacco Industry Sponsorship in the United States, 1995-1999. Boston, MA: Boston University School of Public Health, 2000. http://dcc2.bumc.bu.edu/tobacco. 15. Biener L, Siegel MB. The role of tobacco advertising and promotion in smoking initiation. In: U.S. Department of Health and Human Services. Changing Adolescent Smoking Prevalence: Where It Is and Why (Smoking and Tobacco Control Monograph 14). Bethesda, MD: National Institutes of Health, National Cancer Institute, NIH Publ. No. 02-5086, November 2001, pp. 201-212 (Chapter 13). 16. Siegel M, Biener L. The impact of antismoking media campaigns on progression to established smoking: Results of a longitudinal youth study in Massachusetts. In: Hornik R, ed. Public Health Communication: Evidence for Behavior Change. Mahwah, NJ: Lawrence Erlbaum Associates, 2002, pp. 115-130 (Chapter 7). 17. Blum A, Siegel M. Foundation award is anti-smoking hypocrisy (op-ed). Tuscaloosa News 2005;March18. 18. Siegel M. Burned out by butt-inskis (op-ed). Boston Herald 2006;May 20:22. 19. Siegel M, Blum A. Tobacco legislation laden with loopholes (op-ed). Birmingham News 2006;July 23. 20. Siegel M. No need to exaggerate; the truth is enough (op-ed). St. Paul Pioneer Press 2006;July 23. 21. Siegel M. Unsafe at any level (op-ed). The New York Times 2007; January 28(section 4, page 17). 22. Lotenberg LD, Siegel M. Using marketing in public health (Chapter 22). In: Novick LF, Morrow CB, Mays GP, eds. Public Health Administration: Principles for Population-Based Management, 2nd edition. Sudbury, MA: Jones and Bartlett Publishers, 2008; 621-656. 23. Blum A, Siegel M. Loopholes aid big Tobacco: Plan to let FDA regulate cigarettes would do industry's dirty work (op-ed). USA Today 2007; September 12. 24. Siegel M. Smoking ordinance will backfire (letter to the editor). The Acorn (Agoura Hills, CA), January 31, 2008. 25. Siegel M. There's no room for racist nicknames in Natick (op-ed). The Metrowest Daily News, February 12, 2008. 26. Siegel M. Smoking isn't amoral issue (letter to the editor). The Daily Freeman (Kingston, NY), July 22, 2008. 27. Siegel M. Electronic cigarettes jolt cynical opposition (op-ed). Boston Herald 2009; May 11, p.19. 12 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 225 of 232 PAGEID #: 40989 28. Siegel M. Tobacco regulations are no regulations at all: A proposal to put cigarettes under FDA supervision is so limited that it's really a smoke screen for Big Tobacco (op-ed). The Los Angeles Times 2009; June 3. 29. Siegel M. When smoke clears, e-cigarette foes hazardous to health (op-ed). The Hartford Courant 2009; August 23. 30. Siegel M. Enough secondhand hysteria: Anti-smoking groups exaggerate risks to justify ban in city parks (op-ed). New York Daily News 2009; October 26. 31. Siegel M. Needham Fourth of July tradition racist; Fred Muzi `Native American' costume needs to go (op-ed). The Needham Times 2010; July 27. 32. Siegel M. Reduce your risk of smoking-related cardiovascular disease. Media Planet advertising supplement to the Los Angeles Times, September 2010. 33. Siegel M. Guest opinion: Drugstore tobacco ban sends youth the wrong message. Fall River HeraldNews, March 11, 2011. 34. Siegel M. Slippery slope to Wisconsin (letter to the editor). Boston Globe 2011; May 1. 35. Siegel MB. A smoking ban too far (op-ed). New York Times 2011; May 5. 36. Siegel M. Gruesome cigarette-pack labels say too much (op-ed). Bloomberg View 2011; June 24. 37. Siegel M. Art museum's censorship destroys its integrity. Mondoweiss: The War of Ideas in the Middle East (blog). September 15, 2011. 38. Cahn Z, Siegel M. Tobacco harm reduction and the FDA: Obstacles and Opportunities for Health Promotion (Chapter 11). In: Chowdhury A, ed. Tobacco Regulation and Compliance: An Essential Resource. Washington, DC: Food and Drug Law Institute, 2011, pp. 263-290. 39. DiLoreto J, Siegel M. Health effects of exposure to environmental tobacco smoke. In: Friis RH, ed. The Praeger Handbook of Environmental Health - Volume 3: Water, Air, and Solid Waste (chapter 16), pp. 335-350. 40. Siegel M. Intervention for smoking cessation: From randomized controlled trial to real world. Polosa R, Caponnetto P, eds. Advances in Smoking Cessation. London: Future Medicine, 2013, pp. 54-66. 41. Siegel M. The ambiguous allure of the electronic cigarette: What's not to like? (commentary). New York Times, August 20, 2013. 42. Siegel M. Anti-smoking movement has been co-opted. Half a century after hazardous-to-health warning, smoking kills too many (op-ed). BU Today 2014; February 11. 43. Siegel M. Who mourns for Brianna? Marathon memorials appropriate, but don't forget about other violence victims (op-ed). BU Today 2014; June 6. 44. Siegel M. The e-cigarette gateway myth (op-ed). Wall Street Journal, August 6, 2014. Presentations at Scientific/Professional Meetings 1. Involuntary smoking in the restaurant workplace: evaluation of exposure and health effects (poster). 13 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 226 of 232 PAGEID #: Prevention '93 Conference, St. Louis, MO, A 4 0 9 9 0 3. 2. Panel member and presenter on the effectiveness of tobacco control policies and the role of local tobacco control policies. National Cancer Institute ASSIST training course, Washington, DC, December 2, 1993. 3. Panel member and presenter on the role of government in tobacco control and the effects of preemption on protection of the public from environmental tobacco smoke exposure. California Preemption Education Conference, The Wellness Foundation, San Diego, CA, October 2-3, 1994. 4. Mannino D, Siegel M, Husten C, Rose D, Etzel R. Environmental tobacco smoke exposure and respiratory diseases in children (abstract). Scientific Highlights: Abstracts of Original Investigations. The 60th Annual International Scientific Assembly of the American College of Chest Physicians. Chest 1994;106:115S. 5. The effects of separately ventilated smoking lounges on the health of smokers: Is this an appropriate public health policy? Epidemiology Grand Rounds, CDC, November 8, 1994. 6. Panel member and presenter on evaluation of public health programs. Chronic Disease Conference, National Center for Health Promotion and Disease Prevention, CDC, Washington, DC, December 7 9, 1994. 7. The impact of cigarette advertising on brand market share among adults and adolescents (poster). EIS Conference, CDC, Atlanta, GA, March, 1995. 8. Giovino GA, Siegel M, Tomar SL. Cigarette advertising and brand preference among adolescents and adults: data from U.S. national studies. Paper presented at the 1995 Society for Consumer Psychology Conference: The Role of Advertising in Social Marketing, Atlanta, GA, May 18, 1995. 9. Panel member and presenter on preemption and its effect on public health. National Tobacco Control Conference, Boston, MA, June 2-4, 1995. 10. Faculty member. Tobacco Control Summer Institute, University of North Carolina, July 16-21, 1995. Co-coordinator of course on clean indoor air policy. 11. Speaker. Protecting Youth from Tobacco Conference. Andover, MA, September 21, 1995. 12. Speaker and panelist. Tobacco and the Latino Community seminar, Latino Health Institute. Boston University School of Public Health, October 10, 1995. 13. Workshop leader and presenter. Tobacco Prevention: Connecting for the Future (ASSIST Information Exchange Training). Washington, DC, October 17, 1995. 14. Organizer and guest speaker. Symposium on the Public Health Problem of Environmental Tobacco Smoke Exposure in Restaurants. Boston University School of Public Health, November 13, 1995. 15. The Power of Mass Communication to Promote Health. Boston University School of Public Health, Public Health Forum, January 30, 1996. 16. Pollay RW, Siddarth S, Siegel M. Realized market shares among old and new smokers and advertising share of voice. Conference of the American Academy of Advertising, Vancouver, British Columbia, March 29-April 1, 1996. 17. Speaker. Boston University School of Medicine Cancer Prevention and Control Grand Rounds, May 17, 1996. 14 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 227 of 232 PAGEID #: 18. Pollay RW, Siddarth S, Siegel M. Cigarette a 4 991ig and realized market shares among mature and immature smokers. Marketing and Public Policy Conference, Washington, DC, May 17-18, 1996. 19. Workshop leader and presenter. National Tobacco Control Conference, Chicago, IL, May 29-30, 1996. 20. Keynote speaker. Massachusetts Tobacco Control Conference. Marlboro, MA, June 3, 1996. 21. Course coordinator, "Clean Indoor Air Policies," Tobacco Control Summer Institute, St. Louis, MO, July 8-12, 1996. 22. Workshop leader and presenter. The 1st Annual Conference on Local Control, Chicago, IL, November 15-16, 1996. 23. Siegel M, Connolly G, Celebucki C, Skandera M. Does cigarette advertising in magazines target youths? Presented at the 124th Annual Meeting of the American Public Health Association, New York, NY, November 17-21, 1996. 24. Siegel M, Barnes E, Kot V, Osthimer B. The societal costs of welfare "reform": Homelessness and its public health consequences. Presented at the 124th Annual Meeting of the American Public Health Association, New York, NY, November 17-21, 1996. 25. Pucci L, Siegel M. Does tobacco advertising target adolescents? The nature of stationary outdoor tobacco advertising in six Boston neighborhoods. Presented at Prevention 97, March 19-20, 1997, Atlanta, GA. 26. Siegel M. Global tobacco settlement: Public health victory or resounding defeat? Preventive Medicine Grand Rounds, Carney Hospital, Dorchester, MA, September 23, 1997. 27. The Tobacco Settlement: The Thrill of Victory or the Agony of Defeat?. Boston University School of Public Health, Public Health Forum, October 14, 1997. 28. The Societal Costs of Welfare "Reform." Boston University School of Public Health, Public Health Forum, April 7, 1998. 29. Health effects of secondhand smoke and economic impact of smoke-free bar and restaurant ordinances. Marlborough Community Forum. Marlborough, MA, May 13, 1998. 30. Course coordinator, "Clean Indoor Air Policies," Tobacco Control Summer Institute, Albuquerque, NM, July 27-31, 1998. 31. Health effects of secondhand smoke and economic impact of smoke-free bar and restaurant ordinances. Holyoke Board of Health, Holyoke, MA, July 7, 1998. 32. Siegel M. Ethical implications of a global tobacco settlement. American Public Health Association annual meeting. Washington, DC, November 16, 1998. 33. Siegel M, Carfano E. Teaching public health students how to produce television commercials: Development of an innovative course in health communication. American Public Health Association annual meeting. Washington, DC, November 17, 1998. 34. The impact of tobacco promotions on adolescent smoking: results of a longitudinal study in Massachusetts. Presented at Robert Wood Johnson Foundation Substance Abuse Policy Research Program Annual Meeting. Charleston, SC, December 10, 1998. 35. Biener L, Siegel M. Tobacco product promotions and adolescent smoking: more evidence of a causal 15 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 228 of 232 PAGEID #: relationship (poster). Annual conference of th40992ty for Research on Nicotine and Tobacco (SRNT). San Diego, CA, March 5-7, 1999. 36. Rigotti NA, Siegel M, Biener L. The effect of local tobacco sales laws on adolescent smoking initiation (poster). Annual conference of the Society for Research on Nicotine and Tobacco (SRNT). San Diego, CA, March 5-7, 1999. 37. Marketing public health: Strategies to promote social change. Workshop leader and presenter. Annual conference of the Massachusetts Prevention Centers. Marlboro, MA, March 24, 1999. 38. The effects of the Massachusetts anti-tobacco media campaign on youth tobacco use. Cancer Prevention and Control Grand Rounds. Boston University School of Medicine. May 4, 1999. 39. King C, Siegel M. Adolescent exposure to cigarette advertising in magazines: An evaluation of brand-specific advertising in relation to youth readership. INFORMS (Institute for Operations Research and the Management Sciences) Marketing Science Conference. Syracuse, NY, May 22, 1999. 40. Marketing public health: Strategies to promote social change. Plenary session address. Annual conference of the New York State Public Health Association / New York State Association of County Health Officials. Cooperstown, NY, May 25, 1999. 41. Siegel M. The health effects of secondhand smoke (guest lecture). Tobacco Use Prevention Summer Institute. Atlanta, GA, July 26, 1999. 42. Siegel M, Heaphy D. Bringing television cameras and the internet into the public health classroom: Teaching students to develop a mass media campaign. American Public Health Association Annual Meeting. Chicago, IL, November 9, 1999. 43. Siegel M. Exposure to cigarette advertising in magazines and its impact on youth smoking (poster). American Public Health Association Annual Meeting. Chicago, IL, November 9, 1999. 44. Siegel M. The impact of anti-smoking media campaigns on smoking initiation. American Public Health Association Annual Meeting. Chicago, IL, November 9, 1999. 45. Smoking and fast cars: the use of motor sports sponsorship as a promotional tool. Cancer Prevention and Control Grand Rounds. Boston University School of Medicine. November 7, 2000. 46. Circumventing the cigarette television advertising ban: a review of tobacco industry sponsorship of motor sports events. Harvard University Tobacco Control Working Group. February 6, 2001. 47. Siegel M, King C. Adolescents and cigarette advertising in popular magazines: The fifteen percent rule and beyond (panel presentation and discussion). Marketing and Public Policy Conference. June 1, 2001, Washington, DC. 48. Siegel M. The descriptive epidemiology of local restaurant smoking regulations in Massachusetts: Implications for studying the effectiveness of clean indoor air policies. National Cancer Institute State and Community Tobacco Control Interventions Research Grantees Meeting. January 29, 2002, San Diego, CA. 49. Siegel M. Policies to protect restaurant workers from secondhand smoke (guest lecture). Tobacco Use Prevention Summer Institute. Kansas City, MO, July 11, 2002. 50. King C, Siegel M. Measuring youth exposure to cigarette advertising in magazines post-Master Settlement Agreement. American Public Health Association Annual Meeting. Philadelphia, PA, November 11, 2002. 16 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 229 of 232 PAGEID #: 40993 51. Albers AB, Siegel M. Development and validation of a coding system to assess the strength of local clean indoor air policies. National Tobacco Control Conference. San Francisco, CA, November 19, 2002. 52. Siegel M. Banning smoking in bars and restaurants: Protecting the public's health or infringing on civil liberties? Food for Thought Lecture Series, Boston University. December 3, 2002. 53. Siegel M. Smoking in bars: the last frontier? Cancer Prevention and Control Grand Rounds. Boston University School of Medicine. May 13, 2003. 54. Skeer M, Siegel M. Boston's smoking ban: chaos or compliance? Research Lunch Series. Boston University School of Public Health. September 17, 2003. 55. Siegel M, Albers AB, Skeer M. Effect of local restaurant smoking regulations on secondhand smoke exposure and social norms regarding smoking among youths. American Public Health Association Annual Meeting. San Francisco, CA, November 18, 2003. 56. Siegel M, Albers AB, Skeer M. Impact of local restaurant and bar regulations on adult exposure to secondhand smoke and social norms related to smoking. American Public Health Association Annual Meeting. San Francisco, CA, November 18, 2003. 57. Siegel M, Skeer M. Boston's smoking ban: chaos or compliance? Harvard University Tobacco Control Working Group. December 3, 2003. 58. Siegel M, Godshall WT, Cummings KM, Blum A. FDA regulation of tobacco: Opportunity or diversion for the next decade? (panel presentation). National Conference on Tobacco or Health, Chicago, IL, May 4, 2005. 59. Siegel M. News for a Change (media advocacy training). American Cancer Society, Massachusetts Chapter. Framingham, MA, August 24, 2005. 60. Siegel M. Media advocacy training. Massachusetts Department of Public Health. Boylston, MA, April 21, 2006. 61. Siegel M. Media advocacy training. Massachusetts Department of Public Health. Boston, MA, June 20, 2006. 62. Siegel M. Media advocacy training. Massachusetts Department of Public Health. Boston, MA, August 1, 2006. 63. Fortunato EK, Siegel M. Framing public health as an institution: a case study (poster presentation). American Public Health Association Annual Meeting. Boston, MA, November 7, 2006. 64. Siegel M. Taking it to the House: How the Tobacco Companies Play You for Profit. Reduce the Use Night. Natick High School, Natick, MA, November 15, 2006. 65. Siegel M. Science, Communication and Scientific Integrity: The Example of Secondhand Smoke, and Balancing Health and Autonomy in Public Health Policy: The Example of Car Smoking Bans. Freedom, Tolerance, and Civil Society Conference (sponsored by Institute for Humane Studies, George Mason University). Simmons College, Boston, MA, June 20, 2007. 66. Siegel M. Tobacco Advertising and Health Disparities. STOMP (Stomp Tobacco Out Mass People) Symposium. Zoo New England, Boston, MA, May 15, 2007. 67. Siegel M. Science, Communication and Scientific Integrity: The Example of Secondhand Smoke, and 17 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 230 of 232 PAGEID #: Balancing Health and Autonomy in Public H 40994licy: The Example of Car Smoking Bans. Freedom, Tolerance, and Civil Society Conference (sponsored by Institute for Humane Studies, George Mason University). Simmons College, Boston, MA, June 17, 2008. 68. Siegel M, King C, Ross C, Ostroff J, Jernigan DH. Alcohol Advertising in Magazines: Are Youths Disproportionately Exposed? American Public Health Association Annual Meeting. San Diego, CA, October 27, 2008. 69. Siegel M. Top 10 Myths About Health Care Reform. Lifetime Learning - The Dr. George Altman World Affairs and Politics Lecture Series. Newton, MA, April 7, 2010. 70. Siegel M. Evidence-Based Science and Regulation of Tobacco Products. Tobacco Merchants Association Annual Meeting and Conference. Williamsburg, VA: May 25, 2010. 71. Siegel M, DeJong W, Fortunato EK, Johnson A, DiLoreto J, Ross C, Heeren T, Naimi TS. Descriptive epidemiology of brand-specific alcohol use among underage youths. American Public Health Association Annual Meeting. Denver, CO, November 9, 2010. 72. Siegel M. Underage drinking and the media. Norfolk District Attorney Underage Drinking Prevention Conference, Wrentham, MA, September 20, 2011. 73. Siegel M. Can modified risk tobacco products serve the public's health? Two barriers stand in the way. Tobacco Regulation and Litigation Conference. Food and Drug Law Institute. Washington, DC, December 5, 2011. 74. Siegel M. Top ten myths regarding harmful and potentially harmful tobacco constituents. Tobacco Merchants Association National Meeting and Conference, Williamsburg, VA: May 22, 2012. 75. Siegel M. Top two myths regarding the modified risk tobacco products provisions of the Tobacco Act. Tobacco Merchants Association National Meeting and Conference, Williamsburg, VA: May 22, 2012. 76. Siegel M, Ayers AJ, DeJong W, Naimi T, Jernigan DH. Differences in brand-specific alcohol consumption among youth by age, gender, race, and socioeconomic status - United States, 2011. Annual meeting of the American Public Health Association, San Francisco, CA: October 31, 2012. 77. Siegel M. Keynote address: The nexus of science and law in tobacco control policy. The Future of Global Tobacco Control: Current Constitutional and Treaty-Based Challenges. The American Journal of Law & Medicine 2013 Symposium. Boston University School of Law, January 25, 2013. 78. Siegel M. Alcohol, tobacco, and firearms: from science to policy. Department of Pediatrics Grand Rounds. Boston University Medical Center. January 31, 2013. 79. Siegel M, Naimi TS. From tobacco to alcohol: the need for a brand-specific research agenda. Alcohol Policy 16. Washington, DC, April 3, 2013. 80. Siegel M. Consumption of alcohol by brand among underage youth and adults in the United States. Alcohol Policy 16. Washington, DC, April 4, 2013. 81. Siegel M, Naimi TS. Brand-specific alcohol prices: a new surveillance method and policy implications. Alcohol Policy 16. Washington, DC, April 5, 2013. 82. Siegel M. Interrogation research by Yale medical school faculty members: ethical and human subjects protection concerns. Presented at: Knowledge and Power: A conversation about the Military and National Security in Academia. Yale University, New Haven, CT, April 15, 2013. 18 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 231 of 232 PAGEID #: 83. Siegel M. Do guns kill people or do people k 4 995s? Medicine and Public Health Association at Boston University panel on gun control. Boston University Medical Center, April 25, 2013. 84. Siegel M. Success rates for nicotine replacement therapy. Tobacco Merchants Association National Meeting and Conference, Williamsburg, VA: May 16, 2013. 85. Siegel M. Medicinal and lifestyle nicotine products: what works? Tobacco Merchants Association National Meeting and Conference, Williamsburg, VA: May 17, 2013. 86. Siegel M. Rebel with a cause: harnessing the core values of adolescence to prevent substance abuse. Department of Public Health School Health Conference, Boston, MA: October 1, 2013. 87. Siegel M. Electronic cigarettes: youth use. Tobacco Merchants Association Meeting: FDA Regulation of Electronic Cigarettes, Leesburg, VA: October 30, 2013. 88. Siegel M. What's in a brand? How an understanding of what brands youth are drinking can help identify effective interventions. 9thAnnual New England School Safety Conference, Norwood, MA: April 8, 2014. 89. Siegel M. The safety of electronic cigarettes: What do we know in 2014? Tobacco Merchants Association National Meeting and Conference, Williamsburg, VA: May 22, 2014. Testimony Given in Tobacco Litigation Trial Testimony Norma R. Broin, et al v. Philip Morris Companies, Inc., et al, Case No. 91-49738 CA (22) (Circuit Court of the 11thJudicial Circuit, Dade County, Florida) Attorney: Stanley Rosenblatt Howard A. Engle, et al v. Philip Morris Companies, Inc. et al, Case No. 94-08273 CA (22) (Circuit Court of the 11thJudicial Circuit, Dade County, Florida): Phases I, II, and III and Punitive Damages phase Attorney: Stanley Rosenblatt Dawn Apostolou v. The American Tobacco Company et al., Index No. 34734/00 (Supreme Court of the State of New York, County of Kings): Phases I and II Attorney: Michael London People of the State of California, ex rel. Bill Lockyer, Attorney General of the State of California v. R.J. Reynolds Tobacco Company (Superior Court of California, County of San Diego) Attorney: Alan Lieberman Julien Longden and Sheila Longden v. Philip Morris, Inc., et al., Docket No. 00-C-462 (Superior Court of New Hampshire, Hillsborough) Attorney: Chuck Douglas Koenig vs. Wyeth, Inc., et al., Case No. 02-18165 CA 32 (Circuit Court of the 11thJudicial Circuit, Dade County, Florida) Attorney: Stanley Rosenblatt Depositions Taken Norma R. Broin, et al v. Philip Morris Companies, Inc., et al, Case No. 91-49738 CA (22) (Circuit Court of the 11thJudicial Circuit, Dade County, Florida) Attorney: Stanley Rosenblatt 19 Case: 2:13-md-02433-EAS-EPD Doc #: 2702-5 Filed: 03/26/15 Page: 232 of 232 PAGEID #: Howard A. Engle, et al v. Philip Morris Comj409f ,6nc. et al, Case No. 94-08273 CA (22) (Circuit Court of the 11thJudicial Circuit, Dade County, Florida): Phases I, II, and III and punitive damages phase Attorney: Stanley Rosenblatt Antonio Badillo, et al, v. The American Tobacco Company, Inc., et al, CV-N-97-00573-ECR(RAM) (United States District Court, District of Nevada ) and Joseph Avallone, et al, v. The American Tobacco Company, Inc., et al, Docket No. L-4883-98, Case Code 241 (Superior Court of New Jersey, Middlesex County) Attorney: Perry Nicosia Robert Murphy v. The American Tobacco Company, Inc., et al, CV-S-98-00021-HDM(RJR) (United States District Court, District of Nevada) Attorney: Perry Nicosia People of the State of California, ex rel. Bill Lockyer, Attorney General of the State of California v. R.J. Reynolds Tobacco Company (Superior Court of California, County of San Diego) Attorney: Alan Lieberman Julien Longden and Sheila Longden v. Philip Morris, Inc., et al., Docket No. 00-C-462 (Superior Court of New Hampshire, Hillsborough) Attorney: Chuck Douglas Koenig vs. Wyeth, Inc., et al., Case No. 02-18165 CA 32 (Circuit Court of the 11thJudicial Circuit, Dade County, Florida) Attorney: Stanley Rosenblatt Amicus Briefs Submitted Smoking Everywhere, Inc., and Sottera, Inc., D/B/A NJOYY v. Food and Drug Administration, et al. United States Court of Appeals for the District of Columbia Circuit. Submitted July 8, 2010. 20